data_1u37_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u37 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 C--O 1.231 0.109 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 7.9 tttt -143.12 114.79 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.3 78.16 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' CD2' ' A' ' 64' ' ' LEU . 23.2 t -68.23 123.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.018 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.04 102.86 10.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.127 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 22.3 mm -101.03 103.15 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.82 132.76 36.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -179.54 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 139.53 30.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.9 mttt -49.85 126.08 13.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.731 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.72 33.25 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 94' ' ' LYS . 47.6 mm-40 -127.49 131.2 50.18 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 111.195 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -81.07 151.67 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.334 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.83 -52.09 20.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.89 16.27 17.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 3.6 m -109.01 139.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.05 98.68 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.568 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.4 pp -95.5 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.53 158.42 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.507 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 95.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.356 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.562 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 24.5 p . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.574 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 38' ' ' SER . 72.8 Cg_exo . . . . . 0 CA--C 1.527 0.143 0 N-CA-C 112.62 0.2 . . . . 0.0 112.62 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t -162.5 -61.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.56 156.62 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.88 0.372 . . . . 0.0 111.791 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -139.8 116.63 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.823 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 62.5 mt -61.42 71.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -55.32 -38.79 69.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.75 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -134.58 165.46 25.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.002 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -167.44 126.33 1.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.695 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -66.93 75.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.39 -12.17 7.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.716 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.2 -172.2 4.4 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.699 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.449 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 85.1 Cg_exo -47.03 -47.67 16.21 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.934 2.422 . . . . 0.0 112.905 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.48 -49.73 76.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.087 0.47 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -48.51 81.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -57.78 -30.09 65.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 110.57 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.75 69.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.3 -54.54 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD22 ' CG2' ' A' ' 103' ' ' ILE . 24.3 mt -75.65 125.14 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.514 0.674 . . . . 0.0 111.529 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.523 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.1 p30 -132.57 112.42 12.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.396 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' C ' ' O ' ' A' ' 65' ' ' ASN . 7.2 mt -13.61 114.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.7 -3.21 19.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.33 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.7 m-20 -74.91 133.58 41.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.583 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.08 81.23 6.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.95 0.405 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.502 HG12 HG23 ' A' ' 103' ' ' ILE . 3.7 mt -53.58 145.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.21 -41.59 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.86 158.78 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.408 ' CG2' HD12 ' A' ' 93' ' ' LEU . 9.4 mt -125.48 121.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 49.36 26.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.01 19.38 24.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.731 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.403 ' CG2' ' CD1' ' A' ' 89' ' ' ILE . 5.4 m -113.12 95.79 5.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 p -56.55 125.36 21.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 mt -90.99 -3.47 57.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.55 128.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.103 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.48 -20.85 48.67 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.821 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.87 141.65 23.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.826 0.313 . . . . 0.0 110.878 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.86 -176.37 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.566 2.177 . . . . 0.0 112.358 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.8 -32.9 70.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.045 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.8 p -55.43 -41.78 73.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -68.17 -50.58 53.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.425 ' O ' HG13 ' A' ' 90' ' ' ILE . 17.8 m -57.13 -48.82 77.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -54.29 -47.56 72.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.969 0.414 . . . . 0.0 110.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -59.2 -32.47 69.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.555 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 9.4 mt -67.99 -45.97 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 86' ' ' CYS . 5.1 mt -64.07 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.499 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -36.86 79.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.338 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.83 -4.43 76.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.339 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 64.1 mt -93.16 36.29 1.05 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.813 0.339 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.5 tttt -85.65 -44.51 12.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.553 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.2 p30 -116.82 61.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 97' ' ' SER . 2.5 mm-40 -113.82 -35.4 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.334 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 6.3 m 90.16 -19.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.179 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -167.31 151.51 6.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.174 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.413 ' CG1' HD12 ' A' ' 93' ' ' LEU . 3.4 t -128.58 110.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -90.86 75.56 6.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.477 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 pt? -107.68 119.12 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.325 0.583 . . . . 0.0 111.736 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -86.51 111.55 20.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.246 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.502 HG23 HG12 ' A' ' 70' ' ' ILE . 6.8 pt -99.88 174.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.445 . . . . 0.0 111.882 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 C--O 1.237 0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.6 117.97 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.83 80.12 2.75 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 45.7 t -71.91 127.35 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.598 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.03 102.9 9.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 99' ' ' VAL . 6.1 mm -99.78 103.75 15.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 0.0 110.296 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 112.94 25.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.589 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HD3' ' CG ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -130.47 -170.51 2.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.782 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -95.63 151.74 19.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -60.92 136.98 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.929 0.395 . . . . 0.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.21 11.46 62.89 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.555 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.93 135.92 54.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -86.26 148.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HB3' HG23 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.65 -43.64 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.65 4.75 57.97 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.262 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 HG11 ' CB ' ' A' ' 58' ' ' ALA . 5.2 m -96.44 140.83 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 117.079 0.44 . . . . 0.0 111.301 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.3 t -118.55 98.83 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 pp -97.83 150.98 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 111.937 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.73 164.52 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.494 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.77 103.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.392 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.544 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 43.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.417 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 52.5 Cg_exo . . . . . 0 C--O 1.231 0.147 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -148.91 -71.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -159.32 142.92 5.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.309 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -119.99 118.91 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.353 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 43.3 mt -63.49 71.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.44 -29.11 48.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.55 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.9 m120 -145.06 173.1 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.442 ' CG ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -171.86 129.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.813 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -53.16 128.74 28.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.45 99.01 7.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.04 21.22 11.2 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.522 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' LYS . . . -106.53 -160.57 22.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.433 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 44.5 Cg_exo -57.09 -54.44 3.63 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.733 2.289 . . . . 0.0 112.559 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' HB1' ' CG ' ' A' ' 52' ' ' MET . . . -58.13 -49.31 77.42 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.33 -28.79 68.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.19 0.519 . . . . 0.0 110.196 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -62.36 -48.76 78.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.978 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -48.46 -40.44 26.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.15 27.66 43.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -47.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.056 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 8.2 mt -74.69 107.44 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.032 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.43 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.4 OUTLIER -118.28 138.79 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.761 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 16.9 mt -36.74 114.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.28 -6.15 11.92 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 103' ' ' ILE . 6.0 m-20 -72.43 130.33 40.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.682 0.277 . . . . 0.0 110.643 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.469 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -88.25 79.98 7.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.116 0.484 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.597 HG12 HG21 ' A' ' 103' ' ' ILE . 2.7 mt -55.66 141.78 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttm -116.01 -33.88 4.92 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 94.2 p -153.85 151.96 30.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.77 0.319 . . . . 0.0 111.363 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.443 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 6.9 mt -125.52 123.83 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.411 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 45.98 29.14 0.7 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.85 20.87 20.2 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -122.96 95.49 4.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -68.58 130.88 44.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.1 mp -97.35 15.79 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.81 108.82 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.184 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.43 -26.82 17.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.207 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.52 144.17 42.55 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.185 0.493 . . . . 0.0 111.019 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.66 177.83 3.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.785 2.323 . . . . 0.0 112.643 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.5 tp -64.22 -34.24 77.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -48.64 69.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.999 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.494 ' O ' HG13 ' A' ' 89' ' ' ILE . 17.5 m -65.87 -45.03 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.6 m -56.76 -54.5 45.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.743 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -49.92 -53.49 25.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.259 0.552 . . . . 0.0 110.634 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.519 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 1.5 m -54.47 -34.55 61.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.555 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 7.4 mt -63.96 -46.52 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -61.45 -34.81 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.305 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 2.0 mmmt -68.31 -43.56 77.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.556 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.82 -16.37 51.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 26.9 mt -91.24 38.47 0.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 111.027 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -80.92 -40.47 24.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.802 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -126.07 59.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.745 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -109.61 -35.5 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 0.8 OUTLIER 81.49 -10.79 1.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.17 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.58 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -155.34 150.11 26.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.698 0.285 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 5.0 t -139.99 103.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.939 0.4 . . . . 0.0 112.002 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -93.89 77.53 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.2 pt? -104.78 121.44 43.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.344 0.592 . . . . 0.0 111.676 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.81 106.79 17.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.597 HG21 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -106.48 174.03 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.208 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -146.01 114.9 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.19 74.03 2.32 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 103' ' ' ILE . 38.4 t -64.9 128.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.78 102.91 9.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 12.6 mm -99.04 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.85 0.357 . . . . 0.0 110.906 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.98 128.87 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -149.57 177.75 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -87.44 142.05 28.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG3' ' HB3' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -51.28 126.65 17.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 14.84 34.34 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.443 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.2 mm-40 -123.04 134.0 54.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.1 152.06 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.242 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.426 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 1.7 tp -50.59 -51.96 43.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.91 36.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.649 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG13 ' HG3' ' A' ' 52' ' ' MET . 8.8 m -95.29 138.98 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.063 0.458 . . . . 0.0 111.057 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.75 98.4 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.3 pp -95.94 143.72 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 111.729 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG2' HD13 ' A' ' 48' ' ' ILE . 2.5 m -124.63 161.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.39 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.48 111.87 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.521 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 22.7 t . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.887 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.878 0.282 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 t -170.69 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.88 146.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.814 0.34 . . . . 0.0 111.367 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -130.25 116.61 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.725 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 90.3 mt -61.42 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.39 -38.49 63.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.52 169.16 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.955 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.433 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.83 132.39 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.6 113.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 75.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.75 -4.73 5.1 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.53 -173.16 47.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.649 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.436 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 76.2 Cg_exo -48.5 -47.12 21.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.757 2.305 . . . . 0.0 112.67 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.428 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.38 -49.08 78.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.84 -27.28 64.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -62.73 -48.73 77.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 23' ' ' ILE . 33.1 m -56.0 -32.24 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.31 4.74 80.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -98.28 -56.39 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.412 ' CD2' ' CD1' ' A' ' 49' ' ' ILE . 12.5 mt -72.19 122.66 21.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -131.54 135.74 47.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.337 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -35.14 116.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 111.618 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.36 0.8 29.59 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.119 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 8.9 m-20 -78.25 113.66 16.43 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.914 0.387 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 79.7 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 103' ' ' ILE . 2.2 mt -54.5 145.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.45 -39.45 4.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.5 p -159.23 156.86 29.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.781 0.324 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CG2' ' CG1' ' A' ' 99' ' ' VAL . 7.8 mt -124.26 120.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 51.93 25.87 3.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.216 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.97 27.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -110.71 95.35 5.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 110.66 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.02 128.6 38.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -98.48 -8.91 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.285 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 15.5 t -59.54 109.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.78 -27.09 21.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.952 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -71.9 139.93 83.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.827 0.313 . . . . 0.0 110.723 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.28 179.71 2.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.322 2.015 . . . . 0.0 111.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.53 -41.06 89.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 m -53.9 -36.28 62.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -70.55 -54.34 12.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.008 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.9 m -57.29 -55.27 36.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.828 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -49.62 -54.29 19.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 110.823 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 t -53.31 -37.29 62.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 85' ' ' THR . 6.8 mt -63.96 -46.12 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 mt -60.16 -37.59 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.262 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -35.72 70.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.318 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.53 -7.85 83.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.53 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 87.0 mt -92.51 41.51 1.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.988 0.423 . . . . 0.0 110.688 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -84.77 -48.38 9.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.43 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.443 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 7.4 m-80 -116.74 61.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 97' ' ' SER . 5.5 mm-40 -108.04 -36.88 6.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.18 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 7.6 t 91.29 -18.51 0.15 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.236 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 151.71 3.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.426 ' CG2' ' CD1' ' A' ' 31' ' ' LEU . 8.0 t -131.31 107.54 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -88.17 77.87 8.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 pt? -107.29 119.11 38.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.359 0.6 . . . . 0.0 111.514 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -86.34 107.09 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.128 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -99.78 164.17 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.742 -179.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.531 0.205 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -160.95 141.79 11.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.359 0.6 . . . . 0.0 112.469 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.4 72.79 8.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 76.8 t -58.58 124.52 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.626 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.96 103.28 11.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.915 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 13.3 mm -98.29 102.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.985 0.421 . . . . 0.0 110.258 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.94 117.38 33.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.426 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 22.4 pttt -136.64 -168.33 2.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 152.18 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -59.49 132.96 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.34 13.98 54.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.63 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -122.85 136.26 54.81 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.799 0.333 . . . . 0.0 111.425 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -89.37 161.29 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.806 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.97 -52.11 52.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.102 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.5 -10.93 35.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -95.26 127.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.082 0.467 . . . . 0.0 111.367 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.01 100.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.808 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.4 pp -90.25 137.46 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.094 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -119.95 161.48 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.2 117.99 7.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.806 0.336 . . . . 0.0 110.796 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.458 ' HA ' HD13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.031 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 C--O 1.23 0.115 0 CA-C-O 120.776 0.24 . . . . 0.0 112.269 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.3 -64.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.85 143.48 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.25 117.53 48.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.421 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 58.4 mt -62.59 70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.05 -41.47 62.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.589 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.69 -169.97 2.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.599 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 ptp -168.32 162.51 12.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 8.0 tpp -88.56 117.11 27.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -55.41 103.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.74 77.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.729 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.72 171.91 37.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 88.8 Cg_exo -49.01 -45.16 30.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.886 2.391 . . . . 0.0 112.975 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -57.83 -49.91 75.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.336 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.68 -30.72 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -53.35 -48.66 68.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.737 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 1.4 t -55.7 -43.78 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.51 83.46 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -35.01 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.676 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD21 ' CD1' ' A' ' 103' ' ' ILE . 11.0 mt -90.72 111.39 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 0.7 OUTLIER -120.4 140.89 50.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.1 mt -38.01 126.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.812 0.339 . . . . 0.0 111.412 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.09 -7.66 52.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.989 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' HB3' HD12 ' A' ' 103' ' ' ILE . 3.5 m-20 -69.32 109.24 4.04 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.524 ' HB3' HG22 ' A' ' 104' ' ' VAL . 14.3 tp60 -71.37 85.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.607 HG12 HG21 ' A' ' 103' ' ' ILE . 2.7 mt -58.86 138.9 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.704 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -105.57 -38.28 6.49 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.9 p -159.45 157.67 30.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.332 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.444 HG22 ' ND2' ' A' ' 74' ' ' ASN . 7.7 mt -122.14 126.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.699 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' ND2' HG22 ' A' ' 73' ' ' ILE . 5.9 p30 36.42 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.172 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.75 26.22 9.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.809 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 73' ' ' ILE . 25.3 m -123.86 95.33 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 110.724 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 m -60.62 120.8 10.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.048 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD1' HG23 ' A' ' 47' ' ' VAL . 38.1 mt -91.09 -11.15 39.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.362 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.94 107.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.264 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.26 -26.35 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.793 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.24 127.49 93.26 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.556 0.217 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.59 164.54 2.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.337 2.025 . . . . 0.0 112.012 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 36' ' ' VAL . 8.7 tt -60.23 -44.64 95.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 m -53.49 -33.44 54.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 89' ' ' ILE . 2.9 m -72.88 -47.19 48.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.752 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.451 ' O ' HG13 ' A' ' 90' ' ' ILE . 74.9 m -56.8 -50.01 73.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' NE2' HD12 ' A' ' 35' ' ' ILE . 1.8 mm-40 -57.15 -53.17 61.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.184 0.516 . . . . 0.0 109.966 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -51.57 -39.76 58.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 12.5 mt -61.36 -41.73 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.8 mt -60.4 -35.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.348 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.2 mppt? -76.28 -34.71 59.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.521 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.74 -30.05 76.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 1.7 pp -99.56 38.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.53 -25.47 50.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.912 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 2.1 m120 -126.08 55.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.487 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.42 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 34.5 mm-40 -112.31 -30.39 7.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.555 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 74.97 1.42 3.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.59 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.01 146.9 12.83 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.718 0.294 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 3.6 t -140.14 105.64 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.484 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -94.45 79.65 3.88 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.0 pt? -107.27 125.24 50.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.381 0.61 . . . . 0.0 111.763 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -87.5 109.15 19.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.851 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.611 HG13 ' HG2' ' A' ' 19' ' ' LYS . 1.3 pt -114.88 174.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 69' ' ' GLN . 3.5 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.983 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -146.66 116.82 7.35 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.88 78.14 2.79 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 35.8 t -69.22 125.58 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.507 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.555 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.26 103.12 10.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.515 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 8.9 mm -98.56 103.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.631 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.33 128.49 45.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.559 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.567 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -151.94 -174.96 5.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.942 0.401 . . . . 0.0 110.958 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -85.18 160.82 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.139 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.12 123.25 19.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.303 0.573 . . . . 0.0 110.466 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 95' ' ' ASN . . . 100.68 18.74 19.84 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.299 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.1 mm-40 -117.46 131.49 56.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.676 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pt -87.74 151.2 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.429 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 1.1 tp -48.21 -43.32 31.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.23 -5.06 60.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.783 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.31 125.12 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.28 98.57 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.954 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -95.6 147.31 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' CG2' HD12 ' A' ' 48' ' ' ILE . 27.2 m -132.1 155.29 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -51.73 118.85 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.787 0.327 . . . . 0.0 111.29 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.515 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.792 0.247 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.1 p -144.82 -74.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -159.99 141.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.658 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -127.07 119.07 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.13 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 31.3 mt -62.21 72.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.72 -25.95 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.904 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -165.41 166.67 18.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.705 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.3 ptp -143.48 171.09 14.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 ttm -87.65 112.98 22.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.88 90.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.08 21.91 8.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.438 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.22 179.26 27.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.408 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 78.5 Cg_exo -51.21 -45.38 37.32 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.68 2.253 . . . . 0.0 112.455 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.47 -49.46 77.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.34 -32.28 68.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -58.78 -48.65 80.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB3' ' HD2' ' A' ' 63' ' ' LYS . 7.8 m -50.04 -43.86 51.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.28 85.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.419 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' A' ' 61' ' ' SER . 1.2 mptt -97.85 -53.1 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.44 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 103' ' ' ILE . 13.8 mt -74.62 125.17 28.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.172 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 2.7 p30 -128.24 136.51 51.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.027 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 15.7 mt -37.86 107.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.991 0.424 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.92 -6.93 10.22 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.917 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 10.0 m-20 -71.27 124.38 24.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.564 0.221 . . . . 0.0 110.428 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.63 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -86.97 97.16 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.14 0.495 . . . . 0.0 110.543 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.617 HG12 HG23 ' A' ' 103' ' ' ILE . 1.7 mt -68.23 142.25 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.145 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.6 mmt -111.7 -32.97 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.008 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 45.3 t -159.62 154.6 24.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.139 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 6.1 mt -126.8 123.69 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 45.88 29.82 0.78 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.39 21.87 25.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.371 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -115.54 97.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.97 134.99 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 63.7 mt -109.53 9.71 25.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.026 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -86.19 114.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.398 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.74 -33.99 6.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.146 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.72 127.63 83.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.072 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.81 170.43 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.541 2.161 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 tp -59.52 -34.01 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -53.49 -51.02 64.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.546 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 58.5 m -63.51 -43.38 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.03 -50.57 72.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.87 -38.52 72.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -33.77 74.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.115 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 22.7 mt -64.89 -38.97 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 120.969 0.414 . . . . 0.0 109.916 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -77.19 -42.87 31.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -44.17 97.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.364 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.09 -14.53 61.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.375 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 95.9 mt -93.83 37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' GLU . 7.2 mtpt -79.11 -34.49 43.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HA ' ' H ' ' A' ' 28' ' ' GLY . 1.9 p30 -120.3 64.22 0.83 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.7 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 16.3 mm-40 -119.21 -34.71 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.543 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.567 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 5.5 t 74.11 1.53 3.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.734 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -165.86 145.11 6.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.429 ' CG2' ' CD1' ' A' ' 31' ' ' LEU . 11.1 t -139.89 103.83 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.524 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -91.39 78.38 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.441 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.2 pt? -107.69 118.98 38.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.403 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.99 111.48 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.439 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.617 HG23 HG12 ' A' ' 70' ' ' ILE . 1.1 pt -107.58 174.15 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.336 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 69' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.504 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -147.51 113.77 5.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.12 73.8 2.97 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 47.3 t -61.9 126.1 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.799 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.0 103.83 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.697 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 16.6 mm -100.05 103.44 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.982 0.42 . . . . 0.0 110.99 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 109.94 22.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.241 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.0 pttt -127.79 -170.27 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.6 138.3 40.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.66 124.41 7.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.027 0.442 . . . . 0.0 110.764 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.74 12.95 28.98 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.514 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 94' ' ' LYS . 10.5 mm-40 -129.22 126.63 39.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.278 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.08 153.69 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -47.66 -52.24 18.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.072 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.91 1.21 42.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.451 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 11.7 m -94.53 123.81 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.184 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.3 t -99.85 100.0 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.457 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -95.6 142.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.111 0.481 . . . . 0.0 111.683 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -118.22 167.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.7 105.28 2.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.495 ' HA ' HD11 ' A' ' 48' ' ' ILE . 11.5 p . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.453 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 57.7 Cg_endo . . . . . 0 C--O 1.231 0.132 0 N-CA-C 113.047 0.364 . . . . 0.0 113.047 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.14 -64.85 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.338 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.86 161.15 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -142.42 114.85 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.933 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 48.9 mt -61.1 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.79 -30.73 46.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.816 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.499 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -153.55 167.68 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.899 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 5.0 ttp -154.92 129.21 8.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tpp -54.0 98.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -52.06 123.17 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.66 21.66 59.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.95 -170.31 20.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 53.8 Cg_exo -53.15 -47.62 26.52 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.646 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 52' ' ' MET . . . -58.71 -49.36 77.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.432 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.02 -30.37 63.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -48.57 75.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.401 ' CB ' HD12 ' A' ' 23' ' ' ILE . 98.8 p -56.25 -39.38 72.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.41 63.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.354 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -110.21 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.504 HD23 ' CG2' ' A' ' 103' ' ' ILE . 16.1 mt -72.38 127.83 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.721 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.7 m-80 -130.62 126.72 37.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 14.4 mt -30.61 113.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 121.06 0.457 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.74 5.31 22.36 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.094 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 15.7 m-20 -79.27 120.82 24.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.7 80.92 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.948 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.591 HG12 HG23 ' A' ' 103' ' ' ILE . 2.5 mt -55.76 143.51 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -41.38 4.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.928 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 77.2 p -158.29 156.87 31.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 111.404 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG22 ' CD1' ' A' ' 93' ' ' LEU . 6.7 mt -122.82 122.03 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.3 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.415 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 4.0 p30 40.32 33.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.865 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.51 22.18 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.811 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 m -123.09 95.56 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.49 130.21 43.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' CD1' HG21 ' A' ' 47' ' ' VAL . 59.1 mt -96.23 12.59 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -89.3 123.74 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.63 -25.39 28.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.822 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.44 134.2 29.96 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.761 0.281 . . . . 0.0 110.869 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.03 -176.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.497 2.131 . . . . 0.0 112.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 7.8 tt -75.55 -37.66 59.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -53.43 -36.89 62.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.2 m -68.76 -50.81 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.495 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.5 m -56.77 -48.68 77.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.446 ' NE2' HD13 ' A' ' 35' ' ' ILE . 98.4 mm-40 -54.14 -48.1 71.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 t -61.42 -33.81 74.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.533 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.617 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 38.8 mt -64.6 -46.43 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' HG13 ' A' ' 35' ' ' ILE . 3.6 mt -65.24 -39.08 84.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.443 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -69.35 -32.37 71.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.821 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.27 -11.54 84.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.468 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 93.8 mt -93.17 39.86 1.05 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.934 0.397 . . . . 0.0 110.93 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' GLU . 4.2 tttt -80.87 -37.57 29.62 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -120.71 63.68 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.837 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -117.18 -39.54 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 76.68 -2.12 2.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.698 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.635 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -162.64 139.45 7.76 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.533 0.206 . . . . 0.0 110.451 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 31' ' ' LEU . 10.6 t -136.38 104.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -93.03 80.07 4.57 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.503 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.2 pt? -110.01 120.07 41.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.41 108.45 18.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.048 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.591 HG23 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -101.17 167.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.08 0.467 . . . . 0.0 111.787 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.602 -179.269 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -144.51 115.08 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 75.6 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 45.5 t -66.36 120.8 14.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.524 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.43 103.63 10.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.627 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 14.3 mm -99.18 103.59 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 1.2 tt0 -95.49 111.53 23.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.6 pttt -130.84 -170.73 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.112 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.34 143.4 32.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.575 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 4.9 mttt -51.43 128.57 23.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.987 0.423 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 11.65 43.97 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.581 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -124.09 129.2 50.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -83.33 149.79 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.77 -46.06 29.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.53 7.81 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.05 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 58' ' ' ALA . 4.7 m -95.9 126.09 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 111.438 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -102.41 98.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.092 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.6 pp -101.99 151.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 112.176 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 48' ' ' ILE . 16.2 m -132.26 159.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.186 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.75 117.06 3.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.229 0.072 0 CA-C-O 120.805 0.252 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -141.14 -72.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.171 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -160.12 148.06 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.029 0.442 . . . . 0.0 111.868 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -129.27 113.96 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 36.5 mt -60.98 72.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.05 -28.64 58.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.399 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.0 m120 -145.57 169.52 18.24 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.681 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.451 ' CG ' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -166.77 117.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.676 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 ttm -45.42 124.03 4.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.605 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -68.21 105.83 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.623 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.39 -17.25 57.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -178.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 77.1 Cg_exo -51.0 -47.41 25.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.451 ' HB3' ' CG ' ' A' ' 52' ' ' MET . . . -58.43 -49.08 78.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.76 -26.56 62.5 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.738 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -48.96 75.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.9 p -52.87 -37.94 61.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.04 45.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.173 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -117.66 -61.64 1.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' A' ' 103' ' ' ILE . 14.0 mt -66.06 131.09 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.841 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' ILE . 8.9 m-80 -134.18 123.7 24.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.124 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.504 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.1 mt -28.38 114.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.968 0.413 . . . . 0.0 111.789 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.98 -6.02 22.03 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.983 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' A' ' 103' ' ' ILE . 14.5 m-20 -68.5 135.6 51.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 110.515 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.51 ' HB3' HG21 ' A' ' 104' ' ' VAL . 1.1 tm0? -92.63 81.52 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -54.9 141.32 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.0 ttm -111.26 -34.21 6.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.691 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 87.1 p -156.96 155.11 30.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 4.9 mt -126.66 121.43 58.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.891 0.376 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 46.97 29.04 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.243 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.09 18.19 25.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.622 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 m -119.42 95.63 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.756 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 1.4 m -63.56 131.23 47.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.337 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 81' ' ' LEU . 3.2 mt -98.05 22.49 9.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.14 105.87 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.164 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.68 -30.17 8.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.931 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.411 ' CD1' HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -80.53 143.4 55.12 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.94 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.81 169.94 13.69 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.744 2.296 . . . . 0.0 112.667 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.3 tp -58.38 -37.09 74.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.228 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -53.48 -48.61 68.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.733 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.616 ' O ' HG13 ' A' ' 89' ' ' ILE . 26.1 m -64.47 -43.58 93.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.442 ' HB3' HG12 ' A' ' 47' ' ' VAL . 13.6 m -56.6 -54.92 40.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.94 -53.58 25.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.172 0.511 . . . . 0.0 110.508 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -53.14 -32.21 46.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.422 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 20.6 mt -70.04 -36.98 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.201 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 35' ' ' ILE . 4.3 mt -77.64 -35.49 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.509 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -73.86 -42.7 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.981 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.35 39.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.488 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 21.8 mt -88.15 46.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.65 -30.99 41.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.466 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -135.18 69.16 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.567 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.404 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 8.2 mm-40 -119.1 -36.13 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.343 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.3 p 76.3 1.63 3.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.684 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -162.77 143.3 9.62 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.616 0.246 . . . . 0.0 110.883 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 101' ' ' LEU . 4.1 t -137.58 103.54 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 111.671 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -93.04 74.53 4.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.646 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.4 pt? -104.19 119.5 39.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.277 0.56 . . . . 0.0 111.189 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.94 107.28 18.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.426 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.554 HG22 HG12 ' A' ' 70' ' ' ILE . 5.3 pt -103.06 173.6 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.417 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.316 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.579 0.228 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.585 ' HG2' HG13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -152.9 142.63 21.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 111.99 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.49 72.4 7.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 72.2 t -57.85 125.72 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.25 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.492 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.09 103.83 10.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.249 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 10.1 mm -100.31 103.54 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.59 45.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.603 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -153.74 -172.85 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.968 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -94.88 145.3 25.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.442 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 5.6 mptt -49.2 122.95 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.056 0.455 . . . . 0.0 110.679 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.35 16.65 22.17 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -121.31 119.79 33.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 111.413 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -77.74 151.05 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.32 -52.24 16.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.316 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.98 -1.33 35.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.144 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -94.63 122.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.09 0.471 . . . . 0.0 111.324 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.409 ' CG2' ' ND2' ' A' ' 51' ' ' ASN . 46.1 t -97.17 98.65 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.079 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.8 pp -95.62 149.8 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 112.051 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.409 ' CG2' HD13 ' A' ' 48' ' ' ILE . 2.9 m -133.78 157.72 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.365 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.85 111.99 0.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.853 0.358 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo . . . . . 0 CA--C 1.527 0.148 0 CA-C-O 120.935 0.306 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 p -135.98 -70.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.18 137.61 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -116.08 119.07 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.394 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 53.6 mt -64.75 70.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.34 -33.96 22.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.329 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.21 140.7 13.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.52 . . . . 0.0 110.506 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.414 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 2.8 ttp -123.34 163.03 21.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.408 ' N ' ' CG ' ' A' ' 52' ' ' MET . 2.5 ttm -76.92 137.01 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -80.87 92.78 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.33 -4.4 37.81 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.94 -179.38 50.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.58 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 82.6 Cg_exo -47.36 -47.03 18.51 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.919 2.413 . . . . 0.0 112.902 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.64 -49.48 77.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.259 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.34 -24.78 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -64.45 -47.03 80.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 3.7 t -53.08 -41.73 65.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.802 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.02 85.94 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.349 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' HG23 ' A' ' 21' ' ' VAL . 1.3 mptt -100.16 -56.45 2.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.803 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD21 ' CD1' ' A' ' 103' ' ' ILE . 13.8 mt -70.36 124.49 24.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.204 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 23.1 m-80 -131.09 136.11 48.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.223 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 66' ' ' ILE . 25.0 mt -34.76 124.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.49 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.52 -9.02 48.37 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.985 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HB3' HD12 ' A' ' 103' ' ' ILE . 4.9 m-20 -66.9 120.81 14.21 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.686 0.279 . . . . 0.0 110.693 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.4 82.54 7.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.04 0.448 . . . . 0.0 110.233 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.61 HG12 HG21 ' A' ' 103' ' ' ILE . 2.6 mt -55.68 139.3 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.981 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.9 mmt -106.04 -39.44 5.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.74 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 80.6 p -156.38 164.34 38.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 8.3 mt -128.44 114.3 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.003 0.43 . . . . 0.0 111.471 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.422 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 12.3 p30 42.48 31.94 0.32 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.687 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.84 11.76 27.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.808 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -109.72 95.62 5.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.557 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -56.77 130.01 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.303 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 81' ' ' LEU . 17.4 mt -107.36 22.19 16.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.67 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.26 112.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.328 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.04 -24.56 30.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -85.08 130.92 50.28 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 117.113 0.457 . . . . 0.0 110.975 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.04 -174.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.613 2.209 . . . . 0.0 112.644 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.92 -37.32 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.023 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 m -53.76 -42.72 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' HG13 ' A' ' 89' ' ' ILE . 8.7 m -65.9 -48.02 72.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.0 -53.36 59.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.473 ' NE2' HD13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -49.83 -53.96 22.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 t -53.35 -37.86 62.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 27.5 mt -63.42 -46.44 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 35' ' ' ILE . 3.1 mt -66.57 -37.45 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -33.98 71.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.241 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.33 -14.44 79.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.467 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 94.4 mt -90.93 43.68 1.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.739 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -83.21 -47.78 11.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 1.4 p30 -112.47 57.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.4 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -112.27 -33.9 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.074 0.464 . . . . 0.0 110.09 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.538 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 9.0 t 73.3 5.07 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 2.5 mtm180 -167.37 147.91 5.43 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.356 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 2.8 t -142.65 102.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.0 0.428 . . . . 0.0 111.739 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -92.23 72.54 5.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.5 pt? -99.9 126.47 46.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.067 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.13 114.28 26.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.943 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.61 HG21 HG12 ' A' ' 70' ' ' ILE . 2.5 pt -117.01 173.32 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.452 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 69' ' ' GLN . 3.6 m . . . . . 0 C--O 1.235 0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.217 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CE1' ' CG2' ' A' ' 104' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.621 0.248 . . . . 0.0 110.52 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HG2' HG13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -145.8 150.37 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.26 0.552 . . . . 0.0 112.158 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.71 73.18 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 HG13 ' HG ' ' A' ' 64' ' ' LEU . 93.1 t -59.25 125.77 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.312 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.7 103.74 10.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 mm -99.16 103.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.01 0.434 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 121.14 36.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -171.95 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 111.062 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.56 138.4 38.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -48.32 127.22 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.23 37.81 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 28.6 mm-40 -128.43 130.31 47.43 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.851 0.358 . . . . 0.0 111.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -78.91 154.01 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.404 ' CD2' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.81 -52.17 19.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.59 29.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.122 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.428 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 15.9 m -94.46 148.65 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.197 0.522 . . . . 0.0 111.186 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.0 t -126.99 98.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.626 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.2 pp -94.05 149.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.115 0.483 . . . . 0.0 111.523 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.54 162.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.568 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.14 93.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' PRO . 3.3 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.604 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 38' ' ' SER . 52.6 Cg_exo . . . . . 0 C--O 1.232 0.18 0 N-CA-C 112.602 0.193 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 -66.67 0.41 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.366 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.34 165.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 111.455 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -143.83 116.88 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 76.2 mt -62.6 72.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.93 -26.09 5.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.945 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.453 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 4.6 p-10 -164.96 167.54 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.379 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.413 ' HG3' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -154.25 142.4 20.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.724 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.0 139.32 28.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.29 76.66 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.42 -18.51 7.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.669 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.49 -179.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 82.1 Cg_exo -46.85 -45.18 21.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.795 2.33 . . . . 0.0 112.737 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.428 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.2 -47.63 82.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -70.7 -31.14 67.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.245 0.545 . . . . 0.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -62.46 -48.31 80.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.4 t -53.81 -31.15 48.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.98 20.24 72.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.461 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -113.65 -49.21 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.741 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 103' ' ' ILE . 17.8 mt -82.83 119.65 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 111.804 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -119.9 138.34 53.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.866 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 19.9 mt -37.09 131.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.644 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 4.5 59.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.058 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 4.7 m-20 -77.34 121.27 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.776 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -79.11 81.11 5.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 103' ' ' ILE . 3.9 mt -57.56 143.73 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.029 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 11.1 mmt -108.32 -41.96 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.589 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 64.3 p -156.41 155.2 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.008 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.467 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 6.3 mt -120.15 122.57 68.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 48.3 28.25 1.57 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.0 22.26 20.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.396 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -116.01 96.2 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.387 . . . . 0.0 110.796 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.29 135.39 32.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.214 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HA ' HD11 ' A' ' 81' ' ' LEU . 58.8 mt -108.07 3.92 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.321 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 t -84.95 122.5 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.15 -23.42 36.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.833 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.43 127.85 42.58 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.023 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.34 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.692 2.261 . . . . 0.0 112.675 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.3 tp -69.93 -35.11 74.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -53.33 -45.6 69.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.528 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.3 m -65.09 -48.18 74.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.737 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.0 m -56.96 -50.55 72.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.405 ' NE2' HD11 ' A' ' 35' ' ' ILE . 9.1 mm-40 -53.05 -43.39 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 t -64.52 -31.25 72.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.15 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.698 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 27.9 mt -69.53 -36.7 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.937 0.398 . . . . 0.0 109.956 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 90' ' ' ILE . 6.1 mt -77.23 -41.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.388 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -39.24 89.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.552 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.07 -10.76 65.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.755 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 68.8 mt -93.92 37.49 1.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -80.49 -31.06 37.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -127.88 67.19 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.774 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 14.1 mm-40 -121.25 -38.1 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.428 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.8 3.0 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.549 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -166.27 145.47 5.87 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 3.5 t -140.27 103.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -91.91 76.93 5.5 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 pt? -106.06 126.46 52.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.924 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 2.8 m120 -88.93 123.67 33.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.537 HG21 HG12 ' A' ' 70' ' ' ILE . 4.8 pt -122.29 165.91 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 111.868 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 86.2 t . . . . . 0 C--O 1.234 0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -146.81 117.5 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.6 73.21 2.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.42 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 23.0 t -62.46 126.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.011 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.88 103.57 10.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.872 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 58' ' ' ALA . 15.4 mm -101.0 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.162 0.506 . . . . 0.0 110.23 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.24 118.55 36.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -133.43 -170.01 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.023 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.26 135.89 41.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -47.62 120.83 3.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.191 0.52 . . . . 0.0 111.032 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.67 10.85 22.46 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.23 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -128.13 142.12 51.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pt -93.3 161.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 1.8 tp -47.86 -51.99 20.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.159 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.26 -4.64 41.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.885 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -94.83 127.28 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.052 0.453 . . . . 0.0 111.397 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 11.6 t -95.69 98.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.791 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.3 pp -97.8 150.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 111.771 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 48' ' ' ILE . 16.3 m -133.4 161.38 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.592 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.93 116.16 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.95 0.312 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.461 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 67.0 p -142.01 -72.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -158.67 144.68 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.169 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -124.43 114.62 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.233 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 48.6 mt -61.52 73.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -58.02 -29.28 65.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.498 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 27.5 m120 -147.5 -177.09 5.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.244 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.4 ptp -173.1 144.34 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tpp -65.82 124.27 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 49.7 p-80 -61.0 87.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.09 -14.24 31.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.73 175.87 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.641 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' CB ' ' HD3' ' A' ' 25' ' ' LYS . 71.9 Cg_exo -50.01 -47.43 23.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.706 2.271 . . . . 0.0 112.885 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.46 ' HB3' HG13 ' A' ' 33' ' ' VAL . . . -58.1 -49.44 76.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.0 -27.6 61.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.95 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.589 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.402 ' O ' ' HE3' ' A' ' 63' ' ' LYS . 15.7 p -51.83 -46.88 64.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.33 -24.29 31.06 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.891 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -67.07 -53.93 26.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.009 0.433 . . . . 0.0 110.647 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 103' ' ' ILE . 12.9 mt -72.79 129.97 39.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 0.5 OUTLIER -134.6 137.71 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.158 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.3 mt -39.44 108.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.389 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -5.84 11.19 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.124 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 12.0 m-20 -69.8 119.42 14.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.7 80.04 3.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.04 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.599 HG12 HG21 ' A' ' 103' ' ' ILE . 1.5 mt -55.01 145.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 tpp -115.64 -38.8 3.64 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 43.4 t -153.66 164.53 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 14.1 mt -130.04 112.83 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.655 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 42.71 32.57 0.39 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.107 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 2.49 31.11 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.371 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -102.32 95.67 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.675 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.08 113.77 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.419 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 82.2 mt -82.53 -12.17 57.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.31 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HA ' ' CG2' ' A' ' 46' ' ' THR . 24.4 t -58.66 103.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.182 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.59 -30.27 9.37 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.7 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 78' ' ' LEU . 1.5 mt -66.54 118.61 55.71 Favored Pre-proline 0 C--N 1.33 -0.241 0 O-C-N 122.832 -0.217 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.39 166.14 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 tp -54.39 -42.25 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.152 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 t -53.88 -43.77 69.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.808 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.8 m -68.57 -44.74 73.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.431 ' HB3' HD13 ' A' ' 35' ' ' ILE . 9.6 m -56.97 -56.97 14.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.428 ' NE2' HD12 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -49.73 -54.11 20.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 110.519 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.0 p -51.12 -41.37 60.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.257 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.0 mt -59.75 -45.16 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.96 -38.56 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -47.5 79.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.27 -15.1 50.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.467 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 78.1 mt -91.23 31.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.041 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 29' ' ' GLU . 6.4 tttt -81.01 -37.54 28.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -118.74 62.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.8 mm-40 -117.76 -41.25 2.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.4 t 78.9 -2.57 2.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.54 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.635 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.49 140.19 8.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.62 0.248 . . . . 0.0 110.451 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 93' ' ' LEU . 5.1 t -136.97 104.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 112.111 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -91.08 73.05 6.36 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.5 pt? -101.81 123.83 46.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.557 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.93 109.32 20.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.599 HG21 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -99.9 165.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.472 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.792 -179.381 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.61 121.5 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.21 77.29 5.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 27.7 t -68.2 121.18 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.011 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.27 103.64 11.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.509 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 12.7 mm -99.99 103.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.025 0.44 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.93 117.42 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -134.66 -172.11 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.32 136.66 39.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.656 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -47.51 123.55 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.148 0.499 . . . . 0.0 110.811 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.55 12.82 27.66 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.441 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.3 mm-40 -127.15 133.75 50.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.714 0.292 . . . . 0.0 111.265 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.43 154.37 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.406 ' CD2' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -48.16 -52.11 22.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.025 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.38 -0.39 37.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.454 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 58' ' ' ALA . 2.3 m -94.72 128.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.06 0.43 . . . . 0.0 111.58 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.4 t -100.33 98.27 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.67 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.5 pp -96.95 158.78 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 0.0 111.958 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 48' ' ' ILE . 4.0 m -140.37 157.8 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.412 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.82 121.17 10.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.488 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 5.2 p . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.705 0.211 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.83 -67.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.255 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.4 m -160.39 148.11 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.072 0.463 . . . . 0.0 112.023 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -125.83 117.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.8 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 46.8 mt -61.86 74.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -57.71 -27.85 63.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.643 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 28.3 m120 -148.05 177.46 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.011 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -171.55 128.93 0.67 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.67 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.8 tpp -53.6 136.93 38.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.217 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -77.61 93.63 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.729 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.45 -17.12 28.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.566 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.74 179.02 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.633 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.418 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 81.6 Cg_exo -48.68 -50.26 12.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.777 2.318 . . . . 0.0 112.957 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.16 -49.21 77.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.766 0.317 . . . . 0.0 111.267 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.58 -22.41 61.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -66.0 -48.4 71.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 p -54.22 -43.08 70.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.69 -9.31 78.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.494 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -58.67 2.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.989 0.423 . . . . 0.0 111.107 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 HG22 ' A' ' 103' ' ' ILE . 13.6 mt -68.68 129.55 40.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -134.25 135.06 42.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.033 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 13.0 mt -36.38 109.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 121.028 0.442 . . . . 0.0 111.494 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.48 -0.35 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.214 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.464 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 7.6 m-20 -75.3 118.9 18.71 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.784 0.326 . . . . 0.0 110.705 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -74.39 84.4 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.646 HG12 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -62.44 144.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.416 ' HG3' ' CG2' ' A' ' 104' ' ' VAL . 21.8 mmt -110.05 -41.82 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -158.09 157.75 33.43 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.399 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.423 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 7.1 mt -119.13 118.31 57.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.023 0.44 . . . . 0.0 111.62 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.42 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 11.2 p30 42.37 31.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.87 14.69 24.32 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.945 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -111.62 95.61 5.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.2 p -58.41 126.84 29.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.261 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 89' ' ' ILE . 30.1 mt -97.48 5.55 49.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.223 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 t -88.7 129.6 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.917 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.58 -22.67 37.73 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.817 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.15 144.11 27.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.717 0.294 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.23 175.46 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.673 2.248 . . . . 0.0 112.435 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.51 -33.24 75.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -53.99 -47.99 70.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.806 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.6 m -64.59 -47.54 78.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.426 ' CB ' HD13 ' A' ' 35' ' ' ILE . 13.6 m -56.88 -51.56 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.67 -37.66 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.0 110.467 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -68.41 -35.0 77.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.979 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 18.8 mt -64.06 -46.37 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.08 -37.63 78.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.614 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -34.34 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.878 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.24 -12.53 76.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.138 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 92.6 mt -93.69 33.67 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 110.525 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.7 ttpt -78.36 -30.46 48.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -124.51 65.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.886 0.374 . . . . 0.0 111.727 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.0 -39.31 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m 75.16 1.91 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.522 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -164.85 142.74 6.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.625 0.25 . . . . 0.0 110.326 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 3.9 t -137.62 103.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.827 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.38 73.78 5.27 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.617 178.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.5 pt? -104.57 122.94 46.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 109.73 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.646 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -103.34 173.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.473 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 71' ' ' MET . 98.2 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.51 . . . . 0.0 111.665 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.596 0.236 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -141.92 115.2 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.85 74.41 2.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.81 114.85 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.584 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -108.61 103.39 12.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.574 178.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 6.1 mm -97.49 104.07 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -96.35 112.02 23.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.244 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -134.27 -169.21 2.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.954 0.407 . . . . 0.0 110.997 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -103.45 154.46 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.426 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 95' ' ' ASN . 2.5 mptt -59.54 132.29 53.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.03 14.75 50.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.747 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.4 mp0 -121.07 130.36 53.73 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -84.87 150.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -47.2 -52.04 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.315 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.62 -8.62 37.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.08 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 31' ' ' LEU . 1.4 m -94.86 124.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.67 98.6 7.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.298 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.8 pp -93.61 147.6 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.17 0.509 . . . . 0.0 111.699 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 48' ' ' ILE . 17.1 m -129.19 159.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.197 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.8 114.22 2.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.819 0.342 . . . . 0.0 111.158 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.535 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.753 0.23 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.45 -58.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.26 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.51 155.17 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 111.282 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.61 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -140.29 115.6 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.604 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 20.9 mt -60.27 72.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.79 -24.18 21.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.904 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.499 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.15 166.53 31.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.146 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.405 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.1 ttp -154.44 137.04 15.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.6 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.04 117.64 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -62.77 83.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.49 1.45 19.98 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.568 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.89 -178.43 51.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 86.9 Cg_exo -47.87 -50.83 10.95 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 112.793 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.447 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.16 -42.15 85.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 0.0 110.799 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -66.32 -49.3 67.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' A' ' 23' ' ' ILE . 4.7 m -52.42 -40.76 62.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.93 10.97 82.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.31 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -104.8 -48.71 3.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.881 0.372 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 103' ' ' ILE . 13.8 mt -77.76 119.12 20.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.271 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.405 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 7.4 m-80 -123.9 136.68 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.362 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 28.2 mt -40.6 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.639 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.6 -11.46 8.43 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.151 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 4.9 m-20 -72.36 134.14 45.31 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 117.024 0.412 . . . . 0.0 110.857 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.474 ' HB3' HG23 ' A' ' 104' ' ' VAL . 39.6 tt0 -87.6 83.75 7.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.028 0.442 . . . . 0.0 110.015 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.612 HG12 HG23 ' A' ' 103' ' ' ILE . 2.1 mt -52.04 144.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.789 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.42 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 6.3 mmt -109.24 -41.51 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.8 p -160.99 158.41 27.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.332 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.419 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 7.0 mt -122.27 118.2 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.263 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.22 25.81 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.92 32.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.55 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.407 ' CG2' HD11 ' A' ' 89' ' ' ILE . 18.7 m -107.89 95.76 5.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.726 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.68 131.64 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.234 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -101.48 1.18 37.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.322 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.36 132.81 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.19 -23.71 32.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.64 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.68 140.21 21.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 178.45 2.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.204 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.8 tp -63.98 -33.47 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 p -53.94 -45.7 71.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.821 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.7 m -67.1 -47.76 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.403 ' HB3' HD13 ' A' ' 35' ' ' ILE . 13.3 m -57.23 -47.17 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -56.31 -45.97 80.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -60.26 -35.44 75.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 39.8 mt -63.26 -46.0 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 90' ' ' ILE . 3.9 mt -62.91 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.791 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -42.22 98.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.175 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.13 -13.24 64.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.252 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 92.2 mt -94.06 37.36 1.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.932 0.396 . . . . 0.0 110.677 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.85 -41.2 21.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -120.85 64.18 0.86 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 9.2 mm-40 -113.95 -36.19 4.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 1.7 t 77.62 -2.34 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.697 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.4 mtm180 -161.99 148.46 13.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.569 0.223 . . . . 0.0 110.564 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 5.0 t -141.26 103.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 111.766 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -93.13 75.38 4.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 pt? -107.45 124.55 50.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -90.83 120.28 31.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.214 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.612 HG23 HG12 ' A' ' 70' ' ' ILE . 4.7 pt -117.39 150.89 19.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.546 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.5 m . . . . . 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.276 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.556 0.217 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -143.67 118.88 10.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.25 76.63 3.8 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 46.4 t -67.23 128.8 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.797 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.22 103.61 10.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.891 178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 57' ' ' PRO . 9.3 mm -99.93 102.94 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -100.96 114.66 28.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.145 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 97' ' ' SER . 6.4 pttt -131.47 -168.69 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.18 137.14 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.6 mttt -50.21 125.46 12.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.126 0.489 . . . . 0.0 110.803 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.67 12.71 31.9 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 5.2 mm-40 -126.33 135.2 51.2 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.401 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.07 150.07 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.238 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD2' HG23 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.99 -52.19 20.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.307 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.75 10.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.856 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -112.27 129.57 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.1 t -108.64 98.59 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.108 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -97.78 156.42 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.41 ' CG2' HD13 ' A' ' 48' ' ' ILE . 27.0 m -141.54 155.18 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.407 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.22 119.47 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 111.185 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.507 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 1.7 p . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.808 0.254 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.3 p -142.85 -75.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.09 137.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.448 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -114.39 119.49 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.27 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 50.1 mt -64.18 73.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -51.41 -25.87 6.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.296 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.9 p-10 -173.57 150.29 1.76 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -129.55 167.63 17.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.678 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.426 ' N ' ' CG ' ' A' ' 52' ' ' MET . 2.1 ttm -82.99 128.45 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.44 104.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.94 -21.17 47.48 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.14 174.89 1.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.433 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 81.8 Cg_exo -48.28 -45.49 26.01 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.7 2.266 . . . . 0.0 112.735 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB1' ' CG1' ' A' ' 33' ' ' VAL . . . -58.47 -47.14 85.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -30.18 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.16 82.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.774 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.4 p -53.03 -39.48 63.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.123 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.58 72.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.272 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -117.22 -40.53 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.445 ' CD2' HD11 ' A' ' 103' ' ' ILE . 10.6 mt -88.96 111.24 21.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.308 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -114.16 144.63 42.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.0 mt -44.84 125.03 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.21 38.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.169 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 24.4 m-20 -73.11 125.84 28.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.621 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.524 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -85.59 79.8 9.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.11 0.481 . . . . 0.0 110.43 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.593 HG12 HG21 ' A' ' 103' ' ' ILE . 2.1 mt -53.24 141.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.876 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -33.84 5.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 35.2 t -159.87 156.49 27.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.664 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 9.3 mt -129.23 115.98 38.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.494 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 53.04 23.91 3.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.2 35.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 72' ' ' SER . 11.8 m -106.68 95.05 5.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.937 0.368 . . . . 0.0 110.509 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.6 p -69.06 128.71 37.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.376 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HA ' ' CG ' ' A' ' 81' ' ' LEU . 1.1 mp -94.4 13.3 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.025 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.89 106.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.52 -31.81 7.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.896 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.62 138.82 43.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.983 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 179.35 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.77 2.314 . . . . 0.0 112.507 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.24 -31.81 73.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -48.18 70.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.006 0.431 . . . . 0.0 110.585 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 89' ' ' ILE . 25.8 m -68.11 -45.76 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.807 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -56.77 -44.26 81.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.726 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 9.8 mm-40 -58.6 -52.33 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 3.4 t -56.76 -32.16 65.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -62.74 -46.35 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -61.52 -35.33 66.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.898 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 23.4 mmtt -61.71 -48.69 79.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.125 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.55 -11.55 57.06 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.346 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 83.4 mt -89.28 27.78 1.36 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.914 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -84.71 -40.09 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.435 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -119.79 62.7 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.419 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.7 mm-40 -119.25 -41.01 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.5 t 79.55 -3.24 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.513 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.592 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -160.01 142.82 13.64 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 93' ' ' LEU . 3.3 t -140.25 103.27 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -90.53 74.04 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.4 pt? -102.74 120.93 41.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.622 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.95 114.44 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.593 HG21 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -111.79 171.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.014 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.7 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.616 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.402 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.171 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -129.9 116.78 19.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.44 71.73 2.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 46.7 t -58.92 124.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.403 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.04 103.52 11.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.858 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 5.8 mm -99.34 102.97 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.48 114.01 27.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.383 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -129.89 -169.63 2.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.1 132.7 49.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -45.64 118.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.176 0.512 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.75 12.62 16.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.256 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 94' ' ' LYS . 6.7 mm-40 -130.48 128.01 40.35 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 111.334 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -72.17 153.34 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -49.47 -52.1 31.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.66 20.83 9.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.869 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -114.72 127.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.433 . . . . 0.0 111.11 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.1 97.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.839 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.5 pp -100.94 145.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.926 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.457 ' CG2' HD12 ' A' ' 48' ' ' ILE . 6.1 m -125.98 160.16 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.189 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.34 117.25 5.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.769 0.237 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 -66.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.201 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.42 151.65 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.887 0.375 . . . . 0.0 111.739 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -138.63 115.44 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.889 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 37.9 mt -60.54 71.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.34 -26.3 11.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.3 p-10 -177.46 145.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.331 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.7 ptp -116.48 -170.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.0 tpp -94.46 125.22 38.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.0 81.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.796 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.37 20.44 7.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.41 175.56 28.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.454 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.429 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 88.7 Cg_exo -47.48 -46.14 21.14 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.693 2.262 . . . . 0.0 112.807 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 33' ' ' VAL . . . -58.43 -48.22 81.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.44 -34.36 72.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 110.554 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -58.5 -48.74 79.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -50.5 -39.86 49.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.01 2.39 82.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.599 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -96.94 -37.1 10.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 103' ' ' ILE . 13.0 mt -91.67 111.64 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -110.19 141.0 43.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.9 mt -42.68 121.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.25 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.64 1.87 43.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.086 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB3' HD13 ' A' ' 103' ' ' ILE . 6.4 m-20 -71.49 130.73 42.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 110.782 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.59 78.25 9.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.638 HG12 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -55.62 144.7 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.104 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.413 ' CG ' ' CG2' ' A' ' 104' ' ' VAL . 15.3 mmt -111.11 -41.65 4.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.1 p -160.57 160.43 31.79 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.302 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.468 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 8.7 mt -120.41 115.56 47.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.544 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.421 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 9.8 p30 43.46 33.08 0.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.853 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.94 33.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.133 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -108.59 95.64 5.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.353 . . . . 0.0 110.695 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.54 130.71 48.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.131 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.404 ' CD2' HD11 ' A' ' 89' ' ' ILE . 26.2 mt -99.78 6.41 45.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.249 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.79 128.91 43.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.14 -23.98 33.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.45 143.87 27.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.885 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.31 178.67 2.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.635 2.223 . . . . 0.0 112.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.87 -35.06 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 m -53.81 -40.59 66.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.3 m -71.83 -48.77 43.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.918 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 10.1 m -56.95 -48.91 77.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.782 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -58.7 -46.74 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.331 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -59.01 -35.49 73.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.936 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 85' ' ' THR . 11.4 mt -62.67 -45.27 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -60.92 -35.44 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.984 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -49.29 75.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.028 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.24 -11.01 60.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.103 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 44.8 mt -86.61 18.16 3.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.608 0.242 . . . . 0.0 110.928 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -82.58 -33.66 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.539 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.83 62.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.409 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -124.32 -40.22 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.07 0.462 . . . . 0.0 110.346 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 79.46 -2.06 2.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.59 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.55 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.8 mtm180 -161.13 142.03 11.42 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.96 103.61 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.863 0.364 . . . . 0.0 111.846 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' NZ ' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.45 73.86 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 73' ' ' ILE . 2.4 pt? -102.74 123.65 46.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.28 122.85 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.638 HG22 HG12 ' A' ' 70' ' ' ILE . 2.4 pt -117.4 162.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.706 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.413 ' CG2' ' CG ' ' A' ' 71' ' ' MET . 41.3 t . . . . . 0 C--O 1.235 0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 115.38 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.33 79.07 3.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 40.4 t -69.11 122.41 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.921 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.45 103.07 10.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.423 178.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 9.4 mm -97.75 103.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -103.49 113.43 26.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.896 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -135.96 -174.39 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.807 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -89.53 141.24 28.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.503 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -49.45 119.69 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 110.651 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . 109.0 13.84 16.83 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.054 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.0 mp0 -119.13 127.63 53.52 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.514 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.42 146.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.753 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.49 -39.83 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.824 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.49 61.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.373 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 31' ' ' LEU . 6.2 m -104.18 126.85 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.226 0.513 . . . . 0.0 111.443 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.5 t -100.85 98.29 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.3 pp -100.74 148.11 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.228 0.537 . . . . 0.0 111.774 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.404 ' CG2' HD13 ' A' ' 48' ' ' ILE . 15.7 m -129.7 160.28 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.427 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.41 108.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.531 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 30.5 t . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--O 1.23 0.113 0 CA-C-O 120.825 0.261 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.02 -59.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.8 140.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 0.0 111.655 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -124.28 116.32 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.764 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 64.9 mt -62.7 71.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -28.68 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 25.3 m120 -146.75 168.57 21.03 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.94 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.427 ' CE ' ' HA ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -166.09 134.73 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.24 127.19 26.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -73.78 68.93 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.45 -21.4 3.63 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.35 -176.07 0.61 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.64 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.431 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 84.1 Cg_exo -48.0 -44.07 28.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.749 2.299 . . . . 0.0 112.766 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -58.68 -49.53 77.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.86 -29.68 64.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.514 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -62.99 -48.31 79.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.968 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -53.06 -38.25 62.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.15 19.0 70.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.263 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -116.35 -52.81 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.949 0.404 . . . . 0.0 110.747 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 103' ' ' ILE . 9.7 mt -77.97 120.65 23.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.51 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 13.7 m-80 -129.55 134.7 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.364 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 9.0 mt -33.34 122.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.37 2.31 55.63 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 12.1 m-20 -77.25 120.91 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.803 0.335 . . . . 0.0 110.618 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 86.46 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.625 HG12 HG21 ' A' ' 103' ' ' ILE . 1.5 mt -62.75 143.21 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -40.11 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.813 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.8 p -159.73 156.91 28.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.182 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.456 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 6.9 mt -120.88 125.28 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.13 29.56 0.82 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.44 23.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.369 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.3 m -119.7 95.98 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.5 t -56.0 138.57 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 73' ' ' ILE . 19.5 mt -109.1 4.32 22.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.04 126.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.92 -25.31 28.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.872 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.18 147.36 34.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.796 0.331 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.48 173.97 8.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.354 . . . . 0.0 112.639 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 tp -62.36 -37.2 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -53.67 -46.42 70.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 89' ' ' ILE . 4.0 m -65.27 -44.28 88.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.422 ' HB3' HD12 ' A' ' 35' ' ' ILE . 11.8 m -57.0 -56.2 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.785 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.408 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -49.44 -53.94 20.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.167 0.508 . . . . 0.0 110.854 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -53.72 -39.71 65.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.482 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.684 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 10.0 mt -61.64 -36.9 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -77.99 -44.41 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.019 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.98 91.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.08 -17.36 44.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 69.9 mt -93.27 26.82 2.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.267 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -78.13 -12.23 59.98 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.983 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -134.52 48.46 2.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.877 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 15.4 mm-40 -111.76 -33.21 6.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 110.336 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 77.95 -0.55 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.737 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.572 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.3 mtm180 -160.31 142.87 13.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.598 0.237 . . . . 0.0 110.515 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.35 103.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.898 0.38 . . . . 0.0 111.993 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -91.09 75.4 6.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.804 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 73' ' ' ILE . 2.4 pt? -106.21 120.47 41.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 107.96 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.625 HG21 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -103.33 174.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.13 0.491 . . . . 0.0 111.5 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.23 0.071 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.6 120.25 9.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 79.92 6.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 42.7 t -69.31 122.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.882 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.97 103.25 10.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.252 178.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 12.1 mm -97.26 102.38 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 19.2 mt-10 -95.08 109.84 21.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.492 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -130.03 -169.9 2.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.829 0.347 . . . . 0.0 110.96 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.74 137.11 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 6.3 mttp -47.49 124.56 7.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 110.779 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.01 14.35 24.91 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 78.8 mm-40 -130.45 130.72 44.61 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.635 0.255 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -81.24 151.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.128 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' CD1' HG12 ' A' ' 99' ' ' VAL . 0.5 OUTLIER -47.95 -42.41 27.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.089 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.04 6.62 59.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.034 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.414 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 4.2 m -95.76 143.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.42 . . . . 0.0 111.392 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -119.72 98.65 6.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 pp -95.18 153.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 112.067 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.404 ' CG2' ' CD1' ' A' ' 48' ' ' ILE . 2.8 m -130.21 156.91 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.408 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.79 93.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.746 0.308 . . . . 0.0 111.352 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 6.8 p . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.479 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--O 1.233 0.225 0 N-CA-C 112.799 0.269 . . . . 0.0 112.799 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.417 HG21 HG22 ' A' ' 79' ' ' VAL . 47.3 p -141.64 -73.81 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.021 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.07 141.05 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.745 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -118.37 118.28 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.897 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 58.0 mt -62.83 72.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.38 -28.25 58.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.512 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.0 m120 -145.98 173.59 12.02 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.961 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.442 ' CG ' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -171.76 131.78 0.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.903 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 tpp -56.24 123.49 14.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.51 89.47 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.675 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.83 7.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.1 -163.8 25.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.292 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 52.9 Cg_exo -55.93 -51.3 9.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.662 2.242 . . . . 0.0 112.711 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 52' ' ' MET . . . -58.36 -49.31 77.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.88 -28.14 65.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -64.47 -48.27 75.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 p -51.17 -39.8 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.004 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.74 23.79 59.37 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -121.12 -52.7 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.723 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' CD2' HD13 ' A' ' 103' ' ' ILE . 12.7 mt -77.82 119.79 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.553 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ILE . 2.4 p30 -127.52 133.28 49.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.248 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.512 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.5 mt -32.4 117.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.973 0.416 . . . . 0.0 111.769 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.16 4.81 29.03 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.134 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HB3' HD13 ' A' ' 103' ' ' ILE . 2.7 m-20 -80.32 127.77 32.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 110.771 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.91 83.34 7.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.639 HG12 HG22 ' A' ' 103' ' ' ILE . 1.9 mt -62.19 144.08 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.012 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.406 ' CG ' ' CG2' ' A' ' 104' ' ' VAL . 24.6 mmt -112.85 -36.39 5.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.862 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 52.4 p -160.3 160.11 32.12 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.238 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 9.5 mt -127.5 123.83 62.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.769 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 46.29 29.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.55 17.3 31.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.664 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -111.36 95.83 5.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.372 . . . . 0.0 110.578 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 m -57.29 124.2 18.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 45.7 mt -97.38 21.16 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 46' ' ' THR . 2.7 t -93.02 113.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.281 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.16 28.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.292 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -83.73 142.05 42.04 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 117.034 0.417 . . . . 0.0 110.934 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 -179.58 2.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.661 2.241 . . . . 0.0 112.45 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.15 -31.56 72.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -56.42 -45.92 80.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -67.9 -48.0 67.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.409 ' CB ' HD11 ' A' ' 35' ' ' ILE . 13.4 m -57.32 -53.07 62.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -55.59 -40.16 71.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.95 0.405 . . . . 0.0 110.484 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 p -66.64 -29.27 69.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.963 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 3.8 mt -69.73 -46.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 35' ' ' ILE . 5.4 mt -62.25 -38.99 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.473 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -37.65 79.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.54 -9.5 73.96 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 68.8 mt -93.36 27.33 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.727 0.298 . . . . 0.0 110.786 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -80.96 -33.79 33.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.456 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m-80 -120.53 63.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.934 0.397 . . . . 0.0 111.792 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.433 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -124.65 -41.76 2.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.9 m 77.97 2.03 2.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.293 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.581 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -164.06 138.73 5.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.448 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 31' ' ' LEU . 3.5 t -135.91 103.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.991 0.424 . . . . 0.0 112.023 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.514 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -90.04 72.91 7.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.5 pt? -103.14 120.44 40.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 111.404 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -88.66 112.83 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 70' ' ' ILE . 2.2 pt -106.31 174.17 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.249 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.406 ' CG2' ' CG ' ' A' ' 71' ' ' MET . 46.1 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.158 0.504 . . . . 0.0 111.788 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -148.3 115.58 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.2 77.54 3.01 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 38.5 t -67.19 117.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.06 103.33 11.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.419 178.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 6.1 mm -98.94 103.24 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.845 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 109.97 22.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.178 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -128.36 -170.55 2.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.84 139.7 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.552 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 14.1 mttt -50.18 125.69 12.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.165 0.507 . . . . 0.0 110.826 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.55 15.19 30.27 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 94' ' ' LYS . 13.1 mm-40 -120.53 136.86 54.65 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 111.596 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.14 147.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.231 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.424 ' CD2' ' CG2' ' A' ' 33' ' ' VAL . 7.4 tp -49.94 -45.67 51.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -0.1 62.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.017 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 1.1 m -94.55 125.26 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.318 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.26 98.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.233 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 pp -94.95 150.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.176 0.513 . . . . 0.0 111.787 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 48' ' ' ILE . 2.4 m -132.67 158.94 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.31 117.57 5.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 70.9 Cg_exo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.771 0.238 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' ' CE ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -163.73 -60.48 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.14 152.17 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.002 0.43 . . . . 0.0 111.881 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -134.61 118.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.859 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 47.4 mt -63.25 74.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.3 -34.36 66.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.382 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -140.9 177.55 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.003 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.414 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.85 122.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.598 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -46.52 132.03 10.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.505 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.55 81.46 4.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.3 5.37 8.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.829 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.36 -176.95 51.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.405 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HB3' HG23 ' A' ' 23' ' ' ILE . 70.7 Cg_exo -51.47 -47.74 24.66 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.53 2.153 . . . . 0.0 112.398 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.4 -43.38 88.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.69 -29.77 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.591 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.06 -48.92 74.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -53.16 -39.73 63.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.79 72.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -109.48 -52.8 2.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.622 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 103' ' ' ILE . 12.3 mt -76.05 120.61 21.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.408 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.75 136.54 53.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.156 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -37.17 110.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.66 3.33 22.22 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.127 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 11.6 m-20 -78.16 119.56 21.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.908 0.385 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -75.06 86.61 2.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 103' ' ' ILE . 2.0 mt -64.7 144.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.41 ' CE ' ' CG2' ' A' ' 46' ' ' THR . 4.4 mmt -110.8 -39.84 4.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.709 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.7 p -160.35 157.28 27.64 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.376 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.419 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 6.8 mt -122.12 124.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.482 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 46.46 28.74 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.035 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.99 21.63 22.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.579 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.4 m -115.86 95.84 5.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.369 . . . . 0.0 110.907 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -60.07 122.05 13.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.7 mt -91.37 12.17 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.264 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 4.2 t -87.24 126.31 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.61 -24.1 33.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.634 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.56 142.97 25.87 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.52 171.68 12.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.539 2.159 . . . . 0.0 112.429 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.12 -30.09 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 p -54.61 -49.6 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.794 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -68.07 -42.07 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.433 ' CB ' HD11 ' A' ' 35' ' ' ILE . 15.5 m -57.41 -52.22 66.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.33 -40.69 82.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.324 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 m -64.98 -30.03 70.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.566 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 2.3 mt -69.13 -46.15 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mt -65.84 -38.67 82.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.67 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.14 71.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.067 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.69 -14.09 81.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.185 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 90.5 mt -91.93 38.28 0.99 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.94 0.4 . . . . 0.0 110.598 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.8 mtpt -81.36 -35.04 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 15.6 m-80 -121.92 63.63 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.756 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.58 -39.62 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.58 -4.14 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.599 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.54 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.4 mtm180 -160.92 138.46 9.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 17.7 t -133.74 103.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 112.168 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.09 79.75 5.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.608 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' A' ' 21' ' ' VAL . 2.3 pt? -110.46 120.49 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.113 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.03 108.7 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.649 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -104.48 174.15 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.088 0.47 . . . . 0.0 111.683 -179.552 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.661 0.267 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.08 7.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.48 75.74 2.53 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 41.5 t -67.9 123.49 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.538 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.27 103.24 10.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.452 178.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 11.0 mm -98.03 103.5 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.846 0.355 . . . . 0.0 111.143 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 128.87 41.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.076 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.12 -173.75 4.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 111.169 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.82 136.51 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -47.21 120.39 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.141 0.496 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 12.2 22.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.337 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -122.98 133.19 54.38 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.84 0.352 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.2 pt -83.11 150.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.426 ' HB3' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -47.46 -40.19 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.04 31.1 11.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.868 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.442 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 3.5 m -125.1 124.35 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.411 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.15 98.26 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.009 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.7 pp -99.75 144.9 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.029 0.443 . . . . 0.0 111.854 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' CG2' HD13 ' A' ' 48' ' ' ILE . 3.7 m -124.32 155.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.29 111.12 0.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 111.162 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.708 0.212 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 t -161.8 -62.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.743 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 3.2 m -160.88 150.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 112.035 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -138.85 113.88 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 35.8 mt -60.17 72.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -34.61 62.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.403 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.1 m-80 -141.68 179.54 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.982 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.424 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -171.66 125.41 0.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.636 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.23 124.01 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -72.24 88.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.37 26.1 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.41 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.45 -176.43 20.74 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 89.3 Cg_exo -48.65 -46.12 25.27 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.596 2.197 . . . . 0.0 112.731 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.67 -49.25 78.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.51 -33.94 73.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.243 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -48.63 79.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -53.96 -37.9 64.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.77 17.06 79.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.808 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.62 -53.46 2.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.418 HD21 HG12 ' A' ' 103' ' ' ILE . 15.4 mt -76.08 120.93 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.357 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' ILE . 15.8 m-80 -127.05 133.07 50.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.125 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.508 HG23 HD12 ' A' ' 66' ' ' ILE . 27.5 mt -33.69 113.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.963 0.411 . . . . 0.0 111.935 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.89 -6.87 15.42 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.17 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.53 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 33.6 m-20 -70.47 127.88 34.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.56 0.219 . . . . 0.0 110.519 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.518 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -87.66 81.27 7.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.121 0.486 . . . . 0.0 110.669 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.597 HG12 HG23 ' A' ' 103' ' ' ILE . 2.8 mt -54.3 137.2 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.057 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.0 mmt -105.56 -37.61 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 92.4 p -157.4 153.47 27.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 111.172 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 4.2 mt -124.07 123.95 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.446 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 48.01 28.34 1.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.86 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.402 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -124.72 95.79 4.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.3 130.13 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.434 ' CD2' ' CD1' ' A' ' 89' ' ' ILE . 21.2 mt -95.77 14.29 23.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 t -74.64 112.7 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.499 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.39 -39.45 2.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.068 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 146.43 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.995 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.44 167.88 12.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.9 tp -62.98 -35.05 78.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.86 -42.93 69.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.559 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.562 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.1 m -69.85 -44.45 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.44 ' CB ' HD12 ' A' ' 35' ' ' ILE . 9.8 m -56.62 -53.46 57.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.426 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 3.5 mm-40 -52.9 -50.4 63.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 p -56.05 -36.46 68.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.272 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 85' ' ' THR . 19.9 mt -63.72 -33.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.23 -36.03 65.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.456 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.5 mppt? -75.38 -47.15 28.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.45 -25.4 27.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.393 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 3.5 pp -99.57 31.7 3.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.009 0.433 . . . . 0.0 110.577 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -22.31 50.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -121.65 52.38 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.417 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 37.8 mm-40 -113.49 -31.26 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m 70.58 10.65 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.538 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.3 mtm180 -168.92 139.68 2.4 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.231 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 4.7 t -136.88 103.69 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -90.63 76.68 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.44 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 pt? -107.93 120.78 43.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.316 0.579 . . . . 0.0 111.613 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.92 112.97 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.122 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.597 HG23 HG12 ' A' ' 70' ' ' ILE . 1.1 pt -112.88 160.42 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.613 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' A' ' 69' ' ' GLN . 7.2 m . . . . . 0 C--O 1.235 0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.445 ' CE1' HG23 ' A' ' 104' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.107 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -148.46 117.27 6.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.38 82.1 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -71.87 123.12 25.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.857 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.62 103.73 11.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 11.8 mm -99.62 103.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.963 0.411 . . . . 0.0 110.947 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.74 123.76 38.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.12 -169.75 3.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 111.133 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -101.24 147.83 25.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.31 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 5.5 mttp -55.12 130.84 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.081 0.467 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.76 13.17 54.3 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.639 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.73 139.18 52.68 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.807 0.337 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -87.22 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -52.26 18.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 114.43 -14.1 20.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.344 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 15.0 m -94.09 128.3 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.614 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.04 98.46 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.886 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.5 pp -94.51 140.93 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 111.587 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 48' ' ' ILE . 28.9 m -124.38 161.36 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.183 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.55 118.87 4.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.738 0.304 . . . . 0.0 111.14 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.472 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--O 1.232 0.176 0 N-CA-C 112.912 0.312 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -168.27 -61.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.419 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.34 153.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.576 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -141.13 115.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 53.5 mt -61.38 71.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -49.07 -27.55 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.4 p-10 -163.79 179.48 7.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.283 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.6 ttp -160.92 155.4 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.8 139.55 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.821 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -76.36 99.87 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.15 -19.3 52.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.2 175.44 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.593 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 80.0 Cg_exo -46.81 -45.74 19.77 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.79 2.327 . . . . 0.0 112.876 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.63 -49.32 77.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.378 . . . . 0.0 111.133 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -72.48 -26.02 61.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -60.39 -48.02 83.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' A' ' 63' ' ' LYS . 5.1 t -54.69 -38.09 66.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.749 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.17 12.16 83.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.941 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -104.42 -45.18 4.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.965 0.412 . . . . 0.0 110.999 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.4 mt -81.6 117.11 21.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.532 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.2 137.45 51.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.896 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 20.0 mt -40.25 117.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.85 -3.1 25.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.174 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' HD12 ' A' ' 103' ' ' ILE . 1.7 m-20 -68.55 133.48 48.62 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.563 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -89.5 81.17 6.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.568 HG12 HG23 ' A' ' 103' ' ' ILE . 2.9 mt -55.62 145.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.589 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.52 -38.65 3.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.6 t -156.63 154.09 29.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.431 ' CG2' ' CD2' ' A' ' 93' ' ' LEU . 6.1 mt -123.2 122.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 48.59 27.89 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 20.49 25.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.655 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 m -115.75 97.74 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.5 m -53.32 142.44 21.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.03 -5.76 14.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.377 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.3 t -78.44 129.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.405 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.59 -21.4 44.79 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.056 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 144.92 28.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.938 0.369 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -174.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.0 tp -75.9 -38.77 57.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.062 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.1 p -53.77 -39.28 65.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.566 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.6 m -68.3 -47.22 68.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.5 m -56.53 -53.82 53.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -53.91 22.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.348 0.594 . . . . 0.0 110.211 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -51.26 -35.7 38.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.128 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 85' ' ' THR . 31.8 mt -68.31 -33.6 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.297 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -76.4 -37.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -38.43 57.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.645 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.3 -17.3 56.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 2.8 pp -109.2 39.2 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.701 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -78.95 -26.09 43.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 17.6 m-80 -121.58 54.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.519 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -114.43 -29.89 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 m 71.44 7.96 6.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.158 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.557 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -166.4 143.09 4.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 110.58 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.68 103.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.959 0.409 . . . . 0.0 111.928 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -89.25 73.66 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.5 pt? -104.87 118.04 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.3 0.571 . . . . 0.0 111.491 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 3.3 t-20 -87.3 111.79 21.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.234 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.568 HG23 HG12 ' A' ' 70' ' ' ILE . 6.4 pt -99.48 174.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 18' ' ' PHE . 22.0 t . . . . . 0 C--O 1.236 0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 111.921 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -134.43 117.51 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.15 73.64 2.29 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 44.1 t -64.21 120.41 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.554 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.74 102.85 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.445 178.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 8.7 mm -99.03 103.4 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.132 0.491 . . . . 0.0 110.58 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.08 109.93 22.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.317 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.04 -174.2 3.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.974 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -97.06 134.68 40.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.493 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -46.64 119.32 2.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.51 12.55 16.71 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.365 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' LYS . 4.3 mm-40 -130.19 130.11 44.27 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.396 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CG2' ' CG ' ' A' ' 94' ' ' LYS . 1.1 pt -80.5 154.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.142 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD12 ' CB ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -49.26 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.65 7.87 41.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.898 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG13 ' CB ' ' A' ' 58' ' ' ALA . 13.9 m -100.22 127.2 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.22 101.22 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.216 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -96.48 165.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.204 0.526 . . . . 0.0 112.141 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 48' ' ' ILE . 35.9 m -152.34 148.69 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.6 121.09 6.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.695 0.283 . . . . 0.0 111.338 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.573 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.333 -0.124 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.856 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.758 0.232 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.422 HG21 ' CG2' ' A' ' 79' ' ' VAL . 40.0 p -130.62 -72.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -158.78 137.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 111.684 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -114.59 118.76 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.108 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 53.2 mt -63.56 74.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.85 -24.45 23.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.127 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.484 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -157.07 164.99 37.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.086 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.406 ' HE2' ' HA ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -159.88 128.47 4.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.754 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.3 tpp -46.51 131.36 11.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.452 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -76.99 90.21 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.64 -12.58 25.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.43 -175.48 5.36 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.68 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 73.6 Cg_exo -50.0 -46.06 29.82 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.88 2.386 . . . . 0.0 112.606 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.19 -48.2 81.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.57 -31.32 66.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.252 0.549 . . . . 0.0 110.589 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -60.97 -48.67 80.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.04 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 t -55.28 -30.01 59.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.92 71.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -45.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.758 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 13.5 mt -85.17 114.22 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.46 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.406 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 1.0 OUTLIER -120.98 135.13 55.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.8 mt -34.82 119.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.972 0.415 . . . . 0.0 111.683 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.41 1.48 35.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.054 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.2 m-20 -76.44 119.04 19.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.782 0.325 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 12.4 tt0 -75.99 85.71 2.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.599 HG12 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -61.95 144.78 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.174 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.411 ' CG ' ' CG2' ' A' ' 104' ' ' VAL . 5.0 mmt -110.3 -42.39 4.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.0 p -157.71 165.13 36.22 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.032 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 10.9 mt -126.99 114.57 37.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.032 0.444 . . . . 0.0 111.652 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.419 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 12.7 p30 43.19 33.36 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.78 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.42 6.06 36.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.938 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -104.85 95.42 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.525 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -59.22 133.24 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.212 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.4 mt -107.34 16.45 23.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.804 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.422 ' CG2' HG21 ' A' ' 46' ' ' THR . 3.3 t -92.04 113.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.317 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.18 -27.34 20.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.256 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.54 141.22 45.01 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.081 0.44 . . . . 0.0 111.053 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.17 -179.84 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.605 2.203 . . . . 0.0 112.381 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.7 tp -70.06 -33.32 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -54.02 -45.29 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 89' ' ' ILE . 7.0 m -67.34 -50.36 60.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.95 -43.59 81.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -59.4 -46.16 89.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.452 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -61.23 -31.09 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.296 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 23.6 mt -68.09 -46.2 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -63.86 -36.8 77.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -36.03 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.795 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.28 -10.22 73.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.037 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 35.7 mt -92.59 30.91 1.43 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.559 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' CG ' ' CG2' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -86.3 -12.8 48.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.664 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -143.91 58.08 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.715 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 mm-40 -117.75 -37.76 3.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.437 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.51 -4.73 1.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.527 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mtm180 -161.0 141.67 11.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.512 0.196 . . . . 0.0 110.549 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 101' ' ' LEU . 6.3 t -137.83 105.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 111.89 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -93.34 74.24 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.663 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.4 pt? -104.84 123.55 47.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.319 0.581 . . . . 0.0 111.644 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.22 115.61 25.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.599 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -112.8 174.05 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.563 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 11.2 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.725 0.298 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.3 148.23 52.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 7.9 tttt -143.12 114.79 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.3 78.16 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' CD2' ' A' ' 64' ' ' LEU . 23.2 t -68.23 123.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.018 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.04 102.86 10.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.127 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 22.3 mm -101.03 103.15 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.82 132.76 36.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -179.54 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 139.53 30.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.9 mttt -49.85 126.08 13.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.731 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.72 33.25 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 94' ' ' LYS . 47.6 mm-40 -127.49 131.2 50.18 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 111.195 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -81.07 151.67 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.334 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.83 -52.09 20.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.89 16.27 17.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 3.6 m -109.01 139.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.05 98.68 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.568 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.4 pp -95.5 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.53 158.42 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.507 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 95.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.356 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.562 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 24.5 p -59.85 122.59 14.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.574 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.19 11.65 5.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.0 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.428 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -66.49 -179.74 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.971 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.94 71.57 0.76 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.155 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 43' ' ' ILE . 9.7 t -174.52 151.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.706 0.289 . . . . 0.0 110.812 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 42' ' ' SER . 0.1 OUTLIER 45.55 -169.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.71 117.43 67.58 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.599 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 38' ' ' SER . 72.8 Cg_exo -50.0 132.04 31.68 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.548 2.165 . . . . 0.0 112.62 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t -162.5 -61.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.56 156.62 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.88 0.372 . . . . 0.0 111.791 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -139.8 116.63 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.823 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 62.5 mt -61.42 71.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -55.32 -38.79 69.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.75 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -134.58 165.46 25.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.002 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -167.44 126.33 1.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.695 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -66.93 75.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.39 -12.17 7.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.716 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.2 -172.2 4.4 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.699 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.449 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 85.1 Cg_exo -47.03 -47.67 16.21 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.934 2.422 . . . . 0.0 112.905 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.48 -49.73 76.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.087 0.47 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -48.51 81.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -57.78 -30.09 65.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 110.57 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.75 69.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.3 -54.54 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD22 ' CG2' ' A' ' 103' ' ' ILE . 24.3 mt -75.65 125.14 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.514 0.674 . . . . 0.0 111.529 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.1 p30 -132.57 112.42 12.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.396 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' C ' ' O ' ' A' ' 65' ' ' ASN . 7.2 mt -13.61 114.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.7 -3.21 19.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.33 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 103' ' ' ILE . 2.7 m-20 -74.91 133.58 41.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.583 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.08 81.23 6.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.95 0.405 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.502 HG12 HG23 ' A' ' 103' ' ' ILE . 3.7 mt -53.58 145.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.21 -41.59 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.86 158.78 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.408 ' CG2' HD12 ' A' ' 93' ' ' LEU . 9.4 mt -125.48 121.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 49.36 26.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.01 19.38 24.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.731 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.403 ' CG2' ' CD1' ' A' ' 89' ' ' ILE . 5.4 m -113.12 95.79 5.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 p -56.55 125.36 21.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.5 mt -90.99 -3.47 57.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.55 128.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.103 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.48 -20.85 48.67 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.821 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.87 141.65 23.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.826 0.313 . . . . 0.0 110.878 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.86 -176.37 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.566 2.177 . . . . 0.0 112.358 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.8 -32.9 70.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.045 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.8 p -55.43 -41.78 73.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -68.17 -50.58 53.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.425 ' O ' HG13 ' A' ' 90' ' ' ILE . 17.8 m -57.13 -48.82 77.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -54.29 -47.56 72.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.969 0.414 . . . . 0.0 110.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -59.2 -32.47 69.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.555 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 9.4 mt -67.99 -45.97 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 86' ' ' CYS . 5.1 mt -64.07 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.499 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -36.86 79.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.338 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.83 -4.43 76.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.339 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 64.1 mt -93.16 36.29 1.05 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.813 0.339 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.5 tttt -85.65 -44.51 12.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.553 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.2 p30 -116.82 61.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 97' ' ' SER . 2.5 mm-40 -113.82 -35.4 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.334 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 6.3 m 90.16 -19.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.179 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -167.31 151.51 6.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.174 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.413 ' CG1' HD12 ' A' ' 93' ' ' LEU . 3.4 t -128.58 110.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -90.86 75.56 6.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.477 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 pt? -107.68 119.12 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.325 0.583 . . . . 0.0 111.736 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -86.51 111.55 20.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.246 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.502 HG23 HG12 ' A' ' 70' ' ' ILE . 6.8 pt -99.88 174.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.445 . . . . 0.0 111.882 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.15 128.44 75.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.04 149.09 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.807 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.6 117.97 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.83 80.12 2.75 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 45.7 t -71.91 127.35 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.598 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.03 102.9 9.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 99' ' ' VAL . 6.1 mm -99.78 103.75 15.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 0.0 110.296 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 112.94 25.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.589 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HD3' ' CG ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -130.47 -170.51 2.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.782 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -95.63 151.74 19.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -60.92 136.98 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.929 0.395 . . . . 0.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.21 11.46 62.89 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.555 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.93 135.92 54.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -86.26 148.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HB3' HG23 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.65 -43.64 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.65 4.75 57.97 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.262 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 HG11 ' CB ' ' A' ' 58' ' ' ALA . 5.2 m -96.44 140.83 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 117.079 0.44 . . . . 0.0 111.301 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.3 t -118.55 98.83 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 pp -97.83 150.98 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 111.937 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.73 164.52 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.494 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.77 103.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.392 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.544 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 43.0 p -55.75 142.86 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.1 49.09 0.55 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.91 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.407 ' CH2' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -117.58 -170.26 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.14 54.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.543 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.416 ' CB ' HD13 ' A' ' 43' ' ' ILE . 23.8 t -155.9 144.02 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.821 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.416 HD13 ' CB ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 49.33 -177.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.252 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.37 121.16 70.46 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.366 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.417 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 52.5 Cg_exo -52.81 127.16 23.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.49 2.127 . . . . 0.0 112.836 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.3 p -148.91 -71.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -159.32 142.92 5.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.309 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.697 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -119.99 118.91 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.353 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 43.3 mt -63.49 71.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.44 -29.11 48.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.55 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.9 m120 -145.06 173.1 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.442 ' CG ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -171.86 129.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.813 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -53.16 128.74 28.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.45 99.01 7.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.04 21.22 11.2 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.522 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 60' ' ' LYS . . . -106.53 -160.57 22.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.433 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 44.5 Cg_exo -57.09 -54.44 3.63 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.733 2.289 . . . . 0.0 112.559 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' HB1' ' CG ' ' A' ' 52' ' ' MET . . . -58.13 -49.31 77.42 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.33 -28.79 68.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.19 0.519 . . . . 0.0 110.196 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -62.36 -48.76 78.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.978 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -48.46 -40.44 26.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.15 27.66 43.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -47.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.056 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 8.2 mt -74.69 107.44 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.032 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.43 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.4 OUTLIER -118.28 138.79 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.761 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 16.9 mt -36.74 114.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.28 -6.15 11.92 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 103' ' ' ILE . 6.0 m-20 -72.43 130.33 40.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.682 0.277 . . . . 0.0 110.643 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.469 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -88.25 79.98 7.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.116 0.484 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.597 HG12 HG21 ' A' ' 103' ' ' ILE . 2.7 mt -55.66 141.78 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttm -116.01 -33.88 4.92 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 94.2 p -153.85 151.96 30.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.77 0.319 . . . . 0.0 111.363 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.443 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 6.9 mt -125.52 123.83 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.411 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 45.98 29.14 0.7 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.85 20.87 20.2 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -122.96 95.49 4.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -68.58 130.88 44.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 1.1 mp -97.35 15.79 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -72.81 108.82 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.184 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.43 -26.82 17.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.207 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.52 144.17 42.55 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.185 0.493 . . . . 0.0 111.019 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.66 177.83 3.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.785 2.323 . . . . 0.0 112.643 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.5 tp -64.22 -34.24 77.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -48.64 69.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.999 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.494 ' O ' HG13 ' A' ' 89' ' ' ILE . 17.5 m -65.87 -45.03 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 20.6 m -56.76 -54.5 45.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.743 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -49.92 -53.49 25.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.259 0.552 . . . . 0.0 110.634 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.519 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 1.5 m -54.47 -34.55 61.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.555 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 7.4 mt -63.96 -46.52 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -61.45 -34.81 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.305 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 2.0 mmmt -68.31 -43.56 77.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.556 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.82 -16.37 51.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 26.9 mt -91.24 38.47 0.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 111.027 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -80.92 -40.47 24.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.802 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -126.07 59.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.745 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -109.61 -35.5 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 0.8 OUTLIER 81.49 -10.79 1.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.17 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.58 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -155.34 150.11 26.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.698 0.285 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 5.0 t -139.99 103.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.939 0.4 . . . . 0.0 112.002 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -93.89 77.53 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.2 pt? -104.78 121.44 43.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.344 0.592 . . . . 0.0 111.676 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.81 106.79 17.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.597 HG21 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -106.48 174.03 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.208 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -128.98 139.5 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.281 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.29 148.3 43.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.067 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -146.01 114.9 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.19 74.03 2.32 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 103' ' ' ILE . 38.4 t -64.9 128.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.78 102.91 9.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 12.6 mm -99.04 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.85 0.357 . . . . 0.0 110.906 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.98 128.87 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -149.57 177.75 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -87.44 142.05 28.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG3' ' HB3' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -51.28 126.65 17.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 14.84 34.34 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.443 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.2 mm-40 -123.04 134.0 54.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.1 152.06 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.242 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 1.7 tp -50.59 -51.96 43.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.91 36.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.649 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG13 ' HG3' ' A' ' 52' ' ' MET . 8.8 m -95.29 138.98 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.063 0.458 . . . . 0.0 111.057 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.75 98.4 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.3 pp -95.94 143.72 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 111.729 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG2' HD13 ' A' ' 48' ' ' ILE . 2.5 m -124.63 161.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.39 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.48 111.87 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.521 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 22.7 t -70.26 128.56 36.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.12 5.98 4.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.147 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.405 ' NE1' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -68.69 176.26 3.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.967 0.383 . . . . 0.0 110.868 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.23 66.84 2.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.607 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.408 ' CB ' HD13 ' A' ' 43' ' ' ILE . 20.9 p -167.61 148.68 5.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.019 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.408 HD13 ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 44.72 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.419 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.02 131.95 27.93 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.669 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.86 140.99 88.34 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.531 2.154 . . . . 0.0 112.579 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 t -170.69 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.88 146.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.814 0.34 . . . . 0.0 111.367 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -130.25 116.61 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.725 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 90.3 mt -61.42 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.39 -38.49 63.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.52 169.16 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.955 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.433 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.83 132.39 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.6 113.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 75.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.75 -4.73 5.1 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.53 -173.16 47.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.649 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.436 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 76.2 Cg_exo -48.5 -47.12 21.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.757 2.305 . . . . 0.0 112.67 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.428 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.38 -49.08 78.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.84 -27.28 64.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -62.73 -48.73 77.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 23' ' ' ILE . 33.1 m -56.0 -32.24 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.31 4.74 80.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -98.28 -56.39 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.412 ' CD2' ' CD1' ' A' ' 49' ' ' ILE . 12.5 mt -72.19 122.66 21.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -131.54 135.74 47.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.337 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -35.14 116.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 111.618 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.36 0.8 29.59 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.119 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 8.9 m-20 -78.25 113.66 16.43 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.914 0.387 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.402 ' NE2' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.7 79.7 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.132 -179.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 103' ' ' ILE . 2.2 mt -54.5 145.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.45 -39.45 4.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.5 p -159.23 156.86 29.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.781 0.324 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CG2' ' CG1' ' A' ' 99' ' ' VAL . 7.8 mt -124.26 120.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 51.93 25.87 3.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.216 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.97 27.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -110.71 95.35 5.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 110.66 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.02 128.6 38.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -98.48 -8.91 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.285 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 15.5 t -59.54 109.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.78 -27.09 21.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.952 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -71.9 139.93 83.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.827 0.313 . . . . 0.0 110.723 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.28 179.71 2.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.322 2.015 . . . . 0.0 111.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.53 -41.06 89.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 m -53.9 -36.28 62.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -70.55 -54.34 12.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.008 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.9 m -57.29 -55.27 36.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.828 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -49.62 -54.29 19.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 110.823 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 t -53.31 -37.29 62.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 85' ' ' THR . 6.8 mt -63.96 -46.12 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 mt -60.16 -37.59 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.262 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -35.72 70.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.318 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.53 -7.85 83.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.53 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 87.0 mt -92.51 41.51 1.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.988 0.423 . . . . 0.0 110.688 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -84.77 -48.38 9.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.43 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.443 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 7.4 m-80 -116.74 61.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 97' ' ' SER . 5.5 mm-40 -108.04 -36.88 6.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.18 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 7.6 t 91.29 -18.51 0.15 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.236 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 151.71 3.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.426 ' CG2' ' CD1' ' A' ' 31' ' ' LEU . 8.0 t -131.31 107.54 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -88.17 77.87 8.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.3 pt? -107.29 119.11 38.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.359 0.6 . . . . 0.0 111.514 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -86.34 107.09 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.128 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -99.78 164.17 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.62 139.48 43.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.742 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.522 179.357 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.885 0.374 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.34 148.0 51.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -160.95 141.79 11.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.359 0.6 . . . . 0.0 112.469 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.4 72.79 8.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 76.8 t -58.58 124.52 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.626 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.96 103.28 11.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.915 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 13.3 mm -98.29 102.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.985 0.421 . . . . 0.0 110.258 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.94 117.38 33.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.426 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 22.4 pttt -136.64 -168.33 2.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 152.18 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -59.49 132.96 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.34 13.98 54.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.63 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -122.85 136.26 54.81 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.799 0.333 . . . . 0.0 111.425 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -89.37 161.29 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.806 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 ' CG2' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.97 -52.11 52.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.102 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.5 -10.93 35.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.8 OUTLIER -95.26 127.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.082 0.467 . . . . 0.0 111.367 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.01 100.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.808 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.4 pp -90.25 137.46 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.094 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -119.95 161.48 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.2 117.99 7.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.806 0.336 . . . . 0.0 110.796 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.458 ' HA ' HD13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -57.73 143.17 42.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.031 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.7 -18.13 5.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.89 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -177.06 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.65 23.68 4.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.766 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -71.06 -32.64 69.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -170.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.485 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.98 118.93 71.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.86 143.58 95.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.351 2.034 . . . . 0.0 112.269 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.3 -64.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.85 143.48 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -126.25 117.53 48.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.421 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' ILE . 58.4 mt -62.59 70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.05 -41.47 62.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.589 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.69 -169.97 2.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.599 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 ptp -168.32 162.51 12.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 8.0 tpp -88.56 117.11 27.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -55.41 103.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.74 77.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.729 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.72 171.91 37.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 88.8 Cg_exo -49.01 -45.16 30.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.886 2.391 . . . . 0.0 112.975 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -57.83 -49.91 75.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.336 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.68 -30.72 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -53.35 -48.66 68.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.737 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 1.4 t -55.7 -43.78 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.51 83.46 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -35.01 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.676 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD21 ' CD1' ' A' ' 103' ' ' ILE . 11.0 mt -90.72 111.39 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 0.7 OUTLIER -120.4 140.89 50.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.1 mt -38.01 126.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.812 0.339 . . . . 0.0 111.412 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.09 -7.66 52.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.989 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' HB3' HD12 ' A' ' 103' ' ' ILE . 3.5 m-20 -69.32 109.24 4.04 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.524 ' HB3' HG22 ' A' ' 104' ' ' VAL . 14.3 tp60 -71.37 85.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.607 HG12 HG21 ' A' ' 103' ' ' ILE . 2.7 mt -58.86 138.9 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.704 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -105.57 -38.28 6.49 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.9 p -159.45 157.67 30.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.332 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.444 HG22 ' ND2' ' A' ' 74' ' ' ASN . 7.7 mt -122.14 126.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.699 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' ND2' HG22 ' A' ' 73' ' ' ILE . 5.9 p30 36.42 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.172 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.75 26.22 9.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.809 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 73' ' ' ILE . 25.3 m -123.86 95.33 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 110.724 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 m -60.62 120.8 10.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.048 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD1' HG23 ' A' ' 47' ' ' VAL . 38.1 mt -91.09 -11.15 39.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.362 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.94 107.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.264 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.26 -26.35 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.793 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.24 127.49 93.26 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.556 0.217 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.59 164.54 2.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.337 2.025 . . . . 0.0 112.012 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 36' ' ' VAL . 8.7 tt -60.23 -44.64 95.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 m -53.49 -33.44 54.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 89' ' ' ILE . 2.9 m -72.88 -47.19 48.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.752 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.451 ' O ' HG13 ' A' ' 90' ' ' ILE . 74.9 m -56.8 -50.01 73.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' NE2' HD12 ' A' ' 35' ' ' ILE . 1.8 mm-40 -57.15 -53.17 61.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.184 0.516 . . . . 0.0 109.966 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -51.57 -39.76 58.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 12.5 mt -61.36 -41.73 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.8 mt -60.4 -35.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.348 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.2 mppt? -76.28 -34.71 59.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.521 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.74 -30.05 76.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 1.7 pp -99.56 38.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.53 -25.47 50.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.912 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 2.1 m120 -126.08 55.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.487 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.42 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 34.5 mm-40 -112.31 -30.39 7.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.555 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 74.97 1.42 3.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.59 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.01 146.9 12.83 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.718 0.294 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 3.6 t -140.14 105.64 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.484 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -94.45 79.65 3.88 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.0 pt? -107.27 125.24 50.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.381 0.61 . . . . 0.0 111.763 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -87.5 109.15 19.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.851 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.611 HG13 ' HG2' ' A' ' 19' ' ' LYS . 1.3 pt -114.88 174.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 69' ' ' GLN . 3.5 m -134.22 137.01 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.983 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.654 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -70.45 148.5 48.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.37 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -146.66 116.82 7.35 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.88 78.14 2.79 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 35.8 t -69.22 125.58 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.507 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.555 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.26 103.12 10.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.515 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 8.9 mm -98.56 103.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.631 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.33 128.49 45.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.559 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.567 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -151.94 -174.96 5.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.942 0.401 . . . . 0.0 110.958 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -85.18 160.82 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.139 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.12 123.25 19.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.303 0.573 . . . . 0.0 110.466 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 95' ' ' ASN . . . 100.68 18.74 19.84 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.299 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.1 mm-40 -117.46 131.49 56.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.676 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 pt -87.74 151.2 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.429 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 1.1 tp -48.21 -43.32 31.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.23 -5.06 60.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.783 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.31 125.12 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.28 98.57 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.954 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -95.6 147.31 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.411 ' CG2' HD12 ' A' ' 48' ' ' ILE . 27.2 m -132.1 155.29 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -51.73 118.85 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.787 0.327 . . . . 0.0 111.29 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.515 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -68.34 103.39 1.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.68 10.33 41.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.984 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.47 178.42 4.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.72 55.89 1.64 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.408 ' CB ' HD13 ' A' ' 43' ' ' ILE . 31.4 t -156.82 148.03 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.374 . . . . 0.0 110.817 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.408 HD13 ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 44.98 -166.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.179 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -93.79 142.89 25.67 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.699 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.33 120.93 8.01 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.581 2.187 . . . . 0.0 112.595 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.1 p -144.82 -74.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -159.99 141.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.658 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -127.07 119.07 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.13 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 31.3 mt -62.21 72.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.72 -25.95 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.904 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -165.41 166.67 18.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.705 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.3 ptp -143.48 171.09 14.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 ttm -87.65 112.98 22.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.88 90.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.08 21.91 8.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.438 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.22 179.26 27.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.408 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 78.5 Cg_exo -51.21 -45.38 37.32 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.68 2.253 . . . . 0.0 112.455 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.47 -49.46 77.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.34 -32.28 68.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -58.78 -48.65 80.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB3' ' HD2' ' A' ' 63' ' ' LYS . 7.8 m -50.04 -43.86 51.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.28 85.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.419 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' A' ' 61' ' ' SER . 1.2 mptt -97.85 -53.1 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.44 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 103' ' ' ILE . 13.8 mt -74.62 125.17 28.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.172 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 2.7 p30 -128.24 136.51 51.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.027 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 15.7 mt -37.86 107.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.991 0.424 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.92 -6.93 10.22 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.917 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 10.0 m-20 -71.27 124.38 24.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.564 0.221 . . . . 0.0 110.428 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.63 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -86.97 97.16 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.14 0.495 . . . . 0.0 110.543 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.617 HG12 HG23 ' A' ' 103' ' ' ILE . 1.7 mt -68.23 142.25 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.145 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.6 mmt -111.7 -32.97 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.008 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 45.3 t -159.62 154.6 24.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.139 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 6.1 mt -126.8 123.69 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 45.88 29.82 0.78 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.39 21.87 25.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.371 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -115.54 97.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.97 134.99 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 63.7 mt -109.53 9.71 25.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.026 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -86.19 114.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.398 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.74 -33.99 6.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.146 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.72 127.63 83.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.072 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.81 170.43 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.541 2.161 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 tp -59.52 -34.01 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -53.49 -51.02 64.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.546 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 58.5 m -63.51 -43.38 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.03 -50.57 72.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.87 -38.52 72.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -33.77 74.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.115 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 22.7 mt -64.89 -38.97 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 120.969 0.414 . . . . 0.0 109.916 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -77.19 -42.87 31.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -44.17 97.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.364 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.09 -14.53 61.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.375 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 95.9 mt -93.83 37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' GLU . 7.2 mtpt -79.11 -34.49 43.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HA ' ' H ' ' A' ' 28' ' ' GLY . 1.9 p30 -120.3 64.22 0.83 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.7 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.412 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 16.3 mm-40 -119.21 -34.71 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.543 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.567 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 5.5 t 74.11 1.53 3.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.734 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -165.86 145.11 6.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.429 ' CG2' ' CD1' ' A' ' 31' ' ' LEU . 11.1 t -139.89 103.83 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.524 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -91.39 78.38 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.441 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.2 pt? -107.69 118.98 38.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.403 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.99 111.48 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.439 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.617 HG23 HG12 ' A' ' 70' ' ' ILE . 1.1 pt -107.58 174.15 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.336 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -127.25 145.96 33.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.504 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.462 179.474 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.38 148.28 41.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.79 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -147.51 113.77 5.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.12 73.8 2.97 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 47.3 t -61.9 126.1 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.799 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.0 103.83 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.697 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 16.6 mm -100.05 103.44 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.982 0.42 . . . . 0.0 110.99 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 109.94 22.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.241 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.0 pttt -127.79 -170.27 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.6 138.3 40.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.66 124.41 7.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.027 0.442 . . . . 0.0 110.764 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.74 12.95 28.98 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.514 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 94' ' ' LYS . 10.5 mm-40 -129.22 126.63 39.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.278 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.08 153.69 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -47.66 -52.24 18.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.072 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.91 1.21 42.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.451 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 11.7 m -94.53 123.81 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.184 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.3 t -99.85 100.0 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.457 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -95.6 142.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.111 0.481 . . . . 0.0 111.683 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -118.22 167.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.7 105.28 2.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.495 ' HA ' HD11 ' A' ' 48' ' ' ILE . 11.5 p -64.98 123.41 19.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.453 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.32 4.31 13.64 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.317 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -175.26 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.076 0.438 . . . . 0.0 110.75 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.46 53.96 0.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.986 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -113.03 -33.22 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 110.918 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.2 179.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.516 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.32 135.35 93.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.268 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 57.7 Cg_endo -71.52 145.67 47.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.499 2.133 . . . . 0.0 113.047 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.14 -64.85 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.338 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.86 161.15 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -142.42 114.85 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.933 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 48.9 mt -61.1 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.79 -30.73 46.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.816 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.499 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -153.55 167.68 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.899 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 58' ' ' ALA . 5.0 ttp -154.92 129.21 8.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tpp -54.0 98.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -52.06 123.17 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.66 21.66 59.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.95 -170.31 20.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 53.8 Cg_exo -53.15 -47.62 26.52 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.646 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 52' ' ' MET . . . -58.71 -49.36 77.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.432 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.02 -30.37 63.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -48.57 75.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.401 ' CB ' HD12 ' A' ' 23' ' ' ILE . 98.8 p -56.25 -39.38 72.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.41 63.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.354 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -110.21 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.504 HD23 ' CG2' ' A' ' 103' ' ' ILE . 16.1 mt -72.38 127.83 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.721 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.7 m-80 -130.62 126.72 37.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 14.4 mt -30.61 113.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 121.06 0.457 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.74 5.31 22.36 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.094 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 15.7 m-20 -79.27 120.82 24.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.7 80.92 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.948 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.591 HG12 HG23 ' A' ' 103' ' ' ILE . 2.5 mt -55.76 143.51 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -41.38 4.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.928 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 77.2 p -158.29 156.87 31.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 111.404 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG22 ' CD1' ' A' ' 93' ' ' LEU . 6.7 mt -122.82 122.03 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.3 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.415 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 4.0 p30 40.32 33.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.865 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.51 22.18 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.811 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 m -123.09 95.56 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.49 130.21 43.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' CD1' HG21 ' A' ' 47' ' ' VAL . 59.1 mt -96.23 12.59 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -89.3 123.74 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.63 -25.39 28.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.822 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.44 134.2 29.96 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.761 0.281 . . . . 0.0 110.869 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.03 -176.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.497 2.131 . . . . 0.0 112.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 7.8 tt -75.55 -37.66 59.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -53.43 -36.89 62.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.2 m -68.76 -50.81 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.495 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.5 m -56.77 -48.68 77.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.446 ' NE2' HD13 ' A' ' 35' ' ' ILE . 98.4 mm-40 -54.14 -48.1 71.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 t -61.42 -33.81 74.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.533 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.617 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 38.8 mt -64.6 -46.43 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' HG13 ' A' ' 35' ' ' ILE . 3.6 mt -65.24 -39.08 84.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.443 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -69.35 -32.37 71.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.821 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.27 -11.54 84.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.468 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 93.8 mt -93.17 39.86 1.05 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.934 0.397 . . . . 0.0 110.93 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' GLU . 4.2 tttt -80.87 -37.57 29.62 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -120.71 63.68 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.837 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -117.18 -39.54 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 76.68 -2.12 2.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.698 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.635 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -162.64 139.45 7.76 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.533 0.206 . . . . 0.0 110.451 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 31' ' ' LEU . 10.6 t -136.38 104.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -93.03 80.07 4.57 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.503 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.2 pt? -110.01 120.07 41.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.41 108.45 18.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.048 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.591 HG23 HG12 ' A' ' 70' ' ' ILE . 1.4 pt -101.17 167.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.08 0.467 . . . . 0.0 111.787 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.16 137.31 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.602 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.496 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' ARG . 4.0 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.14 148.61 35.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -144.51 115.08 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 75.6 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 45.5 t -66.36 120.8 14.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.524 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.43 103.63 10.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.627 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 14.3 mm -99.18 103.59 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 1.2 tt0 -95.49 111.53 23.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.6 pttt -130.84 -170.73 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.112 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.34 143.4 32.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.575 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 4.9 mttt -51.43 128.57 23.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.987 0.423 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 11.65 43.97 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.581 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -124.09 129.2 50.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -83.33 149.79 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.77 -46.06 29.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.53 7.81 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.05 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 58' ' ' ALA . 4.7 m -95.9 126.09 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 111.438 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -102.41 98.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.092 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.6 pp -101.99 151.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 112.176 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 48' ' ' ILE . 16.2 m -132.26 159.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.186 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.75 117.06 3.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -64.83 106.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.02 -1.24 63.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.11 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -174.04 2.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.834 0.317 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.0 32.89 3.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.853 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -37.9 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.161 0.505 . . . . 0.0 110.665 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.44 -171.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.624 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.66 130.62 91.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.657 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.65 113.15 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.507 2.138 . . . . 0.0 112.484 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -141.14 -72.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.171 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -160.12 148.06 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.029 0.442 . . . . 0.0 111.868 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -129.27 113.96 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 36.5 mt -60.98 72.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.05 -28.64 58.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.399 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.504 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.0 m120 -145.57 169.52 18.24 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.681 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.451 ' CG ' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -166.77 117.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.676 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 ttm -45.42 124.03 4.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.605 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -68.21 105.83 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.623 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.39 -17.25 57.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -178.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 77.1 Cg_exo -51.0 -47.41 25.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.451 ' HB3' ' CG ' ' A' ' 52' ' ' MET . . . -58.43 -49.08 78.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.76 -26.56 62.5 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.738 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -48.96 75.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.9 p -52.87 -37.94 61.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.04 45.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.173 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -117.66 -61.64 1.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' A' ' 103' ' ' ILE . 14.0 mt -66.06 131.09 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.841 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' ILE . 8.9 m-80 -134.18 123.7 24.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.124 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.1 mt -28.38 114.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.968 0.413 . . . . 0.0 111.789 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.98 -6.02 22.03 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.983 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' A' ' 103' ' ' ILE . 14.5 m-20 -68.5 135.6 51.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 110.515 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.51 ' HB3' HG21 ' A' ' 104' ' ' VAL . 1.1 tm0? -92.63 81.52 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -54.9 141.32 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.0 ttm -111.26 -34.21 6.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.691 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 87.1 p -156.96 155.11 30.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 4.9 mt -126.66 121.43 58.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.891 0.376 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 46.97 29.04 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.243 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.09 18.19 25.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.622 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 m -119.42 95.63 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.756 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 72' ' ' SER . 1.4 m -63.56 131.23 47.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.337 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 81' ' ' LEU . 3.2 mt -98.05 22.49 9.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.14 105.87 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.164 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.68 -30.17 8.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.931 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.411 ' CD1' HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -80.53 143.4 55.12 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.94 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.81 169.94 13.69 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.744 2.296 . . . . 0.0 112.667 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.3 tp -58.38 -37.09 74.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.228 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -53.48 -48.61 68.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.733 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.616 ' O ' HG13 ' A' ' 89' ' ' ILE . 26.1 m -64.47 -43.58 93.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.442 ' HB3' HG12 ' A' ' 47' ' ' VAL . 13.6 m -56.6 -54.92 40.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.94 -53.58 25.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.172 0.511 . . . . 0.0 110.508 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -53.14 -32.21 46.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.422 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 20.6 mt -70.04 -36.98 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.201 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 35' ' ' ILE . 4.3 mt -77.64 -35.49 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.509 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -73.86 -42.7 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.981 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.35 39.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.488 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 21.8 mt -88.15 46.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.65 -30.99 41.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.466 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -135.18 69.16 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.567 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.404 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 8.2 mm-40 -119.1 -36.13 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.343 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.3 p 76.3 1.63 3.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.684 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -162.77 143.3 9.62 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.616 0.246 . . . . 0.0 110.883 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 101' ' ' LEU . 4.1 t -137.58 103.54 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 111.671 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -93.04 74.53 4.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.646 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.4 pt? -104.19 119.5 39.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.277 0.56 . . . . 0.0 111.189 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.94 107.28 18.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.426 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.554 HG22 HG12 ' A' ' 70' ' ' ILE . 5.3 pt -103.06 173.6 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.417 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.6 139.72 51.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.316 179.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.967 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.32 145.99 49.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.793 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.585 ' HG2' HG13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -152.9 142.63 21.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 111.99 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.49 72.4 7.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 72.2 t -57.85 125.72 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.25 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.492 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.09 103.83 10.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.249 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 10.1 mm -100.31 103.54 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.09 131.59 45.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.603 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -153.74 -172.85 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.968 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -94.88 145.3 25.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.442 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 5.6 mptt -49.2 122.95 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.056 0.455 . . . . 0.0 110.679 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.35 16.65 22.17 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -121.31 119.79 33.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 111.413 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -77.74 151.05 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.32 -52.24 16.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.316 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.98 -1.33 35.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.144 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -94.63 122.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.09 0.471 . . . . 0.0 111.324 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' CG2' ' ND2' ' A' ' 51' ' ' ASN . 46.1 t -97.17 98.65 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.079 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.8 pp -95.62 149.8 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 112.051 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.409 ' CG2' HD13 ' A' ' 48' ' ' ILE . 2.9 m -133.78 157.72 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.365 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.85 111.99 0.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.853 0.358 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -63.91 139.12 58.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.71 -9.25 4.44 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.373 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.67 176.16 5.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.009 0.404 . . . . 0.0 110.952 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.01 53.89 0.6 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.832 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.24 -35.34 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 0.0 110.632 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -153.0 171.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.53 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.72 109.21 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.69 119.54 3.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.563 2.175 . . . . 0.0 112.598 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 p -135.98 -70.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -160.18 137.61 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -116.08 119.07 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.394 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 53.6 mt -64.75 70.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.34 -33.96 22.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.329 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.21 140.7 13.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.52 . . . . 0.0 110.506 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.414 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 2.8 ttp -123.34 163.03 21.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.408 ' N ' ' CG ' ' A' ' 52' ' ' MET . 2.5 ttm -76.92 137.01 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -80.87 92.78 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.33 -4.4 37.81 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.94 -179.38 50.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.58 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 82.6 Cg_exo -47.36 -47.03 18.51 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.919 2.413 . . . . 0.0 112.902 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.64 -49.48 77.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.259 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.34 -24.78 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -64.45 -47.03 80.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 3.7 t -53.08 -41.73 65.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.802 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.02 85.94 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.349 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' HG23 ' A' ' 21' ' ' VAL . 1.3 mptt -100.16 -56.45 2.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.803 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD21 ' CD1' ' A' ' 103' ' ' ILE . 13.8 mt -70.36 124.49 24.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.204 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 23.1 m-80 -131.09 136.11 48.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.223 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 66' ' ' ILE . 25.0 mt -34.76 124.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.49 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.52 -9.02 48.37 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.985 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HB3' HD12 ' A' ' 103' ' ' ILE . 4.9 m-20 -66.9 120.81 14.21 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.686 0.279 . . . . 0.0 110.693 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.4 82.54 7.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.04 0.448 . . . . 0.0 110.233 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.61 HG12 HG21 ' A' ' 103' ' ' ILE . 2.6 mt -55.68 139.3 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.981 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.9 mmt -106.04 -39.44 5.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.74 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 80.6 p -156.38 164.34 38.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 8.3 mt -128.44 114.3 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.003 0.43 . . . . 0.0 111.471 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.422 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 12.3 p30 42.48 31.94 0.32 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.687 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.84 11.76 27.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.808 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -109.72 95.62 5.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.557 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -56.77 130.01 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.303 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 81' ' ' LEU . 17.4 mt -107.36 22.19 16.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.67 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 t -98.26 112.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.328 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.04 -24.56 30.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -85.08 130.92 50.28 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 117.113 0.457 . . . . 0.0 110.975 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.04 -174.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.613 2.209 . . . . 0.0 112.644 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 tp -72.92 -37.32 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.023 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 m -53.76 -42.72 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' HG13 ' A' ' 89' ' ' ILE . 8.7 m -65.9 -48.02 72.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.9 m -57.0 -53.36 59.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.473 ' NE2' HD13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -49.83 -53.96 22.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 t -53.35 -37.86 62.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 27.5 mt -63.42 -46.44 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 35' ' ' ILE . 3.1 mt -66.57 -37.45 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -33.98 71.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.241 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.33 -14.44 79.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.467 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 94.4 mt -90.93 43.68 1.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.739 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -83.21 -47.78 11.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 1.4 p30 -112.47 57.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.4 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -112.27 -33.9 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.074 0.464 . . . . 0.0 110.09 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.538 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 9.0 t 73.3 5.07 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 2.5 mtm180 -167.37 147.91 5.43 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.356 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 2.8 t -142.65 102.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.0 0.428 . . . . 0.0 111.739 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -92.23 72.54 5.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.5 pt? -99.9 126.47 46.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.067 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.13 114.28 26.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.943 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.61 HG21 HG12 ' A' ' 70' ' ' ILE . 2.5 pt -117.01 173.32 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.452 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 69' ' ' GLN . 3.6 m -128.7 138.29 54.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.217 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.411 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 3.2 mmm-85 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.729 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CE1' ' CG2' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -92.87 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.52 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HG2' HG13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -145.8 150.37 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.26 0.552 . . . . 0.0 112.158 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.71 73.18 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 HG13 ' HG ' ' A' ' 64' ' ' LEU . 93.1 t -59.25 125.77 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.312 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.7 103.74 10.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 mm -99.16 103.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.01 0.434 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 121.14 36.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -171.95 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 111.062 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.56 138.4 38.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -48.32 127.22 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.23 37.81 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 28.6 mm-40 -128.43 130.31 47.43 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.851 0.358 . . . . 0.0 111.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -78.91 154.01 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' CD2' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.81 -52.17 19.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.59 29.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.122 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.428 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 15.9 m -94.46 148.65 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.197 0.522 . . . . 0.0 111.186 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.0 t -126.99 98.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.626 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.2 pp -94.05 149.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.115 0.483 . . . . 0.0 111.523 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.54 162.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.568 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.14 93.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 45' ' ' PRO . 3.3 t -61.58 83.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.604 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.33 62.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.088 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CH2' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -114.35 -170.22 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.029 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.96 65.9 0.59 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.72 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.433 ' CB ' HD12 ' A' ' 43' ' ' ILE . 14.8 t -176.81 142.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.989 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.433 HD12 ' CB ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 51.44 178.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.22 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.53 116.73 60.39 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 38' ' ' SER . 52.6 Cg_exo -55.62 117.3 3.9 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.578 2.186 . . . . 0.0 112.602 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.59 -66.67 0.41 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.366 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.34 165.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 111.455 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -143.83 116.88 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 76.2 mt -62.6 72.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.93 -26.09 5.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.945 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.453 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 4.6 p-10 -164.96 167.54 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.379 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.413 ' HG3' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -154.25 142.4 20.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.724 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.0 139.32 28.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.29 76.66 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.42 -18.51 7.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.669 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.49 -179.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 82.1 Cg_exo -46.85 -45.18 21.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.795 2.33 . . . . 0.0 112.737 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.428 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.2 -47.63 82.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -70.7 -31.14 67.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.245 0.545 . . . . 0.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -62.46 -48.31 80.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.4 t -53.81 -31.15 48.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.98 20.24 72.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.461 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -113.65 -49.21 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.741 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 103' ' ' ILE . 17.8 mt -82.83 119.65 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 111.804 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -119.9 138.34 53.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.866 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 19.9 mt -37.09 131.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.644 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 4.5 59.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.058 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 4.7 m-20 -77.34 121.27 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.776 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -79.11 81.11 5.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 103' ' ' ILE . 3.9 mt -57.56 143.73 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.029 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 11.1 mmt -108.32 -41.96 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.589 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 64.3 p -156.41 155.2 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.008 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.467 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 6.3 mt -120.15 122.57 68.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 48.3 28.25 1.57 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.0 22.26 20.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.396 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -116.01 96.2 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.387 . . . . 0.0 110.796 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.29 135.39 32.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.214 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HA ' HD11 ' A' ' 81' ' ' LEU . 58.8 mt -108.07 3.92 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.321 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 t -84.95 122.5 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.15 -23.42 36.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.833 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.43 127.85 42.58 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.023 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.34 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.692 2.261 . . . . 0.0 112.675 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.3 tp -69.93 -35.11 74.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -53.33 -45.6 69.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.528 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.3 m -65.09 -48.18 74.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.737 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.0 m -56.96 -50.55 72.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.405 ' NE2' HD11 ' A' ' 35' ' ' ILE . 9.1 mm-40 -53.05 -43.39 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 t -64.52 -31.25 72.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.15 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.698 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 27.9 mt -69.53 -36.7 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.937 0.398 . . . . 0.0 109.956 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 90' ' ' ILE . 6.1 mt -77.23 -41.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.388 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -39.24 89.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.552 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.07 -10.76 65.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.755 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 68.8 mt -93.92 37.49 1.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -80.49 -31.06 37.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -127.88 67.19 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.774 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 14.1 mm-40 -121.25 -38.1 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.428 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.8 3.0 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.549 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -166.27 145.47 5.87 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 3.5 t -140.27 103.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -91.91 76.93 5.5 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 pt? -106.06 126.46 52.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.924 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 2.8 m120 -88.93 123.67 33.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.537 HG21 HG12 ' A' ' 70' ' ' ILE . 4.8 pt -122.29 165.91 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 111.868 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.427 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 86.2 t -122.66 147.48 26.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.907 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -74.46 148.13 41.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.979 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -146.81 117.5 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.6 73.21 2.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.42 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 23.0 t -62.46 126.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.011 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.88 103.57 10.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.872 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 58' ' ' ALA . 15.4 mm -101.0 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.162 0.506 . . . . 0.0 110.23 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.24 118.55 36.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -133.43 -170.01 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.023 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.26 135.89 41.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -47.62 120.83 3.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.191 0.52 . . . . 0.0 111.032 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.67 10.85 22.46 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.23 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -128.13 142.12 51.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 pt -93.3 161.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 1.8 tp -47.86 -51.99 20.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.159 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.26 -4.64 41.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.885 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -94.83 127.28 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.052 0.453 . . . . 0.0 111.397 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 11.6 t -95.69 98.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.791 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.3 pp -97.8 150.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 111.771 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 48' ' ' ILE . 16.3 m -133.4 161.38 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.592 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.93 116.16 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -58.95 141.32 54.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.61 -7.21 8.26 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.965 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -174.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.858 0.329 . . . . 0.0 110.846 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.63 48.86 0.94 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.826 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -106.46 -31.08 8.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 110.805 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.18 170.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.517 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.62 110.05 2.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.521 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.04 128.54 22.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.511 2.141 . . . . 0.0 112.564 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.461 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 67.0 p -142.01 -72.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -158.67 144.68 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.169 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -124.43 114.62 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.233 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 48.6 mt -61.52 73.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -58.02 -29.28 65.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.498 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 27.5 m120 -147.5 -177.09 5.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.244 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.4 ptp -173.1 144.34 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tpp -65.82 124.27 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 49.7 p-80 -61.0 87.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.09 -14.24 31.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.73 175.87 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.641 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' CB ' ' HD3' ' A' ' 25' ' ' LYS . 71.9 Cg_exo -50.01 -47.43 23.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.706 2.271 . . . . 0.0 112.885 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' HB3' HG13 ' A' ' 33' ' ' VAL . . . -58.1 -49.44 76.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.0 -27.6 61.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.95 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.589 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.402 ' O ' ' HE3' ' A' ' 63' ' ' LYS . 15.7 p -51.83 -46.88 64.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.33 -24.29 31.06 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.891 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -67.07 -53.93 26.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.009 0.433 . . . . 0.0 110.647 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 103' ' ' ILE . 12.9 mt -72.79 129.97 39.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 0.5 OUTLIER -134.6 137.71 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.158 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.3 mt -39.44 108.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.389 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -5.84 11.19 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.124 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 12.0 m-20 -69.8 119.42 14.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.7 80.04 3.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.04 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.599 HG12 HG21 ' A' ' 103' ' ' ILE . 1.5 mt -55.01 145.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.5 tpp -115.64 -38.8 3.64 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 43.4 t -153.66 164.53 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 14.1 mt -130.04 112.83 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.655 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.1 p30 42.71 32.57 0.39 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.107 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 2.49 31.11 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.371 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -102.32 95.67 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.675 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.08 113.77 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.419 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 82.2 mt -82.53 -12.17 57.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.31 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HA ' ' CG2' ' A' ' 46' ' ' THR . 24.4 t -58.66 103.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.182 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.59 -30.27 9.37 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.7 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 78' ' ' LEU . 1.5 mt -66.54 118.61 55.71 Favored Pre-proline 0 C--N 1.33 -0.241 0 O-C-N 122.832 -0.217 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.39 166.14 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.7 tp -54.39 -42.25 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.152 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 t -53.88 -43.77 69.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.808 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.8 m -68.57 -44.74 73.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.431 ' HB3' HD13 ' A' ' 35' ' ' ILE . 9.6 m -56.97 -56.97 14.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.428 ' NE2' HD12 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -49.73 -54.11 20.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 110.519 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.0 p -51.12 -41.37 60.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.257 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.0 mt -59.75 -45.16 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.96 -38.56 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -47.5 79.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.27 -15.1 50.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.467 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 78.1 mt -91.23 31.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.041 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 29' ' ' GLU . 6.4 tttt -81.01 -37.54 28.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -118.74 62.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.449 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.8 mm-40 -117.76 -41.25 2.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.4 t 78.9 -2.57 2.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.54 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.635 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.49 140.19 8.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.62 0.248 . . . . 0.0 110.451 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 93' ' ' LEU . 5.1 t -136.97 104.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 112.111 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -91.08 73.05 6.36 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.5 pt? -101.81 123.83 46.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.557 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.93 109.32 20.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.599 HG21 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -99.9 165.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.472 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.2 t -119.42 136.97 54.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.792 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.061 179.311 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.862 0.363 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -78.34 148.58 33.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.877 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.61 121.5 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.21 77.29 5.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 27.7 t -68.2 121.18 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.011 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.27 103.64 11.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.509 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 12.7 mm -99.99 103.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.025 0.44 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.93 117.42 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -134.66 -172.11 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.32 136.66 39.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.656 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -47.51 123.55 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.148 0.499 . . . . 0.0 110.811 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.55 12.82 27.66 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.441 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.3 mm-40 -127.15 133.75 50.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.714 0.292 . . . . 0.0 111.265 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.43 154.37 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.406 ' CD2' ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -48.16 -52.11 22.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.025 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.38 -0.39 37.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.454 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 58' ' ' ALA . 2.3 m -94.72 128.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.06 0.43 . . . . 0.0 111.58 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.4 t -100.33 98.27 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.67 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.5 pp -96.95 158.78 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 0.0 111.958 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 48' ' ' ILE . 4.0 m -140.37 157.8 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.412 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.82 121.17 10.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.488 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 5.2 p -58.01 149.21 23.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.13 -23.1 3.97 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.929 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.33 -177.27 1.4 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.13 25.61 3.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.689 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -27.83 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -148.8 178.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.648 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 117.87 29.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.581 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.01 138.38 56.74 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.346 2.03 . . . . 0.0 112.429 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.83 -67.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.255 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 1.4 m -160.39 148.11 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.072 0.463 . . . . 0.0 112.023 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -125.83 117.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.8 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 46.8 mt -61.86 74.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -57.71 -27.85 63.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.643 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 28.3 m120 -148.05 177.46 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.011 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -171.55 128.93 0.67 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.67 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.8 tpp -53.6 136.93 38.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.217 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -77.61 93.63 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.729 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.45 -17.12 28.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.566 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.74 179.02 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.633 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.418 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 81.6 Cg_exo -48.68 -50.26 12.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.777 2.318 . . . . 0.0 112.957 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.16 -49.21 77.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.766 0.317 . . . . 0.0 111.267 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.58 -22.41 61.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -66.0 -48.4 71.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 p -54.22 -43.08 70.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.69 -9.31 78.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.494 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -58.67 2.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.989 0.423 . . . . 0.0 111.107 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 HG22 ' A' ' 103' ' ' ILE . 13.6 mt -68.68 129.55 40.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -134.25 135.06 42.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.033 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 13.0 mt -36.38 109.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 121.028 0.442 . . . . 0.0 111.494 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.48 -0.35 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.214 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.464 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 7.6 m-20 -75.3 118.9 18.71 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.784 0.326 . . . . 0.0 110.705 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -74.39 84.4 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.646 HG12 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -62.44 144.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.416 ' HG3' ' CG2' ' A' ' 104' ' ' VAL . 21.8 mmt -110.05 -41.82 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -158.09 157.75 33.43 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.399 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.423 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 7.1 mt -119.13 118.31 57.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.023 0.44 . . . . 0.0 111.62 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.42 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 11.2 p30 42.37 31.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.87 14.69 24.32 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.945 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -111.62 95.61 5.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.2 p -58.41 126.84 29.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.261 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 89' ' ' ILE . 30.1 mt -97.48 5.55 49.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.223 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 t -88.7 129.6 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.917 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.58 -22.67 37.73 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.817 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.15 144.11 27.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.717 0.294 . . . . 0.0 110.856 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.23 175.46 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.673 2.248 . . . . 0.0 112.435 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.51 -33.24 75.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -53.99 -47.99 70.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.806 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.6 m -64.59 -47.54 78.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.426 ' CB ' HD13 ' A' ' 35' ' ' ILE . 13.6 m -56.88 -51.56 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.67 -37.66 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.0 110.467 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -68.41 -35.0 77.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.979 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 18.8 mt -64.06 -46.37 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.08 -37.63 78.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.614 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -34.34 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.878 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.24 -12.53 76.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.138 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 92.6 mt -93.69 33.67 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 110.525 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.7 ttpt -78.36 -30.46 48.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -124.51 65.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.886 0.374 . . . . 0.0 111.727 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.0 -39.31 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m 75.16 1.91 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.522 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -164.85 142.74 6.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.625 0.25 . . . . 0.0 110.326 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 3.9 t -137.62 103.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.827 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.38 73.78 5.27 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.617 178.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.5 pt? -104.57 122.94 46.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 109.73 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.646 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -103.34 173.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.473 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 71' ' ' MET . 98.2 t -133.99 148.53 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.51 . . . . 0.0 111.665 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.373 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -61.84 148.42 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.375 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -141.92 115.2 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.85 74.41 2.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.81 114.85 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.584 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -108.61 103.39 12.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.574 178.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 6.1 mm -97.49 104.07 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -96.35 112.02 23.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.244 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -134.27 -169.21 2.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.954 0.407 . . . . 0.0 110.997 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -103.45 154.46 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.426 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 95' ' ' ASN . 2.5 mptt -59.54 132.29 53.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.03 14.75 50.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.747 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.4 mp0 -121.07 130.36 53.73 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -84.87 150.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -47.2 -52.04 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.315 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.62 -8.62 37.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.08 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 31' ' ' LEU . 1.4 m -94.86 124.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.67 98.6 7.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.298 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.8 pp -93.61 147.6 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.17 0.509 . . . . 0.0 111.699 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 48' ' ' ILE . 17.1 m -129.19 159.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.197 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.8 114.22 2.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.819 0.342 . . . . 0.0 111.158 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.535 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -62.29 129.15 39.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.43 45.63 1.11 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.663 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -169.84 1.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 59.77 0.35 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.69 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.424 ' CB ' HD12 ' A' ' 43' ' ' ILE . 69.1 m -162.59 151.59 15.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 45.68 -168.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.186 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.04 114.55 64.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.89 131.63 34.91 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.574 2.182 . . . . 0.0 112.4 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.45 -58.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.26 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.51 155.17 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 111.282 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.61 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -140.29 115.6 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.604 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 20.9 mt -60.27 72.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.79 -24.18 21.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.904 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.499 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.15 166.53 31.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.146 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.405 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.1 ttp -154.44 137.04 15.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.6 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.04 117.64 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -62.77 83.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.49 1.45 19.98 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.568 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.89 -178.43 51.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 86.9 Cg_exo -47.87 -50.83 10.95 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 112.793 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.447 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.16 -42.15 85.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 0.0 110.799 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -66.32 -49.3 67.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' A' ' 23' ' ' ILE . 4.7 m -52.42 -40.76 62.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.93 10.97 82.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.31 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -104.8 -48.71 3.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.881 0.372 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 103' ' ' ILE . 13.8 mt -77.76 119.12 20.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.271 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.405 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 7.4 m-80 -123.9 136.68 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.362 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 28.2 mt -40.6 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.639 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.6 -11.46 8.43 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.151 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 4.9 m-20 -72.36 134.14 45.31 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 117.024 0.412 . . . . 0.0 110.857 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.474 ' HB3' HG23 ' A' ' 104' ' ' VAL . 39.6 tt0 -87.6 83.75 7.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.028 0.442 . . . . 0.0 110.015 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.612 HG12 HG23 ' A' ' 103' ' ' ILE . 2.1 mt -52.04 144.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.789 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.42 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 6.3 mmt -109.24 -41.51 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.8 p -160.99 158.41 27.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.332 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.419 ' CG2' ' CD1' ' A' ' 93' ' ' LEU . 7.0 mt -122.27 118.2 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.263 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 52.22 25.81 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.92 32.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.55 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.407 ' CG2' HD11 ' A' ' 89' ' ' ILE . 18.7 m -107.89 95.76 5.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.726 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.68 131.64 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.234 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -101.48 1.18 37.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.322 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.36 132.81 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.19 -23.71 32.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.64 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.68 140.21 21.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 178.45 2.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.204 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.8 tp -63.98 -33.47 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 p -53.94 -45.7 71.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.821 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.7 m -67.1 -47.76 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.403 ' HB3' HD13 ' A' ' 35' ' ' ILE . 13.3 m -57.23 -47.17 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -56.31 -45.97 80.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -60.26 -35.44 75.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 39.8 mt -63.26 -46.0 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 90' ' ' ILE . 3.9 mt -62.91 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.791 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -42.22 98.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.175 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.13 -13.24 64.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.252 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 92.2 mt -94.06 37.36 1.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.932 0.396 . . . . 0.0 110.677 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -81.85 -41.2 21.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -120.85 64.18 0.86 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 9.2 mm-40 -113.95 -36.19 4.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 1.7 t 77.62 -2.34 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.697 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.4 mtm180 -161.99 148.46 13.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.569 0.223 . . . . 0.0 110.564 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 5.0 t -141.26 103.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 111.766 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -93.13 75.38 4.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 pt? -107.45 124.55 50.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -90.83 120.28 31.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.214 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.612 HG23 HG12 ' A' ' 70' ' ' ILE . 4.7 pt -117.39 150.89 19.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.546 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.5 m -104.12 135.07 43.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.276 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.95 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.825 0.345 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.26 148.54 47.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.448 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -143.67 118.88 10.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.25 76.63 3.8 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 46.4 t -67.23 128.8 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.797 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.22 103.61 10.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.891 178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 57' ' ' PRO . 9.3 mm -99.93 102.94 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -100.96 114.66 28.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.145 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 97' ' ' SER . 6.4 pttt -131.47 -168.69 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.18 137.14 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.6 mttt -50.21 125.46 12.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.126 0.489 . . . . 0.0 110.803 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.67 12.71 31.9 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 5.2 mm-40 -126.33 135.2 51.2 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.401 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.07 150.07 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.238 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD2' HG23 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.99 -52.19 20.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.307 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.75 10.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.856 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -112.27 129.57 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.1 t -108.64 98.59 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.108 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -97.78 156.42 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.41 ' CG2' HD13 ' A' ' 48' ' ' ILE . 27.0 m -141.54 155.18 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.407 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.22 119.47 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 111.185 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.507 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 1.7 p -57.44 135.32 56.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.719 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.89 -5.2 47.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.158 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -91.17 -177.64 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.99 0.395 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.13 26.2 3.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.78 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -30.91 58.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.199 0.523 . . . . 0.0 110.752 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.65 174.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.487 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.45 109.16 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.794 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 129.68 35.76 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.252 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.3 p -142.85 -75.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.09 137.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.448 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -114.39 119.49 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.27 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 50.1 mt -64.18 73.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -51.41 -25.87 6.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.296 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.9 p-10 -173.57 150.29 1.76 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -129.55 167.63 17.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.678 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.426 ' N ' ' CG ' ' A' ' 52' ' ' MET . 2.1 ttm -82.99 128.45 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.44 104.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.94 -21.17 47.48 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.14 174.89 1.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.433 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 81.8 Cg_exo -48.28 -45.49 26.01 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.7 2.266 . . . . 0.0 112.735 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB1' ' CG1' ' A' ' 33' ' ' VAL . . . -58.47 -47.14 85.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -30.18 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.16 82.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.774 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.4 p -53.03 -39.48 63.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.123 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.58 72.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.272 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -117.22 -40.53 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.445 ' CD2' HD11 ' A' ' 103' ' ' ILE . 10.6 mt -88.96 111.24 21.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.308 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -114.16 144.63 42.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.0 mt -44.84 125.03 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.21 38.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.169 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 24.4 m-20 -73.11 125.84 28.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.621 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.524 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -85.59 79.8 9.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.11 0.481 . . . . 0.0 110.43 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.593 HG12 HG21 ' A' ' 103' ' ' ILE . 2.1 mt -53.24 141.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.876 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -33.84 5.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 35.2 t -159.87 156.49 27.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.664 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 9.3 mt -129.23 115.98 38.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.494 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 53.04 23.91 3.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.2 35.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 72' ' ' SER . 11.8 m -106.68 95.05 5.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.937 0.368 . . . . 0.0 110.509 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.6 p -69.06 128.71 37.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.376 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HA ' ' CG ' ' A' ' 81' ' ' LEU . 1.1 mp -94.4 13.3 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.025 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.89 106.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.52 -31.81 7.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.896 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.62 138.82 43.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.983 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 179.35 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.77 2.314 . . . . 0.0 112.507 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.24 -31.81 73.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -48.18 70.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.006 0.431 . . . . 0.0 110.585 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 89' ' ' ILE . 25.8 m -68.11 -45.76 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.807 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -56.77 -44.26 81.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.726 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 9.8 mm-40 -58.6 -52.33 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 3.4 t -56.76 -32.16 65.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -62.74 -46.35 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.6 mt -61.52 -35.33 66.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.898 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 23.4 mmtt -61.71 -48.69 79.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.125 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.55 -11.55 57.06 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.346 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 83.4 mt -89.28 27.78 1.36 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.914 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -84.71 -40.09 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.435 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -119.79 62.7 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.419 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.7 mm-40 -119.25 -41.01 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.5 t 79.55 -3.24 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.513 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.592 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -160.01 142.82 13.64 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 93' ' ' LEU . 3.3 t -140.25 103.27 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -90.53 74.04 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.4 pt? -102.74 120.93 41.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.622 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.95 114.44 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.593 HG21 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -111.79 171.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.014 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.7 m -125.84 145.84 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.616 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.486 179.486 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.402 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -72.35 137.93 46.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.082 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -129.9 116.78 19.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.44 71.73 2.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 46.7 t -58.92 124.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.403 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.04 103.52 11.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.858 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 5.8 mm -99.34 102.97 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.48 114.01 27.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.383 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -129.89 -169.63 2.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.1 132.7 49.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -45.64 118.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.176 0.512 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.75 12.62 16.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.256 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 94' ' ' LYS . 6.7 mm-40 -130.48 128.01 40.35 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 111.334 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -72.17 153.34 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -49.47 -52.1 31.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.66 20.83 9.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.869 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -114.72 127.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.433 . . . . 0.0 111.11 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.1 97.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.839 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.5 pp -100.94 145.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.926 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.457 ' CG2' HD12 ' A' ' 48' ' ' ILE . 6.1 m -125.98 160.16 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.189 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.34 117.25 5.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -61.61 97.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.711 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.22 4.45 81.01 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.212 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -175.78 5.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.887 0.344 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.03 32.75 3.71 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.76 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -39.83 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 110.71 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.64 175.65 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.687 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 110.59 2.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.79 129.75 21.43 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.532 2.155 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 -66.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.201 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.42 151.65 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.887 0.375 . . . . 0.0 111.739 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -138.63 115.44 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.889 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 37.9 mt -60.54 71.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.34 -26.3 11.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.3 p-10 -177.46 145.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.331 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.7 ptp -116.48 -170.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.0 tpp -94.46 125.22 38.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.0 81.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.796 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.37 20.44 7.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.41 175.56 28.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.454 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 88.7 Cg_exo -47.48 -46.14 21.14 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.693 2.262 . . . . 0.0 112.807 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 33' ' ' VAL . . . -58.43 -48.22 81.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.44 -34.36 72.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 110.554 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -58.5 -48.74 79.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.4 p -50.5 -39.86 49.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.01 2.39 82.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.599 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -96.94 -37.1 10.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 103' ' ' ILE . 13.0 mt -91.67 111.64 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -110.19 141.0 43.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.9 mt -42.68 121.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.25 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.64 1.87 43.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.086 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB3' HD13 ' A' ' 103' ' ' ILE . 6.4 m-20 -71.49 130.73 42.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 110.782 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.59 78.25 9.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.638 HG12 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -55.62 144.7 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.104 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.413 ' CG ' ' CG2' ' A' ' 104' ' ' VAL . 15.3 mmt -111.11 -41.65 4.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.1 p -160.57 160.43 31.79 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.302 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.468 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 8.7 mt -120.41 115.56 47.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.544 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.421 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 9.8 p30 43.46 33.08 0.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.853 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.94 33.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.133 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -108.59 95.64 5.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.353 . . . . 0.0 110.695 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.54 130.71 48.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.131 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.404 ' CD2' HD11 ' A' ' 89' ' ' ILE . 26.2 mt -99.78 6.41 45.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.249 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.79 128.91 43.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.14 -23.98 33.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.45 143.87 27.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.885 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.31 178.67 2.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.635 2.223 . . . . 0.0 112.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 tp -66.87 -35.06 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.967 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 m -53.81 -40.59 66.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.527 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.3 m -71.83 -48.77 43.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.918 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 10.1 m -56.95 -48.91 77.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.782 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -58.7 -46.74 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.331 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -59.01 -35.49 73.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.936 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 85' ' ' THR . 11.4 mt -62.67 -45.27 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -60.92 -35.44 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.984 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -49.29 75.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.028 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.24 -11.01 60.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.103 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 44.8 mt -86.61 18.16 3.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.608 0.242 . . . . 0.0 110.928 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -82.58 -33.66 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.539 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.83 62.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.409 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -124.32 -40.22 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.07 0.462 . . . . 0.0 110.346 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 79.46 -2.06 2.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.59 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.55 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.8 mtm180 -161.13 142.03 11.42 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.96 103.61 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.863 0.364 . . . . 0.0 111.846 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' NZ ' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.45 73.86 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 73' ' ' ILE . 2.4 pt? -102.74 123.65 46.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.28 122.85 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.638 HG22 HG12 ' A' ' 70' ' ' ILE . 2.4 pt -117.4 162.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.706 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.413 ' CG2' ' CG ' ' A' ' 71' ' ' MET . 41.3 t -107.35 132.06 55.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.398 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.151 0.5 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 149.31 25.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.995 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 115.38 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.33 79.07 3.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 40.4 t -69.11 122.41 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.921 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.45 103.07 10.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.423 178.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 9.4 mm -97.75 103.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -103.49 113.43 26.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.896 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -135.96 -174.39 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.807 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -89.53 141.24 28.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.503 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -49.45 119.69 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 110.651 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . 109.0 13.84 16.83 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.054 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.0 mp0 -119.13 127.63 53.52 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.514 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.42 146.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.753 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.49 -39.83 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.824 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.49 61.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.373 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 31' ' ' LEU . 6.2 m -104.18 126.85 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.226 0.513 . . . . 0.0 111.443 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.5 t -100.85 98.29 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.3 pp -100.74 148.11 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.228 0.537 . . . . 0.0 111.774 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.404 ' CG2' HD13 ' A' ' 48' ' ' ILE . 15.7 m -129.7 160.28 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.427 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.41 108.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.531 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 30.5 t -59.17 138.93 57.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.749 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.37 1.79 5.73 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.26 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.424 ' CD1' ' OG ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -81.2 -178.87 7.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.988 0.394 . . . . 0.0 110.888 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.43 55.56 0.58 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.33 -37.64 4.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.214 0.53 . . . . 0.0 111.007 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -149.97 174.8 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.14 109.12 1.51 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.75 129.59 34.78 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.113 . . . . 0.0 112.513 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.02 -59.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.8 140.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 0.0 111.655 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -124.28 116.32 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.764 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 64.9 mt -62.7 71.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -28.68 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 25.3 m120 -146.75 168.57 21.03 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.94 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.427 ' CE ' ' HA ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -166.09 134.73 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.24 127.19 26.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -73.78 68.93 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.45 -21.4 3.63 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.35 -176.07 0.61 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.64 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 84.1 Cg_exo -48.0 -44.07 28.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.749 2.299 . . . . 0.0 112.766 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . -58.68 -49.53 77.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.86 -29.68 64.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.514 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -62.99 -48.31 79.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.968 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -53.06 -38.25 62.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.15 19.0 70.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.263 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -116.35 -52.81 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.949 0.404 . . . . 0.0 110.747 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 103' ' ' ILE . 9.7 mt -77.97 120.65 23.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.51 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 13.7 m-80 -129.55 134.7 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.364 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 9.0 mt -33.34 122.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.37 2.31 55.63 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 12.1 m-20 -77.25 120.91 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.803 0.335 . . . . 0.0 110.618 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 86.46 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.625 HG12 HG21 ' A' ' 103' ' ' ILE . 1.5 mt -62.75 143.21 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.36 -40.11 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.813 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.8 p -159.73 156.91 28.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.182 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.456 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 6.9 mt -120.88 125.28 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.13 29.56 0.82 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.44 23.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.369 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.3 m -119.7 95.98 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.5 t -56.0 138.57 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 73' ' ' ILE . 19.5 mt -109.1 4.32 22.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.04 126.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.92 -25.31 28.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.872 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.18 147.36 34.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.796 0.331 . . . . 0.0 111.016 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.48 173.97 8.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.354 . . . . 0.0 112.639 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.1 tp -62.36 -37.2 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -53.67 -46.42 70.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 89' ' ' ILE . 4.0 m -65.27 -44.28 88.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.422 ' HB3' HD12 ' A' ' 35' ' ' ILE . 11.8 m -57.0 -56.2 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.785 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.408 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -49.44 -53.94 20.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.167 0.508 . . . . 0.0 110.854 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -53.72 -39.71 65.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.482 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.684 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 10.0 mt -61.64 -36.9 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mt -77.99 -44.41 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.019 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.98 91.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.08 -17.36 44.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 69.9 mt -93.27 26.82 2.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.267 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -78.13 -12.23 59.98 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.983 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -134.52 48.46 2.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.877 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 15.4 mm-40 -111.76 -33.21 6.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 110.336 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 77.95 -0.55 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.737 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.572 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.3 mtm180 -160.31 142.87 13.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.598 0.237 . . . . 0.0 110.515 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.35 103.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.898 0.38 . . . . 0.0 111.993 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -91.09 75.4 6.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.804 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 73' ' ' ILE . 2.4 pt? -106.21 120.47 41.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 107.96 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.625 HG21 HG12 ' A' ' 70' ' ' ILE . 1.3 pt -103.33 174.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.01 129.12 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.13 0.491 . . . . 0.0 111.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.363 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.897 0.379 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -77.15 148.27 36.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.6 120.25 9.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 79.92 6.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 42.7 t -69.31 122.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.882 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.97 103.25 10.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.252 178.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 12.1 mm -97.26 102.38 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 19.2 mt-10 -95.08 109.84 21.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.492 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -130.03 -169.9 2.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.829 0.347 . . . . 0.0 110.96 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.74 137.11 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 6.3 mttp -47.49 124.56 7.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 110.779 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.01 14.35 24.91 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 78.8 mm-40 -130.45 130.72 44.61 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.635 0.255 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -81.24 151.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.128 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' CD1' HG12 ' A' ' 99' ' ' VAL . 0.5 OUTLIER -47.95 -42.41 27.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.089 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.04 6.62 59.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.034 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.414 ' CG1' ' HB1' ' A' ' 58' ' ' ALA . 4.2 m -95.76 143.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.42 . . . . 0.0 111.392 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -119.72 98.65 6.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 pp -95.18 153.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 112.067 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.404 ' CG2' ' CD1' ' A' ' 48' ' ' ILE . 2.8 m -130.21 156.91 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.408 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.79 93.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.746 0.308 . . . . 0.0 111.352 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.478 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 6.8 p -63.43 104.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.479 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.59 17.28 8.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.014 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -69.44 176.68 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 110.923 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.44 57.56 4.19 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.518 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.413 ' O ' HD12 ' A' ' 43' ' ' ILE . 8.3 t -159.63 145.59 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 45.72 -171.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.55 128.64 52.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.04 118.14 4.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.53 2.153 . . . . 0.0 112.799 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.417 HG21 HG22 ' A' ' 79' ' ' VAL . 47.3 p -141.64 -73.81 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.021 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.07 141.05 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.745 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -118.37 118.28 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.897 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 58.0 mt -62.83 72.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.38 -28.25 58.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.512 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.0 m120 -145.98 173.59 12.02 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.961 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.442 ' CG ' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -171.76 131.78 0.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.903 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 tpp -56.24 123.49 14.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.51 89.47 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.675 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.83 7.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.1 -163.8 25.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.292 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 52.9 Cg_exo -55.93 -51.3 9.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.662 2.242 . . . . 0.0 112.711 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 52' ' ' MET . . . -58.36 -49.31 77.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.88 -28.14 65.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -64.47 -48.27 75.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 p -51.17 -39.8 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.004 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.74 23.79 59.37 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -121.12 -52.7 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.723 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' CD2' HD13 ' A' ' 103' ' ' ILE . 12.7 mt -77.82 119.79 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.553 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ILE . 2.4 p30 -127.52 133.28 49.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.248 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.512 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.5 mt -32.4 117.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.973 0.416 . . . . 0.0 111.769 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.16 4.81 29.03 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.134 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HB3' HD13 ' A' ' 103' ' ' ILE . 2.7 m-20 -80.32 127.77 32.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 110.771 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.91 83.34 7.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.639 HG12 HG22 ' A' ' 103' ' ' ILE . 1.9 mt -62.19 144.08 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.012 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.406 ' CG ' ' CG2' ' A' ' 104' ' ' VAL . 24.6 mmt -112.85 -36.39 5.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.862 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 52.4 p -160.3 160.11 32.12 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.238 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 9.5 mt -127.5 123.83 62.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.769 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 46.29 29.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.55 17.3 31.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.664 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -111.36 95.83 5.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.372 . . . . 0.0 110.578 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 m -57.29 124.2 18.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 45.7 mt -97.38 21.16 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 46' ' ' THR . 2.7 t -93.02 113.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.281 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.16 28.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.292 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -83.73 142.05 42.04 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 117.034 0.417 . . . . 0.0 110.934 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 -179.58 2.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.661 2.241 . . . . 0.0 112.45 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -66.15 -31.56 72.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -56.42 -45.92 80.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -67.9 -48.0 67.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.409 ' CB ' HD11 ' A' ' 35' ' ' ILE . 13.4 m -57.32 -53.07 62.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -55.59 -40.16 71.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.95 0.405 . . . . 0.0 110.484 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 p -66.64 -29.27 69.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.963 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 3.8 mt -69.73 -46.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 35' ' ' ILE . 5.4 mt -62.25 -38.99 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.473 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -37.65 79.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.54 -9.5 73.96 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 68.8 mt -93.36 27.33 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.727 0.298 . . . . 0.0 110.786 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -80.96 -33.79 33.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.456 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m-80 -120.53 63.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.934 0.397 . . . . 0.0 111.792 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.433 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -124.65 -41.76 2.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.9 m 77.97 2.03 2.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.293 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.581 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -164.06 138.73 5.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.448 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 31' ' ' LEU . 3.5 t -135.91 103.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.991 0.424 . . . . 0.0 112.023 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.514 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -90.04 72.91 7.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.5 pt? -103.14 120.44 40.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 111.404 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -88.66 112.83 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 70' ' ' ILE . 2.2 pt -106.31 174.17 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.249 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.406 ' CG2' ' CG ' ' A' ' 71' ' ' MET . 46.1 t -130.6 148.56 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.158 0.504 . . . . 0.0 111.788 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.365 179.592 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.835 0.35 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -70.29 148.61 48.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -148.3 115.58 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.2 77.54 3.01 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 38.5 t -67.19 117.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.06 103.33 11.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.419 178.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 6.1 mm -98.94 103.24 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.845 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 109.97 22.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.178 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -128.36 -170.55 2.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.84 139.7 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.552 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 14.1 mttt -50.18 125.69 12.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.165 0.507 . . . . 0.0 110.826 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.55 15.19 30.27 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 94' ' ' LYS . 13.1 mm-40 -120.53 136.86 54.65 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 111.596 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.14 147.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.231 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.424 ' CD2' ' CG2' ' A' ' 33' ' ' VAL . 7.4 tp -49.94 -45.67 51.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -0.1 62.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.017 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 1.1 m -94.55 125.26 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.318 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.26 98.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.233 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.0 pp -94.95 150.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.176 0.513 . . . . 0.0 111.787 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 48' ' ' ILE . 2.4 m -132.67 158.94 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.31 117.57 5.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -60.65 139.69 57.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.796 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.51 33.86 2.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.724 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -170.73 1.71 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.44 65.67 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.711 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.432 ' CB ' HD11 ' A' ' 43' ' ' ILE . 48.5 m -164.62 151.06 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.432 HD11 ' CB ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 47.96 -174.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.238 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.8 113.53 58.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.642 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 70.9 Cg_exo -49.12 131.6 26.44 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.599 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' ' CE ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -163.73 -60.48 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.14 152.17 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.002 0.43 . . . . 0.0 111.881 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -134.61 118.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.859 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 47.4 mt -63.25 74.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.3 -34.36 66.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.382 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -140.9 177.55 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.003 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.414 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.85 122.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.598 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -46.52 132.03 10.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.505 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.55 81.46 4.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.3 5.37 8.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.829 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.36 -176.95 51.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.405 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HB3' HG23 ' A' ' 23' ' ' ILE . 70.7 Cg_exo -51.47 -47.74 24.66 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.53 2.153 . . . . 0.0 112.398 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.4 -43.38 88.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.69 -29.77 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.591 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.06 -48.92 74.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.1 p -53.16 -39.73 63.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.79 72.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -109.48 -52.8 2.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.622 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 HG22 ' A' ' 103' ' ' ILE . 12.3 mt -76.05 120.61 21.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.408 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.75 136.54 53.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.156 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -37.17 110.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.66 3.33 22.22 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.127 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 11.6 m-20 -78.16 119.56 21.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.908 0.385 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -75.06 86.61 2.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 103' ' ' ILE . 2.0 mt -64.7 144.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.41 ' CE ' ' CG2' ' A' ' 46' ' ' THR . 4.4 mmt -110.8 -39.84 4.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.709 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.7 p -160.35 157.28 27.64 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.376 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.419 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 6.8 mt -122.12 124.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.482 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 46.46 28.74 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.035 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.99 21.63 22.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.579 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.4 m -115.86 95.84 5.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.369 . . . . 0.0 110.907 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -60.07 122.05 13.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.7 mt -91.37 12.17 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.264 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 4.2 t -87.24 126.31 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.61 -24.1 33.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.634 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.56 142.97 25.87 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.52 171.68 12.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.539 2.159 . . . . 0.0 112.429 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.12 -30.09 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 p -54.61 -49.6 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.794 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -68.07 -42.07 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.433 ' CB ' HD11 ' A' ' 35' ' ' ILE . 15.5 m -57.41 -52.22 66.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.33 -40.69 82.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.324 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 m -64.98 -30.03 70.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.566 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 2.3 mt -69.13 -46.15 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mt -65.84 -38.67 82.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.67 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.14 71.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.067 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.69 -14.09 81.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.185 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 90.5 mt -91.93 38.28 0.99 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.94 0.4 . . . . 0.0 110.598 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.8 mtpt -81.36 -35.04 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 15.6 m-80 -121.92 63.63 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.756 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.58 -39.62 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.58 -4.14 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.599 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.54 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.4 mtm180 -160.92 138.46 9.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 17.7 t -133.74 103.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 112.168 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.508 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.09 79.75 5.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.608 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' A' ' 21' ' ' VAL . 2.3 pt? -110.46 120.49 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.113 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.03 108.7 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.649 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -104.48 174.15 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.3 t -132.77 144.44 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.088 0.47 . . . . 0.0 111.683 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 179.501 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.36 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.59 148.4 24.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.415 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.08 7.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.48 75.74 2.53 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' HB ' ' HG ' ' A' ' 101' ' ' LEU . 41.5 t -67.9 123.49 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.538 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.27 103.24 10.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.452 178.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 11.0 mm -98.03 103.5 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.846 0.355 . . . . 0.0 111.143 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 128.87 41.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.076 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.12 -173.75 4.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 111.169 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.82 136.51 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -47.21 120.39 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.141 0.496 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 12.2 22.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.337 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -122.98 133.19 54.38 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.84 0.352 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.2 pt -83.11 150.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' HB3' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -47.46 -40.19 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.04 31.1 11.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.868 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.442 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 3.5 m -125.1 124.35 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.411 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.15 98.26 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.009 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.7 pp -99.75 144.9 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.029 0.443 . . . . 0.0 111.854 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' CG2' HD13 ' A' ' 48' ' ' ILE . 3.7 m -124.32 155.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.29 111.12 0.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 111.162 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -61.34 84.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.803 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.19 22.78 36.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.844 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.56 -179.44 6.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.98 72.79 0.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.527 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -174.68 147.26 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.313 . . . . 0.0 110.957 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 44.83 -167.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.96 128.5 47.63 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.615 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.55 130.43 31.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.542 2.161 . . . . 0.0 112.464 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 t -161.8 -62.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.743 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 3.2 m -160.88 150.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 112.035 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -138.85 113.88 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 35.8 mt -60.17 72.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -34.61 62.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.403 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.1 m-80 -141.68 179.54 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.982 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.424 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -171.66 125.41 0.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.636 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.23 124.01 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.35 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -72.24 88.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.37 26.1 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.41 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.45 -176.43 20.74 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 89.3 Cg_exo -48.65 -46.12 25.27 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.596 2.197 . . . . 0.0 112.731 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.67 -49.25 78.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.51 -33.94 73.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.243 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -48.63 79.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -53.96 -37.9 64.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.77 17.06 79.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.808 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.62 -53.46 2.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.418 HD21 HG12 ' A' ' 103' ' ' ILE . 15.4 mt -76.08 120.93 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.357 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' ILE . 15.8 m-80 -127.05 133.07 50.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.125 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.508 HG23 HD12 ' A' ' 66' ' ' ILE . 27.5 mt -33.69 113.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.963 0.411 . . . . 0.0 111.935 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.89 -6.87 15.42 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.17 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 33.6 m-20 -70.47 127.88 34.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.56 0.219 . . . . 0.0 110.519 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.518 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -87.66 81.27 7.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.121 0.486 . . . . 0.0 110.669 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.597 HG12 HG23 ' A' ' 103' ' ' ILE . 2.8 mt -54.3 137.2 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.057 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.0 mmt -105.56 -37.61 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 92.4 p -157.4 153.47 27.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 111.172 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 4.2 mt -124.07 123.95 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.446 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 48.01 28.34 1.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.86 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.402 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -124.72 95.79 4.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.3 130.13 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' CD2' ' CD1' ' A' ' 89' ' ' ILE . 21.2 mt -95.77 14.29 23.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 t -74.64 112.7 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.499 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.39 -39.45 2.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.068 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.32 146.43 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.995 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.44 167.88 12.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.9 tp -62.98 -35.05 78.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.86 -42.93 69.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.559 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.562 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.1 m -69.85 -44.45 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.44 ' CB ' HD12 ' A' ' 35' ' ' ILE . 9.8 m -56.62 -53.46 57.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.426 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 3.5 mm-40 -52.9 -50.4 63.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 p -56.05 -36.46 68.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.272 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 85' ' ' THR . 19.9 mt -63.72 -33.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 mt -70.23 -36.03 65.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.456 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.5 mppt? -75.38 -47.15 28.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.45 -25.4 27.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.393 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 3.5 pp -99.57 31.7 3.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.009 0.433 . . . . 0.0 110.577 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -22.31 50.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.824 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -121.65 52.38 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.417 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 37.8 mm-40 -113.49 -31.26 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.2 m 70.58 10.65 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.538 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.3 mtm180 -168.92 139.68 2.4 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.231 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 23' ' ' ILE . 4.7 t -136.88 103.69 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -90.63 76.68 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.44 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.4 pt? -107.93 120.78 43.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.316 0.579 . . . . 0.0 111.613 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.92 112.97 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.122 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.597 HG23 HG12 ' A' ' 70' ' ' ILE . 1.1 pt -112.88 160.42 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.613 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' A' ' 69' ' ' GLN . 7.2 m -109.39 140.99 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.825 -179.639 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.445 ' CE1' HG23 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -75.58 148.56 38.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.124 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -148.46 117.27 6.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.38 82.1 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -71.87 123.12 25.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.857 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.62 103.73 11.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 11.8 mm -99.62 103.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.963 0.411 . . . . 0.0 110.947 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.74 123.76 38.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.12 -169.75 3.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 111.133 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -101.24 147.83 25.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.31 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 5.5 mttp -55.12 130.84 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.081 0.467 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.76 13.17 54.3 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.639 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.73 139.18 52.68 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.807 0.337 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -87.22 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -52.26 18.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 114.43 -14.1 20.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.344 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' A' ' 58' ' ' ALA . 15.0 m -94.09 128.3 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.614 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.04 98.46 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.886 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.5 pp -94.51 140.93 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 111.587 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 48' ' ' ILE . 28.9 m -124.38 161.36 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.183 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.55 118.87 4.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.738 0.304 . . . . 0.0 111.14 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.472 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.29 136.95 48.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.48 -0.95 3.98 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.116 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.65 -177.47 1.55 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.086 0.443 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.46 54.73 0.59 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.787 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.2 m -116.31 -39.96 3.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.267 0.556 . . . . 0.0 110.766 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.405 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -149.21 179.84 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.445 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.13 131.13 95.04 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.304 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.43 141.42 95.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.572 2.181 . . . . 0.0 112.912 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -168.27 -61.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.419 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -161.34 153.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.576 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -141.13 115.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 53.5 mt -61.38 71.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -49.07 -27.55 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.4 p-10 -163.79 179.48 7.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.283 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.6 ttp -160.92 155.4 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.8 139.55 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.821 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -76.36 99.87 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.15 -19.3 52.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.2 175.44 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.593 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 80.0 Cg_exo -46.81 -45.74 19.77 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.79 2.327 . . . . 0.0 112.876 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . -58.63 -49.32 77.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.378 . . . . 0.0 111.133 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -72.48 -26.02 61.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -60.39 -48.02 83.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' A' ' 63' ' ' LYS . 5.1 t -54.69 -38.09 66.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.749 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.17 12.16 83.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.941 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -104.42 -45.18 4.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.965 0.412 . . . . 0.0 110.999 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.4 mt -81.6 117.11 21.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.532 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.2 137.45 51.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.896 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 20.0 mt -40.25 117.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.85 -3.1 25.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.174 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' HD12 ' A' ' 103' ' ' ILE . 1.7 m-20 -68.55 133.48 48.62 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.563 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -89.5 81.17 6.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.568 HG12 HG23 ' A' ' 103' ' ' ILE . 2.9 mt -55.62 145.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.589 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.52 -38.65 3.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.6 t -156.63 154.09 29.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.431 ' CG2' ' CD2' ' A' ' 93' ' ' LEU . 6.1 mt -123.2 122.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 48.59 27.89 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 20.49 25.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.655 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.4 m -115.75 97.74 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.5 m -53.32 142.44 21.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.03 -5.76 14.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.377 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.3 t -78.44 129.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.405 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.59 -21.4 44.79 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.056 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.15 144.92 28.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.938 0.369 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -174.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.0 tp -75.9 -38.77 57.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.062 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.1 p -53.77 -39.28 65.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.566 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.6 m -68.3 -47.22 68.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.5 m -56.53 -53.82 53.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -53.91 22.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.348 0.594 . . . . 0.0 110.211 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -51.26 -35.7 38.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.128 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 85' ' ' THR . 31.8 mt -68.31 -33.6 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.297 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 mt -76.4 -37.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -38.43 57.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.645 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.3 -17.3 56.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 2.8 pp -109.2 39.2 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.701 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -78.95 -26.09 43.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 17.6 m-80 -121.58 54.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.519 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -114.43 -29.89 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 m 71.44 7.96 6.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.158 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.557 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -166.4 143.09 4.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 110.58 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.68 103.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.959 0.409 . . . . 0.0 111.928 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -89.25 73.66 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 2.5 pt? -104.87 118.04 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.3 0.571 . . . . 0.0 111.491 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 3.3 t-20 -87.3 111.79 21.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.234 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.568 HG23 HG12 ' A' ' 70' ' ' ILE . 6.4 pt -99.48 174.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 18' ' ' PHE . 22.0 t -130.58 144.78 36.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 111.921 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.077 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.904 0.383 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.7 148.48 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -134.43 117.51 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.15 73.64 2.29 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG1' ' HG ' ' A' ' 64' ' ' LEU . 44.1 t -64.21 120.41 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.554 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.74 102.85 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.445 178.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 98' ' ' ARG . 8.7 mm -99.03 103.4 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.132 0.491 . . . . 0.0 110.58 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.08 109.93 22.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.317 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.04 -174.2 3.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.974 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -97.06 134.68 40.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.493 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -46.64 119.32 2.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.51 12.55 16.71 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.365 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' LYS . 4.3 mm-40 -130.19 130.11 44.27 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.396 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CG2' ' CG ' ' A' ' 94' ' ' LYS . 1.1 pt -80.5 154.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.142 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD12 ' CB ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -49.26 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.65 7.87 41.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.898 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG13 ' CB ' ' A' ' 58' ' ' ALA . 13.9 m -100.22 127.2 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.22 101.22 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.216 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -96.48 165.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.204 0.526 . . . . 0.0 112.141 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 48' ' ' ILE . 35.9 m -152.34 148.69 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.6 121.09 6.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.695 0.283 . . . . 0.0 111.338 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.573 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -61.92 152.84 30.88 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.856 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.13 7.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.825 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -175.49 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.781 0.324 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.52 26.34 2.8 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.737 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.19 -26.06 29.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.902 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -147.0 169.15 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.661 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 108.64 1.29 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.829 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.78 118.65 5.57 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.42 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.422 HG21 ' CG2' ' A' ' 79' ' ' VAL . 40.0 p -130.62 -72.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -158.78 137.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 111.684 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -114.59 118.76 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.108 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 68' ' ' ASP . 53.2 mt -63.56 74.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.85 -24.45 23.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.127 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.484 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -157.07 164.99 37.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.086 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.406 ' HE2' ' HA ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -159.88 128.47 4.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.754 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.3 tpp -46.51 131.36 11.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.452 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -76.99 90.21 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.64 -12.58 25.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.43 -175.48 5.36 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.68 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . 73.6 Cg_exo -50.0 -46.06 29.82 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.88 2.386 . . . . 0.0 112.606 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.19 -48.2 81.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.57 -31.32 66.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.252 0.549 . . . . 0.0 110.589 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -60.97 -48.67 80.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.04 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 t -55.28 -30.01 59.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.92 71.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -45.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.758 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 13.5 mt -85.17 114.22 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.46 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' HA ' ' HE2' ' A' ' 52' ' ' MET . 1.0 OUTLIER -120.98 135.13 55.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.8 mt -34.82 119.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.972 0.415 . . . . 0.0 111.683 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.41 1.48 35.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.054 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.2 m-20 -76.44 119.04 19.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.782 0.325 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 12.4 tt0 -75.99 85.71 2.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.599 HG12 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -61.95 144.78 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.174 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.411 ' CG ' ' CG2' ' A' ' 104' ' ' VAL . 5.0 mmt -110.3 -42.39 4.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.0 p -157.71 165.13 36.22 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.032 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' HA ' ' CB ' ' A' ' 101' ' ' LEU . 10.9 mt -126.99 114.57 37.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.032 0.444 . . . . 0.0 111.652 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.419 ' ND2' ' CG2' ' A' ' 73' ' ' ILE . 12.7 p30 43.19 33.36 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.78 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.42 6.06 36.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.938 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -104.85 95.42 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.525 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.9 t -59.22 133.24 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.212 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.4 mt -107.34 16.45 23.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.804 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.422 ' CG2' HG21 ' A' ' 46' ' ' THR . 3.3 t -92.04 113.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.317 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.18 -27.34 20.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.256 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.54 141.22 45.01 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.081 0.44 . . . . 0.0 111.053 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.17 -179.84 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.605 2.203 . . . . 0.0 112.381 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.7 tp -70.06 -33.32 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -54.02 -45.29 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 89' ' ' ILE . 7.0 m -67.34 -50.36 60.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.95 -43.59 81.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -59.4 -46.16 89.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.452 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -61.23 -31.09 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.296 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 23.6 mt -68.09 -46.2 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -63.86 -36.8 77.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -36.03 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.795 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.28 -10.22 73.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.037 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 35.7 mt -92.59 30.91 1.43 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.559 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' CG ' ' CG2' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -86.3 -12.8 48.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.664 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -143.91 58.08 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.715 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 mm-40 -117.75 -37.76 3.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.437 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.51 -4.73 1.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.527 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mtm180 -161.0 141.67 11.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.512 0.196 . . . . 0.0 110.549 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 101' ' ' LEU . 6.3 t -137.83 105.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 111.89 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -93.34 74.24 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.663 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.4 pt? -104.84 123.55 47.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.319 0.581 . . . . 0.0 111.644 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.22 115.61 25.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.599 HG22 HG12 ' A' ' 70' ' ' ILE . 1.2 pt -112.8 174.05 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.563 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 11.2 t -118.16 121.5 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.089 -179.887 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 C--O 1.231 0.109 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 7.9 tttt -143.12 114.79 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.3 78.16 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.716 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.2 t -68.23 123.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.018 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.04 102.86 10.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.127 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 22.3 mm -101.03 103.15 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 2.4 mt-10 -92.82 132.76 36.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -179.54 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 139.53 30.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.9 mttt -49.85 126.08 13.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.731 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.72 33.25 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 94' ' ' LYS . 47.6 mm-40 -127.49 131.2 50.18 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 111.195 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.46 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.07 151.67 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.334 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.076 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.83 -52.09 20.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.89 16.27 17.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.83 HG13 ' HB2' ' A' ' 58' ' ' ALA . 3.6 m -109.01 139.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.05 98.68 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.568 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 90' ' ' ILE . 1.4 pp -95.5 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.971 HG23 HD12 ' A' ' 48' ' ' ILE . 1.8 m -123.53 158.42 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.507 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 95.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.356 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.842 ' HA ' HD11 ' A' ' 48' ' ' ILE . 24.5 p . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.574 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 72.8 Cg_exo . . . . . 0 CA--C 1.527 0.143 0 N-CA-C 112.62 0.2 . . . . 0.0 112.62 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.2 t -162.5 -61.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.56 156.62 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.88 0.372 . . . . 0.0 111.791 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.971 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.8 116.63 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.823 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.93 HD12 ' HB2' ' A' ' 68' ' ' ASP . 62.5 mt -61.42 71.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -55.32 -38.79 69.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.75 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -134.58 165.46 25.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.002 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.44 126.33 1.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.695 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -66.93 75.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.39 -12.17 7.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.716 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.2 -172.2 4.4 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.699 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.556 ' O ' HG23 ' A' ' 23' ' ' ILE . 85.1 Cg_exo -47.03 -47.67 16.21 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.934 2.422 . . . . 0.0 112.905 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.83 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.48 -49.73 76.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.087 0.47 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -48.51 81.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 4.5 t -57.78 -30.09 65.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 110.57 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.75 69.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.3 -54.54 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.865 ' CD2' HD13 ' A' ' 103' ' ' ILE . 24.3 mt -75.65 125.14 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.514 0.674 . . . . 0.0 111.529 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.523 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.1 p30 -132.57 112.42 12.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.396 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' C ' ' O ' ' A' ' 65' ' ' ASN . 7.2 mt -13.61 114.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.7 -3.21 19.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.33 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.93 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -74.91 133.58 41.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.583 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.404 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 2.3 tt0 -89.08 81.23 6.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.95 0.405 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 103' ' ' ILE . 3.7 mt -53.58 145.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.511 ' HE2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -110.21 -41.59 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.86 158.78 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.08 HG21 HD11 ' A' ' 93' ' ' LEU . 9.4 mt -125.48 121.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 49.36 26.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.01 19.38 24.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.731 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.527 HG21 ' CD1' ' A' ' 89' ' ' ILE . 5.4 m -113.12 95.79 5.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.7 p -56.55 125.36 21.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HA ' HD11 ' A' ' 81' ' ' LEU . 40.5 mt -90.99 -3.47 57.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.55 128.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.103 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.48 -20.85 48.67 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.821 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.757 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -99.87 141.65 23.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.826 0.313 . . . . 0.0 110.878 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.86 -176.37 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.566 2.177 . . . . 0.0 112.358 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.8 -32.9 70.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.045 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.8 p -55.43 -41.78 73.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -68.17 -50.58 53.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' A' ' 78' ' ' LEU . 17.8 m -57.13 -48.82 77.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -54.29 -47.56 72.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.969 0.414 . . . . 0.0 110.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -59.2 -32.47 69.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 9.4 mt -67.99 -45.97 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.78 HD11 HG13 ' A' ' 35' ' ' ILE . 5.1 mt -64.07 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.499 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -36.86 79.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.338 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.83 -4.43 76.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.339 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.08 HD11 HG21 ' A' ' 73' ' ' ILE . 64.1 mt -93.16 36.29 1.05 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.813 0.339 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 30' ' ' ILE . 2.5 tttt -85.65 -44.51 12.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.553 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.438 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.4 p-10 -116.82 61.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG3' HD23 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -113.82 -35.4 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.334 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 6.3 m 90.16 -19.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.179 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -167.31 151.51 6.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.174 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.076 HG21 HD12 ' A' ' 31' ' ' LEU . 3.4 t -128.58 110.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -90.86 75.56 6.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.477 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.841 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.4 pt? -107.68 119.12 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.325 0.583 . . . . 0.0 111.736 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 m-20 -86.51 111.55 20.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.246 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.865 HD13 ' CD2' ' A' ' 64' ' ' LEU . 6.8 pt -99.88 174.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.445 . . . . 0.0 111.882 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 71.9 t . . . . . 0 C--O 1.237 0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.6 117.97 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.83 80.12 2.75 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.711 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.7 t -71.91 127.35 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.598 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.03 102.9 9.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.913 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -99.78 103.75 15.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 0.0 110.296 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 112.94 25.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.589 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HD3' ' CG ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -130.47 -170.51 2.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.782 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -95.63 151.74 19.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.4 mttt -60.92 136.98 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.929 0.395 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.21 11.46 62.89 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.555 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.93 135.92 54.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -86.26 148.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.857 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.65 -43.64 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 97.65 4.75 57.97 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.262 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 58' ' ' ALA . 5.2 m -96.44 140.83 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 117.079 0.44 . . . . 0.0 111.301 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.3 t -118.55 98.83 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -97.83 150.98 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 111.937 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.941 HG23 HD12 ' A' ' 48' ' ' ILE . 3.5 m -129.73 164.52 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.494 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.77 103.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.392 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.845 ' HA ' HD11 ' A' ' 48' ' ' ILE . 43.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 52.5 Cg_exo . . . . . 0 C--O 1.231 0.147 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 79' ' ' VAL . 73.3 p -148.91 -71.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.654 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -159.32 142.92 5.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.309 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.941 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -119.99 118.91 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.353 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 43.3 mt -63.49 71.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.44 -29.11 48.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 85.0 m-20 -145.06 173.1 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -171.86 129.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.813 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.468 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -53.16 128.74 28.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.45 99.01 7.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.04 21.22 11.2 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.522 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 -160.57 22.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 44.5 Cg_exo -57.09 -54.44 3.63 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.733 2.289 . . . . 0.0 112.559 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.13 -49.31 77.42 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.33 -28.79 68.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.19 0.519 . . . . 0.0 110.196 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -48.76 78.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.978 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.913 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.5 m -48.46 -40.44 26.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.15 27.66 43.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -47.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.056 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 101' ' ' LEU . 8.2 mt -74.69 107.44 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.032 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.28 138.79 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.761 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 16.9 mt -36.74 114.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.28 -6.15 11.92 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.0 m-20 -72.43 130.33 40.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.682 0.277 . . . . 0.0 110.643 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.515 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -88.25 79.98 7.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.116 0.484 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -55.66 141.78 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttm -116.01 -33.88 4.92 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 94.2 p -153.85 151.96 30.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.77 0.319 . . . . 0.0 111.363 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 93' ' ' LEU . 6.9 mt -125.52 123.83 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.411 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 45.98 29.14 0.7 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.85 20.87 20.2 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.432 ' CG2' HD13 ' A' ' 89' ' ' ILE . 90.8 m -122.96 95.49 4.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.451 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.2 p -68.58 130.88 44.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -97.35 15.79 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.9 t -72.81 108.82 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.184 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.43 -26.82 17.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.207 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.52 144.17 42.55 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.185 0.493 . . . . 0.0 111.019 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.66 177.83 3.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.785 2.323 . . . . 0.0 112.643 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.707 HD13 ' HA ' ' A' ' 36' ' ' VAL . 33.5 tp -64.22 -34.24 77.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -48.64 69.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.999 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 17.5 m -65.87 -45.03 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.409 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 20.6 m -56.76 -54.5 45.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.743 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.641 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.92 -53.49 25.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.259 0.552 . . . . 0.0 110.634 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.548 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 1.5 m -54.47 -34.55 61.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.555 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 7.4 mt -63.96 -46.52 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 35' ' ' ILE . 4.3 mt -61.45 -34.81 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.305 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 2.0 mmmt -68.31 -43.56 77.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.556 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.82 -16.37 51.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.984 HD11 HG21 ' A' ' 73' ' ' ILE . 26.9 mt -91.24 38.47 0.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 111.027 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -80.92 -40.47 24.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.802 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.3 p30 -126.07 59.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.745 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -109.61 -35.5 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 0.8 OUTLIER 81.49 -10.79 1.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.17 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -155.34 150.11 26.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.698 0.285 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.715 HG12 HD22 ' A' ' 101' ' ' LEU . 5.0 t -139.99 103.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.939 0.4 . . . . 0.0 112.002 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -93.89 77.53 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -104.78 121.44 43.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.344 0.592 . . . . 0.0 111.676 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.81 106.79 17.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.289 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.982 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -106.48 174.03 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.208 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -146.01 114.9 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.19 74.03 2.32 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.779 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.4 t -64.9 128.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.78 102.91 9.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.861 HD13 ' OG ' ' A' ' 61' ' ' SER . 12.6 mm -99.04 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.85 0.357 . . . . 0.0 110.906 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.98 128.87 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 31' ' ' LEU . 2.0 pttp -149.57 177.75 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -87.44 142.05 28.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -51.28 126.65 17.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 14.84 34.34 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.443 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.2 mm-40 -123.04 134.0 54.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -86.1 152.06 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.242 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 99' ' ' VAL . 1.7 tp -50.59 -51.96 43.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.91 36.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.649 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 58' ' ' ALA . 8.8 m -95.29 138.98 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.063 0.458 . . . . 0.0 111.057 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.75 98.4 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 HG13 HD11 ' A' ' 90' ' ' ILE . 1.3 pp -95.94 143.72 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 111.729 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.007 HG23 HD12 ' A' ' 48' ' ' ILE . 2.5 m -124.63 161.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.39 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.48 111.87 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.809 ' HA ' HD11 ' A' ' 48' ' ' ILE . 22.7 t . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.887 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.878 0.282 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.5 t -170.69 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.772 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.88 146.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.814 0.34 . . . . 0.0 111.367 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.007 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.25 116.61 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.725 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 68' ' ' ASP . 90.3 mt -61.42 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.39 -38.49 63.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.52 169.16 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.955 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.568 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.83 132.39 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.6 113.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 75.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.75 -4.73 5.1 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.53 -173.16 47.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.649 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' ILE . 76.2 Cg_exo -48.5 -47.12 21.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.757 2.305 . . . . 0.0 112.67 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.38 -49.08 78.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.84 -27.28 64.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -62.73 -48.73 77.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.861 ' OG ' HD13 ' A' ' 23' ' ' ILE . 33.1 m -56.0 -32.24 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.31 4.74 80.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -98.28 -56.39 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 101' ' ' LEU . 12.5 mt -72.19 122.66 21.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 2.5 m120 -131.54 135.74 47.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' ILE . 12.3 mt -35.14 116.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 111.618 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.36 0.8 29.59 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.119 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 1.011 ' HB2' HD12 ' A' ' 49' ' ' ILE . 8.9 m-20 -78.25 113.66 16.43 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.914 0.387 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 79.7 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.136 HG23 HG22 ' A' ' 103' ' ' ILE . 2.2 mt -54.5 145.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.479 ' SD ' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -112.45 -39.45 4.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.5 p -159.23 156.86 29.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.781 0.324 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 93' ' ' LEU . 7.8 mt -124.26 120.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.459 ' ND2' HG13 ' A' ' 99' ' ' VAL . 60.0 m-20 51.93 25.87 3.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.97 27.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.554 HG21 ' CD1' ' A' ' 89' ' ' ILE . 21.7 m -110.71 95.35 5.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 110.66 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.633 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -59.02 128.6 38.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.179 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.772 HD12 HG21 ' A' ' 47' ' ' VAL . 29.8 mt -98.48 -8.91 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.285 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 15.5 t -59.54 109.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.78 -27.09 21.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.952 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -71.9 139.93 83.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.827 0.313 . . . . 0.0 110.723 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.28 179.71 2.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.322 2.015 . . . . 0.0 111.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.53 -41.06 89.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 m -53.9 -36.28 62.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -70.55 -54.34 12.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.008 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.9 m -57.29 -55.27 36.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.828 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -54.29 19.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 110.823 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 t -53.31 -37.29 62.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.554 ' CD1' HG21 ' A' ' 76' ' ' THR . 6.8 mt -63.96 -46.12 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' ILE . 4.2 mt -60.16 -37.59 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.262 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -35.72 70.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.318 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.53 -7.85 83.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.53 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.088 HD11 HG21 ' A' ' 73' ' ' ILE . 87.0 mt -92.51 41.51 1.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.988 0.423 . . . . 0.0 110.688 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -84.77 -48.38 9.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.43 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 7.4 m-80 -116.74 61.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 97' ' ' SER . 1.1 mm100 -108.04 -36.88 6.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.18 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 7.6 t 91.29 -18.51 0.15 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.236 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 151.71 3.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 31' ' ' LEU . 8.0 t -131.31 107.54 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -88.17 77.87 8.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -107.29 119.11 38.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.359 0.6 . . . . 0.0 111.514 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -86.34 107.09 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.128 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.136 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -99.78 164.17 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.479 HG21 ' SD ' ' A' ' 71' ' ' MET . 45.1 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.742 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.531 0.205 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.674 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -160.95 141.79 11.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.359 0.6 . . . . 0.0 112.469 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.4 72.79 8.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.722 HG11 ' HG ' ' A' ' 64' ' ' LEU . 76.8 t -58.58 124.52 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.626 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.96 103.28 11.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.915 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 61' ' ' SER . 13.3 mm -98.29 102.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.985 0.421 . . . . 0.0 110.258 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.94 117.38 33.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.426 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' SER . 22.4 pttt -136.64 -168.33 2.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 152.18 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -59.49 132.96 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.34 13.98 54.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.63 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -122.85 136.26 54.81 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.799 0.333 . . . . 0.0 111.425 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -89.37 161.29 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.806 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.972 HD11 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -51.97 -52.11 52.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.102 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.5 -10.93 35.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.26 127.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.082 0.467 . . . . 0.0 111.367 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.01 100.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.808 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.688 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.4 pp -90.25 137.46 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.094 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.053 HG23 HD12 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -119.95 161.48 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.646 ' H ' HD12 ' A' ' 83' ' ' LEU . 2.1 tt0 -63.2 117.99 7.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.806 0.336 . . . . 0.0 110.796 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.657 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.031 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 C--O 1.23 0.115 0 CA-C-O 120.776 0.24 . . . . 0.0 112.269 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -170.3 -64.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.85 143.48 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.053 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.25 117.53 48.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.421 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.96 HD11 HD22 ' A' ' 64' ' ' LEU . 58.4 mt -62.59 70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.05 -41.47 62.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.589 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.69 -169.97 2.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.599 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 5.3 ptp -168.32 162.51 12.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 8.0 tpp -88.56 117.11 27.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -55.41 103.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.74 77.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.729 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.72 171.91 37.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 23' ' ' ILE . 88.8 Cg_exo -49.01 -45.16 30.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.886 2.391 . . . . 0.0 112.975 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.768 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -57.83 -49.91 75.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.336 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.68 -30.72 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -53.35 -48.66 68.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.737 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 23' ' ' ILE . 1.4 t -55.7 -43.78 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.51 83.46 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -87.77 -35.01 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.676 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 101' ' ' LEU . 11.0 mt -90.72 111.39 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 4.4 p-10 -120.4 140.89 50.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.1 mt -38.01 126.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.812 0.339 . . . . 0.0 111.412 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.09 -7.66 52.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.989 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.895 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.5 m-20 -69.32 109.24 4.04 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.682 ' OE1' HG23 ' A' ' 48' ' ' ILE . 14.3 tp60 -71.37 85.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.012 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -58.86 138.9 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.704 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -105.57 -38.28 6.49 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.9 p -159.45 157.67 30.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.332 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 93' ' ' LEU . 7.7 mt -122.14 126.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.699 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.523 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER 36.42 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.172 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.75 26.22 9.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.809 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.783 HG21 HD13 ' A' ' 89' ' ' ILE . 25.3 m -123.86 95.33 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 110.724 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 81' ' ' LEU . 5.0 m -60.62 120.8 10.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.048 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.775 HD21 HD12 ' A' ' 89' ' ' ILE . 38.1 mt -91.09 -11.15 39.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.362 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.9 t -55.94 107.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.264 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.26 -26.35 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.793 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 77' ' ' SER . 4.6 mt -68.24 127.49 93.26 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.556 0.217 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.59 164.54 2.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.337 2.025 . . . . 0.0 112.012 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.646 HD12 ' H ' ' A' ' 37' ' ' GLU . 8.7 tt -60.23 -44.64 95.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 m -53.49 -33.44 54.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.525 ' O ' HG13 ' A' ' 89' ' ' ILE . 2.9 m -72.88 -47.19 48.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.752 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.473 ' O ' HG13 ' A' ' 90' ' ' ILE . 74.9 m -56.8 -50.01 73.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' CG ' HD23 ' A' ' 83' ' ' LEU . 7.9 mm100 -57.15 -53.17 61.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.184 0.516 . . . . 0.0 109.966 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 9.0 p -51.57 -39.76 58.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.783 HD13 HG21 ' A' ' 76' ' ' THR . 12.5 mt -61.36 -41.73 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.8 mt -60.4 -35.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.348 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.2 mppt? -76.28 -34.71 59.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.521 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.74 -30.05 76.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 73' ' ' ILE . 1.7 pp -99.56 38.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.53 -25.47 50.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.912 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.44 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 2.1 m120 -126.08 55.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.487 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.431 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 34.5 mm-40 -112.31 -30.39 7.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.555 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 74.97 1.42 3.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.599 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.01 146.9 12.83 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.718 0.294 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.972 HG11 HD11 ' A' ' 31' ' ' LEU . 3.6 t -140.14 105.64 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -94.45 79.65 3.88 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 pt? -107.27 125.24 50.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.381 0.61 . . . . 0.0 111.763 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -87.5 109.15 19.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.851 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.012 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -114.88 174.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 69' ' ' GLN . 3.5 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.983 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 2.6 m-85 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -146.66 116.82 7.35 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.88 78.14 2.79 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.738 HG11 ' HG ' ' A' ' 64' ' ' LEU . 35.8 t -69.22 125.58 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.507 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.26 103.12 10.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.515 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.897 HD13 ' OG ' ' A' ' 61' ' ' SER . 8.9 mm -98.56 103.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.631 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -99.33 128.49 45.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.559 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -151.94 -174.96 5.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.942 0.401 . . . . 0.0 110.958 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -85.18 160.82 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.139 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -67.12 123.25 19.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.303 0.573 . . . . 0.0 110.466 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' H ' ' HA ' ' A' ' 95' ' ' ASN . . . 100.68 18.74 19.84 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.299 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.1 mm-40 -117.46 131.49 56.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.676 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -87.74 151.2 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.1 tp -48.21 -43.32 31.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 98.23 -5.06 60.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.783 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.935 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.31 125.12 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.28 98.57 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.954 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.853 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.4 pp -95.6 147.31 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.995 HG23 HD12 ' A' ' 48' ' ' ILE . 27.2 m -132.1 155.29 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -51.73 118.85 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.787 0.327 . . . . 0.0 111.29 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.792 0.247 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 79' ' ' VAL . 82.1 p -144.82 -74.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.908 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -159.99 141.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.658 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.07 119.07 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.13 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.924 HD12 ' HB2' ' A' ' 68' ' ' ASP . 31.3 mt -62.21 72.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.72 -25.95 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.904 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -165.41 166.67 18.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.705 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.551 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.3 ptp -143.48 171.09 14.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.401 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.9 ttm -87.65 112.98 22.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.88 90.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.08 21.91 8.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.438 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.22 179.26 27.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.408 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB3' HG22 ' A' ' 23' ' ' ILE . 78.5 Cg_exo -51.21 -45.38 37.32 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.68 2.253 . . . . 0.0 112.455 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.935 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.47 -49.46 77.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.34 -32.28 68.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -58.78 -48.65 80.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.897 ' OG ' HD13 ' A' ' 23' ' ' ILE . 7.8 m -50.04 -43.86 51.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.28 85.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.419 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 61' ' ' SER . 1.2 mptt -97.85 -53.1 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.44 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.074 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -74.62 125.17 28.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.172 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.551 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.2 p-10 -128.24 136.51 51.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.027 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 15.7 mt -37.86 107.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.991 0.424 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.92 -6.93 10.22 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.917 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.924 ' HB2' HD12 ' A' ' 49' ' ' ILE . 10.0 m-20 -71.27 124.38 24.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.564 0.221 . . . . 0.0 110.428 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -86.97 97.16 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.14 0.495 . . . . 0.0 110.543 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.151 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -68.23 142.25 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.145 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.6 mmt -111.7 -32.97 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.008 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 45.3 t -159.62 154.6 24.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.139 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.834 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.1 mt -126.8 123.69 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 45.88 29.82 0.78 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.39 21.87 25.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.371 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -115.54 97.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.69 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -52.97 134.99 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 81' ' ' LEU . 63.7 mt -109.53 9.71 25.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.026 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.916 ' HA ' HG22 ' A' ' 46' ' ' THR . 11.8 t -86.19 114.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.398 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.74 -33.99 6.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.146 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.919 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -76.72 127.63 83.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.072 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.81 170.43 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.541 2.161 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 tp -59.52 -34.01 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -53.49 -51.02 64.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.546 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 89' ' ' ILE . 58.5 m -63.51 -43.38 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.425 ' HB3' HG11 ' A' ' 47' ' ' VAL . 18.6 m -57.03 -50.57 72.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.87 -38.52 72.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -33.77 74.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.115 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 22.7 mt -64.89 -38.97 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 120.969 0.414 . . . . 0.0 109.916 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -77.19 -42.87 31.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -44.17 97.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.364 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.09 -14.53 61.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.375 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 95.9 mt -93.83 37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.794 ' HG3' HG22 ' A' ' 30' ' ' ILE . 7.2 mtpt -79.11 -34.49 43.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' GLY . 1.9 p30 -120.3 64.22 0.83 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.7 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HG3' HD22 ' A' ' 93' ' ' LEU . 4.2 mm100 -119.21 -34.71 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.543 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.603 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 5.5 t 74.11 1.53 3.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.734 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.563 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -165.86 145.11 6.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.826 HG21 ' CD1' ' A' ' 31' ' ' LEU . 11.1 t -139.89 103.83 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -91.39 78.38 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.441 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.896 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -107.69 118.98 38.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.403 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.99 111.48 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.439 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.151 HG22 HG23 ' A' ' 70' ' ' ILE . 1.1 pt -107.58 174.15 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.336 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.504 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -147.51 113.77 5.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.12 73.8 2.97 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.794 HG11 ' HG ' ' A' ' 64' ' ' LEU . 47.3 t -61.9 126.1 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.799 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.0 103.83 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.697 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 61' ' ' SER . 16.6 mm -100.05 103.44 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.982 0.42 . . . . 0.0 110.99 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 109.94 22.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.241 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 3.0 pttt -127.79 -170.27 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.6 138.3 40.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -47.66 124.41 7.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.027 0.442 . . . . 0.0 110.764 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.74 12.95 28.98 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.514 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' LYS . 10.5 mm-40 -129.22 126.63 39.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.278 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.08 153.69 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -47.66 -52.24 18.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.072 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.91 1.21 42.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 58' ' ' ALA . 11.7 m -94.53 123.81 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.184 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.3 t -99.85 100.0 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.457 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.689 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.7 pp -95.6 142.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.111 0.481 . . . . 0.0 111.683 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -118.22 167.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.7 105.28 2.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 48' ' ' ILE . 11.5 p . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.453 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 57.7 Cg_endo . . . . . 0 C--O 1.231 0.132 0 N-CA-C 113.047 0.364 . . . . 0.0 113.047 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -175.14 -64.85 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.338 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.86 161.15 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.985 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -142.42 114.85 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.933 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.9 mt -61.1 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 36' ' ' VAL . . . -53.79 -30.73 46.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.816 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.518 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -153.55 167.68 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.899 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 5.0 ttp -154.92 129.21 8.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tpp -54.0 98.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -52.06 123.17 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.66 21.66 59.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.95 -170.31 20.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 23' ' ' ILE . 53.8 Cg_exo -53.15 -47.62 26.52 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.646 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.796 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.71 -49.36 77.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.432 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.02 -30.37 63.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -48.57 75.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.689 ' HB3' HD13 ' A' ' 23' ' ' ILE . 98.8 p -56.25 -39.38 72.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.41 63.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.354 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -110.21 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 101' ' ' LEU . 16.1 mt -72.38 127.83 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.721 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.7 m-80 -130.62 126.72 37.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 14.4 mt -30.61 113.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 121.06 0.457 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.74 5.31 22.36 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.094 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.964 ' HB2' HD12 ' A' ' 49' ' ' ILE . 15.7 m-20 -79.27 120.82 24.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.7 80.92 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.948 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.976 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -55.76 143.51 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -41.38 4.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.928 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 77.2 p -158.29 156.87 31.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 111.404 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.945 HG21 HD11 ' A' ' 93' ' ' LEU . 6.7 mt -122.82 122.03 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.3 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.741 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.5 OUTLIER 40.32 33.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.865 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.51 22.18 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.811 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 89' ' ' ILE . 33.5 m -123.09 95.56 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.756 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.49 130.21 43.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.797 ' CD2' HD12 ' A' ' 89' ' ' ILE . 59.1 mt -96.23 12.59 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -89.3 123.74 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.63 -25.39 28.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.822 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.756 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -91.44 134.2 29.96 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.761 0.281 . . . . 0.0 110.869 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.03 -176.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.497 2.131 . . . . 0.0 112.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 7.8 tt -75.55 -37.66 59.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -53.43 -36.89 62.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.556 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.2 m -68.76 -50.81 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.495 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.403 ' O ' HG13 ' A' ' 90' ' ' ILE . 21.5 m -56.77 -48.68 77.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -54.14 -48.1 71.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.633 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 t -61.42 -33.81 74.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.533 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 78' ' ' LEU . 38.8 mt -64.6 -46.43 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 35' ' ' ILE . 3.6 mt -65.24 -39.08 84.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.443 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -69.35 -32.37 71.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.821 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.27 -11.54 84.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.468 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.945 HD11 HG21 ' A' ' 73' ' ' ILE . 93.8 mt -93.17 39.86 1.05 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.934 0.397 . . . . 0.0 110.93 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 29' ' ' GLU . 4.2 tttt -80.87 -37.57 29.62 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 3.2 p30 -120.71 63.68 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.837 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.405 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 3.8 mm100 -117.18 -39.54 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 76.68 -2.12 2.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.698 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -162.64 139.45 7.76 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.533 0.206 . . . . 0.0 110.451 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.785 HG12 HD22 ' A' ' 101' ' ' LEU . 10.6 t -136.38 104.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -93.03 80.07 4.57 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.503 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.886 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.2 pt? -110.01 120.07 41.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -86.41 108.45 18.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.048 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.976 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -101.17 167.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.08 0.467 . . . . 0.0 111.787 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.602 -179.269 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -144.51 115.08 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 75.6 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.804 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.5 t -66.36 120.8 14.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.524 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.43 103.63 10.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.627 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 58' ' ' ALA . 14.3 mm -99.18 103.59 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.442 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 1.2 tt0 -95.49 111.53 23.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.6 pttt -130.84 -170.73 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.112 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.34 143.4 32.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.575 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 4.9 mttt -51.43 128.57 23.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.987 0.423 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 11.65 43.97 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.581 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -124.09 129.2 50.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -83.33 149.79 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -47.77 -46.06 29.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.53 7.81 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.05 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.69 HG13 ' CB ' ' A' ' 58' ' ' ALA . 4.7 m -95.9 126.09 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 111.438 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -102.41 98.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.092 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.817 HD13 HG12 ' A' ' 47' ' ' VAL . 2.6 pp -101.99 151.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 112.176 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.901 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.2 m -132.26 159.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.186 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.75 117.06 3.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.692 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.229 0.072 0 CA-C-O 120.805 0.252 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 79' ' ' VAL . 71.1 p -141.14 -72.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.171 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -160.12 148.06 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.029 0.442 . . . . 0.0 111.868 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.901 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -129.27 113.96 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 68' ' ' ASP . 36.5 mt -60.98 72.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.05 -28.64 58.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.399 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 85.3 m-20 -145.57 169.52 18.24 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.681 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.684 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -166.77 117.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.676 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 ttm -45.42 124.03 4.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.605 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -68.21 105.83 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.623 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.39 -17.25 57.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -178.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' O ' HG23 ' A' ' 23' ' ' ILE . 77.1 Cg_exo -51.0 -47.41 25.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.902 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.43 -49.08 78.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.76 -26.56 62.5 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.738 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -48.96 75.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.9 p -52.87 -37.94 61.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.04 45.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.173 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -117.66 -61.64 1.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 101' ' ' LEU . 14.0 mt -66.06 131.09 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.841 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' ILE . 8.1 m120 -134.18 123.7 24.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.124 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.1 mt -28.38 114.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.968 0.413 . . . . 0.0 111.789 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.98 -6.02 22.03 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.983 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.96 ' HB2' HD12 ' A' ' 49' ' ' ILE . 14.5 m-20 -68.5 135.6 51.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 110.515 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -92.63 81.52 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.862 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -54.9 141.32 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.0 ttm -111.26 -34.21 6.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.691 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 87.1 p -156.96 155.11 30.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -126.66 121.43 58.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.891 0.376 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 46.97 29.04 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.243 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.09 18.19 25.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.622 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 89' ' ' ILE . 9.0 m -119.42 95.63 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.756 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.774 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.4 m -63.56 131.23 47.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.337 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.966 HD13 HG21 ' A' ' 47' ' ' VAL . 3.2 mt -98.05 22.49 9.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.906 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.1 t -88.14 105.87 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.68 -30.17 8.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.931 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -80.53 143.4 55.12 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.94 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.81 169.94 13.69 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.744 2.296 . . . . 0.0 112.667 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.55 HD11 HE22 ' A' ' 87' ' ' GLN . 27.3 tp -58.38 -37.09 74.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -53.48 -48.61 68.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.733 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.628 ' O ' HG13 ' A' ' 89' ' ' ILE . 26.1 m -64.47 -43.58 93.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.497 ' HB3' HG11 ' A' ' 47' ' ' VAL . 13.6 m -56.6 -54.92 40.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.55 HE22 HD11 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -49.94 -53.58 25.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.172 0.511 . . . . 0.0 110.508 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -53.14 -32.21 46.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.422 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.638 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 20.6 mt -70.04 -36.98 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.201 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 33' ' ' VAL . 4.3 mt -77.64 -35.49 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.509 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -73.86 -42.7 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.981 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.35 39.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.488 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.687 HD11 HG21 ' A' ' 73' ' ' ILE . 21.8 mt -88.15 46.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.65 -30.99 41.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -135.18 69.16 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.567 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.417 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mm100 -119.1 -36.13 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.343 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.3 p 76.3 1.63 3.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.684 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -162.77 143.3 9.62 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.616 0.246 . . . . 0.0 110.883 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.777 HG11 ' CD1' ' A' ' 31' ' ' LEU . 4.1 t -137.58 103.54 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 111.671 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -93.04 74.53 4.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.646 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.19 119.5 39.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.277 0.56 . . . . 0.0 111.189 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.94 107.28 18.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.426 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.862 HG22 HG23 ' A' ' 70' ' ' ILE . 5.3 pt -103.06 173.6 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.417 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.316 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.579 0.228 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.81 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -152.9 142.63 21.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 111.99 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.49 72.4 7.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.784 HG11 ' HG ' ' A' ' 64' ' ' LEU . 72.2 t -57.85 125.72 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.25 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.09 103.83 10.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.249 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 61' ' ' SER . 10.1 mm -100.31 103.54 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -100.09 131.59 45.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.603 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -153.74 -172.85 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.968 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -94.88 145.3 25.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.442 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 5.6 mptt -49.2 122.95 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.056 0.455 . . . . 0.0 110.679 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.35 16.65 22.17 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -121.31 119.79 33.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 111.413 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -77.74 151.05 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.877 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.32 -52.24 16.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.316 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.98 -1.33 35.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.144 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.798 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -94.63 122.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.09 0.471 . . . . 0.0 111.324 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.42 HG21 ' OD1' ' A' ' 51' ' ' ASN . 46.1 t -97.17 98.65 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.079 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -95.62 149.8 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 112.051 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 2.9 m -133.78 157.72 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.365 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.85 111.99 0.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.853 0.358 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.725 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo . . . . . 0 CA--C 1.527 0.148 0 CA-C-O 120.935 0.306 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.928 HG22 ' HA ' ' A' ' 79' ' ' VAL . 41.2 p -135.98 -70.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.18 137.61 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -116.08 119.07 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.394 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.6 mt -64.75 70.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.34 -33.96 22.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.329 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.21 140.7 13.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.52 . . . . 0.0 110.506 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.444 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 2.8 ttp -123.34 163.03 21.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.47 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.5 ttm -76.92 137.01 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -80.87 92.78 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.33 -4.4 37.81 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.94 -179.38 50.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.58 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 23' ' ' ILE . 82.6 Cg_exo -47.36 -47.03 18.51 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.919 2.413 . . . . 0.0 112.902 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.798 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.64 -49.48 77.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.259 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.34 -24.78 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -64.45 -47.03 80.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.816 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.7 t -53.08 -41.73 65.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.802 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.02 85.94 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.349 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 1.3 mptt -100.16 -56.45 2.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.803 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.084 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -70.36 124.49 24.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.204 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' ILE . 16.0 m120 -131.09 136.11 48.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.223 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 25.0 mt -34.76 124.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.49 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.52 -9.02 48.37 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.985 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -66.9 120.81 14.21 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.686 0.279 . . . . 0.0 110.693 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.4 82.54 7.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.04 0.448 . . . . 0.0 110.233 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.996 HG23 HG22 ' A' ' 103' ' ' ILE . 2.6 mt -55.68 139.3 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.981 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.42 ' HE3' HG21 ' A' ' 104' ' ' VAL . 2.9 mmt -106.04 -39.44 5.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.74 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 80.6 p -156.38 164.34 38.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 93' ' ' LEU . 8.3 mt -128.44 114.3 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.003 0.43 . . . . 0.0 111.471 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.8 OUTLIER 42.48 31.94 0.32 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.687 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.84 11.76 27.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.808 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.684 ' CG2' HD13 ' A' ' 89' ' ' ILE . 3.8 m -109.72 95.62 5.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.557 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.1 t -56.77 130.01 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.861 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.4 mt -107.36 22.19 16.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.67 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.928 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.2 t -98.26 112.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.328 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.04 -24.56 30.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.736 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -85.08 130.92 50.28 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 117.113 0.457 . . . . 0.0 110.975 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.04 -174.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.613 2.209 . . . . 0.0 112.644 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.627 HD11 HE22 ' A' ' 87' ' ' GLN . 35.0 tp -72.92 -37.32 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.023 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 m -53.76 -42.72 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 8.7 m -65.9 -48.02 72.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.575 ' SG ' HD22 ' A' ' 78' ' ' LEU . 19.9 m -57.0 -53.36 59.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.627 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.83 -53.96 22.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 t -53.35 -37.86 62.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.684 HD13 ' CG2' ' A' ' 76' ' ' THR . 27.5 mt -63.42 -46.44 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.506 HD11 HG13 ' A' ' 35' ' ' ILE . 3.1 mt -66.57 -37.45 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -33.98 71.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.241 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.33 -14.44 79.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.467 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 73' ' ' ILE . 94.4 mt -90.93 43.68 1.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.739 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 17.8 mttt -83.21 -47.78 11.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 1.4 p30 -112.47 57.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -112.27 -33.9 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.074 0.464 . . . . 0.0 110.09 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.577 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 9.0 t 73.3 5.07 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 2.5 mtm180 -167.37 147.91 5.43 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.356 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.877 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.8 t -142.65 102.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.0 0.428 . . . . 0.0 111.739 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -92.23 72.54 5.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.939 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -99.9 126.47 46.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.067 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.5 m120 -90.13 114.28 26.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.943 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.084 HG21 HD21 ' A' ' 64' ' ' LEU . 2.5 pt -117.01 173.32 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.452 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' GLN . 3.6 m . . . . . 0 C--O 1.235 0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.217 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CD1' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.621 0.248 . . . . 0.0 110.52 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HE2' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -145.8 150.37 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.26 0.552 . . . . 0.0 112.158 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.71 73.18 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HG ' ' A' ' 64' ' ' LEU . 93.1 t -59.25 125.77 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.312 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.7 103.74 10.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' HA ' ' A' ' 58' ' ' ALA . 7.6 mm -99.16 103.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.01 0.434 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 121.14 36.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.73 -171.95 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 111.062 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.56 138.4 38.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 7.5 mttt -48.32 127.22 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.23 37.81 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 28.6 mm-40 -128.43 130.31 47.43 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.851 0.358 . . . . 0.0 111.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.5 HD11 ' HE1' ' A' ' 53' ' ' MET . 1.1 pt -78.91 154.01 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.843 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.81 -52.17 19.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.59 29.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.122 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 58' ' ' ALA . 15.9 m -94.46 148.65 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.197 0.522 . . . . 0.0 111.186 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.0 t -126.99 98.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.626 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.2 pp -94.05 149.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.115 0.483 . . . . 0.0 111.523 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.5 m -122.54 162.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.568 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.14 93.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.629 ' HA ' HD11 ' A' ' 48' ' ' ILE . 3.3 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.604 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' SER . 52.6 Cg_exo . . . . . 0 C--O 1.232 0.18 0 N-CA-C 112.602 0.193 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -141.59 -66.67 0.41 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.366 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.788 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.34 165.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 111.455 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -143.83 116.88 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 76.2 mt -62.6 72.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.93 -26.09 5.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.945 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.472 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.8 p30 -164.96 167.54 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.379 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.436 ' HG3' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -154.25 142.4 20.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.724 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -53.0 139.32 28.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.29 76.66 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.42 -18.51 7.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.669 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.49 -179.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 23' ' ' ILE . 82.1 Cg_exo -46.85 -45.18 21.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.795 2.33 . . . . 0.0 112.737 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.849 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.2 -47.63 82.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -70.7 -31.14 67.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.245 0.545 . . . . 0.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -62.46 -48.31 80.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.799 ' CB ' HD13 ' A' ' 23' ' ' ILE . 44.4 t -53.81 -31.15 48.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.98 20.24 72.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.461 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -113.65 -49.21 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.741 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 17.8 mt -82.83 119.65 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 111.804 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -119.9 138.34 53.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.866 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 19.9 mt -37.09 131.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.644 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 4.5 59.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.058 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.7 m-20 -77.34 121.27 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.776 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -79.11 81.11 5.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.894 HG23 HG22 ' A' ' 103' ' ' ILE . 3.9 mt -57.56 143.73 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.029 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.693 ' CG ' HG23 ' A' ' 104' ' ' VAL . 11.1 mmt -108.32 -41.96 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.589 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 64.3 p -156.41 155.2 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.008 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.008 HG21 HD11 ' A' ' 93' ' ' LEU . 6.3 mt -120.15 122.57 68.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 48.3 28.25 1.57 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.0 22.26 20.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.396 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -116.01 96.2 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.387 . . . . 0.0 110.796 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.482 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.29 135.39 32.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.214 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.788 HD13 HG21 ' A' ' 47' ' ' VAL . 58.8 mt -108.07 3.92 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.321 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 t -84.95 122.5 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.15 -23.42 36.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.833 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.688 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.43 127.85 42.58 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.023 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.34 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.692 2.261 . . . . 0.0 112.675 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.512 HD13 ' HA ' ' A' ' 36' ' ' VAL . 40.3 tp -69.93 -35.11 74.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -53.33 -45.6 69.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.3 m -65.09 -48.18 74.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.737 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.0 m -56.96 -50.55 72.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -53.05 -43.39 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 t -64.52 -31.25 72.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.15 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.778 HD12 ' CD2' ' A' ' 78' ' ' LEU . 27.9 mt -69.53 -36.7 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.937 0.398 . . . . 0.0 109.956 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.702 HD11 HG13 ' A' ' 35' ' ' ILE . 6.1 mt -77.23 -41.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.388 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -39.24 89.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.552 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.07 -10.76 65.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.755 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.008 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.92 37.49 1.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -80.49 -31.06 37.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 4.2 m-80 -127.88 67.19 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.774 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 3.6 mm100 -121.25 -38.1 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.428 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.8 3.0 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -166.27 145.47 5.87 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.5 t -140.27 103.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -91.91 76.93 5.5 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.366 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.064 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -106.06 126.46 52.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.924 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 2.8 m120 -88.93 123.67 33.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 4.8 pt -122.29 165.91 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 111.868 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.693 HG23 ' CG ' ' A' ' 71' ' ' MET . 86.2 t . . . . . 0 C--O 1.234 0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CE1' HG22 ' A' ' 104' ' ' VAL . 1.7 m-85 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -146.81 117.5 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.6 73.21 2.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.789 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.0 t -62.46 126.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.011 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.88 103.57 10.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.872 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 58' ' ' ALA . 15.4 mm -101.0 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.162 0.506 . . . . 0.0 110.23 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.24 118.55 36.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE2' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -133.43 -170.01 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.023 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.26 135.89 41.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.0 mttt -47.62 120.83 3.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.191 0.52 . . . . 0.0 111.032 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.67 10.85 22.46 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.23 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -128.13 142.12 51.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.582 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.3 pt -93.3 161.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.8 tp -47.86 -51.99 20.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.159 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 105.26 -4.64 41.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.885 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.95 ' CG2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -94.83 127.28 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.052 0.453 . . . . 0.0 111.397 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 11.6 t -95.69 98.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.791 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.838 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -97.8 150.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 111.771 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.902 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.3 m -133.4 161.38 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.592 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.93 116.16 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.95 0.312 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 67.0 p -142.01 -72.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -158.67 144.68 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.169 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.902 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.43 114.62 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.233 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.951 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.6 mt -61.52 73.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -58.02 -29.28 65.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.507 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 84.9 m-20 -147.5 -177.09 5.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.244 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.4 ptp -173.1 144.34 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tpp -65.82 124.27 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 49.7 p-80 -61.0 87.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.09 -14.24 31.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.73 175.87 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.641 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.564 ' O ' HG23 ' A' ' 23' ' ' ILE . 71.9 Cg_exo -50.01 -47.43 23.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.706 2.271 . . . . 0.0 112.885 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.838 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.1 -49.44 76.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.0 -27.6 61.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.95 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.589 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 23' ' ' ILE . 15.7 p -51.83 -46.88 64.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.33 -24.29 31.06 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.891 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -53.93 26.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.009 0.433 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 mt -72.79 129.97 39.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 5.0 p30 -134.6 137.71 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.158 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.3 mt -39.44 108.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.389 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -5.84 11.19 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.124 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.0 m-20 -69.8 119.42 14.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.7 80.04 3.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.04 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.058 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -55.01 145.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.915 ' CE ' HG21 ' A' ' 104' ' ' VAL . 2.5 tpp -115.64 -38.8 3.64 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 43.4 t -153.66 164.53 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.127 HG21 HD11 ' A' ' 93' ' ' LEU . 14.1 mt -130.04 112.83 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.655 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.748 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.7 OUTLIER 42.71 32.57 0.39 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.107 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 2.49 31.11 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.371 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 89' ' ' ILE . 2.8 m -102.32 95.67 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.675 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -61.08 113.77 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 47' ' ' VAL . 82.2 mt -82.53 -12.17 57.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.31 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 24.4 t -58.66 103.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.182 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.59 -30.27 9.37 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.7 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.598 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.5 mt -66.54 118.61 55.71 Favored Pre-proline 0 C--N 1.33 -0.241 0 O-C-N 122.832 -0.217 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.39 166.14 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.563 HD13 ' HA ' ' A' ' 36' ' ' VAL . 32.7 tp -54.39 -42.25 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 t -53.88 -43.77 69.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.808 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.51 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.8 m -68.57 -44.74 73.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.97 -56.97 14.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.509 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.73 -54.11 20.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 110.519 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.0 p -51.12 -41.37 60.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.257 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 HG21 ' A' ' 76' ' ' THR . 11.0 mt -59.75 -45.16 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -59.96 -38.56 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -47.5 79.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.27 -15.1 50.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.467 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.127 HD11 HG21 ' A' ' 73' ' ' ILE . 78.1 mt -91.23 31.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.041 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.4 tttt -81.01 -37.54 28.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 3.5 p30 -118.74 62.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.5 mm100 -117.76 -41.25 2.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.4 t 78.9 -2.57 2.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.54 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.49 140.19 8.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.62 0.248 . . . . 0.0 110.451 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 31' ' ' LEU . 5.1 t -136.97 104.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 112.111 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -91.08 73.05 6.36 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -101.81 123.83 46.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.557 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.93 109.32 20.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.058 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -99.9 165.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.472 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.915 HG21 ' CE ' ' A' ' 71' ' ' MET . 22.2 t . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.792 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.61 121.5 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.21 77.29 5.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 27.7 t -68.2 121.18 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.011 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.27 103.64 11.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.509 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.7 mm -99.99 103.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.025 0.44 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.93 117.42 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -134.66 -172.11 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.32 136.66 39.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.656 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -47.51 123.55 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.148 0.499 . . . . 0.0 110.811 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.55 12.82 27.66 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.441 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.3 mm-40 -127.15 133.75 50.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.714 0.292 . . . . 0.0 111.265 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -84.43 154.37 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -48.16 -52.11 22.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.025 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.38 -0.39 37.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.454 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.855 HG13 ' CB ' ' A' ' 58' ' ' ALA . 2.3 m -94.72 128.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.06 0.43 . . . . 0.0 111.58 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.4 t -100.33 98.27 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.67 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.631 HD13 ' CG1' ' A' ' 47' ' ' VAL . 2.5 pp -96.95 158.78 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 0.0 111.958 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 48' ' ' ILE . 4.0 m -140.37 157.8 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.412 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.82 121.17 10.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.693 ' HA ' HD11 ' A' ' 48' ' ' ILE . 5.2 p . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.705 0.211 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.636 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -155.83 -67.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.255 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 78' ' ' LEU . 1.4 m -160.39 148.11 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.072 0.463 . . . . 0.0 112.023 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.997 HD12 HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -125.83 117.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.8 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 46.8 mt -61.86 74.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -57.71 -27.85 63.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.643 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.523 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 84.1 m-20 -148.05 177.46 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.011 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 6.1 ttp -171.55 128.93 0.67 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.67 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.8 tpp -53.6 136.93 38.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.217 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -77.61 93.63 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.729 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.45 -17.12 28.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.566 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.74 179.02 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.633 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.521 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.6 Cg_exo -48.68 -50.26 12.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.777 2.318 . . . . 0.0 112.957 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.892 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.16 -49.21 77.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.766 0.317 . . . . 0.0 111.267 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.58 -22.41 61.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -66.0 -48.4 71.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB3' HD13 ' A' ' 23' ' ' ILE . 18.8 p -54.22 -43.08 70.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.69 -9.31 78.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.494 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -58.67 2.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.989 0.423 . . . . 0.0 111.107 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 13.6 mt -68.68 129.55 40.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.44 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.3 m120 -134.25 135.06 42.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.033 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 13.0 mt -36.38 109.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 121.028 0.442 . . . . 0.0 111.494 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.48 -0.35 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.214 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.6 m-20 -75.3 118.9 18.71 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.784 0.326 . . . . 0.0 110.705 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -74.39 84.4 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.035 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -62.44 144.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.637 ' HG3' HG23 ' A' ' 104' ' ' VAL . 21.8 mmt -110.05 -41.82 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -158.09 157.75 33.43 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.399 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HD11 ' A' ' 93' ' ' LEU . 7.1 mt -119.13 118.31 57.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.023 0.44 . . . . 0.0 111.62 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.779 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.8 OUTLIER 42.37 31.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.837 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.87 14.69 24.32 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.945 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.694 HG21 HD13 ' A' ' 89' ' ' ILE . 5.2 m -111.62 95.61 5.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 99.2 p -58.41 126.84 29.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.261 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.837 ' CD1' HG21 ' A' ' 47' ' ' VAL . 30.1 mt -97.48 5.55 49.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.223 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 t -88.7 129.6 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.917 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.58 -22.67 37.73 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.817 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -95.15 144.11 27.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.717 0.294 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.23 175.46 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.673 2.248 . . . . 0.0 112.435 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 36' ' ' VAL . 22.7 tp -66.51 -33.24 75.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -53.99 -47.99 70.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.806 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.6 m -64.59 -47.54 78.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.6 m -56.88 -51.56 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.67 -37.66 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.0 110.467 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -68.41 -35.0 77.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.979 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.694 HD13 HG21 ' A' ' 76' ' ' THR . 18.8 mt -64.06 -46.37 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.475 HD11 HG13 ' A' ' 35' ' ' ILE . 3.5 mt -62.08 -37.63 78.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.614 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -34.34 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.878 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.24 -12.53 76.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.138 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.045 HD11 HG21 ' A' ' 73' ' ' ILE . 92.6 mt -93.69 33.67 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 110.525 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.7 ttpt -78.36 -30.46 48.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -124.51 65.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.886 0.374 . . . . 0.0 111.727 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.406 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 7.6 mm-40 -122.0 -39.31 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m 75.16 1.91 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.522 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.595 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -164.85 142.74 6.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.625 0.25 . . . . 0.0 110.326 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 31' ' ' LEU . 3.9 t -137.62 103.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.827 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.38 73.78 5.27 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.617 178.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.028 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -104.57 122.94 46.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 109.73 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -103.34 173.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.473 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 71' ' ' MET . 98.2 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.51 . . . . 0.0 111.665 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.596 0.236 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -141.92 115.2 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.85 74.41 2.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.774 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.5 t -65.81 114.85 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.584 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -108.61 103.39 12.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.574 178.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.852 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -97.49 104.07 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -96.35 112.02 23.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.244 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -134.27 -169.21 2.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.954 0.407 . . . . 0.0 110.997 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -103.45 154.46 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.426 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 95' ' ' ASN . 2.5 mptt -59.54 132.29 53.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.03 14.75 50.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.747 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.4 mp0 -121.07 130.36 53.73 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -84.87 150.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.01 HD11 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -47.2 -52.04 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.315 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.62 -8.62 37.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.08 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.878 HG13 ' CB ' ' A' ' 58' ' ' ALA . 1.4 m -94.86 124.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.67 98.6 7.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.298 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -93.61 147.6 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.17 0.509 . . . . 0.0 111.699 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 17.1 m -129.19 159.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.197 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.8 114.22 2.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.819 0.342 . . . . 0.0 111.158 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.847 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.753 0.23 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -159.45 -58.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.26 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.532 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.51 155.17 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 111.282 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.29 115.6 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.604 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.032 HD11 HD22 ' A' ' 64' ' ' LEU . 20.9 mt -60.27 72.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.79 -24.18 21.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.904 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -159.15 166.53 31.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.146 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.59 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.1 ttp -154.44 137.04 15.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.6 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.04 117.64 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -62.77 83.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.49 1.45 19.98 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.568 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.89 -178.43 51.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 86.9 Cg_exo -47.87 -50.83 10.95 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 112.793 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.878 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.16 -42.15 85.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 0.0 110.799 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -66.32 -49.3 67.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.852 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 m -52.42 -40.76 62.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.93 10.97 82.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.31 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mptt -104.8 -48.71 3.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.881 0.372 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.107 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -77.76 119.12 20.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.271 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -123.9 136.68 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.362 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 28.2 mt -40.6 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.639 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.6 -11.46 8.43 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.151 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -72.36 134.14 45.31 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 117.024 0.412 . . . . 0.0 110.857 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.626 ' HB3' HG23 ' A' ' 104' ' ' VAL . 39.6 tt0 -87.6 83.75 7.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.028 0.442 . . . . 0.0 110.015 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.871 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -52.04 144.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.789 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.422 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 6.3 mmt -109.24 -41.51 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.8 p -160.99 158.41 27.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.332 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 93' ' ' LEU . 7.0 mt -122.27 118.2 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.263 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.533 HD22 HG22 ' A' ' 73' ' ' ILE . 70.0 m-80 52.22 25.81 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.92 32.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.55 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -107.89 95.76 5.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.726 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.486 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -55.68 131.64 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.234 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 89' ' ' ILE . 33.3 mt -101.48 1.18 37.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.322 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.36 132.81 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.19 -23.71 32.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.64 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.68 140.21 21.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.871 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 178.45 2.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.204 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.8 tp -63.98 -33.47 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 p -53.94 -45.7 71.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.821 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.7 m -67.1 -47.76 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.412 ' O ' HG13 ' A' ' 90' ' ' ILE . 13.3 m -57.23 -47.17 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.31 -45.97 80.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -60.26 -35.44 75.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 78' ' ' LEU . 39.8 mt -63.26 -46.0 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -62.91 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.791 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -42.22 98.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.175 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.13 -13.24 64.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.252 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.976 HD11 HG21 ' A' ' 73' ' ' ILE . 92.2 mt -94.06 37.36 1.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.932 0.396 . . . . 0.0 110.677 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -81.85 -41.2 21.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 4.5 p-10 -120.85 64.18 0.86 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 2.2 mm100 -113.95 -36.19 4.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 1.7 t 77.62 -2.34 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.697 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.4 mtm180 -161.99 148.46 13.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.569 0.223 . . . . 0.0 110.564 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.01 HG11 HD11 ' A' ' 31' ' ' LEU . 5.0 t -141.26 103.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 111.766 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -93.13 75.38 4.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.45 124.55 50.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -90.83 120.28 31.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.214 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.107 HG21 HD21 ' A' ' 64' ' ' LEU . 4.7 pt -117.39 150.89 19.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.546 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.5 m . . . . . 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.276 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.556 0.217 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -143.67 118.88 10.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.25 76.63 3.8 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.801 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.4 t -67.23 128.8 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.797 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.22 103.61 10.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.891 178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.774 HD12 ' HA ' ' A' ' 58' ' ' ALA . 9.3 mm -99.93 102.94 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' SER . 18.8 mt-10 -100.96 114.66 28.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 97' ' ' SER . 6.4 pttt -131.47 -168.69 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.18 137.14 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.6 mttt -50.21 125.46 12.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.126 0.489 . . . . 0.0 110.803 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.67 12.71 31.9 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 5.2 mm-40 -126.33 135.2 51.2 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.401 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.07 150.07 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.238 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.99 -52.19 20.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.307 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.15 18.75 10.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.856 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -112.27 129.57 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.1 t -108.64 98.59 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.108 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -97.78 156.42 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.993 HG23 HD12 ' A' ' 48' ' ' ILE . 27.0 m -141.54 155.18 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.407 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.22 119.47 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 111.185 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.752 ' HA ' HD11 ' A' ' 48' ' ' ILE . 1.7 p . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.808 0.254 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.883 HG22 ' HA ' ' A' ' 79' ' ' VAL . 72.3 p -142.85 -75.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.09 137.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.448 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.993 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.39 119.49 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.27 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 68' ' ' ASP . 50.1 mt -64.18 73.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -51.41 -25.87 6.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.296 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.477 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 12.5 p30 -173.57 150.29 1.76 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -129.55 167.63 17.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.678 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.1 ttm -82.99 128.45 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.44 104.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.94 -21.17 47.48 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.14 174.89 1.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.8 Cg_exo -48.28 -45.49 26.01 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.7 2.266 . . . . 0.0 112.735 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.47 -47.14 85.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -30.18 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.16 82.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.774 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB3' HD13 ' A' ' 23' ' ' ILE . 95.4 p -53.03 -39.48 63.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.58 72.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.272 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.5 mmpt? -117.22 -40.53 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.121 HD21 HG21 ' A' ' 103' ' ' ILE . 10.6 mt -88.96 111.24 21.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.308 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -114.16 144.63 42.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.0 mt -44.84 125.03 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.21 38.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.169 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.947 ' HB2' HD12 ' A' ' 49' ' ' ILE . 24.4 m-20 -73.11 125.84 28.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.621 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -85.59 79.8 9.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.11 0.481 . . . . 0.0 110.43 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.038 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -53.24 141.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.876 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -33.84 5.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 35.2 t -159.87 156.49 27.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.664 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.039 HG21 HD11 ' A' ' 93' ' ' LEU . 9.3 mt -129.23 115.98 38.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.494 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.612 HD21 HG13 ' A' ' 99' ' ' VAL . 69.2 m-80 53.04 23.91 3.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.2 35.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' SER . 11.8 m -106.68 95.05 5.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.937 0.368 . . . . 0.0 110.509 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' HD21 ' A' ' 81' ' ' LEU . 54.6 p -69.06 128.71 37.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.376 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.607 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -94.4 13.3 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.025 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 46' ' ' THR . 5.1 t -74.89 106.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.52 -31.81 7.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.896 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.721 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -82.62 138.82 43.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.983 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 179.35 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.77 2.314 . . . . 0.0 112.507 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.0 tp -65.24 -31.81 73.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -48.18 70.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.006 0.431 . . . . 0.0 110.585 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 89' ' ' ILE . 25.8 m -68.11 -45.76 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.807 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -56.77 -44.26 81.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.726 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 16.0 mm100 -58.6 -52.33 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 3.4 t -56.76 -32.16 65.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.548 HG21 HD12 ' A' ' 73' ' ' ILE . 8.5 mt -62.74 -46.35 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 33' ' ' VAL . 3.6 mt -61.52 -35.33 66.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.898 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 23.4 mmtt -61.71 -48.69 79.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.125 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.55 -11.55 57.06 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.346 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.039 HD11 HG21 ' A' ' 73' ' ' ILE . 83.4 mt -89.28 27.78 1.36 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.914 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -84.71 -40.09 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.435 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 3.3 p-10 -119.79 62.7 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.5 mm100 -119.25 -41.01 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.5 t 79.55 -3.24 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.513 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -160.01 142.82 13.64 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.612 HG13 HD21 ' A' ' 74' ' ' ASN . 3.3 t -140.25 103.27 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -90.53 74.04 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 120.93 41.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.622 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -87.95 114.44 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.121 HG21 HD21 ' A' ' 64' ' ' LEU . 1.3 pt -111.79 171.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.014 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 69' ' ' GLN . 2.7 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.616 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.537 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.171 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -129.9 116.78 19.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' OD1' ' ND2' ' A' ' 102' ' ' ASN . 10.5 m-20 -75.44 71.73 2.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.708 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.7 t -58.92 124.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.403 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.04 103.52 11.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.858 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 58' ' ' ALA . 5.8 mm -99.34 102.97 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -100.48 114.01 27.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.383 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -129.89 -169.63 2.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.1 132.7 49.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -45.64 118.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.176 0.512 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.75 12.62 16.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.256 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 94' ' ' LYS . 6.7 mm-40 -130.48 128.01 40.35 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 111.334 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -72.17 153.34 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.84 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -49.47 -52.1 31.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.66 20.83 9.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.869 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -114.72 127.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.433 . . . . 0.0 111.11 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.1 97.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.839 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -100.94 145.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.926 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.909 HG23 ' CD1' ' A' ' 48' ' ' ILE . 6.1 m -125.98 160.16 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.189 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.34 117.25 5.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.734 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.769 0.237 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.705 HG21 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -156.41 -66.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.201 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.42 151.65 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.887 0.375 . . . . 0.0 111.739 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.909 ' CD1' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.63 115.44 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.889 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 68' ' ' ASP . 37.9 mt -60.54 71.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.34 -26.3 11.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 14.3 p30 -177.46 145.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.331 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.7 ptp -116.48 -170.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.0 tpp -94.46 125.22 38.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.0 81.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.796 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.37 20.44 7.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.41 175.56 28.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.454 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 23' ' ' ILE . 88.7 Cg_exo -47.48 -46.14 21.14 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.693 2.262 . . . . 0.0 112.807 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.871 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.43 -48.22 81.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.44 -34.36 72.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 110.554 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -58.5 -48.74 79.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.814 ' HB3' HD13 ' A' ' 23' ' ' ILE . 83.4 p -50.5 -39.86 49.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.01 2.39 82.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.599 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.7 mmpt? -96.94 -37.1 10.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.071 HD21 HG21 ' A' ' 103' ' ' ILE . 13.0 mt -91.67 111.64 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -110.19 141.0 43.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.9 mt -42.68 121.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.25 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.64 1.87 43.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.086 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.929 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.4 m-20 -71.49 130.73 42.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 110.782 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.59 78.25 9.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.987 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -55.62 144.7 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.104 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.762 ' HG2' HG23 ' A' ' 104' ' ' VAL . 15.3 mmt -111.11 -41.65 4.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.1 p -160.57 160.43 31.79 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.302 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HD11 ' A' ' 93' ' ' LEU . 8.7 mt -120.41 115.56 47.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.544 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.805 ' OD1' HG22 ' A' ' 73' ' ' ILE . 1.0 OUTLIER 43.46 33.08 0.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.853 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.94 33.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.133 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 89' ' ' ILE . 3.5 m -108.59 95.64 5.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.353 . . . . 0.0 110.695 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.707 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -58.54 130.71 48.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.131 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.767 ' HA ' HD11 ' A' ' 81' ' ' LEU . 26.2 mt -99.78 6.41 45.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.249 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.79 128.91 43.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.14 -23.98 33.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.45 143.87 27.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.885 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.31 178.67 2.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.635 2.223 . . . . 0.0 112.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 36' ' ' VAL . 15.6 tp -66.87 -35.06 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.967 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 m -53.81 -40.59 66.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.3 m -71.83 -48.77 43.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.918 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 10.1 m -56.95 -48.91 77.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.782 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -58.7 -46.74 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.331 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -59.01 -35.49 73.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.936 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.644 HD13 HG21 ' A' ' 76' ' ' THR . 11.4 mt -62.67 -45.27 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 93' ' ' LEU . 3.1 mt -60.92 -35.44 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.984 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -49.29 75.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.028 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.24 -11.01 60.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.103 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 73' ' ' ILE . 44.8 mt -86.61 18.16 3.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.608 0.242 . . . . 0.0 110.928 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.58 -33.66 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.539 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.83 62.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -124.32 -40.22 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.07 0.462 . . . . 0.0 110.346 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 79.46 -2.06 2.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.59 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.8 mtm180 -161.13 142.03 11.42 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.4 t -140.96 103.61 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.863 0.364 . . . . 0.0 111.846 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' NZ ' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.45 73.86 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 123.65 46.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' ND2' ' OD1' ' A' ' 20' ' ' ASP . 3.9 m-20 -88.28 122.85 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.071 HG21 HD21 ' A' ' 64' ' ' LEU . 2.4 pt -117.4 162.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.706 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 71' ' ' MET . 41.3 t . . . . . 0 C--O 1.235 0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 115.38 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.33 79.07 3.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HG ' ' A' ' 64' ' ' LEU . 40.4 t -69.11 122.41 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.921 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.45 103.07 10.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.423 178.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.777 HD13 ' HB3' ' A' ' 61' ' ' SER . 9.4 mm -97.75 103.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -103.49 113.43 26.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.896 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -135.96 -174.39 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.807 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -89.53 141.24 28.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.503 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -49.45 119.69 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 110.651 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . 109.0 13.84 16.83 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.054 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.0 mp0 -119.13 127.63 53.52 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.514 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.42 146.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.753 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.49 -39.83 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.824 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . 90.95 11.49 61.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.373 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 58' ' ' ALA . 6.2 m -104.18 126.85 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.226 0.513 . . . . 0.0 111.443 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.5 t -100.85 98.29 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.83 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -100.74 148.11 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.228 0.537 . . . . 0.0 111.774 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG2' HD12 ' A' ' 48' ' ' ILE . 15.7 m -129.7 160.28 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.427 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.41 108.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.836 ' HA ' HD11 ' A' ' 48' ' ' ILE . 30.5 t . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--O 1.23 0.113 0 CA-C-O 120.825 0.261 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.519 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -158.02 -59.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.722 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.8 140.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 0.0 111.655 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.928 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.28 116.32 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.764 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 ' HB2' ' A' ' 68' ' ' ASP . 64.9 mt -62.7 71.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -28.68 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 85.7 m-20 -146.75 168.57 21.03 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.94 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.557 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.09 134.73 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.24 127.19 26.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -73.78 68.93 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.45 -21.4 3.63 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.35 -176.07 0.61 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.64 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 23' ' ' ILE . 84.1 Cg_exo -48.0 -44.07 28.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.749 2.299 . . . . 0.0 112.766 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.68 -49.53 77.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.86 -29.68 64.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.514 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -62.99 -48.31 79.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.968 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.777 ' HB3' HD13 ' A' ' 23' ' ' ILE . 96.4 p -53.06 -38.25 62.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.15 19.0 70.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.263 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB2' HG13 ' A' ' 21' ' ' VAL . 6.4 mmpt? -116.35 -52.81 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.949 0.404 . . . . 0.0 110.747 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 101' ' ' LEU . 9.7 mt -77.97 120.65 23.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.51 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.436 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 13.7 m-80 -129.55 134.7 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.364 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 9.0 mt -33.34 122.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.37 2.31 55.63 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.994 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.1 m-20 -77.25 120.91 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.803 0.335 . . . . 0.0 110.618 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 86.46 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -62.75 143.21 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.46 ' HE2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -110.36 -40.11 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.813 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.8 p -159.73 156.91 28.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.182 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.819 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.9 mt -120.88 125.28 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.13 29.56 0.82 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.44 23.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.369 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.618 ' CG2' HD13 ' A' ' 89' ' ' ILE . 63.3 m -119.7 95.98 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.5 t -56.0 138.57 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.819 HD11 ' CD1' ' A' ' 73' ' ' ILE . 19.5 mt -109.1 4.32 22.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.04 126.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.92 -25.31 28.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.872 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.18 147.36 34.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.796 0.331 . . . . 0.0 111.016 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.48 173.97 8.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.354 . . . . 0.0 112.639 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.564 HD11 HE22 ' A' ' 87' ' ' GLN . 34.1 tp -62.36 -37.2 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.161 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -53.67 -46.42 70.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 89' ' ' ILE . 4.0 m -65.27 -44.28 88.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 90' ' ' ILE . 11.8 m -57.0 -56.2 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.785 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.564 HE22 HD11 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -49.44 -53.94 20.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.167 0.508 . . . . 0.0 110.854 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -53.72 -39.71 65.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.482 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 10.0 mt -61.64 -36.9 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.9 mt -77.99 -44.41 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.019 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.98 91.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.08 -17.36 44.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 69.9 mt -93.27 26.82 2.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.267 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -78.13 -12.23 59.98 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.983 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -134.52 48.46 2.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.877 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.476 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 4.1 mm100 -111.76 -33.21 6.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 110.336 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 77.95 -0.55 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.737 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.589 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.3 mtm180 -160.31 142.87 13.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.598 0.237 . . . . 0.0 110.515 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 31' ' ' LEU . 4.0 t -139.35 103.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.898 0.38 . . . . 0.0 111.993 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -91.09 75.4 6.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.804 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -106.21 120.47 41.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 107.96 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.025 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -103.33 174.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.13 0.491 . . . . 0.0 111.5 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.23 0.071 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.6 120.25 9.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 79.92 6.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.713 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.7 t -69.31 122.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.882 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.97 103.25 10.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.252 178.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.1 mm -97.26 102.38 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.5 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 19.2 mt-10 -95.08 109.84 21.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.492 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -130.03 -169.9 2.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.829 0.347 . . . . 0.0 110.96 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.74 137.11 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 6.3 mttp -47.49 124.56 7.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 110.779 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.01 14.35 24.91 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 78.8 mm-40 -130.45 130.72 44.61 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.635 0.255 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.638 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -81.24 151.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.128 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.891 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.95 -42.41 27.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.089 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.04 6.62 59.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.034 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 HD13 ' A' ' 90' ' ' ILE . 4.2 m -95.76 143.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.42 . . . . 0.0 111.392 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -119.72 98.65 6.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 90' ' ' ILE . 2.0 pp -95.18 153.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 112.067 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.919 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.8 m -130.21 156.91 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.408 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.79 93.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.746 0.308 . . . . 0.0 111.352 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.72 ' HA ' HD11 ' A' ' 48' ' ' ILE . 6.8 p . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.479 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 17.8 Cg_endo . . . . . 0 C--O 1.233 0.225 0 N-CA-C 112.799 0.269 . . . . 0.0 112.799 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 47.3 p -141.64 -73.81 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.021 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.961 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.07 141.05 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.745 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.919 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -118.37 118.28 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.897 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 58.0 mt -62.83 72.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.38 -28.25 58.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 85.3 m-20 -145.98 173.59 12.02 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.961 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.76 131.78 0.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.903 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 tpp -56.24 123.49 14.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.51 89.47 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.675 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.83 7.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.1 -163.8 25.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.292 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 23' ' ' ILE . 52.9 Cg_exo -55.93 -51.3 9.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.662 2.242 . . . . 0.0 112.711 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.891 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.36 -49.31 77.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.88 -28.14 65.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -64.47 -48.27 75.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.739 ' HB3' HD13 ' A' ' 23' ' ' ILE . 70.4 p -51.17 -39.8 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.74 23.79 59.37 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -121.12 -52.7 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.723 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.076 HD21 HG21 ' A' ' 103' ' ' ILE . 12.7 mt -77.82 119.79 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.553 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ILE . 9.8 p-10 -127.52 133.28 49.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.248 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.5 mt -32.4 117.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.973 0.416 . . . . 0.0 111.769 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.16 4.81 29.03 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.134 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -80.32 127.77 32.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 110.771 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.91 83.34 7.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.091 HG23 HG22 ' A' ' 103' ' ' ILE . 1.9 mt -62.19 144.08 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.012 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.66 ' HG2' HG23 ' A' ' 104' ' ' VAL . 24.6 mmt -112.85 -36.39 5.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.862 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 52.4 p -160.3 160.11 32.12 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.238 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.005 HG21 HD11 ' A' ' 93' ' ' LEU . 9.5 mt -127.5 123.83 62.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.769 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 46.29 29.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.55 17.3 31.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.664 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.546 HG21 HD13 ' A' ' 89' ' ' ILE . 4.6 m -111.36 95.83 5.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.372 . . . . 0.0 110.578 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.8 m -57.29 124.2 18.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.961 HD13 HG21 ' A' ' 47' ' ' VAL . 45.7 mt -97.38 21.16 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 2.7 t -93.02 113.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.281 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.16 28.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.292 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.886 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -83.73 142.05 42.04 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 117.034 0.417 . . . . 0.0 110.934 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 -179.58 2.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.661 2.241 . . . . 0.0 112.45 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HA ' ' A' ' 36' ' ' VAL . 16.1 tp -66.15 -31.56 72.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.009 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -56.42 -45.92 80.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -67.9 -48.0 67.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.4 m -57.32 -53.07 62.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -55.59 -40.16 71.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.95 0.405 . . . . 0.0 110.484 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 p -66.64 -29.27 69.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.963 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 78' ' ' LEU . 3.8 mt -69.73 -46.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.779 HD13 HG23 ' A' ' 33' ' ' VAL . 5.4 mt -62.25 -38.99 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.473 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -37.65 79.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.54 -9.5 73.96 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.005 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.36 27.33 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.727 0.298 . . . . 0.0 110.786 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -80.96 -33.79 33.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.456 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m-80 -120.53 63.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.934 0.397 . . . . 0.0 111.792 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -124.65 -41.76 2.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.9 m 77.97 2.03 2.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.293 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.594 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -164.06 138.73 5.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.448 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.544 HG12 HD22 ' A' ' 101' ' ' LEU . 3.5 t -135.91 103.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.991 0.424 . . . . 0.0 112.023 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -90.04 72.91 7.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.044 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -103.14 120.44 40.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 111.404 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -88.66 112.83 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.091 HG22 HG23 ' A' ' 70' ' ' ILE . 2.2 pt -106.31 174.17 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.249 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.66 HG23 ' HG2' ' A' ' 71' ' ' MET . 46.1 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.158 0.504 . . . . 0.0 111.788 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -148.3 115.58 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.2 77.54 3.01 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.5 t -67.19 117.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.06 103.33 11.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.419 178.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 61' ' ' SER . 6.1 mm -98.94 103.24 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.845 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 109.97 22.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.178 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -128.36 -170.55 2.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.84 139.7 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.552 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 14.1 mttt -50.18 125.69 12.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.165 0.507 . . . . 0.0 110.826 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.55 15.19 30.27 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 94' ' ' LYS . 13.1 mm-40 -120.53 136.86 54.65 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 111.596 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.894 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -87.14 147.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.231 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.943 HD23 ' CG2' ' A' ' 33' ' ' VAL . 7.4 tp -49.94 -45.67 51.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -0.1 62.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.017 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.943 ' CG2' HD23 ' A' ' 31' ' ' LEU . 1.1 m -94.55 125.26 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.318 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.26 98.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.233 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -94.95 150.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.176 0.513 . . . . 0.0 111.787 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.992 HG23 HD12 ' A' ' 48' ' ' ILE . 2.4 m -132.67 158.94 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.31 117.57 5.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 70.9 Cg_exo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.771 0.238 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.774 HG21 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -163.73 -60.48 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.14 152.17 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.002 0.43 . . . . 0.0 111.881 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.992 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.61 118.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.859 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 68' ' ' ASP . 47.4 mt -63.25 74.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.3 -34.36 66.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.382 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.6 m120 -140.9 177.55 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.003 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.4 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -170.85 122.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.598 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -46.52 132.03 10.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.505 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.55 81.46 4.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.3 5.37 8.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.829 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.36 -176.95 51.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.405 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' HG23 ' A' ' 23' ' ' ILE . 70.7 Cg_exo -51.47 -47.74 24.66 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.53 2.153 . . . . 0.0 112.398 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.88 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.4 -43.38 88.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.69 -29.77 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.591 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.06 -48.92 74.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.8 ' HB3' HD13 ' A' ' 23' ' ' ILE . 79.1 p -53.16 -39.73 63.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.79 72.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.0 mmtt -109.48 -52.8 2.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.099 HD21 HG21 ' A' ' 103' ' ' ILE . 12.3 mt -76.05 120.61 21.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.408 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.75 136.54 53.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.156 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -37.17 110.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.66 3.33 22.22 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.127 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.6 m-20 -78.16 119.56 21.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.908 0.385 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -75.06 86.61 2.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.079 HG23 HG22 ' A' ' 103' ' ' ILE . 2.0 mt -64.7 144.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.774 ' HE2' HG21 ' A' ' 46' ' ' THR . 4.4 mmt -110.8 -39.84 4.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.709 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.7 p -160.35 157.28 27.64 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.376 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 93' ' ' LEU . 6.8 mt -122.12 124.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.482 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 46.46 28.74 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.035 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.99 21.63 22.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.579 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.623 HG21 HD13 ' A' ' 89' ' ' ILE . 8.4 m -115.86 95.84 5.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.369 . . . . 0.0 110.907 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' HD21 ' A' ' 81' ' ' LEU . 51.0 m -60.07 122.05 13.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.753 HD11 ' CD1' ' A' ' 73' ' ' ILE . 51.7 mt -91.37 12.17 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.264 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 4.2 t -87.24 126.31 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.61 -24.1 33.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.634 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -93.56 142.97 25.87 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.52 171.68 12.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.539 2.159 . . . . 0.0 112.429 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 35' ' ' ILE . 28.7 tp -60.12 -30.09 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 p -54.61 -49.6 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.794 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -68.07 -42.07 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.5 m -57.41 -52.22 66.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.33 -40.69 82.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.324 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 m -64.98 -30.03 70.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 76' ' ' THR . 2.3 mt -69.13 -46.15 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.503 HD13 HG23 ' A' ' 33' ' ' VAL . 4.8 mt -65.84 -38.67 82.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.67 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.14 71.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.067 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.69 -14.09 81.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.185 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.923 HD11 HG21 ' A' ' 73' ' ' ILE . 90.5 mt -91.93 38.28 0.99 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.94 0.4 . . . . 0.0 110.598 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.894 ' HG3' HG22 ' A' ' 30' ' ' ILE . 5.8 mtpt -81.36 -35.04 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 15.6 m-80 -121.92 63.63 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.756 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.58 -39.62 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.58 -4.14 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.599 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.4 mtm180 -160.92 138.46 9.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.896 HG12 HD22 ' A' ' 101' ' ' LEU . 17.7 t -133.74 103.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 112.168 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.09 79.75 5.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.608 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.062 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -110.46 120.49 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.113 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.03 108.7 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.099 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -104.48 174.15 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.605 HG23 ' CG ' ' A' ' 71' ' ' MET . 57.3 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.088 0.47 . . . . 0.0 111.683 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.661 0.267 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.08 7.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.48 75.74 2.53 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG11 ' HG ' ' A' ' 64' ' ' LEU . 41.5 t -67.9 123.49 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.27 103.24 10.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.452 178.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 58' ' ' ALA . 11.0 mm -98.03 103.5 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.846 0.355 . . . . 0.0 111.143 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 128.87 41.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.076 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -149.12 -173.75 4.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 111.169 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.82 136.51 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -47.21 120.39 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.141 0.496 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 12.2 22.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.337 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -122.98 133.19 54.38 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.84 0.352 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 32' ' ' GLY . 1.2 pt -83.11 150.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.813 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.46 -40.19 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 90.04 31.1 11.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.868 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG13 ' CB ' ' A' ' 58' ' ' ALA . 3.5 m -125.1 124.35 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.411 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.15 98.26 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.009 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 47' ' ' VAL . 2.7 pp -99.75 144.9 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.029 0.443 . . . . 0.0 111.854 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.908 HG23 HD12 ' A' ' 48' ' ' ILE . 3.7 m -124.32 155.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.29 111.12 0.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 111.162 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.732 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.708 0.212 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.3 t -161.8 -62.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.743 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 35' ' ' ILE . 3.2 m -160.88 150.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 112.035 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.908 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.85 113.88 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.986 HD12 ' HB2' ' A' ' 68' ' ' ASP . 35.8 mt -60.17 72.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -34.61 62.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.403 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.508 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.7 m120 -141.68 179.54 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.982 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.66 125.41 0.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.442 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -48.23 124.01 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.35 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -72.24 88.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.37 26.1 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.41 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.45 -176.43 20.74 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 23' ' ' ILE . 89.3 Cg_exo -48.65 -46.12 25.27 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.596 2.197 . . . . 0.0 112.731 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.67 -49.25 78.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.51 -33.94 73.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.243 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -48.63 79.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.738 ' HB2' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -53.96 -37.9 64.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.77 17.06 79.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.808 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.62 -53.46 2.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 101' ' ' LEU . 15.4 mt -76.08 120.93 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.357 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' ILE . 11.2 m120 -127.05 133.07 50.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.125 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.5 mt -33.69 113.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.963 0.411 . . . . 0.0 111.935 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.89 -6.87 15.42 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.17 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.986 ' HB2' HD12 ' A' ' 49' ' ' ILE . 33.6 m-20 -70.47 127.88 34.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.56 0.219 . . . . 0.0 110.519 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.761 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -87.66 81.27 7.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.121 0.486 . . . . 0.0 110.669 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.93 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -54.3 137.2 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.057 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.0 mmt -105.56 -37.61 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 92.4 p -157.4 153.47 27.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 111.172 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 78' ' ' LEU . 4.2 mt -124.07 123.95 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.446 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 48.01 28.34 1.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.86 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.402 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.702 HG21 HD13 ' A' ' 89' ' ' ILE . 91.3 m -124.72 95.79 4.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.608 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -68.3 130.13 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.897 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.2 mt -95.77 14.29 23.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 t -74.64 112.7 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.499 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.39 -39.45 2.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.068 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -73.32 146.43 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.995 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.44 167.88 12.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 35' ' ' ILE . 21.9 tp -62.98 -35.05 78.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.86 -42.93 69.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.559 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.572 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.1 m -69.85 -44.45 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 78' ' ' LEU . 9.8 m -56.62 -53.46 57.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 3.5 mm-40 -52.9 -50.4 63.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 14.1 p -56.05 -36.46 68.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.272 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' CD2' ' A' ' 78' ' ' LEU . 19.9 mt -63.72 -33.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 33' ' ' VAL . 6.1 mt -70.23 -36.03 65.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.456 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.5 mppt? -75.38 -47.15 28.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.45 -25.4 27.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.393 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.729 ' CD2' HG21 ' A' ' 73' ' ' ILE . 3.5 pp -99.57 31.7 3.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.009 0.433 . . . . 0.0 110.577 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.67 -22.31 50.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.824 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -121.65 52.38 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 37.8 mm-40 -113.49 -31.26 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.2 m 70.58 10.65 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.3 mtm180 -168.92 139.68 2.4 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.231 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.813 HG21 HD12 ' A' ' 31' ' ' LEU . 4.7 t -136.88 103.69 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -90.63 76.68 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.44 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.93 120.78 43.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.316 0.579 . . . . 0.0 111.613 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.92 112.97 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.122 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.995 HG21 HD21 ' A' ' 64' ' ' LEU . 1.1 pt -112.88 160.42 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.613 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 69' ' ' GLN . 7.2 m . . . . . 0 C--O 1.235 0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.107 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -148.46 117.27 6.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.38 82.1 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.681 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -71.87 123.12 25.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.857 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.62 103.73 11.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 61' ' ' SER . 11.8 mm -99.62 103.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.963 0.411 . . . . 0.0 110.947 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.74 123.76 38.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.12 -169.75 3.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 111.133 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -101.24 147.83 25.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.31 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 5.5 mttp -55.12 130.84 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.081 0.467 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.76 13.17 54.3 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.639 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.73 139.18 52.68 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.807 0.337 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -87.22 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.86 HD22 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.69 -52.26 18.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 114.43 -14.1 20.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.344 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.943 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.0 m -94.09 128.3 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.614 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.04 98.46 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.886 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.5 pp -94.51 140.93 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 111.587 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 48' ' ' ILE . 28.9 m -124.38 161.36 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.183 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -54.55 118.87 4.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.738 0.304 . . . . 0.0 111.14 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--O 1.232 0.176 0 N-CA-C 112.912 0.312 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.8 t -168.27 -61.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.34 153.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.576 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.13 115.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.965 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.5 mt -61.38 71.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -49.07 -27.55 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 14.2 p30 -163.79 179.48 7.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.283 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.6 ttp -160.92 155.4 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.8 139.55 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.821 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -76.36 99.87 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.15 -19.3 52.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.2 175.44 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.593 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 23' ' ' ILE . 80.0 Cg_exo -46.81 -45.74 19.77 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.79 2.327 . . . . 0.0 112.876 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.943 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.63 -49.32 77.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.378 . . . . 0.0 111.133 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -72.48 -26.02 61.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -60.39 -48.02 83.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.811 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.1 t -54.69 -38.09 66.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.749 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.17 12.16 83.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.941 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -104.42 -45.18 4.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.965 0.412 . . . . 0.0 110.999 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.119 HD21 HG21 ' A' ' 103' ' ' ILE . 17.4 mt -81.6 117.11 21.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.532 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.2 137.45 51.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.896 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 20.0 mt -40.25 117.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.85 -3.1 25.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.174 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.965 ' HB2' HD12 ' A' ' 49' ' ' ILE . 1.7 m-20 -68.55 133.48 48.62 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.563 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -89.5 81.17 6.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.806 HG23 HG22 ' A' ' 103' ' ' ILE . 2.9 mt -55.62 145.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.589 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.52 -38.65 3.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.6 t -156.63 154.09 29.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.712 HG21 ' CD2' ' A' ' 93' ' ' LEU . 6.1 mt -123.2 122.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 48.59 27.89 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 20.49 25.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.655 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.601 ' CG2' HD13 ' A' ' 89' ' ' ILE . 6.4 m -115.75 97.74 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.5 m -53.32 142.44 21.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.765 HD12 HG21 ' A' ' 47' ' ' VAL . 22.2 mt -112.03 -5.76 14.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.377 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.3 t -78.44 129.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.405 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.59 -21.4 44.79 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.056 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.15 144.92 28.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.938 0.369 . . . . 0.0 110.975 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -174.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.579 HD11 HE22 ' A' ' 87' ' ' GLN . 31.0 tp -75.9 -38.77 57.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.1 p -53.77 -39.28 65.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.573 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.6 m -68.3 -47.22 68.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.5 m -56.53 -53.82 53.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.579 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.76 -53.91 22.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.348 0.594 . . . . 0.0 110.211 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -51.26 -35.7 38.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.128 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 78' ' ' LEU . 31.8 mt -68.31 -33.6 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.297 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 35' ' ' ILE . 6.7 mt -76.4 -37.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -38.43 57.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.645 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.3 -17.3 56.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' CD2' HG21 ' A' ' 73' ' ' ILE . 2.8 pp -109.2 39.2 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.701 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -78.95 -26.09 43.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 17.6 m-80 -121.58 54.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.519 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.416 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 7.8 mm100 -114.43 -29.89 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 m 71.44 7.96 6.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.158 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.559 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -166.4 143.09 4.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 110.58 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.829 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.6 t -138.68 103.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.959 0.409 . . . . 0.0 111.928 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -89.25 73.66 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.807 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.5 pt? -104.87 118.04 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.3 0.571 . . . . 0.0 111.491 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.563 ' ND2' ' CD2' ' A' ' 18' ' ' PHE . 3.1 t30 -87.3 111.79 21.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.234 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.119 HG21 HD21 ' A' ' 64' ' ' LEU . 6.4 pt -99.48 174.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.574 HG22 ' CE1' ' A' ' 18' ' ' PHE . 22.0 t . . . . . 0 C--O 1.236 0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 111.921 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -134.43 117.51 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.15 73.64 2.29 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 64' ' ' LEU . 44.1 t -64.21 120.41 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.554 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.522 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.74 102.85 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.445 178.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 8.7 mm -99.03 103.4 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.132 0.491 . . . . 0.0 110.58 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.08 109.93 22.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.317 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -127.04 -174.2 3.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.974 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -97.06 134.68 40.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.493 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -46.64 119.32 2.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 94' ' ' LYS . . . 110.51 12.55 16.71 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.365 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' LYS . 4.3 mm-40 -130.19 130.11 44.27 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.396 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.511 HG23 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -80.5 154.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.142 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -49.26 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.65 7.87 41.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.898 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 58' ' ' ALA . 13.9 m -100.22 127.2 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.22 101.22 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.216 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -96.48 165.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.204 0.526 . . . . 0.0 112.141 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 48' ' ' ILE . 35.9 m -152.34 148.69 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.6 121.09 6.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.695 0.283 . . . . 0.0 111.338 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.877 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.333 -0.124 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.856 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.758 0.232 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 79' ' ' VAL . 40.0 p -130.62 -72.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -158.78 137.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 111.684 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.032 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.59 118.76 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.108 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.95 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.2 mt -63.56 74.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.85 -24.45 23.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.127 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -157.07 164.99 37.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.086 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -159.88 128.47 4.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.754 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.3 tpp -46.51 131.36 11.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.452 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -76.99 90.21 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.64 -12.58 25.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.43 -175.48 5.36 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.68 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HB3' HG22 ' A' ' 23' ' ' ILE . 73.6 Cg_exo -50.0 -46.06 29.82 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.88 2.386 . . . . 0.0 112.606 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.19 -48.2 81.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.57 -31.32 66.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.252 0.549 . . . . 0.0 110.589 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -60.97 -48.67 80.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.04 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.8 t -55.28 -30.01 59.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.92 71.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -45.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.758 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 101' ' ' LEU . 13.5 mt -85.17 114.22 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.46 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.5 p-10 -120.98 135.13 55.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.213 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.8 mt -34.82 119.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.972 0.415 . . . . 0.0 111.683 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.41 1.48 35.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.054 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.95 ' HB2' HD12 ' A' ' 49' ' ' ILE . 20.2 m-20 -76.44 119.04 19.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.782 0.325 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 12.4 tt0 -75.99 85.71 2.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.02 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -61.95 144.78 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.174 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 104' ' ' VAL . 5.0 mmt -110.3 -42.39 4.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.0 p -157.71 165.13 36.22 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.032 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.876 HG21 HD11 ' A' ' 93' ' ' LEU . 10.9 mt -126.99 114.57 37.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.032 0.444 . . . . 0.0 111.652 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.8 ' OD1' HG22 ' A' ' 73' ' ' ILE . 1.2 p-10 43.19 33.36 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.78 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.42 6.06 36.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.938 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.625 HG21 HD13 ' A' ' 89' ' ' ILE . 3.3 m -104.85 95.42 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.701 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.9 t -59.22 133.24 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.212 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.861 HD13 HG21 ' A' ' 47' ' ' VAL . 88.4 mt -107.34 16.45 23.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.804 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 46' ' ' THR . 3.3 t -92.04 113.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.317 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.18 -27.34 20.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.256 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -82.54 141.22 45.01 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.081 0.44 . . . . 0.0 111.053 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.17 -179.84 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.605 2.203 . . . . 0.0 112.381 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 36' ' ' VAL . 21.7 tp -70.06 -33.32 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.012 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -54.02 -45.29 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 7.0 m -67.34 -50.36 60.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.95 -43.59 81.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -59.4 -46.16 89.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.452 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -61.23 -31.09 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.296 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.625 HD13 HG21 ' A' ' 76' ' ' THR . 23.6 mt -68.09 -46.2 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.711 HD13 HG23 ' A' ' 33' ' ' VAL . 3.5 mt -63.86 -36.8 77.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -36.03 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.795 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.28 -10.22 73.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.037 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 73' ' ' ILE . 35.7 mt -92.59 30.91 1.43 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.559 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -86.3 -12.8 48.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.664 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -143.91 58.08 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.715 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 mm-40 -117.75 -37.76 3.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.437 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 79.51 -4.73 1.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mtm180 -161.0 141.67 11.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.512 0.196 . . . . 0.0 110.549 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 31' ' ' LEU . 6.3 t -137.83 105.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 111.89 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -93.34 74.24 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.663 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.84 123.55 47.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.319 0.581 . . . . 0.0 111.644 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.22 115.61 25.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.059 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -112.8 174.05 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.563 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 71' ' ' MET . 11.2 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.725 0.298 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.3 148.23 52.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 7.9 tttt -143.12 114.79 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.3 78.16 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.716 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.2 t -68.23 123.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.018 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.04 102.86 10.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.127 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 22.3 mm -101.03 103.15 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 2.4 mt-10 -92.82 132.76 36.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -179.54 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 139.53 30.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.9 mttt -49.85 126.08 13.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.731 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.72 33.25 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 94' ' ' LYS . 47.6 mm-40 -127.49 131.2 50.18 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 111.195 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.07 151.67 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.334 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.076 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.83 -52.09 20.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.89 16.27 17.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.83 HG13 ' HB2' ' A' ' 58' ' ' ALA . 3.6 m -109.01 139.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.05 98.68 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.568 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 90' ' ' ILE . 1.4 pp -95.5 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.971 HG23 HD12 ' A' ' 48' ' ' ILE . 1.8 m -123.53 158.42 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.507 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 95.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.356 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.842 ' HA ' HD11 ' A' ' 48' ' ' ILE . 24.5 p -59.85 122.59 14.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.574 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.19 11.65 5.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.0 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.428 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -66.49 -179.74 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.971 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.94 71.57 0.76 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.155 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.685 ' C ' HD12 ' A' ' 43' ' ' ILE . 9.7 t -174.52 151.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.706 0.289 . . . . 0.0 110.812 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.876 HG21 HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER 45.55 -169.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -92.71 117.43 67.58 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.599 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 72.8 Cg_exo -50.0 132.04 31.68 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.548 2.165 . . . . 0.0 112.62 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.2 t -162.5 -61.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.56 156.62 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.88 0.372 . . . . 0.0 111.791 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.971 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.8 116.63 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.823 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.93 HD12 ' HB2' ' A' ' 68' ' ' ASP . 62.5 mt -61.42 71.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -55.32 -38.79 69.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.75 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -134.58 165.46 25.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.002 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.44 126.33 1.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.695 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -66.93 75.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.39 -12.17 7.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.716 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.2 -172.2 4.4 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.699 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.556 ' O ' HG23 ' A' ' 23' ' ' ILE . 85.1 Cg_exo -47.03 -47.67 16.21 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.934 2.422 . . . . 0.0 112.905 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.83 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.48 -49.73 76.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.087 0.47 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -48.51 81.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 4.5 t -57.78 -30.09 65.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 110.57 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.75 69.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.3 -54.54 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.865 ' CD2' HD13 ' A' ' 103' ' ' ILE . 24.3 mt -75.65 125.14 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.514 0.674 . . . . 0.0 111.529 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.1 p30 -132.57 112.42 12.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.396 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' C ' ' O ' ' A' ' 65' ' ' ASN . 7.2 mt -13.61 114.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.7 -3.21 19.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.33 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.93 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -74.91 133.58 41.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.583 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.607 ' OE1' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -89.08 81.23 6.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.95 0.405 . . . . 0.0 110.766 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 103' ' ' ILE . 3.7 mt -53.58 145.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.532 ' HE2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -110.21 -41.59 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.86 158.78 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.08 HG21 HD11 ' A' ' 93' ' ' LEU . 9.4 mt -125.48 121.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 49.36 26.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.01 19.38 24.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.731 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.527 HG21 ' CD1' ' A' ' 89' ' ' ILE . 5.4 m -113.12 95.79 5.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.7 p -56.55 125.36 21.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HA ' HD11 ' A' ' 81' ' ' LEU . 40.5 mt -90.99 -3.47 57.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.55 128.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.103 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.48 -20.85 48.67 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.821 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.757 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -99.87 141.65 23.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.826 0.313 . . . . 0.0 110.878 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.86 -176.37 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.566 2.177 . . . . 0.0 112.358 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.8 -32.9 70.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.045 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.8 p -55.43 -41.78 73.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -68.17 -50.58 53.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' A' ' 78' ' ' LEU . 17.8 m -57.13 -48.82 77.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -54.29 -47.56 72.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.969 0.414 . . . . 0.0 110.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -59.2 -32.47 69.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 9.4 mt -67.99 -45.97 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.78 HD11 HG13 ' A' ' 35' ' ' ILE . 5.1 mt -64.07 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.499 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -36.86 79.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.338 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.83 -4.43 76.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.339 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.08 HD11 HG21 ' A' ' 73' ' ' ILE . 64.1 mt -93.16 36.29 1.05 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.813 0.339 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 30' ' ' ILE . 2.5 tttt -85.65 -44.51 12.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.553 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.438 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.4 p-10 -116.82 61.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG3' HD23 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -113.82 -35.4 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.334 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 6.3 m 90.16 -19.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.179 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -167.31 151.51 6.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.174 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.076 HG21 HD12 ' A' ' 31' ' ' LEU . 3.4 t -128.58 110.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -90.86 75.56 6.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.477 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.841 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.4 pt? -107.68 119.12 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.325 0.583 . . . . 0.0 111.736 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 m-20 -86.51 111.55 20.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.246 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.865 HD13 ' CD2' ' A' ' 64' ' ' LEU . 6.8 pt -99.88 174.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.445 . . . . 0.0 111.882 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.876 HG11 HG21 ' A' ' 43' ' ' ILE . 71.9 t -118.15 128.44 75.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.04 149.09 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.807 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.6 117.97 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.83 80.12 2.75 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.711 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.7 t -71.91 127.35 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.598 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.03 102.9 9.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.913 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -99.78 103.75 15.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 0.0 110.296 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 112.94 25.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.589 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HD3' ' CG ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -130.47 -170.51 2.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.782 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -95.63 151.74 19.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.4 mttt -60.92 136.98 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.929 0.395 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.21 11.46 62.89 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.555 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.93 135.92 54.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -86.26 148.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.857 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.65 -43.64 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 97.65 4.75 57.97 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.262 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 58' ' ' ALA . 5.2 m -96.44 140.83 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 117.079 0.44 . . . . 0.0 111.301 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.3 t -118.55 98.83 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -97.83 150.98 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 111.937 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.941 HG23 HD12 ' A' ' 48' ' ' ILE . 3.5 m -129.73 164.52 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.494 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.77 103.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.392 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.845 ' HA ' HD11 ' A' ' 48' ' ' ILE . 43.0 p -55.75 142.86 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.1 49.09 0.55 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.91 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -170.26 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.14 54.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.543 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.659 ' C ' HD12 ' A' ' 43' ' ' ILE . 23.8 t -155.9 144.02 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.821 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.659 HD12 ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 49.33 -177.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.252 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 HG23 ' A' ' 46' ' ' THR . 1.1 pp -88.37 121.16 70.46 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.366 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 52.5 Cg_exo -52.81 127.16 23.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.49 2.127 . . . . 0.0 112.836 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 79' ' ' VAL . 73.3 p -148.91 -71.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.654 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -159.32 142.92 5.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.309 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.941 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -119.99 118.91 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.353 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 43.3 mt -63.49 71.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.44 -29.11 48.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 85.0 m-20 -145.06 173.1 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -171.86 129.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.813 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.468 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -53.16 128.74 28.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.45 99.01 7.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.04 21.22 11.2 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.522 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 -160.57 22.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 44.5 Cg_exo -57.09 -54.44 3.63 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.733 2.289 . . . . 0.0 112.559 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.13 -49.31 77.42 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.33 -28.79 68.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.19 0.519 . . . . 0.0 110.196 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -48.76 78.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.978 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.913 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.5 m -48.46 -40.44 26.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.15 27.66 43.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -47.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.056 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 101' ' ' LEU . 8.2 mt -74.69 107.44 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.032 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.28 138.79 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.761 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 16.9 mt -36.74 114.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.28 -6.15 11.92 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.0 m-20 -72.43 130.33 40.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.682 0.277 . . . . 0.0 110.643 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.515 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -88.25 79.98 7.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.116 0.484 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -55.66 141.78 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.521 ' SD ' HD21 ' A' ' 44' ' ' LEU . 5.5 ttm -116.01 -33.88 4.92 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 94.2 p -153.85 151.96 30.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.77 0.319 . . . . 0.0 111.363 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 93' ' ' LEU . 6.9 mt -125.52 123.83 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.411 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 45.98 29.14 0.7 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.85 20.87 20.2 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.432 ' CG2' HD13 ' A' ' 89' ' ' ILE . 90.8 m -122.96 95.49 4.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.451 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.2 p -68.58 130.88 44.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -97.35 15.79 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.9 t -72.81 108.82 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.184 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.43 -26.82 17.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.207 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.52 144.17 42.55 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.185 0.493 . . . . 0.0 111.019 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.66 177.83 3.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.785 2.323 . . . . 0.0 112.643 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.707 HD13 ' HA ' ' A' ' 36' ' ' VAL . 33.5 tp -64.22 -34.24 77.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -48.64 69.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.999 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 17.5 m -65.87 -45.03 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.409 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 20.6 m -56.76 -54.5 45.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.743 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.641 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.92 -53.49 25.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.259 0.552 . . . . 0.0 110.634 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.548 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 1.5 m -54.47 -34.55 61.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.555 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 7.4 mt -63.96 -46.52 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 35' ' ' ILE . 4.3 mt -61.45 -34.81 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.305 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 2.0 mmmt -68.31 -43.56 77.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.556 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.82 -16.37 51.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.984 HD11 HG21 ' A' ' 73' ' ' ILE . 26.9 mt -91.24 38.47 0.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 111.027 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -80.92 -40.47 24.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.802 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.3 p30 -126.07 59.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.745 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -109.61 -35.5 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 0.8 OUTLIER 81.49 -10.79 1.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.17 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -155.34 150.11 26.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.698 0.285 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.715 HG12 HD22 ' A' ' 101' ' ' LEU . 5.0 t -139.99 103.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.939 0.4 . . . . 0.0 112.002 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -93.89 77.53 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -104.78 121.44 43.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.344 0.592 . . . . 0.0 111.676 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.81 106.79 17.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.289 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.982 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -106.48 174.03 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.208 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -128.98 139.5 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.281 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.29 148.3 43.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.067 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -146.01 114.9 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.19 74.03 2.32 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.779 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.4 t -64.9 128.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.78 102.91 9.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.861 HD13 ' OG ' ' A' ' 61' ' ' SER . 12.6 mm -99.04 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.85 0.357 . . . . 0.0 110.906 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.98 128.87 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 31' ' ' LEU . 2.0 pttp -149.57 177.75 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -87.44 142.05 28.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -51.28 126.65 17.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 14.84 34.34 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.443 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.2 mm-40 -123.04 134.0 54.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -86.1 152.06 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.242 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 99' ' ' VAL . 1.7 tp -50.59 -51.96 43.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.91 36.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.649 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 58' ' ' ALA . 8.8 m -95.29 138.98 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.063 0.458 . . . . 0.0 111.057 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.75 98.4 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 HG13 HD11 ' A' ' 90' ' ' ILE . 1.3 pp -95.94 143.72 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 111.729 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.007 HG23 HD12 ' A' ' 48' ' ' ILE . 2.5 m -124.63 161.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.39 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.48 111.87 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.809 ' HA ' HD11 ' A' ' 48' ' ' ILE . 22.7 t -70.26 128.56 36.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.12 5.98 4.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.147 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.405 ' NE1' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -68.69 176.26 3.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.967 0.383 . . . . 0.0 110.868 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.23 66.84 2.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.607 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.67 ' C ' HD12 ' A' ' 43' ' ' ILE . 20.9 p -167.61 148.68 5.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.019 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 44.72 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.419 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD12 HG13 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -96.02 131.95 27.93 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.669 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.86 140.99 88.34 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.531 2.154 . . . . 0.0 112.579 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.5 t -170.69 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.772 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.88 146.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.814 0.34 . . . . 0.0 111.367 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.007 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.25 116.61 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.725 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 68' ' ' ASP . 90.3 mt -61.42 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.39 -38.49 63.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.52 169.16 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.955 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.568 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.83 132.39 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.6 113.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 75.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.75 -4.73 5.1 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.53 -173.16 47.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.649 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' ILE . 76.2 Cg_exo -48.5 -47.12 21.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.757 2.305 . . . . 0.0 112.67 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.38 -49.08 78.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.84 -27.28 64.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -62.73 -48.73 77.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.861 ' OG ' HD13 ' A' ' 23' ' ' ILE . 33.1 m -56.0 -32.24 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.31 4.74 80.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -98.28 -56.39 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 101' ' ' LEU . 12.5 mt -72.19 122.66 21.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 2.5 m120 -131.54 135.74 47.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' ILE . 12.3 mt -35.14 116.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 111.618 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.36 0.8 29.59 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.119 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 1.011 ' HB2' HD12 ' A' ' 49' ' ' ILE . 8.9 m-20 -78.25 113.66 16.43 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.914 0.387 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' NE2' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.7 79.7 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.132 -179.253 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.136 HG23 HG22 ' A' ' 103' ' ' ILE . 2.2 mt -54.5 145.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.479 ' SD ' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -112.45 -39.45 4.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.5 p -159.23 156.86 29.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.781 0.324 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 93' ' ' LEU . 7.8 mt -124.26 120.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' ND2' HG13 ' A' ' 99' ' ' VAL . 60.0 m-20 51.93 25.87 3.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.97 27.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.554 HG21 ' CD1' ' A' ' 89' ' ' ILE . 21.7 m -110.71 95.35 5.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 110.66 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.633 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -59.02 128.6 38.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.179 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.772 HD12 HG21 ' A' ' 47' ' ' VAL . 29.8 mt -98.48 -8.91 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.285 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG13 HD12 ' A' ' 44' ' ' LEU . 15.5 t -59.54 109.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.78 -27.09 21.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.952 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -71.9 139.93 83.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.827 0.313 . . . . 0.0 110.723 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.28 179.71 2.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.322 2.015 . . . . 0.0 111.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.53 -41.06 89.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 m -53.9 -36.28 62.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -70.55 -54.34 12.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.008 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.9 m -57.29 -55.27 36.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.828 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -54.29 19.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 110.823 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 t -53.31 -37.29 62.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.554 ' CD1' HG21 ' A' ' 76' ' ' THR . 6.8 mt -63.96 -46.12 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' ILE . 4.2 mt -60.16 -37.59 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.262 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -35.72 70.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.318 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.53 -7.85 83.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.53 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.088 HD11 HG21 ' A' ' 73' ' ' ILE . 87.0 mt -92.51 41.51 1.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.988 0.423 . . . . 0.0 110.688 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -84.77 -48.38 9.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.43 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 7.4 m-80 -116.74 61.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 97' ' ' SER . 1.1 mm100 -108.04 -36.88 6.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.18 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 7.6 t 91.29 -18.51 0.15 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.236 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 151.71 3.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 31' ' ' LEU . 8.0 t -131.31 107.54 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -88.17 77.87 8.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -107.29 119.11 38.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.359 0.6 . . . . 0.0 111.514 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -86.34 107.09 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.128 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.136 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -99.78 164.17 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HG21 ' A' ' 43' ' ' ILE . 45.1 t -116.62 139.48 43.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.742 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.404 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 2.1 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.522 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 1.5 tt0 . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.885 0.374 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.34 148.0 51.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.674 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -160.95 141.79 11.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.359 0.6 . . . . 0.0 112.469 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.4 72.79 8.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.722 HG11 ' HG ' ' A' ' 64' ' ' LEU . 76.8 t -58.58 124.52 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.626 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.96 103.28 11.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.915 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 61' ' ' SER . 13.3 mm -98.29 102.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.985 0.421 . . . . 0.0 110.258 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.94 117.38 33.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.426 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' SER . 22.4 pttt -136.64 -168.33 2.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 152.18 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -59.49 132.96 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.34 13.98 54.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.63 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -122.85 136.26 54.81 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.799 0.333 . . . . 0.0 111.425 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -89.37 161.29 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.806 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.972 HD11 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -51.97 -52.11 52.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.102 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.5 -10.93 35.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.26 127.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.082 0.467 . . . . 0.0 111.367 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.01 100.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.808 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.688 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.4 pp -90.25 137.46 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.094 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.053 HG23 HD12 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -119.95 161.48 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.646 ' H ' HD12 ' A' ' 83' ' ' LEU . 2.1 tt0 -63.2 117.99 7.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.806 0.336 . . . . 0.0 110.796 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.657 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -57.73 143.17 42.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.031 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.7 -18.13 5.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.89 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -177.06 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.65 23.68 4.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.766 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -71.06 -32.64 69.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.29 -170.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.485 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.5 OUTLIER -71.98 118.93 71.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.86 143.58 95.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.351 2.034 . . . . 0.0 112.269 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -170.3 -64.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.85 143.48 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.053 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.25 117.53 48.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.421 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.96 HD11 HD22 ' A' ' 64' ' ' LEU . 58.4 mt -62.59 70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.05 -41.47 62.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.589 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.69 -169.97 2.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.599 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 5.3 ptp -168.32 162.51 12.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 8.0 tpp -88.56 117.11 27.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -55.41 103.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.74 77.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.729 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.72 171.91 37.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 23' ' ' ILE . 88.8 Cg_exo -49.01 -45.16 30.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.886 2.391 . . . . 0.0 112.975 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.768 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -57.83 -49.91 75.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.336 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.68 -30.72 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -53.35 -48.66 68.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.737 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 23' ' ' ILE . 1.4 t -55.7 -43.78 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.51 83.46 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -87.77 -35.01 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.676 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 101' ' ' LEU . 11.0 mt -90.72 111.39 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.7 OUTLIER -120.4 140.89 50.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.1 mt -38.01 126.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.812 0.339 . . . . 0.0 111.412 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.09 -7.66 52.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.989 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.895 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.5 m-20 -69.32 109.24 4.04 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.682 ' OE1' HG23 ' A' ' 48' ' ' ILE . 14.3 tp60 -71.37 85.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.012 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -58.86 138.9 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.704 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.57 -38.28 6.49 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.9 p -159.45 157.67 30.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.332 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 93' ' ' LEU . 7.7 mt -122.14 126.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.699 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.523 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER 36.42 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.172 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.75 26.22 9.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.809 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.783 HG21 HD13 ' A' ' 89' ' ' ILE . 25.3 m -123.86 95.33 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 110.724 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 81' ' ' LEU . 5.0 m -60.62 120.8 10.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.048 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.775 HD21 HD12 ' A' ' 89' ' ' ILE . 38.1 mt -91.09 -11.15 39.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.362 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.528 HG22 HD12 ' A' ' 44' ' ' LEU . 21.9 t -55.94 107.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.264 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.26 -26.35 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.793 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 77' ' ' SER . 4.6 mt -68.24 127.49 93.26 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.556 0.217 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.59 164.54 2.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.337 2.025 . . . . 0.0 112.012 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.646 HD12 ' H ' ' A' ' 37' ' ' GLU . 8.7 tt -60.23 -44.64 95.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 m -53.49 -33.44 54.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.525 ' O ' HG13 ' A' ' 89' ' ' ILE . 2.9 m -72.88 -47.19 48.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.752 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.473 ' O ' HG13 ' A' ' 90' ' ' ILE . 74.9 m -56.8 -50.01 73.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' CG ' HD23 ' A' ' 83' ' ' LEU . 7.9 mm100 -57.15 -53.17 61.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.184 0.516 . . . . 0.0 109.966 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 9.0 p -51.57 -39.76 58.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.783 HD13 HG21 ' A' ' 76' ' ' THR . 12.5 mt -61.36 -41.73 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.8 mt -60.4 -35.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.348 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.2 mppt? -76.28 -34.71 59.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.521 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.74 -30.05 76.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 73' ' ' ILE . 1.7 pp -99.56 38.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.53 -25.47 50.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.912 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 2.1 m120 -126.08 55.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.487 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.431 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 34.5 mm-40 -112.31 -30.39 7.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.555 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 74.97 1.42 3.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.599 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.01 146.9 12.83 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.718 0.294 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.972 HG11 HD11 ' A' ' 31' ' ' LEU . 3.6 t -140.14 105.64 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -94.45 79.65 3.88 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 pt? -107.27 125.24 50.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.381 0.61 . . . . 0.0 111.763 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -87.5 109.15 19.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.851 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.012 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -114.88 174.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 69' ' ' GLN . 3.5 m -134.22 137.01 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.983 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.654 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 105' ' ' ARG . 2.3 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 2.6 m-85 -70.45 148.5 48.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -146.66 116.82 7.35 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.88 78.14 2.79 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.738 HG11 ' HG ' ' A' ' 64' ' ' LEU . 35.8 t -69.22 125.58 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.507 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.26 103.12 10.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.515 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.897 HD13 ' OG ' ' A' ' 61' ' ' SER . 8.9 mm -98.56 103.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.631 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -99.33 128.49 45.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.559 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -151.94 -174.96 5.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.942 0.401 . . . . 0.0 110.958 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -85.18 160.82 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.139 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -67.12 123.25 19.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.303 0.573 . . . . 0.0 110.466 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' H ' ' HA ' ' A' ' 95' ' ' ASN . . . 100.68 18.74 19.84 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.299 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.1 mm-40 -117.46 131.49 56.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.676 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -87.74 151.2 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.1 tp -48.21 -43.32 31.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 98.23 -5.06 60.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.783 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.935 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.31 125.12 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.28 98.57 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.954 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.853 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.4 pp -95.6 147.31 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.995 HG23 HD12 ' A' ' 48' ' ' ILE . 27.2 m -132.1 155.29 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -51.73 118.85 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.787 0.327 . . . . 0.0 111.29 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -68.34 103.39 1.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.68 10.33 41.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.984 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.47 178.42 4.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.72 55.89 1.64 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.661 ' C ' HD12 ' A' ' 43' ' ' ILE . 31.4 t -156.82 148.03 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.374 . . . . 0.0 110.817 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.661 HD12 ' C ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 44.98 -166.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.179 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.684 HD12 HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -93.79 142.89 25.67 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.699 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.33 120.93 8.01 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.581 2.187 . . . . 0.0 112.595 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 79' ' ' VAL . 82.1 p -144.82 -74.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.908 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -159.99 141.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.658 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.07 119.07 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.13 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.924 HD12 ' HB2' ' A' ' 68' ' ' ASP . 31.3 mt -62.21 72.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.72 -25.95 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.904 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -165.41 166.67 18.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.705 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.551 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.3 ptp -143.48 171.09 14.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.401 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.9 ttm -87.65 112.98 22.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.88 90.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.08 21.91 8.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.438 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.22 179.26 27.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.408 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB3' HG22 ' A' ' 23' ' ' ILE . 78.5 Cg_exo -51.21 -45.38 37.32 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.68 2.253 . . . . 0.0 112.455 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.935 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.47 -49.46 77.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.34 -32.28 68.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -58.78 -48.65 80.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.897 ' OG ' HD13 ' A' ' 23' ' ' ILE . 7.8 m -50.04 -43.86 51.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.28 85.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.419 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 61' ' ' SER . 1.2 mptt -97.85 -53.1 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.44 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.074 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -74.62 125.17 28.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.172 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.551 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.2 p-10 -128.24 136.51 51.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.027 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 15.7 mt -37.86 107.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.991 0.424 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.92 -6.93 10.22 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.917 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.924 ' HB2' HD12 ' A' ' 49' ' ' ILE . 10.0 m-20 -71.27 124.38 24.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.564 0.221 . . . . 0.0 110.428 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -86.97 97.16 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.14 0.495 . . . . 0.0 110.543 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.151 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -68.23 142.25 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.145 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.65 ' HE2' HG21 ' A' ' 104' ' ' VAL . 7.6 mmt -111.7 -32.97 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.008 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 45.3 t -159.62 154.6 24.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.139 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.834 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.1 mt -126.8 123.69 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 45.88 29.82 0.78 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.39 21.87 25.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.371 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -115.54 97.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.69 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -52.97 134.99 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 81' ' ' LEU . 63.7 mt -109.53 9.71 25.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.026 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.916 ' HA ' HG22 ' A' ' 46' ' ' THR . 11.8 t -86.19 114.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.398 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.74 -33.99 6.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.146 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.919 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -76.72 127.63 83.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.072 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.81 170.43 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.541 2.161 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 tp -59.52 -34.01 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -53.49 -51.02 64.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.546 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 89' ' ' ILE . 58.5 m -63.51 -43.38 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.425 ' HB3' HG11 ' A' ' 47' ' ' VAL . 18.6 m -57.03 -50.57 72.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.87 -38.52 72.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -33.77 74.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.115 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 22.7 mt -64.89 -38.97 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 120.969 0.414 . . . . 0.0 109.916 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -77.19 -42.87 31.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -44.17 97.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.364 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.09 -14.53 61.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.375 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 95.9 mt -93.83 37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.794 ' HG3' HG22 ' A' ' 30' ' ' ILE . 7.2 mtpt -79.11 -34.49 43.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' GLY . 1.9 p30 -120.3 64.22 0.83 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.7 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HG3' HD22 ' A' ' 93' ' ' LEU . 4.2 mm100 -119.21 -34.71 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.543 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.603 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 5.5 t 74.11 1.53 3.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.734 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.563 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -165.86 145.11 6.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.826 HG21 ' CD1' ' A' ' 31' ' ' LEU . 11.1 t -139.89 103.83 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -91.39 78.38 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.441 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.896 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -107.69 118.98 38.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.403 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.99 111.48 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.439 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.151 HG22 HG23 ' A' ' 70' ' ' ILE . 1.1 pt -107.58 174.15 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.336 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -127.25 145.96 33.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.504 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 1.3 mtt-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.462 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.38 148.28 41.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.79 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -147.51 113.77 5.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.12 73.8 2.97 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.794 HG11 ' HG ' ' A' ' 64' ' ' LEU . 47.3 t -61.9 126.1 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.799 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.0 103.83 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.697 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 61' ' ' SER . 16.6 mm -100.05 103.44 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.982 0.42 . . . . 0.0 110.99 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 109.94 22.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.241 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 3.0 pttt -127.79 -170.27 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.6 138.3 40.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -47.66 124.41 7.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.027 0.442 . . . . 0.0 110.764 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.74 12.95 28.98 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.514 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' LYS . 10.5 mm-40 -129.22 126.63 39.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.278 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.08 153.69 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -47.66 -52.24 18.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.072 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.91 1.21 42.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 58' ' ' ALA . 11.7 m -94.53 123.81 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.184 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.3 t -99.85 100.0 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.457 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.689 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.7 pp -95.6 142.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.111 0.481 . . . . 0.0 111.683 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -118.22 167.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.7 105.28 2.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 48' ' ' ILE . 11.5 p -64.98 123.41 19.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.453 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.32 4.31 13.64 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.317 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -175.26 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.076 0.438 . . . . 0.0 110.75 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.46 53.96 0.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.986 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -113.03 -33.22 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 110.918 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.2 179.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.516 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.008 HD11 ' HE2' ' A' ' 71' ' ' MET . 4.0 pp -61.32 135.35 93.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.268 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 57.7 Cg_endo -71.52 145.67 47.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.499 2.133 . . . . 0.0 113.047 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -175.14 -64.85 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.338 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.86 161.15 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.985 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -142.42 114.85 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.933 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.9 mt -61.1 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 36' ' ' VAL . . . -53.79 -30.73 46.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.816 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.518 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -153.55 167.68 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.899 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 5.0 ttp -154.92 129.21 8.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tpp -54.0 98.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -52.06 123.17 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.66 21.66 59.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.95 -170.31 20.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 23' ' ' ILE . 53.8 Cg_exo -53.15 -47.62 26.52 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.646 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.796 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.71 -49.36 77.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.432 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.02 -30.37 63.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -48.57 75.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.689 ' HB3' HD13 ' A' ' 23' ' ' ILE . 98.8 p -56.25 -39.38 72.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.41 63.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.354 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -110.21 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 101' ' ' LEU . 16.1 mt -72.38 127.83 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.721 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.7 m-80 -130.62 126.72 37.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 14.4 mt -30.61 113.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 121.06 0.457 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.74 5.31 22.36 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.094 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.964 ' HB2' HD12 ' A' ' 49' ' ' ILE . 15.7 m-20 -79.27 120.82 24.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.7 80.92 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.948 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.976 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -55.76 143.51 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 1.008 ' HE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.64 -41.38 4.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.928 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 77.2 p -158.29 156.87 31.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 111.404 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.945 HG21 HD11 ' A' ' 93' ' ' LEU . 6.7 mt -122.82 122.03 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.3 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.741 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.5 OUTLIER 40.32 33.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.865 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.51 22.18 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.811 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 89' ' ' ILE . 33.5 m -123.09 95.56 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.756 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.49 130.21 43.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.797 ' CD2' HD12 ' A' ' 89' ' ' ILE . 59.1 mt -96.23 12.59 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.428 ' CG1' HD13 ' A' ' 44' ' ' LEU . 6.8 t -89.3 123.74 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.087 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.63 -25.39 28.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.822 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.756 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -91.44 134.2 29.96 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.761 0.281 . . . . 0.0 110.869 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.03 -176.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.497 2.131 . . . . 0.0 112.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 7.8 tt -75.55 -37.66 59.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -53.43 -36.89 62.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.556 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.2 m -68.76 -50.81 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.495 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.403 ' O ' HG13 ' A' ' 90' ' ' ILE . 21.5 m -56.77 -48.68 77.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -54.14 -48.1 71.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.633 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 t -61.42 -33.81 74.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.533 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 78' ' ' LEU . 38.8 mt -64.6 -46.43 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 35' ' ' ILE . 3.6 mt -65.24 -39.08 84.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.443 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -69.35 -32.37 71.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.821 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.27 -11.54 84.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.468 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.945 HD11 HG21 ' A' ' 73' ' ' ILE . 93.8 mt -93.17 39.86 1.05 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.934 0.397 . . . . 0.0 110.93 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 29' ' ' GLU . 4.2 tttt -80.87 -37.57 29.62 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 3.2 p30 -120.71 63.68 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.837 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.405 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 3.8 mm100 -117.18 -39.54 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 76.68 -2.12 2.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.698 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -162.64 139.45 7.76 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.533 0.206 . . . . 0.0 110.451 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.785 HG12 HD22 ' A' ' 101' ' ' LEU . 10.6 t -136.38 104.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -93.03 80.07 4.57 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.503 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.886 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.2 pt? -110.01 120.07 41.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -86.41 108.45 18.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.048 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.976 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -101.17 167.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.08 0.467 . . . . 0.0 111.787 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 43' ' ' ILE . 38.3 t -116.16 137.31 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.602 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.496 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 105' ' ' ARG . 4.0 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.14 148.61 35.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -144.51 115.08 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 75.6 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.804 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.5 t -66.36 120.8 14.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.524 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.43 103.63 10.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.627 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 58' ' ' ALA . 14.3 mm -99.18 103.59 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.442 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 1.2 tt0 -95.49 111.53 23.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.6 pttt -130.84 -170.73 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.112 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.34 143.4 32.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.575 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 4.9 mttt -51.43 128.57 23.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.987 0.423 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 11.65 43.97 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.581 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -124.09 129.2 50.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -83.33 149.79 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -47.77 -46.06 29.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.53 7.81 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.05 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.69 HG13 ' CB ' ' A' ' 58' ' ' ALA . 4.7 m -95.9 126.09 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 111.438 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -102.41 98.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.092 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.817 HD13 HG12 ' A' ' 47' ' ' VAL . 2.6 pp -101.99 151.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 112.176 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.901 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.2 m -132.26 159.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.186 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.75 117.06 3.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.692 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -64.83 106.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.02 -1.24 63.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.11 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -174.04 2.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.834 0.317 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.0 32.89 3.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.853 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -37.9 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.161 0.505 . . . . 0.0 110.665 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.615 ' HB ' HE21 ' A' ' 69' ' ' GLN . 0.1 OUTLIER -144.44 -171.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.624 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.616 HD11 ' HE2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -68.66 130.62 91.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.657 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.65 113.15 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.507 2.138 . . . . 0.0 112.484 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 79' ' ' VAL . 71.1 p -141.14 -72.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.171 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -160.12 148.06 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.029 0.442 . . . . 0.0 111.868 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.901 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -129.27 113.96 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 68' ' ' ASP . 36.5 mt -60.98 72.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.05 -28.64 58.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.399 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 85.3 m-20 -145.57 169.52 18.24 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.681 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.684 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -166.77 117.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.676 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 ttm -45.42 124.03 4.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.605 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -68.21 105.83 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.623 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.39 -17.25 57.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -178.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' O ' HG23 ' A' ' 23' ' ' ILE . 77.1 Cg_exo -51.0 -47.41 25.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.902 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.43 -49.08 78.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.76 -26.56 62.5 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.738 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -48.96 75.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.9 p -52.87 -37.94 61.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.04 45.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.173 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -117.66 -61.64 1.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 101' ' ' LEU . 14.0 mt -66.06 131.09 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.841 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' ILE . 8.1 m120 -134.18 123.7 24.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.124 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.1 mt -28.38 114.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.968 0.413 . . . . 0.0 111.789 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.98 -6.02 22.03 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.983 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.96 ' HB2' HD12 ' A' ' 49' ' ' ILE . 14.5 m-20 -68.5 135.6 51.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 110.515 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.615 HE21 ' HB ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -92.63 81.52 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.862 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -54.9 141.32 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.616 ' HE2' HD11 ' A' ' 44' ' ' LEU . 4.0 ttm -111.26 -34.21 6.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.691 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 87.1 p -156.96 155.11 30.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -126.66 121.43 58.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.891 0.376 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 46.97 29.04 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.243 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.09 18.19 25.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.622 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 89' ' ' ILE . 9.0 m -119.42 95.63 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.756 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.774 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.4 m -63.56 131.23 47.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.337 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.966 HD13 HG21 ' A' ' 47' ' ' VAL . 3.2 mt -98.05 22.49 9.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.906 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.1 t -88.14 105.87 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.68 -30.17 8.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.931 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -80.53 143.4 55.12 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.94 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.81 169.94 13.69 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.744 2.296 . . . . 0.0 112.667 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.55 HD11 HE22 ' A' ' 87' ' ' GLN . 27.3 tp -58.38 -37.09 74.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -53.48 -48.61 68.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.733 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.628 ' O ' HG13 ' A' ' 89' ' ' ILE . 26.1 m -64.47 -43.58 93.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.497 ' HB3' HG11 ' A' ' 47' ' ' VAL . 13.6 m -56.6 -54.92 40.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.55 HE22 HD11 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -49.94 -53.58 25.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.172 0.511 . . . . 0.0 110.508 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -53.14 -32.21 46.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.422 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.638 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 20.6 mt -70.04 -36.98 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.201 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 33' ' ' VAL . 4.3 mt -77.64 -35.49 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.509 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -73.86 -42.7 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.981 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.35 39.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.488 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.687 HD11 HG21 ' A' ' 73' ' ' ILE . 21.8 mt -88.15 46.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.65 -30.99 41.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -135.18 69.16 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.567 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.417 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mm100 -119.1 -36.13 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.343 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.3 p 76.3 1.63 3.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.684 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -162.77 143.3 9.62 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.616 0.246 . . . . 0.0 110.883 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.777 HG11 ' CD1' ' A' ' 31' ' ' LEU . 4.1 t -137.58 103.54 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 111.671 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -93.04 74.53 4.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.646 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.19 119.5 39.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.277 0.56 . . . . 0.0 111.189 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.94 107.28 18.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.426 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.862 HG22 HG23 ' A' ' 70' ' ' ILE . 5.3 pt -103.06 173.6 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.417 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.6 139.72 51.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.316 179.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.967 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.32 145.99 49.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.793 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -152.9 142.63 21.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 111.99 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.49 72.4 7.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.784 HG11 ' HG ' ' A' ' 64' ' ' LEU . 72.2 t -57.85 125.72 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.25 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.09 103.83 10.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.249 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 61' ' ' SER . 10.1 mm -100.31 103.54 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -100.09 131.59 45.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.603 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -153.74 -172.85 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.968 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -94.88 145.3 25.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.442 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 5.6 mptt -49.2 122.95 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.056 0.455 . . . . 0.0 110.679 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.35 16.65 22.17 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -121.31 119.79 33.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 111.413 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -77.74 151.05 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.877 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.32 -52.24 16.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.316 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.98 -1.33 35.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.144 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.798 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -94.63 122.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.09 0.471 . . . . 0.0 111.324 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 HG21 ' OD1' ' A' ' 51' ' ' ASN . 46.1 t -97.17 98.65 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.079 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -95.62 149.8 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 112.051 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 2.9 m -133.78 157.72 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.365 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.85 111.99 0.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.853 0.358 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.725 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -63.91 139.12 58.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.71 -9.25 4.44 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.373 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.67 176.16 5.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.009 0.404 . . . . 0.0 110.952 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.01 53.89 0.6 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.832 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.24 -35.34 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 0.0 110.632 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -153.0 171.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.53 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -55.72 109.21 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.69 119.54 3.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.563 2.175 . . . . 0.0 112.598 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.928 HG22 ' HA ' ' A' ' 79' ' ' VAL . 41.2 p -135.98 -70.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.18 137.61 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -116.08 119.07 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.394 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.6 mt -64.75 70.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.34 -33.96 22.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.329 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.21 140.7 13.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.52 . . . . 0.0 110.506 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.444 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 2.8 ttp -123.34 163.03 21.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.47 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.5 ttm -76.92 137.01 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -80.87 92.78 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.33 -4.4 37.81 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.94 -179.38 50.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.58 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 23' ' ' ILE . 82.6 Cg_exo -47.36 -47.03 18.51 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.919 2.413 . . . . 0.0 112.902 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.798 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.64 -49.48 77.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.259 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.34 -24.78 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -64.45 -47.03 80.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.816 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.7 t -53.08 -41.73 65.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.802 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.02 85.94 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.349 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 1.3 mptt -100.16 -56.45 2.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.803 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.084 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -70.36 124.49 24.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.204 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' ILE . 16.0 m120 -131.09 136.11 48.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.223 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 25.0 mt -34.76 124.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.49 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.52 -9.02 48.37 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.985 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -66.9 120.81 14.21 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.686 0.279 . . . . 0.0 110.693 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.4 82.54 7.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.04 0.448 . . . . 0.0 110.233 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.996 HG23 HG22 ' A' ' 103' ' ' ILE . 2.6 mt -55.68 139.3 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.981 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.9 mmt -106.04 -39.44 5.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.74 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 80.6 p -156.38 164.34 38.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 93' ' ' LEU . 8.3 mt -128.44 114.3 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.003 0.43 . . . . 0.0 111.471 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.8 OUTLIER 42.48 31.94 0.32 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.687 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.84 11.76 27.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.808 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.684 ' CG2' HD13 ' A' ' 89' ' ' ILE . 3.8 m -109.72 95.62 5.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.557 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.1 t -56.77 130.01 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.861 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.4 mt -107.36 22.19 16.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.67 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.928 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.2 t -98.26 112.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.328 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.04 -24.56 30.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.736 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -85.08 130.92 50.28 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 117.113 0.457 . . . . 0.0 110.975 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.04 -174.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.613 2.209 . . . . 0.0 112.644 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.627 HD11 HE22 ' A' ' 87' ' ' GLN . 35.0 tp -72.92 -37.32 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.023 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 m -53.76 -42.72 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 8.7 m -65.9 -48.02 72.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.575 ' SG ' HD22 ' A' ' 78' ' ' LEU . 19.9 m -57.0 -53.36 59.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.627 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.83 -53.96 22.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 t -53.35 -37.86 62.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.684 HD13 ' CG2' ' A' ' 76' ' ' THR . 27.5 mt -63.42 -46.44 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.506 HD11 HG13 ' A' ' 35' ' ' ILE . 3.1 mt -66.57 -37.45 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -33.98 71.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.241 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.33 -14.44 79.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.467 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 73' ' ' ILE . 94.4 mt -90.93 43.68 1.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.739 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 17.8 mttt -83.21 -47.78 11.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 1.4 p30 -112.47 57.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -112.27 -33.9 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.074 0.464 . . . . 0.0 110.09 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.577 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 9.0 t 73.3 5.07 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 2.5 mtm180 -167.37 147.91 5.43 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.356 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.877 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.8 t -142.65 102.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.0 0.428 . . . . 0.0 111.739 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -92.23 72.54 5.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.939 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -99.9 126.47 46.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.067 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.5 m120 -90.13 114.28 26.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.943 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.084 HG21 HD21 ' A' ' 64' ' ' LEU . 2.5 pt -117.01 173.32 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.452 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' GLN . 3.6 m -128.7 138.29 54.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.217 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 3.2 mmm-85 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.729 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CD1' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -92.87 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.52 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HE2' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -145.8 150.37 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.26 0.552 . . . . 0.0 112.158 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.71 73.18 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HG ' ' A' ' 64' ' ' LEU . 93.1 t -59.25 125.77 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.312 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.7 103.74 10.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' HA ' ' A' ' 58' ' ' ALA . 7.6 mm -99.16 103.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.01 0.434 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 121.14 36.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.73 -171.95 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 111.062 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.56 138.4 38.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 7.5 mttt -48.32 127.22 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.23 37.81 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 28.6 mm-40 -128.43 130.31 47.43 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.851 0.358 . . . . 0.0 111.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.5 HD11 ' HE1' ' A' ' 53' ' ' MET . 1.1 pt -78.91 154.01 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.843 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.81 -52.17 19.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.59 29.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.122 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 58' ' ' ALA . 15.9 m -94.46 148.65 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.197 0.522 . . . . 0.0 111.186 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.0 t -126.99 98.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.626 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.2 pp -94.05 149.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.115 0.483 . . . . 0.0 111.523 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.5 m -122.54 162.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.568 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.14 93.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.629 ' HA ' HD11 ' A' ' 48' ' ' ILE . 3.3 t -61.58 83.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.604 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.33 62.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.088 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CH2' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -114.35 -170.22 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.029 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.96 65.9 0.59 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.72 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.664 ' C ' HD12 ' A' ' 43' ' ' ILE . 14.8 t -176.81 142.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.989 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.89 HD13 ' OE1' ' A' ' 69' ' ' GLN . 0.2 OUTLIER 51.44 178.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.22 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.736 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -77.53 116.73 60.39 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' SER . 52.6 Cg_exo -55.62 117.3 3.9 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.578 2.186 . . . . 0.0 112.602 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -141.59 -66.67 0.41 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.366 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.788 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.34 165.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 111.455 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -143.83 116.88 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 76.2 mt -62.6 72.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.93 -26.09 5.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.945 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.472 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.8 p30 -164.96 167.54 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.379 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.436 ' HG3' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -154.25 142.4 20.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.724 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -53.0 139.32 28.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.29 76.66 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.42 -18.51 7.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.669 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.49 -179.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 23' ' ' ILE . 82.1 Cg_exo -46.85 -45.18 21.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.795 2.33 . . . . 0.0 112.737 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.849 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.2 -47.63 82.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -70.7 -31.14 67.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.245 0.545 . . . . 0.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -62.46 -48.31 80.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.799 ' CB ' HD13 ' A' ' 23' ' ' ILE . 44.4 t -53.81 -31.15 48.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.98 20.24 72.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.461 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -113.65 -49.21 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.741 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 17.8 mt -82.83 119.65 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 111.804 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -119.9 138.34 53.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.866 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 19.9 mt -37.09 131.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.644 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 4.5 59.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.058 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.7 m-20 -77.34 121.27 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.776 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.89 ' OE1' HD13 ' A' ' 43' ' ' ILE . 31.8 tt0 -79.11 81.11 5.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.894 HG23 HG22 ' A' ' 103' ' ' ILE . 3.9 mt -57.56 143.73 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.029 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.736 ' SD ' HD11 ' A' ' 44' ' ' LEU . 11.1 mmt -108.32 -41.96 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.589 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 64.3 p -156.41 155.2 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.008 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.008 HG21 HD11 ' A' ' 93' ' ' LEU . 6.3 mt -120.15 122.57 68.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 48.3 28.25 1.57 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.0 22.26 20.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.396 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -116.01 96.2 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.387 . . . . 0.0 110.796 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.482 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.29 135.39 32.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.214 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.788 HD13 HG21 ' A' ' 47' ' ' VAL . 58.8 mt -108.07 3.92 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.321 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 44' ' ' LEU . 5.5 t -84.95 122.5 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.15 -23.42 36.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.833 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.688 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.43 127.85 42.58 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.023 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.34 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.692 2.261 . . . . 0.0 112.675 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.512 HD13 ' HA ' ' A' ' 36' ' ' VAL . 40.3 tp -69.93 -35.11 74.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -53.33 -45.6 69.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.3 m -65.09 -48.18 74.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.737 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.0 m -56.96 -50.55 72.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -53.05 -43.39 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 t -64.52 -31.25 72.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.15 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.778 HD12 ' CD2' ' A' ' 78' ' ' LEU . 27.9 mt -69.53 -36.7 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.937 0.398 . . . . 0.0 109.956 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.702 HD11 HG13 ' A' ' 35' ' ' ILE . 6.1 mt -77.23 -41.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.388 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -39.24 89.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.552 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.07 -10.76 65.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.755 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.008 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.92 37.49 1.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -80.49 -31.06 37.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 4.2 m-80 -127.88 67.19 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.774 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 3.6 mm100 -121.25 -38.1 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.428 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.8 3.0 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -166.27 145.47 5.87 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.5 t -140.27 103.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -91.91 76.93 5.5 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.366 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.064 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -106.06 126.46 52.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.924 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 2.8 m120 -88.93 123.67 33.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 4.8 pt -122.29 165.91 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 111.868 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.693 HG23 ' CG ' ' A' ' 71' ' ' MET . 86.2 t -122.66 147.48 26.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.435 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.907 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 5.4 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CE1' HG22 ' A' ' 104' ' ' VAL . 1.7 m-85 -74.46 148.13 41.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.979 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -146.81 117.5 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.6 73.21 2.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.789 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.0 t -62.46 126.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.011 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.88 103.57 10.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.872 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 58' ' ' ALA . 15.4 mm -101.0 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.162 0.506 . . . . 0.0 110.23 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.24 118.55 36.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE2' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -133.43 -170.01 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.023 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.26 135.89 41.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.0 mttt -47.62 120.83 3.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.191 0.52 . . . . 0.0 111.032 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.67 10.85 22.46 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.23 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -128.13 142.12 51.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.582 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.3 pt -93.3 161.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.8 tp -47.86 -51.99 20.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.159 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 105.26 -4.64 41.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.885 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.95 ' CG2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -94.83 127.28 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.052 0.453 . . . . 0.0 111.397 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 11.6 t -95.69 98.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.791 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.838 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -97.8 150.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 111.771 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.902 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.3 m -133.4 161.38 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.592 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.93 116.16 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -58.95 141.32 54.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.61 -7.21 8.26 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.965 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -174.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.858 0.329 . . . . 0.0 110.846 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.63 48.86 0.94 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.826 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -106.46 -31.08 8.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 110.805 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.18 170.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.517 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD11 ' HE3' ' A' ' 71' ' ' MET . 0.2 OUTLIER -57.62 110.05 2.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.521 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.04 128.54 22.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.511 2.141 . . . . 0.0 112.564 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 67.0 p -142.01 -72.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -158.67 144.68 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.169 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.902 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.43 114.62 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.233 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.951 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.6 mt -61.52 73.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -58.02 -29.28 65.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.507 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 84.9 m-20 -147.5 -177.09 5.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.244 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.4 ptp -173.1 144.34 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tpp -65.82 124.27 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 49.7 p-80 -61.0 87.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.09 -14.24 31.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.73 175.87 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.641 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.564 ' O ' HG23 ' A' ' 23' ' ' ILE . 71.9 Cg_exo -50.01 -47.43 23.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.706 2.271 . . . . 0.0 112.885 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.838 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.1 -49.44 76.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.0 -27.6 61.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.95 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.589 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 23' ' ' ILE . 15.7 p -51.83 -46.88 64.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.33 -24.29 31.06 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.891 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -53.93 26.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.009 0.433 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 mt -72.79 129.97 39.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -134.6 137.71 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.158 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.3 mt -39.44 108.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.389 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -5.84 11.19 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.124 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.0 m-20 -69.8 119.42 14.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.7 80.04 3.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.04 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.058 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -55.01 145.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.915 ' CE ' HG21 ' A' ' 104' ' ' VAL . 2.5 tpp -115.64 -38.8 3.64 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 43.4 t -153.66 164.53 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.127 HG21 HD11 ' A' ' 93' ' ' LEU . 14.1 mt -130.04 112.83 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.655 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.748 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.7 OUTLIER 42.71 32.57 0.39 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.107 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 2.49 31.11 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.371 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 89' ' ' ILE . 2.8 m -102.32 95.67 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.675 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -61.08 113.77 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 47' ' ' VAL . 82.2 mt -82.53 -12.17 57.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.31 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 24.4 t -58.66 103.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.182 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.59 -30.27 9.37 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.7 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.598 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.5 mt -66.54 118.61 55.71 Favored Pre-proline 0 C--N 1.33 -0.241 0 O-C-N 122.832 -0.217 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.39 166.14 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.563 HD13 ' HA ' ' A' ' 36' ' ' VAL . 32.7 tp -54.39 -42.25 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 t -53.88 -43.77 69.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.808 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.51 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.8 m -68.57 -44.74 73.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.97 -56.97 14.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.509 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.73 -54.11 20.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 110.519 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.0 p -51.12 -41.37 60.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.257 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 HG21 ' A' ' 76' ' ' THR . 11.0 mt -59.75 -45.16 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -59.96 -38.56 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -47.5 79.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.27 -15.1 50.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.467 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.127 HD11 HG21 ' A' ' 73' ' ' ILE . 78.1 mt -91.23 31.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.041 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.4 tttt -81.01 -37.54 28.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 3.5 p30 -118.74 62.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.5 mm100 -117.76 -41.25 2.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.4 t 78.9 -2.57 2.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.54 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.49 140.19 8.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.62 0.248 . . . . 0.0 110.451 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 31' ' ' LEU . 5.1 t -136.97 104.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 112.111 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -91.08 73.05 6.36 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -101.81 123.83 46.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.557 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.93 109.32 20.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.058 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -99.9 165.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.472 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.915 HG21 ' CE ' ' A' ' 71' ' ' MET . 22.2 t -119.42 136.97 54.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.792 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 3.8 mtp85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.061 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.862 0.363 . . . . 0.0 111.605 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -78.34 148.58 33.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.877 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.61 121.5 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.21 77.29 5.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 27.7 t -68.2 121.18 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.011 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.27 103.64 11.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.509 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.7 mm -99.99 103.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.025 0.44 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.93 117.42 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -134.66 -172.11 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.32 136.66 39.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.656 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -47.51 123.55 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.148 0.499 . . . . 0.0 110.811 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.55 12.82 27.66 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.441 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.3 mm-40 -127.15 133.75 50.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.714 0.292 . . . . 0.0 111.265 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -84.43 154.37 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -48.16 -52.11 22.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.025 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.38 -0.39 37.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.454 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.855 HG13 ' CB ' ' A' ' 58' ' ' ALA . 2.3 m -94.72 128.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.06 0.43 . . . . 0.0 111.58 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.4 t -100.33 98.27 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.67 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.631 HD13 ' CG1' ' A' ' 47' ' ' VAL . 2.5 pp -96.95 158.78 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 0.0 111.958 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 48' ' ' ILE . 4.0 m -140.37 157.8 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.412 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.82 121.17 10.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.693 ' HA ' HD11 ' A' ' 48' ' ' ILE . 5.2 p -58.01 149.21 23.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.13 -23.1 3.97 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.929 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.33 -177.27 1.4 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.13 25.61 3.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.689 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -27.83 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.585 HD13 ' CD ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -148.8 178.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.648 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.3 OUTLIER -60.88 117.87 29.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.581 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.01 138.38 56.74 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.346 2.03 . . . . 0.0 112.429 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.636 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -155.83 -67.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.255 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 78' ' ' LEU . 1.4 m -160.39 148.11 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.072 0.463 . . . . 0.0 112.023 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.997 HD12 HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -125.83 117.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.8 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 46.8 mt -61.86 74.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -57.71 -27.85 63.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.643 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.523 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 84.1 m-20 -148.05 177.46 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.011 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 6.1 ttp -171.55 128.93 0.67 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.67 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.8 tpp -53.6 136.93 38.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.217 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -77.61 93.63 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.729 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.45 -17.12 28.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.566 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.74 179.02 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.633 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.521 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.6 Cg_exo -48.68 -50.26 12.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.777 2.318 . . . . 0.0 112.957 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.892 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.16 -49.21 77.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.766 0.317 . . . . 0.0 111.267 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.58 -22.41 61.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -66.0 -48.4 71.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB3' HD13 ' A' ' 23' ' ' ILE . 18.8 p -54.22 -43.08 70.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.69 -9.31 78.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.494 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -58.67 2.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.989 0.423 . . . . 0.0 111.107 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 13.6 mt -68.68 129.55 40.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.44 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.3 m120 -134.25 135.06 42.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.033 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 13.0 mt -36.38 109.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 121.028 0.442 . . . . 0.0 111.494 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.48 -0.35 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.214 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.6 m-20 -75.3 118.9 18.71 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.784 0.326 . . . . 0.0 110.705 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.585 ' CD ' HD13 ' A' ' 43' ' ' ILE . 8.2 tt0 -74.39 84.4 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.035 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -62.44 144.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.637 ' HG3' HG23 ' A' ' 104' ' ' VAL . 21.8 mmt -110.05 -41.82 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -158.09 157.75 33.43 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.399 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HD11 ' A' ' 93' ' ' LEU . 7.1 mt -119.13 118.31 57.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.023 0.44 . . . . 0.0 111.62 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.779 ' OD1' HG22 ' A' ' 73' ' ' ILE . 0.8 OUTLIER 42.37 31.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.837 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.87 14.69 24.32 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.945 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.694 HG21 HD13 ' A' ' 89' ' ' ILE . 5.2 m -111.62 95.61 5.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 99.2 p -58.41 126.84 29.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.261 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.837 ' CD1' HG21 ' A' ' 47' ' ' VAL . 30.1 mt -97.48 5.55 49.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.223 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 44' ' ' LEU . 8.0 t -88.7 129.6 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.58 -22.67 37.73 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.817 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -95.15 144.11 27.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.717 0.294 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.23 175.46 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.673 2.248 . . . . 0.0 112.435 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 36' ' ' VAL . 22.7 tp -66.51 -33.24 75.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -53.99 -47.99 70.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.806 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.6 m -64.59 -47.54 78.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.6 m -56.88 -51.56 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.67 -37.66 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.0 110.467 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -68.41 -35.0 77.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.979 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.694 HD13 HG21 ' A' ' 76' ' ' THR . 18.8 mt -64.06 -46.37 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.475 HD11 HG13 ' A' ' 35' ' ' ILE . 3.5 mt -62.08 -37.63 78.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.614 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -34.34 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.878 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.24 -12.53 76.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.138 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.045 HD11 HG21 ' A' ' 73' ' ' ILE . 92.6 mt -93.69 33.67 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 110.525 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.7 ttpt -78.36 -30.46 48.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -124.51 65.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.886 0.374 . . . . 0.0 111.727 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.406 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 7.6 mm-40 -122.0 -39.31 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m 75.16 1.91 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.522 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.595 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -164.85 142.74 6.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.625 0.25 . . . . 0.0 110.326 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 31' ' ' LEU . 3.9 t -137.62 103.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.827 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.38 73.78 5.27 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.617 178.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.028 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -104.57 122.94 46.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 109.73 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -103.34 173.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.473 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 71' ' ' MET . 98.2 t -133.99 148.53 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.51 . . . . 0.0 111.665 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.373 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -61.84 148.42 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.375 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -141.92 115.2 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.85 74.41 2.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.774 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.5 t -65.81 114.85 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.584 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -108.61 103.39 12.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.574 178.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.852 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -97.49 104.07 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -96.35 112.02 23.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.244 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -134.27 -169.21 2.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.954 0.407 . . . . 0.0 110.997 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -103.45 154.46 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.426 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 95' ' ' ASN . 2.5 mptt -59.54 132.29 53.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.03 14.75 50.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.747 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.4 mp0 -121.07 130.36 53.73 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -84.87 150.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.01 HD11 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -47.2 -52.04 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.315 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.62 -8.62 37.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.08 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.878 HG13 ' CB ' ' A' ' 58' ' ' ALA . 1.4 m -94.86 124.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.67 98.6 7.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.298 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -93.61 147.6 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.17 0.509 . . . . 0.0 111.699 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 17.1 m -129.19 159.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.197 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.8 114.22 2.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.819 0.342 . . . . 0.0 111.158 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.847 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -62.29 129.15 39.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.43 45.63 1.11 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.663 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -169.84 1.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 59.77 0.35 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.69 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.667 ' C ' HD12 ' A' ' 43' ' ' ILE . 69.1 m -162.59 151.59 15.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 45.68 -168.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.186 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -96.04 114.55 64.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.89 131.63 34.91 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.574 2.182 . . . . 0.0 112.4 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -159.45 -58.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.26 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.532 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.51 155.17 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 111.282 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.29 115.6 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.604 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.032 HD11 HD22 ' A' ' 64' ' ' LEU . 20.9 mt -60.27 72.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.79 -24.18 21.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.904 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -159.15 166.53 31.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.146 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.59 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.1 ttp -154.44 137.04 15.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.6 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.04 117.64 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -62.77 83.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.49 1.45 19.98 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.568 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.89 -178.43 51.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 86.9 Cg_exo -47.87 -50.83 10.95 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 112.793 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.878 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.16 -42.15 85.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 0.0 110.799 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -66.32 -49.3 67.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.852 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 m -52.42 -40.76 62.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.93 10.97 82.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.31 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mptt -104.8 -48.71 3.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.881 0.372 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.107 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -77.76 119.12 20.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.271 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -123.9 136.68 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.362 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 28.2 mt -40.6 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.639 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.6 -11.46 8.43 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.151 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -72.36 134.14 45.31 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 117.024 0.412 . . . . 0.0 110.857 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.626 ' HB3' HG23 ' A' ' 104' ' ' VAL . 39.6 tt0 -87.6 83.75 7.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.028 0.442 . . . . 0.0 110.015 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.871 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -52.04 144.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.789 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.422 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 6.3 mmt -109.24 -41.51 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.8 p -160.99 158.41 27.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.332 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 93' ' ' LEU . 7.0 mt -122.27 118.2 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.263 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.533 HD22 HG22 ' A' ' 73' ' ' ILE . 70.0 m-80 52.22 25.81 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.92 32.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.55 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -107.89 95.76 5.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.726 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.486 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -55.68 131.64 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.234 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 89' ' ' ILE . 33.3 mt -101.48 1.18 37.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.322 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 44' ' ' LEU . 9.0 t -83.36 132.81 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 111.052 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.19 -23.71 32.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.64 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.68 140.21 21.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.871 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 178.45 2.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.204 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.8 tp -63.98 -33.47 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 p -53.94 -45.7 71.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.821 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.7 m -67.1 -47.76 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.412 ' O ' HG13 ' A' ' 90' ' ' ILE . 13.3 m -57.23 -47.17 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.31 -45.97 80.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -60.26 -35.44 75.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 78' ' ' LEU . 39.8 mt -63.26 -46.0 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -62.91 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.791 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -42.22 98.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.175 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.13 -13.24 64.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.252 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.976 HD11 HG21 ' A' ' 73' ' ' ILE . 92.2 mt -94.06 37.36 1.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.932 0.396 . . . . 0.0 110.677 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -81.85 -41.2 21.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 4.5 p-10 -120.85 64.18 0.86 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 2.2 mm100 -113.95 -36.19 4.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 1.7 t 77.62 -2.34 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.697 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.4 mtm180 -161.99 148.46 13.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.569 0.223 . . . . 0.0 110.564 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.01 HG11 HD11 ' A' ' 31' ' ' LEU . 5.0 t -141.26 103.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 111.766 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -93.13 75.38 4.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.45 124.55 50.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -90.83 120.28 31.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.214 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.107 HG21 HD21 ' A' ' 64' ' ' LEU . 4.7 pt -117.39 150.89 19.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.546 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.5 m -104.12 135.07 43.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.276 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.95 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.825 0.345 . . . . 0.0 111.125 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.26 148.54 47.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.448 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -143.67 118.88 10.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.25 76.63 3.8 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.801 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.4 t -67.23 128.8 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.797 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.22 103.61 10.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.891 178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.774 HD12 ' HA ' ' A' ' 58' ' ' ALA . 9.3 mm -99.93 102.94 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' SER . 18.8 mt-10 -100.96 114.66 28.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 97' ' ' SER . 6.4 pttt -131.47 -168.69 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.18 137.14 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.6 mttt -50.21 125.46 12.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.126 0.489 . . . . 0.0 110.803 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.67 12.71 31.9 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 5.2 mm-40 -126.33 135.2 51.2 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.401 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.07 150.07 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.238 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.99 -52.19 20.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.307 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.15 18.75 10.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.856 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -112.27 129.57 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.1 t -108.64 98.59 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.108 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -97.78 156.42 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.993 HG23 HD12 ' A' ' 48' ' ' ILE . 27.0 m -141.54 155.18 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.407 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.22 119.47 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 111.185 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.752 ' HA ' HD11 ' A' ' 48' ' ' ILE . 1.7 p -57.44 135.32 56.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.719 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.89 -5.2 47.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.158 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -91.17 -177.64 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.99 0.395 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.13 26.2 3.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.78 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -30.91 58.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.199 0.523 . . . . 0.0 110.752 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.489 HD13 ' OE1' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -145.65 174.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.487 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.627 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -57.45 109.16 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.794 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 129.68 35.76 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.252 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.883 HG22 ' HA ' ' A' ' 79' ' ' VAL . 72.3 p -142.85 -75.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.09 137.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.448 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.993 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.39 119.49 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.27 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 68' ' ' ASP . 50.1 mt -64.18 73.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -51.41 -25.87 6.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.296 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.477 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 12.5 p30 -173.57 150.29 1.76 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -129.55 167.63 17.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.678 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.1 ttm -82.99 128.45 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.44 104.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.94 -21.17 47.48 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.14 174.89 1.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.8 Cg_exo -48.28 -45.49 26.01 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.7 2.266 . . . . 0.0 112.735 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.47 -47.14 85.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -30.18 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.16 82.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.774 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB3' HD13 ' A' ' 23' ' ' ILE . 95.4 p -53.03 -39.48 63.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.58 72.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.272 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.5 mmpt? -117.22 -40.53 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.121 HD21 HG21 ' A' ' 103' ' ' ILE . 10.6 mt -88.96 111.24 21.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.308 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -114.16 144.63 42.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.0 mt -44.84 125.03 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.21 38.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.169 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.947 ' HB2' HD12 ' A' ' 49' ' ' ILE . 24.4 m-20 -73.11 125.84 28.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.621 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -85.59 79.8 9.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.11 0.481 . . . . 0.0 110.43 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.038 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -53.24 141.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.876 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.627 ' SD ' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -114.63 -33.84 5.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 35.2 t -159.87 156.49 27.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.664 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.039 HG21 HD11 ' A' ' 93' ' ' LEU . 9.3 mt -129.23 115.98 38.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.494 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.612 HD21 HG13 ' A' ' 99' ' ' VAL . 69.2 m-80 53.04 23.91 3.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.2 35.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' SER . 11.8 m -106.68 95.05 5.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.937 0.368 . . . . 0.0 110.509 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' HD21 ' A' ' 81' ' ' LEU . 54.6 p -69.06 128.71 37.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.376 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.607 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -94.4 13.3 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.025 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 46' ' ' THR . 5.1 t -74.89 106.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.52 -31.81 7.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.896 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.721 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -82.62 138.82 43.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.983 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 179.35 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.77 2.314 . . . . 0.0 112.507 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.0 tp -65.24 -31.81 73.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -48.18 70.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.006 0.431 . . . . 0.0 110.585 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 89' ' ' ILE . 25.8 m -68.11 -45.76 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.807 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -56.77 -44.26 81.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.726 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 16.0 mm100 -58.6 -52.33 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 3.4 t -56.76 -32.16 65.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.548 HG21 HD12 ' A' ' 73' ' ' ILE . 8.5 mt -62.74 -46.35 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 33' ' ' VAL . 3.6 mt -61.52 -35.33 66.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.898 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 23.4 mmtt -61.71 -48.69 79.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.125 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.55 -11.55 57.06 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.346 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.039 HD11 HG21 ' A' ' 73' ' ' ILE . 83.4 mt -89.28 27.78 1.36 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.914 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -84.71 -40.09 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.435 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 3.3 p-10 -119.79 62.7 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.5 mm100 -119.25 -41.01 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.5 t 79.55 -3.24 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.513 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -160.01 142.82 13.64 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.612 HG13 HD21 ' A' ' 74' ' ' ASN . 3.3 t -140.25 103.27 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -90.53 74.04 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 120.93 41.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.622 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -87.95 114.44 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.121 HG21 HD21 ' A' ' 64' ' ' LEU . 1.3 pt -111.79 171.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.014 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 69' ' ' GLN . 2.7 m -125.84 145.84 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.616 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 3.5 mtm180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.486 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.537 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -72.35 137.93 46.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.082 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -129.9 116.78 19.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' OD1' ' ND2' ' A' ' 102' ' ' ASN . 10.5 m-20 -75.44 71.73 2.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.708 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.7 t -58.92 124.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.403 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.04 103.52 11.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.858 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 58' ' ' ALA . 5.8 mm -99.34 102.97 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -100.48 114.01 27.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.383 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -129.89 -169.63 2.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.1 132.7 49.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -45.64 118.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.176 0.512 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.75 12.62 16.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.256 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 94' ' ' LYS . 6.7 mm-40 -130.48 128.01 40.35 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 111.334 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -72.17 153.34 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.84 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -49.47 -52.1 31.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.66 20.83 9.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.869 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -114.72 127.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.433 . . . . 0.0 111.11 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.1 97.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.839 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -100.94 145.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.926 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.909 HG23 ' CD1' ' A' ' 48' ' ' ILE . 6.1 m -125.98 160.16 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.189 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.34 117.25 5.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.734 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -61.61 97.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.711 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.22 4.45 81.01 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.212 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -175.78 5.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.887 0.344 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.03 32.75 3.71 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.76 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -39.83 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 110.71 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.801 HD13 ' HG3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -143.64 175.65 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.687 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -58.49 110.59 2.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.914 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.79 129.75 21.43 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.532 2.155 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.561 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -156.41 -66.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.201 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.42 151.65 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.887 0.375 . . . . 0.0 111.739 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.909 ' CD1' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.63 115.44 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.889 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 68' ' ' ASP . 37.9 mt -60.54 71.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.34 -26.3 11.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 14.3 p30 -177.46 145.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.331 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.7 ptp -116.48 -170.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.0 tpp -94.46 125.22 38.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.0 81.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.796 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.37 20.44 7.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.41 175.56 28.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.454 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 23' ' ' ILE . 88.7 Cg_exo -47.48 -46.14 21.14 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.693 2.262 . . . . 0.0 112.807 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.871 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.43 -48.22 81.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.44 -34.36 72.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 110.554 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -58.5 -48.74 79.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.814 ' HB3' HD13 ' A' ' 23' ' ' ILE . 83.4 p -50.5 -39.86 49.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.01 2.39 82.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.599 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.7 mmpt? -96.94 -37.1 10.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.071 HD21 HG21 ' A' ' 103' ' ' ILE . 13.0 mt -91.67 111.64 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -110.19 141.0 43.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.9 mt -42.68 121.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.25 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.64 1.87 43.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.086 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.929 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.4 m-20 -71.49 130.73 42.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 110.782 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.801 ' HG3' HD13 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -86.59 78.25 9.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.987 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -55.62 144.7 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.104 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.762 ' HG2' HG23 ' A' ' 104' ' ' VAL . 15.3 mmt -111.11 -41.65 4.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.1 p -160.57 160.43 31.79 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.302 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HD11 ' A' ' 93' ' ' LEU . 8.7 mt -120.41 115.56 47.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.544 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.805 ' OD1' HG22 ' A' ' 73' ' ' ILE . 1.0 OUTLIER 43.46 33.08 0.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.853 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.94 33.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.133 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 89' ' ' ILE . 3.5 m -108.59 95.64 5.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.353 . . . . 0.0 110.695 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.707 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -58.54 130.71 48.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.131 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.767 ' HA ' HD11 ' A' ' 81' ' ' LEU . 26.2 mt -99.78 6.41 45.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.249 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 44' ' ' LEU . 6.4 t -91.79 128.91 43.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.891 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.14 -23.98 33.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.45 143.87 27.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.885 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.31 178.67 2.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.635 2.223 . . . . 0.0 112.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 36' ' ' VAL . 15.6 tp -66.87 -35.06 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.967 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 m -53.81 -40.59 66.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.3 m -71.83 -48.77 43.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.918 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 10.1 m -56.95 -48.91 77.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.782 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -58.7 -46.74 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.331 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -59.01 -35.49 73.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.936 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.644 HD13 HG21 ' A' ' 76' ' ' THR . 11.4 mt -62.67 -45.27 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 93' ' ' LEU . 3.1 mt -60.92 -35.44 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.984 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -49.29 75.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.028 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.24 -11.01 60.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.103 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 73' ' ' ILE . 44.8 mt -86.61 18.16 3.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.608 0.242 . . . . 0.0 110.928 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.58 -33.66 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.539 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.83 62.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -124.32 -40.22 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.07 0.462 . . . . 0.0 110.346 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 79.46 -2.06 2.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.59 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.8 mtm180 -161.13 142.03 11.42 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.4 t -140.96 103.61 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.863 0.364 . . . . 0.0 111.846 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' NZ ' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.45 73.86 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 123.65 46.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' ND2' ' OD1' ' A' ' 20' ' ' ASP . 3.9 m-20 -88.28 122.85 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.071 HG21 HD21 ' A' ' 64' ' ' LEU . 2.4 pt -117.4 162.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.706 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 71' ' ' MET . 41.3 t -107.35 132.06 55.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.398 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.151 0.5 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 149.31 25.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.995 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 115.38 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.33 79.07 3.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HG ' ' A' ' 64' ' ' LEU . 40.4 t -69.11 122.41 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.921 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.45 103.07 10.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.423 178.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.777 HD13 ' HB3' ' A' ' 61' ' ' SER . 9.4 mm -97.75 103.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -103.49 113.43 26.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.896 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -135.96 -174.39 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.807 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -89.53 141.24 28.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.503 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -49.45 119.69 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 110.651 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . 109.0 13.84 16.83 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.054 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.0 mp0 -119.13 127.63 53.52 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.514 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.42 146.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.753 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.49 -39.83 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.824 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . 90.95 11.49 61.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.373 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 58' ' ' ALA . 6.2 m -104.18 126.85 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.226 0.513 . . . . 0.0 111.443 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.5 t -100.85 98.29 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.83 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -100.74 148.11 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.228 0.537 . . . . 0.0 111.774 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG2' HD12 ' A' ' 48' ' ' ILE . 15.7 m -129.7 160.28 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.427 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.41 108.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.836 ' HA ' HD11 ' A' ' 48' ' ' ILE . 30.5 t -59.17 138.93 57.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.749 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.37 1.79 5.73 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.26 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.424 ' CD1' ' OG ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -81.2 -178.87 7.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.988 0.394 . . . . 0.0 110.888 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.43 55.56 0.58 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.33 -37.64 4.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.214 0.53 . . . . 0.0 111.007 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -149.97 174.8 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -57.14 109.12 1.51 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.75 129.59 34.78 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.113 . . . . 0.0 112.513 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.519 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -158.02 -59.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.722 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.8 140.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 0.0 111.655 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.928 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.28 116.32 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.764 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 ' HB2' ' A' ' 68' ' ' ASP . 64.9 mt -62.7 71.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -28.68 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 85.7 m-20 -146.75 168.57 21.03 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.94 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.557 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.09 134.73 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.24 127.19 26.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -73.78 68.93 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.45 -21.4 3.63 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.35 -176.07 0.61 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.64 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 23' ' ' ILE . 84.1 Cg_exo -48.0 -44.07 28.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.749 2.299 . . . . 0.0 112.766 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.68 -49.53 77.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.86 -29.68 64.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.514 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -62.99 -48.31 79.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.968 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.777 ' HB3' HD13 ' A' ' 23' ' ' ILE . 96.4 p -53.06 -38.25 62.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.15 19.0 70.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.263 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB2' HG13 ' A' ' 21' ' ' VAL . 6.4 mmpt? -116.35 -52.81 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.949 0.404 . . . . 0.0 110.747 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 101' ' ' LEU . 9.7 mt -77.97 120.65 23.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.51 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.436 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 13.7 m-80 -129.55 134.7 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.364 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 9.0 mt -33.34 122.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.37 2.31 55.63 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.994 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.1 m-20 -77.25 120.91 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.803 0.335 . . . . 0.0 110.618 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.409 ' CD ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.68 86.46 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -62.75 143.21 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.778 ' SD ' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.36 -40.11 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.813 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.8 p -159.73 156.91 28.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.182 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.819 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.9 mt -120.88 125.28 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.13 29.56 0.82 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.44 23.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.369 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.618 ' CG2' HD13 ' A' ' 89' ' ' ILE . 63.3 m -119.7 95.98 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.5 t -56.0 138.57 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.819 HD11 ' CD1' ' A' ' 73' ' ' ILE . 19.5 mt -109.1 4.32 22.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.04 126.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.92 -25.31 28.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.872 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.18 147.36 34.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.796 0.331 . . . . 0.0 111.016 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.48 173.97 8.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.354 . . . . 0.0 112.639 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.564 HD11 HE22 ' A' ' 87' ' ' GLN . 34.1 tp -62.36 -37.2 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.161 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -53.67 -46.42 70.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 89' ' ' ILE . 4.0 m -65.27 -44.28 88.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 90' ' ' ILE . 11.8 m -57.0 -56.2 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.785 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.564 HE22 HD11 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -49.44 -53.94 20.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.167 0.508 . . . . 0.0 110.854 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -53.72 -39.71 65.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.482 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 10.0 mt -61.64 -36.9 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.9 mt -77.99 -44.41 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.019 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.98 91.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.08 -17.36 44.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 69.9 mt -93.27 26.82 2.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.267 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -78.13 -12.23 59.98 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.983 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -134.52 48.46 2.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.877 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.476 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 4.1 mm100 -111.76 -33.21 6.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 110.336 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 77.95 -0.55 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.737 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.589 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.3 mtm180 -160.31 142.87 13.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.598 0.237 . . . . 0.0 110.515 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 31' ' ' LEU . 4.0 t -139.35 103.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.898 0.38 . . . . 0.0 111.993 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -91.09 75.4 6.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.804 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -106.21 120.47 41.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 107.96 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.025 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -103.33 174.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.01 129.12 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.13 0.491 . . . . 0.0 111.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.363 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.897 0.379 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -77.15 148.27 36.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.6 120.25 9.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 79.92 6.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.713 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.7 t -69.31 122.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.882 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.97 103.25 10.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.252 178.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.1 mm -97.26 102.38 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.5 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 19.2 mt-10 -95.08 109.84 21.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.492 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -130.03 -169.9 2.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.829 0.347 . . . . 0.0 110.96 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.74 137.11 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 6.3 mttp -47.49 124.56 7.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 110.779 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.01 14.35 24.91 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 78.8 mm-40 -130.45 130.72 44.61 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.635 0.255 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.638 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -81.24 151.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.128 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.891 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.95 -42.41 27.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.089 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.04 6.62 59.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.034 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 HD13 ' A' ' 90' ' ' ILE . 4.2 m -95.76 143.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.42 . . . . 0.0 111.392 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -119.72 98.65 6.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 90' ' ' ILE . 2.0 pp -95.18 153.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 112.067 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.919 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.8 m -130.21 156.91 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.408 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.79 93.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.746 0.308 . . . . 0.0 111.352 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.72 ' HA ' HD11 ' A' ' 48' ' ' ILE . 6.8 p -63.43 104.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.479 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.59 17.28 8.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.014 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -69.44 176.68 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 110.923 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.44 57.56 4.19 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.518 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.683 ' C ' HD12 ' A' ' 43' ' ' ILE . 8.3 t -159.63 145.59 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.683 HD12 ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 45.72 -171.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -88.55 128.64 52.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 17.8 Cg_endo -59.04 118.14 4.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.53 2.153 . . . . 0.0 112.799 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 47.3 p -141.64 -73.81 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.021 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.961 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.07 141.05 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.745 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.919 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -118.37 118.28 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.897 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 58.0 mt -62.83 72.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.38 -28.25 58.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 85.3 m-20 -145.98 173.59 12.02 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.961 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.76 131.78 0.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.903 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 tpp -56.24 123.49 14.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.51 89.47 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.675 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.83 7.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.1 -163.8 25.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.292 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 23' ' ' ILE . 52.9 Cg_exo -55.93 -51.3 9.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.662 2.242 . . . . 0.0 112.711 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.891 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.36 -49.31 77.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.88 -28.14 65.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -64.47 -48.27 75.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.739 ' HB3' HD13 ' A' ' 23' ' ' ILE . 70.4 p -51.17 -39.8 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.74 23.79 59.37 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -121.12 -52.7 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.723 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.076 HD21 HG21 ' A' ' 103' ' ' ILE . 12.7 mt -77.82 119.79 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.553 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ILE . 9.8 p-10 -127.52 133.28 49.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.248 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.5 mt -32.4 117.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.973 0.416 . . . . 0.0 111.769 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.16 4.81 29.03 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.134 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -80.32 127.77 32.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 110.771 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.642 ' HG3' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -82.91 83.34 7.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.091 HG23 HG22 ' A' ' 103' ' ' ILE . 1.9 mt -62.19 144.08 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.012 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.66 ' HG2' HG23 ' A' ' 104' ' ' VAL . 24.6 mmt -112.85 -36.39 5.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.862 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 52.4 p -160.3 160.11 32.12 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.238 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.005 HG21 HD11 ' A' ' 93' ' ' LEU . 9.5 mt -127.5 123.83 62.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.769 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 46.29 29.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.55 17.3 31.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.664 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.546 HG21 HD13 ' A' ' 89' ' ' ILE . 4.6 m -111.36 95.83 5.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.372 . . . . 0.0 110.578 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.8 m -57.29 124.2 18.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.961 HD13 HG21 ' A' ' 47' ' ' VAL . 45.7 mt -97.38 21.16 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 2.7 t -93.02 113.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.281 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.16 28.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.292 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.886 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -83.73 142.05 42.04 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 117.034 0.417 . . . . 0.0 110.934 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 -179.58 2.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.661 2.241 . . . . 0.0 112.45 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HA ' ' A' ' 36' ' ' VAL . 16.1 tp -66.15 -31.56 72.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.009 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -56.42 -45.92 80.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -67.9 -48.0 67.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.4 m -57.32 -53.07 62.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -55.59 -40.16 71.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.95 0.405 . . . . 0.0 110.484 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 p -66.64 -29.27 69.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.963 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 78' ' ' LEU . 3.8 mt -69.73 -46.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.779 HD13 HG23 ' A' ' 33' ' ' VAL . 5.4 mt -62.25 -38.99 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.473 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -37.65 79.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.54 -9.5 73.96 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.005 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.36 27.33 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.727 0.298 . . . . 0.0 110.786 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -80.96 -33.79 33.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.456 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m-80 -120.53 63.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.934 0.397 . . . . 0.0 111.792 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -124.65 -41.76 2.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.9 m 77.97 2.03 2.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.293 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.594 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -164.06 138.73 5.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.448 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.544 HG12 HD22 ' A' ' 101' ' ' LEU . 3.5 t -135.91 103.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.991 0.424 . . . . 0.0 112.023 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -90.04 72.91 7.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.044 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -103.14 120.44 40.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 111.404 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -88.66 112.83 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.091 HG22 HG23 ' A' ' 70' ' ' ILE . 2.2 pt -106.31 174.17 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.249 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.66 HG23 ' HG2' ' A' ' 71' ' ' MET . 46.1 t -130.6 148.56 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.158 0.504 . . . . 0.0 111.788 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.365 179.592 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 3.9 tt0 . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.835 0.35 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -70.29 148.61 48.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -148.3 115.58 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.2 77.54 3.01 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.5 t -67.19 117.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.06 103.33 11.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.419 178.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 61' ' ' SER . 6.1 mm -98.94 103.24 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.845 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 109.97 22.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.178 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -128.36 -170.55 2.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.84 139.7 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.552 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 14.1 mttt -50.18 125.69 12.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.165 0.507 . . . . 0.0 110.826 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.55 15.19 30.27 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 94' ' ' LYS . 13.1 mm-40 -120.53 136.86 54.65 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 111.596 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.894 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -87.14 147.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.231 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.943 HD23 ' CG2' ' A' ' 33' ' ' VAL . 7.4 tp -49.94 -45.67 51.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -0.1 62.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.017 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.943 ' CG2' HD23 ' A' ' 31' ' ' LEU . 1.1 m -94.55 125.26 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.318 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.26 98.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.233 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -94.95 150.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.176 0.513 . . . . 0.0 111.787 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.992 HG23 HD12 ' A' ' 48' ' ' ILE . 2.4 m -132.67 158.94 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.31 117.57 5.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -60.65 139.69 57.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.796 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.51 33.86 2.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.724 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -170.73 1.71 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.44 65.67 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.711 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.681 ' C ' HD12 ' A' ' 43' ' ' ILE . 48.5 m -164.62 151.06 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.681 HD12 ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 47.96 -174.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.238 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 46' ' ' THR . 0.3 OUTLIER -90.8 113.53 58.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.642 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 70.9 Cg_exo -49.12 131.6 26.44 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.599 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.778 HG21 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -163.73 -60.48 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.14 152.17 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.002 0.43 . . . . 0.0 111.881 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.992 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.61 118.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.859 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 68' ' ' ASP . 47.4 mt -63.25 74.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.3 -34.36 66.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.382 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.6 m120 -140.9 177.55 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.003 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.4 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -170.85 122.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.598 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -46.52 132.03 10.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.505 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.55 81.46 4.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.3 5.37 8.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.829 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.36 -176.95 51.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.405 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' HG23 ' A' ' 23' ' ' ILE . 70.7 Cg_exo -51.47 -47.74 24.66 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.53 2.153 . . . . 0.0 112.398 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.88 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.4 -43.38 88.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.69 -29.77 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.591 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.06 -48.92 74.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.8 ' HB3' HD13 ' A' ' 23' ' ' ILE . 79.1 p -53.16 -39.73 63.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.79 72.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.0 mmtt -109.48 -52.8 2.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.099 HD21 HG21 ' A' ' 103' ' ' ILE . 12.3 mt -76.05 120.61 21.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.408 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.75 136.54 53.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.156 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -37.17 110.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.66 3.33 22.22 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.127 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.6 m-20 -78.16 119.56 21.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.908 0.385 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.469 ' HG3' HD13 ' A' ' 43' ' ' ILE . 3.3 tm0? -75.06 86.61 2.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.079 HG23 HG22 ' A' ' 103' ' ' ILE . 2.0 mt -64.7 144.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.778 ' HE2' HG21 ' A' ' 46' ' ' THR . 4.4 mmt -110.8 -39.84 4.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.709 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.7 p -160.35 157.28 27.64 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.376 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 93' ' ' LEU . 6.8 mt -122.12 124.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.482 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 46.46 28.74 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.035 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.99 21.63 22.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.579 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.623 HG21 HD13 ' A' ' 89' ' ' ILE . 8.4 m -115.86 95.84 5.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.369 . . . . 0.0 110.907 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' HD21 ' A' ' 81' ' ' LEU . 51.0 m -60.07 122.05 13.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.753 HD11 ' CD1' ' A' ' 73' ' ' ILE . 51.7 mt -91.37 12.17 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.264 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.584 HG21 ' CD1' ' A' ' 44' ' ' LEU . 4.2 t -87.24 126.31 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.61 -24.1 33.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.634 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -93.56 142.97 25.87 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.52 171.68 12.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.539 2.159 . . . . 0.0 112.429 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 35' ' ' ILE . 28.7 tp -60.12 -30.09 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 p -54.61 -49.6 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.794 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -68.07 -42.07 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.5 m -57.41 -52.22 66.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.33 -40.69 82.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.324 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 m -64.98 -30.03 70.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 76' ' ' THR . 2.3 mt -69.13 -46.15 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.503 HD13 HG23 ' A' ' 33' ' ' VAL . 4.8 mt -65.84 -38.67 82.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.67 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.14 71.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.067 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.69 -14.09 81.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.185 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.923 HD11 HG21 ' A' ' 73' ' ' ILE . 90.5 mt -91.93 38.28 0.99 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.94 0.4 . . . . 0.0 110.598 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.894 ' HG3' HG22 ' A' ' 30' ' ' ILE . 5.8 mtpt -81.36 -35.04 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 15.6 m-80 -121.92 63.63 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.756 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.58 -39.62 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.58 -4.14 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.599 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.4 mtm180 -160.92 138.46 9.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.896 HG12 HD22 ' A' ' 101' ' ' LEU . 17.7 t -133.74 103.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 112.168 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.09 79.75 5.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.608 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.062 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -110.46 120.49 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.113 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.03 108.7 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.099 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -104.48 174.15 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.605 HG23 ' CG ' ' A' ' 71' ' ' MET . 57.3 t -132.77 144.44 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.088 0.47 . . . . 0.0 111.683 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 2.8 ttp85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.36 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.59 148.4 24.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.415 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.08 7.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.48 75.74 2.53 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG11 ' HG ' ' A' ' 64' ' ' LEU . 41.5 t -67.9 123.49 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.27 103.24 10.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.452 178.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 58' ' ' ALA . 11.0 mm -98.03 103.5 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.846 0.355 . . . . 0.0 111.143 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 128.87 41.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.076 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -149.12 -173.75 4.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 111.169 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.82 136.51 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -47.21 120.39 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.141 0.496 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 12.2 22.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.337 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -122.98 133.19 54.38 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.84 0.352 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 32' ' ' GLY . 1.2 pt -83.11 150.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.813 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.46 -40.19 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 90.04 31.1 11.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.868 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG13 ' CB ' ' A' ' 58' ' ' ALA . 3.5 m -125.1 124.35 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.411 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.15 98.26 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.009 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 47' ' ' VAL . 2.7 pp -99.75 144.9 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.029 0.443 . . . . 0.0 111.854 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.908 HG23 HD12 ' A' ' 48' ' ' ILE . 3.7 m -124.32 155.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.29 111.12 0.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 111.162 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.732 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -61.34 84.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.803 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.19 22.78 36.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.844 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.56 -179.44 6.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.98 72.79 0.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.527 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.676 ' C ' HD12 ' A' ' 43' ' ' ILE . 22.7 t -174.68 147.26 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.313 . . . . 0.0 110.957 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.8 HD13 ' OE1' ' A' ' 69' ' ' GLN . 0.1 OUTLIER 44.83 -167.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.541 HD12 HG13 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -90.96 128.5 47.63 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.615 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.55 130.43 31.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.542 2.161 . . . . 0.0 112.464 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.3 t -161.8 -62.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.743 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 35' ' ' ILE . 3.2 m -160.88 150.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 112.035 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.908 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.85 113.88 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.986 HD12 ' HB2' ' A' ' 68' ' ' ASP . 35.8 mt -60.17 72.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -34.61 62.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.403 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.508 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.7 m120 -141.68 179.54 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.982 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.66 125.41 0.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.442 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -48.23 124.01 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.35 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -72.24 88.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.37 26.1 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.41 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.45 -176.43 20.74 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 23' ' ' ILE . 89.3 Cg_exo -48.65 -46.12 25.27 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.596 2.197 . . . . 0.0 112.731 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.67 -49.25 78.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.51 -33.94 73.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.243 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -48.63 79.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.738 ' HB2' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -53.96 -37.9 64.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.77 17.06 79.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.808 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.62 -53.46 2.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 101' ' ' LEU . 15.4 mt -76.08 120.93 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.357 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' ILE . 11.2 m120 -127.05 133.07 50.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.125 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.5 mt -33.69 113.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.963 0.411 . . . . 0.0 111.935 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.89 -6.87 15.42 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.17 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.986 ' HB2' HD12 ' A' ' 49' ' ' ILE . 33.6 m-20 -70.47 127.88 34.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.56 0.219 . . . . 0.0 110.519 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.8 ' OE1' HD13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -87.66 81.27 7.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.121 0.486 . . . . 0.0 110.669 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.93 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -54.3 137.2 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.057 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.0 mmt -105.56 -37.61 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 92.4 p -157.4 153.47 27.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 111.172 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 78' ' ' LEU . 4.2 mt -124.07 123.95 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.446 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 48.01 28.34 1.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.86 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.402 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.702 HG21 HD13 ' A' ' 89' ' ' ILE . 91.3 m -124.72 95.79 4.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.608 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -68.3 130.13 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.897 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.2 mt -95.77 14.29 23.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.541 HG13 HD12 ' A' ' 44' ' ' LEU . 8.6 t -74.64 112.7 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.499 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.39 -39.45 2.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.068 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -73.32 146.43 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.995 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.44 167.88 12.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 35' ' ' ILE . 21.9 tp -62.98 -35.05 78.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.86 -42.93 69.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.559 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.572 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.1 m -69.85 -44.45 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 78' ' ' LEU . 9.8 m -56.62 -53.46 57.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 3.5 mm-40 -52.9 -50.4 63.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 14.1 p -56.05 -36.46 68.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.272 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' CD2' ' A' ' 78' ' ' LEU . 19.9 mt -63.72 -33.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 33' ' ' VAL . 6.1 mt -70.23 -36.03 65.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.456 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.5 mppt? -75.38 -47.15 28.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.45 -25.4 27.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.393 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.729 ' CD2' HG21 ' A' ' 73' ' ' ILE . 3.5 pp -99.57 31.7 3.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.009 0.433 . . . . 0.0 110.577 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.67 -22.31 50.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.824 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -121.65 52.38 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 37.8 mm-40 -113.49 -31.26 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.2 m 70.58 10.65 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.3 mtm180 -168.92 139.68 2.4 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.231 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.813 HG21 HD12 ' A' ' 31' ' ' LEU . 4.7 t -136.88 103.69 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -90.63 76.68 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.44 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.93 120.78 43.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.316 0.579 . . . . 0.0 111.613 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.92 112.97 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.122 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.995 HG21 HD21 ' A' ' 64' ' ' LEU . 1.1 pt -112.88 160.42 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.613 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 69' ' ' GLN . 7.2 m -109.39 140.99 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.825 -179.639 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 105' ' ' ARG . 12.4 mm-40 . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -75.58 148.56 38.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.124 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -148.46 117.27 6.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.38 82.1 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.681 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -71.87 123.12 25.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.857 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.62 103.73 11.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 61' ' ' SER . 11.8 mm -99.62 103.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.963 0.411 . . . . 0.0 110.947 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.74 123.76 38.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.12 -169.75 3.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 111.133 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -101.24 147.83 25.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.31 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 5.5 mttp -55.12 130.84 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.081 0.467 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.76 13.17 54.3 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.639 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.73 139.18 52.68 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.807 0.337 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -87.22 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.86 HD22 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.69 -52.26 18.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 114.43 -14.1 20.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.344 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.943 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.0 m -94.09 128.3 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.614 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.04 98.46 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.886 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.5 pp -94.51 140.93 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 111.587 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 48' ' ' ILE . 28.9 m -124.38 161.36 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.183 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -54.55 118.87 4.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.738 0.304 . . . . 0.0 111.14 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.29 136.95 48.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.48 -0.95 3.98 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.116 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.65 -177.47 1.55 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.086 0.443 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.46 54.73 0.59 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.787 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.2 m -116.31 -39.96 3.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.267 0.556 . . . . 0.0 110.766 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.594 HD13 ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -149.21 179.84 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.445 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.754 HD12 ' CG1' ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.13 131.13 95.04 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.304 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.43 141.42 95.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.572 2.181 . . . . 0.0 112.912 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.8 t -168.27 -61.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.34 153.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.576 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.13 115.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.965 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.5 mt -61.38 71.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -49.07 -27.55 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 14.2 p30 -163.79 179.48 7.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.283 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.6 ttp -160.92 155.4 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.8 139.55 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.821 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -76.36 99.87 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.15 -19.3 52.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.2 175.44 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.593 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 23' ' ' ILE . 80.0 Cg_exo -46.81 -45.74 19.77 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.79 2.327 . . . . 0.0 112.876 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.943 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.63 -49.32 77.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.378 . . . . 0.0 111.133 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -72.48 -26.02 61.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -60.39 -48.02 83.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.811 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.1 t -54.69 -38.09 66.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.749 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.17 12.16 83.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.941 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -104.42 -45.18 4.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.965 0.412 . . . . 0.0 110.999 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.119 HD21 HG21 ' A' ' 103' ' ' ILE . 17.4 mt -81.6 117.11 21.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.532 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.2 137.45 51.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.896 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 20.0 mt -40.25 117.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.85 -3.1 25.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.174 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.965 ' HB2' HD12 ' A' ' 49' ' ' ILE . 1.7 m-20 -68.55 133.48 48.62 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.563 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.594 ' CD ' HD13 ' A' ' 43' ' ' ILE . 3.0 tt0 -89.5 81.17 6.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.949 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.806 HG23 HG22 ' A' ' 103' ' ' ILE . 2.9 mt -55.62 145.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.589 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.698 ' HE1' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -115.52 -38.65 3.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.6 t -156.63 154.09 29.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.712 HG21 ' CD2' ' A' ' 93' ' ' LEU . 6.1 mt -123.2 122.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 48.59 27.89 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 20.49 25.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.655 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.601 ' CG2' HD13 ' A' ' 89' ' ' ILE . 6.4 m -115.75 97.74 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.5 m -53.32 142.44 21.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.765 HD12 HG21 ' A' ' 47' ' ' VAL . 22.2 mt -112.03 -5.76 14.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.377 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.754 ' CG1' HD12 ' A' ' 44' ' ' LEU . 15.3 t -78.44 129.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.59 -21.4 44.79 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.056 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.15 144.92 28.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.938 0.369 . . . . 0.0 110.975 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -174.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.579 HD11 HE22 ' A' ' 87' ' ' GLN . 31.0 tp -75.9 -38.77 57.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.1 p -53.77 -39.28 65.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.573 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.6 m -68.3 -47.22 68.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.5 m -56.53 -53.82 53.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.579 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.76 -53.91 22.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.348 0.594 . . . . 0.0 110.211 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -51.26 -35.7 38.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.128 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 78' ' ' LEU . 31.8 mt -68.31 -33.6 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.297 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 35' ' ' ILE . 6.7 mt -76.4 -37.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -38.43 57.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.645 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.3 -17.3 56.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' CD2' HG21 ' A' ' 73' ' ' ILE . 2.8 pp -109.2 39.2 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.701 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -78.95 -26.09 43.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 17.6 m-80 -121.58 54.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.519 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.416 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 7.8 mm100 -114.43 -29.89 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 m 71.44 7.96 6.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.158 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.559 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -166.4 143.09 4.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 110.58 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.829 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.6 t -138.68 103.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.959 0.409 . . . . 0.0 111.928 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -89.25 73.66 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.807 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.5 pt? -104.87 118.04 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.3 0.571 . . . . 0.0 111.491 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.563 ' ND2' ' CD2' ' A' ' 18' ' ' PHE . 3.1 t30 -87.3 111.79 21.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.234 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.119 HG21 HD21 ' A' ' 64' ' ' LEU . 6.4 pt -99.48 174.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.574 HG22 ' CE1' ' A' ' 18' ' ' PHE . 22.0 t -130.58 144.78 36.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 111.921 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.077 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.904 0.383 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.7 148.48 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -134.43 117.51 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.15 73.64 2.29 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 64' ' ' LEU . 44.1 t -64.21 120.41 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.554 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.522 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.74 102.85 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.445 178.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 8.7 mm -99.03 103.4 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.132 0.491 . . . . 0.0 110.58 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.08 109.93 22.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.317 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -127.04 -174.2 3.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.974 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -97.06 134.68 40.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.493 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -46.64 119.32 2.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 94' ' ' LYS . . . 110.51 12.55 16.71 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.365 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' LYS . 4.3 mm-40 -130.19 130.11 44.27 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.396 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.511 HG23 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -80.5 154.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.142 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -49.26 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.65 7.87 41.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.898 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 58' ' ' ALA . 13.9 m -100.22 127.2 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.22 101.22 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.216 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -96.48 165.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.204 0.526 . . . . 0.0 112.141 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 48' ' ' ILE . 35.9 m -152.34 148.69 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.6 121.09 6.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.695 0.283 . . . . 0.0 111.338 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.877 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -61.92 152.84 30.88 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.856 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.13 7.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.825 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -175.49 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.781 0.324 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.52 26.34 2.8 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.737 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.19 -26.06 29.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.902 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -147.0 169.15 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.661 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.85 108.64 1.29 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.829 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.78 118.65 5.57 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.42 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 79' ' ' VAL . 40.0 p -130.62 -72.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -158.78 137.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 111.684 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.032 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.59 118.76 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.108 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.95 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.2 mt -63.56 74.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.85 -24.45 23.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.127 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -157.07 164.99 37.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.086 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -159.88 128.47 4.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.754 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.3 tpp -46.51 131.36 11.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.452 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -76.99 90.21 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.64 -12.58 25.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.43 -175.48 5.36 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.68 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HB3' HG22 ' A' ' 23' ' ' ILE . 73.6 Cg_exo -50.0 -46.06 29.82 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.88 2.386 . . . . 0.0 112.606 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.19 -48.2 81.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.57 -31.32 66.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.252 0.549 . . . . 0.0 110.589 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -60.97 -48.67 80.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.04 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.8 t -55.28 -30.01 59.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.92 71.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -45.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.758 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 101' ' ' LEU . 13.5 mt -85.17 114.22 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.46 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.5 p-10 -120.98 135.13 55.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.213 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.8 mt -34.82 119.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.972 0.415 . . . . 0.0 111.683 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.41 1.48 35.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.054 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.95 ' HB2' HD12 ' A' ' 49' ' ' ILE . 20.2 m-20 -76.44 119.04 19.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.782 0.325 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 12.4 tt0 -75.99 85.71 2.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.02 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -61.95 144.78 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.174 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 104' ' ' VAL . 5.0 mmt -110.3 -42.39 4.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.0 p -157.71 165.13 36.22 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.032 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.876 HG21 HD11 ' A' ' 93' ' ' LEU . 10.9 mt -126.99 114.57 37.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.032 0.444 . . . . 0.0 111.652 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.8 ' OD1' HG22 ' A' ' 73' ' ' ILE . 1.2 p-10 43.19 33.36 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.78 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.42 6.06 36.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.938 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.625 HG21 HD13 ' A' ' 89' ' ' ILE . 3.3 m -104.85 95.42 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.701 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.9 t -59.22 133.24 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.212 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.861 HD13 HG21 ' A' ' 47' ' ' VAL . 88.4 mt -107.34 16.45 23.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.804 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 46' ' ' THR . 3.3 t -92.04 113.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.317 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.18 -27.34 20.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.256 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -82.54 141.22 45.01 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.081 0.44 . . . . 0.0 111.053 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.17 -179.84 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.605 2.203 . . . . 0.0 112.381 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 36' ' ' VAL . 21.7 tp -70.06 -33.32 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.012 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -54.02 -45.29 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 7.0 m -67.34 -50.36 60.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.95 -43.59 81.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -59.4 -46.16 89.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.452 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -61.23 -31.09 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.296 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.625 HD13 HG21 ' A' ' 76' ' ' THR . 23.6 mt -68.09 -46.2 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.711 HD13 HG23 ' A' ' 33' ' ' VAL . 3.5 mt -63.86 -36.8 77.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -36.03 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.795 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.28 -10.22 73.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.037 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 73' ' ' ILE . 35.7 mt -92.59 30.91 1.43 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.559 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -86.3 -12.8 48.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.664 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -143.91 58.08 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.715 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 mm-40 -117.75 -37.76 3.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.437 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 79.51 -4.73 1.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mtm180 -161.0 141.67 11.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.512 0.196 . . . . 0.0 110.549 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 31' ' ' LEU . 6.3 t -137.83 105.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 111.89 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -93.34 74.24 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.663 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.84 123.55 47.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.319 0.581 . . . . 0.0 111.644 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.22 115.61 25.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.059 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -112.8 174.05 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.563 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 71' ' ' MET . 11.2 t -118.16 121.5 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.089 -179.887 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 C--O 1.231 0.109 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 7.9 tttt -143.12 114.79 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.3 78.16 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.716 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.2 t -68.23 123.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.018 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.04 102.86 10.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.127 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 22.3 mm -101.03 103.15 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 2.4 mt-10 -92.82 132.76 36.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -179.54 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 139.53 30.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.9 mttt -49.85 126.08 13.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.731 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.72 33.25 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 94' ' ' LYS . 47.6 mm-40 -127.49 131.2 50.18 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 111.195 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.46 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.07 151.67 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.334 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.076 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.83 -52.09 20.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.89 16.27 17.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.83 HG13 ' HB2' ' A' ' 58' ' ' ALA . 3.6 m -109.01 139.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.05 98.68 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.568 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 90' ' ' ILE . 1.4 pp -95.5 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.971 HG23 HD12 ' A' ' 48' ' ' ILE . 1.8 m -123.53 158.42 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.507 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 95.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.356 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.842 ' HA ' HD11 ' A' ' 48' ' ' ILE . 24.5 p . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.574 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 72.8 Cg_exo . . . . . 0 CA--C 1.527 0.143 0 N-CA-C 112.62 0.2 . . . . 0.0 112.62 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.2 t -162.5 -61.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.56 156.62 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.88 0.372 . . . . 0.0 111.791 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.971 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.8 116.63 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.823 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.93 HD12 ' HB2' ' A' ' 68' ' ' ASP . 62.5 mt -61.42 71.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -55.32 -38.79 69.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.75 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -134.58 165.46 25.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.002 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.44 126.33 1.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.695 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -66.93 75.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.39 -12.17 7.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.716 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.2 -172.2 4.4 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.699 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.556 ' O ' HG23 ' A' ' 23' ' ' ILE . 85.1 Cg_exo -47.03 -47.67 16.21 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.934 2.422 . . . . 0.0 112.905 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.83 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.48 -49.73 76.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.087 0.47 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -48.51 81.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 4.5 t -57.78 -30.09 65.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 110.57 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.75 69.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.3 -54.54 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.865 ' CD2' HD13 ' A' ' 103' ' ' ILE . 24.3 mt -75.65 125.14 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.514 0.674 . . . . 0.0 111.529 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.523 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.1 p30 -132.57 112.42 12.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.396 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' C ' ' O ' ' A' ' 65' ' ' ASN . 7.2 mt -13.61 114.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.7 -3.21 19.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.33 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.93 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -74.91 133.58 41.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.583 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.404 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -89.08 81.23 6.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.95 0.405 . . . . 0.0 110.766 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 103' ' ' ILE . 3.7 mt -53.58 145.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.539 ' HE2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -110.21 -41.59 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.86 158.78 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.08 HG21 HD11 ' A' ' 93' ' ' LEU . 9.4 mt -125.48 121.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 49.36 26.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.01 19.38 24.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.731 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.527 HG21 ' CD1' ' A' ' 89' ' ' ILE . 5.4 m -113.12 95.79 5.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.7 p -56.55 125.36 21.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HA ' HD11 ' A' ' 81' ' ' LEU . 40.5 mt -90.99 -3.47 57.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.55 128.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.103 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.48 -20.85 48.67 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.821 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.757 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -99.87 141.65 23.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.826 0.313 . . . . 0.0 110.878 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.86 -176.37 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.566 2.177 . . . . 0.0 112.358 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.8 -32.9 70.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.045 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.8 p -55.43 -41.78 73.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -68.17 -50.58 53.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' A' ' 78' ' ' LEU . 17.8 m -57.13 -48.82 77.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -54.29 -47.56 72.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.969 0.414 . . . . 0.0 110.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -59.2 -32.47 69.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 9.4 mt -67.99 -45.97 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.78 HD11 HG13 ' A' ' 35' ' ' ILE . 5.1 mt -64.07 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.499 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -36.86 79.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.338 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.83 -4.43 76.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.339 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.08 HD11 HG21 ' A' ' 73' ' ' ILE . 64.1 mt -93.16 36.29 1.05 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.813 0.339 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 30' ' ' ILE . 2.5 tttt -85.65 -44.51 12.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.553 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.438 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.2 p30 -116.82 61.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG3' HD23 ' A' ' 93' ' ' LEU . 2.5 mm-40 -113.82 -35.4 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.334 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 6.3 m 90.16 -19.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.179 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -167.31 151.51 6.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.174 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.076 HG21 HD12 ' A' ' 31' ' ' LEU . 3.4 t -128.58 110.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -90.86 75.56 6.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.477 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.841 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.4 pt? -107.68 119.12 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.325 0.583 . . . . 0.0 111.736 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -86.51 111.55 20.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.246 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.865 HD13 ' CD2' ' A' ' 64' ' ' LEU . 6.8 pt -99.88 174.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.445 . . . . 0.0 111.882 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 71.9 t . . . . . 0 C--O 1.237 0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.6 117.97 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.83 80.12 2.75 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.711 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.7 t -71.91 127.35 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.598 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.03 102.9 9.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.913 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -99.78 103.75 15.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 0.0 110.296 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 112.94 25.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.589 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HD3' ' CG ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -130.47 -170.51 2.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.782 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -95.63 151.74 19.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.4 mttt -60.92 136.98 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.929 0.395 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.21 11.46 62.89 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.555 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.93 135.92 54.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -86.26 148.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.857 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.65 -43.64 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 97.65 4.75 57.97 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.262 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 58' ' ' ALA . 5.2 m -96.44 140.83 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 117.079 0.44 . . . . 0.0 111.301 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.3 t -118.55 98.83 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -97.83 150.98 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 111.937 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.941 HG23 HD12 ' A' ' 48' ' ' ILE . 3.5 m -129.73 164.52 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.494 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.77 103.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.392 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.845 ' HA ' HD11 ' A' ' 48' ' ' ILE . 43.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 52.5 Cg_exo . . . . . 0 C--O 1.231 0.147 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 79' ' ' VAL . 73.3 p -148.91 -71.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.654 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -159.32 142.92 5.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.309 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.941 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -119.99 118.91 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.353 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 43.3 mt -63.49 71.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.44 -29.11 48.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.9 m120 -145.06 173.1 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -171.86 129.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.813 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.468 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -53.16 128.74 28.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.45 99.01 7.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.04 21.22 11.2 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.522 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 -160.57 22.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 44.5 Cg_exo -57.09 -54.44 3.63 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.733 2.289 . . . . 0.0 112.559 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.13 -49.31 77.42 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.33 -28.79 68.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.19 0.519 . . . . 0.0 110.196 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -48.76 78.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.978 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.913 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.5 m -48.46 -40.44 26.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.15 27.66 43.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -47.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.056 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 101' ' ' LEU . 8.2 mt -74.69 107.44 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.032 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.28 138.79 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.761 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 16.9 mt -36.74 114.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.28 -6.15 11.92 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.0 m-20 -72.43 130.33 40.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.682 0.277 . . . . 0.0 110.643 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.515 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -88.25 79.98 7.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.116 0.484 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -55.66 141.78 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttm -116.01 -33.88 4.92 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 94.2 p -153.85 151.96 30.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.77 0.319 . . . . 0.0 111.363 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 93' ' ' LEU . 6.9 mt -125.52 123.83 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.411 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 45.98 29.14 0.7 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.85 20.87 20.2 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.432 ' CG2' HD13 ' A' ' 89' ' ' ILE . 90.8 m -122.96 95.49 4.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.451 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.2 p -68.58 130.88 44.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -97.35 15.79 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.9 t -72.81 108.82 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.184 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.43 -26.82 17.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.207 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.52 144.17 42.55 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.185 0.493 . . . . 0.0 111.019 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.66 177.83 3.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.785 2.323 . . . . 0.0 112.643 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.707 HD13 ' HA ' ' A' ' 36' ' ' VAL . 33.5 tp -64.22 -34.24 77.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -48.64 69.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.999 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 17.5 m -65.87 -45.03 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.409 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 20.6 m -56.76 -54.5 45.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.743 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.641 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.92 -53.49 25.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.259 0.552 . . . . 0.0 110.634 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.548 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 1.5 m -54.47 -34.55 61.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.555 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 7.4 mt -63.96 -46.52 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 35' ' ' ILE . 4.3 mt -61.45 -34.81 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.305 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 2.0 mmmt -68.31 -43.56 77.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.556 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.82 -16.37 51.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.984 HD11 HG21 ' A' ' 73' ' ' ILE . 26.9 mt -91.24 38.47 0.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 111.027 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -80.92 -40.47 24.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.802 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.3 p30 -126.07 59.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.745 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -109.61 -35.5 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 0.8 OUTLIER 81.49 -10.79 1.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.17 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -155.34 150.11 26.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.698 0.285 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.715 HG12 HD22 ' A' ' 101' ' ' LEU . 5.0 t -139.99 103.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.939 0.4 . . . . 0.0 112.002 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -93.89 77.53 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -104.78 121.44 43.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.344 0.592 . . . . 0.0 111.676 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.81 106.79 17.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.982 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -106.48 174.03 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.208 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -146.01 114.9 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.19 74.03 2.32 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.779 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.4 t -64.9 128.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.78 102.91 9.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.861 HD13 ' OG ' ' A' ' 61' ' ' SER . 12.6 mm -99.04 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.85 0.357 . . . . 0.0 110.906 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.98 128.87 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 31' ' ' LEU . 2.0 pttp -149.57 177.75 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -87.44 142.05 28.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -51.28 126.65 17.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 14.84 34.34 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.443 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.2 mm-40 -123.04 134.0 54.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -86.1 152.06 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.242 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 99' ' ' VAL . 1.7 tp -50.59 -51.96 43.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.91 36.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.649 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 58' ' ' ALA . 8.8 m -95.29 138.98 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.063 0.458 . . . . 0.0 111.057 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.75 98.4 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 HG13 HD11 ' A' ' 90' ' ' ILE . 1.3 pp -95.94 143.72 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 111.729 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.007 HG23 HD12 ' A' ' 48' ' ' ILE . 2.5 m -124.63 161.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.39 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.48 111.87 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.809 ' HA ' HD11 ' A' ' 48' ' ' ILE . 22.7 t . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.887 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.878 0.282 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.5 t -170.69 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.772 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.88 146.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.814 0.34 . . . . 0.0 111.367 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.007 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.25 116.61 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.725 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 68' ' ' ASP . 90.3 mt -61.42 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.39 -38.49 63.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.52 169.16 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.955 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.568 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.83 132.39 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.6 113.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 75.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.75 -4.73 5.1 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.53 -173.16 47.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.649 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' ILE . 76.2 Cg_exo -48.5 -47.12 21.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.757 2.305 . . . . 0.0 112.67 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.38 -49.08 78.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.84 -27.28 64.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -62.73 -48.73 77.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.861 ' OG ' HD13 ' A' ' 23' ' ' ILE . 33.1 m -56.0 -32.24 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.31 4.74 80.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -98.28 -56.39 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 101' ' ' LEU . 12.5 mt -72.19 122.66 21.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 2.2 m-80 -131.54 135.74 47.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' ILE . 12.3 mt -35.14 116.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 111.618 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.36 0.8 29.59 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.119 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 1.011 ' HB2' HD12 ' A' ' 49' ' ' ILE . 8.9 m-20 -78.25 113.66 16.43 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.914 0.387 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 79.7 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.136 HG23 HG22 ' A' ' 103' ' ' ILE . 2.2 mt -54.5 145.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.479 ' SD ' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -112.45 -39.45 4.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.5 p -159.23 156.86 29.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.781 0.324 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 93' ' ' LEU . 7.8 mt -124.26 120.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.459 ' ND2' HG13 ' A' ' 99' ' ' VAL . 60.0 m-20 51.93 25.87 3.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.97 27.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.554 HG21 ' CD1' ' A' ' 89' ' ' ILE . 21.7 m -110.71 95.35 5.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 110.66 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.633 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -59.02 128.6 38.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.179 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.772 HD12 HG21 ' A' ' 47' ' ' VAL . 29.8 mt -98.48 -8.91 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.285 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 15.5 t -59.54 109.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.78 -27.09 21.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.952 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -71.9 139.93 83.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.827 0.313 . . . . 0.0 110.723 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.28 179.71 2.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.322 2.015 . . . . 0.0 111.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.53 -41.06 89.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 m -53.9 -36.28 62.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -70.55 -54.34 12.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.008 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.9 m -57.29 -55.27 36.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.828 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -54.29 19.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 110.823 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 t -53.31 -37.29 62.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.554 ' CD1' HG21 ' A' ' 76' ' ' THR . 6.8 mt -63.96 -46.12 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' ILE . 4.2 mt -60.16 -37.59 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.262 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -35.72 70.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.318 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.53 -7.85 83.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.53 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.088 HD11 HG21 ' A' ' 73' ' ' ILE . 87.0 mt -92.51 41.51 1.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.988 0.423 . . . . 0.0 110.688 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -84.77 -48.38 9.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.43 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 7.4 m-80 -116.74 61.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 97' ' ' SER . 5.5 mm-40 -108.04 -36.88 6.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.18 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 7.6 t 91.29 -18.51 0.15 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.236 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 151.71 3.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 31' ' ' LEU . 8.0 t -131.31 107.54 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -88.17 77.87 8.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -107.29 119.11 38.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.359 0.6 . . . . 0.0 111.514 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -86.34 107.09 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.128 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.136 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -99.78 164.17 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.479 HG21 ' SD ' ' A' ' 71' ' ' MET . 45.1 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.742 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.531 0.205 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.674 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -160.95 141.79 11.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.359 0.6 . . . . 0.0 112.469 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.4 72.79 8.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.722 HG11 ' HG ' ' A' ' 64' ' ' LEU . 76.8 t -58.58 124.52 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.626 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.96 103.28 11.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.915 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 61' ' ' SER . 13.3 mm -98.29 102.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.985 0.421 . . . . 0.0 110.258 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.94 117.38 33.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.426 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' SER . 22.4 pttt -136.64 -168.33 2.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 152.18 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -59.49 132.96 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.34 13.98 54.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.63 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -122.85 136.26 54.81 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.799 0.333 . . . . 0.0 111.425 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -89.37 161.29 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.806 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.972 HD11 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -51.97 -52.11 52.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.102 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.5 -10.93 35.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.26 127.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.082 0.467 . . . . 0.0 111.367 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.01 100.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.808 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.688 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.4 pp -90.25 137.46 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.094 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.053 HG23 HD12 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -119.95 161.48 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.646 ' H ' HD12 ' A' ' 83' ' ' LEU . 2.1 tt0 -63.2 117.99 7.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.806 0.336 . . . . 0.0 110.796 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.657 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.031 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 C--O 1.23 0.115 0 CA-C-O 120.776 0.24 . . . . 0.0 112.269 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -170.3 -64.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.85 143.48 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.053 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.25 117.53 48.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.421 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.96 HD11 HD22 ' A' ' 64' ' ' LEU . 58.4 mt -62.59 70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.05 -41.47 62.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.589 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.69 -169.97 2.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.599 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 5.3 ptp -168.32 162.51 12.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 8.0 tpp -88.56 117.11 27.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -55.41 103.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.74 77.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.729 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.72 171.91 37.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 23' ' ' ILE . 88.8 Cg_exo -49.01 -45.16 30.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.886 2.391 . . . . 0.0 112.975 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.768 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -57.83 -49.91 75.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.336 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.68 -30.72 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -53.35 -48.66 68.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.737 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 23' ' ' ILE . 1.4 t -55.7 -43.78 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.51 83.46 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -87.77 -35.01 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.676 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 101' ' ' LEU . 11.0 mt -90.72 111.39 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.7 OUTLIER -120.4 140.89 50.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.1 mt -38.01 126.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.812 0.339 . . . . 0.0 111.412 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.09 -7.66 52.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.989 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.895 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.5 m-20 -69.32 109.24 4.04 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.682 ' OE1' HG23 ' A' ' 48' ' ' ILE . 14.3 tp60 -71.37 85.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.012 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -58.86 138.9 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.704 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -105.57 -38.28 6.49 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.9 p -159.45 157.67 30.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.332 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 93' ' ' LEU . 7.7 mt -122.14 126.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.699 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.673 ' ND2' HG22 ' A' ' 73' ' ' ILE . 5.9 p30 36.42 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.172 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.75 26.22 9.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.809 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.783 HG21 HD13 ' A' ' 89' ' ' ILE . 25.3 m -123.86 95.33 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 110.724 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 81' ' ' LEU . 5.0 m -60.62 120.8 10.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.048 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.775 HD21 HD12 ' A' ' 89' ' ' ILE . 38.1 mt -91.09 -11.15 39.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.362 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 21.9 t -55.94 107.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.264 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.26 -26.35 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.793 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 77' ' ' SER . 4.6 mt -68.24 127.49 93.26 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.556 0.217 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.59 164.54 2.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.337 2.025 . . . . 0.0 112.012 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.646 HD12 ' H ' ' A' ' 37' ' ' GLU . 8.7 tt -60.23 -44.64 95.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 m -53.49 -33.44 54.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.525 ' O ' HG13 ' A' ' 89' ' ' ILE . 2.9 m -72.88 -47.19 48.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.752 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.473 ' O ' HG13 ' A' ' 90' ' ' ILE . 74.9 m -56.8 -50.01 73.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' CG ' HD23 ' A' ' 83' ' ' LEU . 1.8 mm-40 -57.15 -53.17 61.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.184 0.516 . . . . 0.0 109.966 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 9.0 p -51.57 -39.76 58.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.783 HD13 HG21 ' A' ' 76' ' ' THR . 12.5 mt -61.36 -41.73 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.8 mt -60.4 -35.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.348 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.2 mppt? -76.28 -34.71 59.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.521 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.74 -30.05 76.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 73' ' ' ILE . 1.7 pp -99.56 38.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.53 -25.47 50.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.912 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.44 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 2.1 m120 -126.08 55.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.487 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.431 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 34.5 mm-40 -112.31 -30.39 7.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.555 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 74.97 1.42 3.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.599 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.01 146.9 12.83 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.718 0.294 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.972 HG11 HD11 ' A' ' 31' ' ' LEU . 3.6 t -140.14 105.64 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -94.45 79.65 3.88 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 pt? -107.27 125.24 50.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.381 0.61 . . . . 0.0 111.763 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -87.5 109.15 19.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.851 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.012 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -114.88 174.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 69' ' ' GLN . 3.5 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.983 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 2.6 m-85 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -146.66 116.82 7.35 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.88 78.14 2.79 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.738 HG11 ' HG ' ' A' ' 64' ' ' LEU . 35.8 t -69.22 125.58 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.507 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.26 103.12 10.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.515 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.897 HD13 ' OG ' ' A' ' 61' ' ' SER . 8.9 mm -98.56 103.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.631 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -99.33 128.49 45.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.559 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -151.94 -174.96 5.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.942 0.401 . . . . 0.0 110.958 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -85.18 160.82 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.139 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -67.12 123.25 19.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.303 0.573 . . . . 0.0 110.466 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' H ' ' HA ' ' A' ' 95' ' ' ASN . . . 100.68 18.74 19.84 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.299 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.1 mm-40 -117.46 131.49 56.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.676 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -87.74 151.2 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.1 tp -48.21 -43.32 31.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 98.23 -5.06 60.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.783 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.935 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.31 125.12 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.28 98.57 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.954 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.853 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.4 pp -95.6 147.31 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.995 HG23 HD12 ' A' ' 48' ' ' ILE . 27.2 m -132.1 155.29 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -51.73 118.85 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.787 0.327 . . . . 0.0 111.29 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.792 0.247 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 79' ' ' VAL . 82.1 p -144.82 -74.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.908 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -159.99 141.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.658 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.07 119.07 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.13 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.924 HD12 ' HB2' ' A' ' 68' ' ' ASP . 31.3 mt -62.21 72.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.72 -25.95 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.904 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -165.41 166.67 18.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.705 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.551 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.3 ptp -143.48 171.09 14.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.401 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.9 ttm -87.65 112.98 22.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.88 90.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.08 21.91 8.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.438 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.22 179.26 27.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.408 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB3' HG22 ' A' ' 23' ' ' ILE . 78.5 Cg_exo -51.21 -45.38 37.32 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.68 2.253 . . . . 0.0 112.455 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.935 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.47 -49.46 77.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.34 -32.28 68.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -58.78 -48.65 80.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.897 ' OG ' HD13 ' A' ' 23' ' ' ILE . 7.8 m -50.04 -43.86 51.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.28 85.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.419 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 61' ' ' SER . 1.2 mptt -97.85 -53.1 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.44 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.074 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -74.62 125.17 28.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.172 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.551 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.7 p30 -128.24 136.51 51.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.027 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 15.7 mt -37.86 107.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.991 0.424 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.92 -6.93 10.22 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.917 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.924 ' HB2' HD12 ' A' ' 49' ' ' ILE . 10.0 m-20 -71.27 124.38 24.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.564 0.221 . . . . 0.0 110.428 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -86.97 97.16 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.14 0.495 . . . . 0.0 110.543 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.151 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -68.23 142.25 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.145 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.6 mmt -111.7 -32.97 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.008 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 45.3 t -159.62 154.6 24.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.139 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.834 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.1 mt -126.8 123.69 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 45.88 29.82 0.78 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.39 21.87 25.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.371 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -115.54 97.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.69 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -52.97 134.99 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 81' ' ' LEU . 63.7 mt -109.53 9.71 25.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.026 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.916 ' HA ' HG22 ' A' ' 46' ' ' THR . 11.8 t -86.19 114.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.398 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.74 -33.99 6.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.146 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.919 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -76.72 127.63 83.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.072 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.81 170.43 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.541 2.161 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 tp -59.52 -34.01 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -53.49 -51.02 64.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.546 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 89' ' ' ILE . 58.5 m -63.51 -43.38 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.425 ' HB3' HG11 ' A' ' 47' ' ' VAL . 18.6 m -57.03 -50.57 72.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.87 -38.52 72.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -33.77 74.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.115 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 22.7 mt -64.89 -38.97 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 120.969 0.414 . . . . 0.0 109.916 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -77.19 -42.87 31.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -44.17 97.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.364 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.09 -14.53 61.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.375 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 95.9 mt -93.83 37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.794 ' HG3' HG22 ' A' ' 30' ' ' ILE . 7.2 mtpt -79.11 -34.49 43.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' GLY . 1.9 p30 -120.3 64.22 0.83 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.7 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HG3' HD22 ' A' ' 93' ' ' LEU . 16.3 mm-40 -119.21 -34.71 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.543 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.603 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 5.5 t 74.11 1.53 3.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.734 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.563 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -165.86 145.11 6.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.826 HG21 ' CD1' ' A' ' 31' ' ' LEU . 11.1 t -139.89 103.83 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -91.39 78.38 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.441 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.896 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -107.69 118.98 38.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.403 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.99 111.48 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.439 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.151 HG22 HG23 ' A' ' 70' ' ' ILE . 1.1 pt -107.58 174.15 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.336 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.504 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -147.51 113.77 5.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.12 73.8 2.97 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.794 HG11 ' HG ' ' A' ' 64' ' ' LEU . 47.3 t -61.9 126.1 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.799 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.0 103.83 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.697 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 61' ' ' SER . 16.6 mm -100.05 103.44 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.982 0.42 . . . . 0.0 110.99 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 109.94 22.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.241 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 3.0 pttt -127.79 -170.27 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.6 138.3 40.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -47.66 124.41 7.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.027 0.442 . . . . 0.0 110.764 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.74 12.95 28.98 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.514 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' LYS . 10.5 mm-40 -129.22 126.63 39.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.278 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.08 153.69 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -47.66 -52.24 18.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.072 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.91 1.21 42.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 58' ' ' ALA . 11.7 m -94.53 123.81 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.184 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.3 t -99.85 100.0 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.457 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.689 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.7 pp -95.6 142.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.111 0.481 . . . . 0.0 111.683 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -118.22 167.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.7 105.28 2.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 48' ' ' ILE . 11.5 p . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.453 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 57.7 Cg_endo . . . . . 0 C--O 1.231 0.132 0 N-CA-C 113.047 0.364 . . . . 0.0 113.047 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -175.14 -64.85 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.338 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.86 161.15 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.985 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -142.42 114.85 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.933 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.9 mt -61.1 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 36' ' ' VAL . . . -53.79 -30.73 46.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.816 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.518 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -153.55 167.68 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.899 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 5.0 ttp -154.92 129.21 8.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tpp -54.0 98.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -52.06 123.17 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.66 21.66 59.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.95 -170.31 20.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 23' ' ' ILE . 53.8 Cg_exo -53.15 -47.62 26.52 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.646 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.796 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.71 -49.36 77.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.432 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.02 -30.37 63.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -48.57 75.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.689 ' HB3' HD13 ' A' ' 23' ' ' ILE . 98.8 p -56.25 -39.38 72.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.41 63.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.354 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -110.21 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 101' ' ' LEU . 16.1 mt -72.38 127.83 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.721 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.7 m-80 -130.62 126.72 37.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 14.4 mt -30.61 113.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 121.06 0.457 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.74 5.31 22.36 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.094 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.964 ' HB2' HD12 ' A' ' 49' ' ' ILE . 15.7 m-20 -79.27 120.82 24.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.7 80.92 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.948 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.976 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -55.76 143.51 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -41.38 4.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.928 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 77.2 p -158.29 156.87 31.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 111.404 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.945 HG21 HD11 ' A' ' 93' ' ' LEU . 6.7 mt -122.82 122.03 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.3 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.888 ' ND2' HG22 ' A' ' 73' ' ' ILE . 4.0 p30 40.32 33.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.865 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.51 22.18 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.811 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 89' ' ' ILE . 33.5 m -123.09 95.56 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.756 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.49 130.21 43.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.797 ' CD2' HD12 ' A' ' 89' ' ' ILE . 59.1 mt -96.23 12.59 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -89.3 123.74 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.63 -25.39 28.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.822 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.756 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -91.44 134.2 29.96 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.761 0.281 . . . . 0.0 110.869 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.03 -176.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.497 2.131 . . . . 0.0 112.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 7.8 tt -75.55 -37.66 59.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -53.43 -36.89 62.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.556 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.2 m -68.76 -50.81 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.495 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.403 ' O ' HG13 ' A' ' 90' ' ' ILE . 21.5 m -56.77 -48.68 77.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.462 ' NE2' HD12 ' A' ' 35' ' ' ILE . 98.4 mm-40 -54.14 -48.1 71.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 t -61.42 -33.81 74.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.533 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 78' ' ' LEU . 38.8 mt -64.6 -46.43 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 35' ' ' ILE . 3.6 mt -65.24 -39.08 84.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.443 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -69.35 -32.37 71.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.821 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.27 -11.54 84.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.468 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.945 HD11 HG21 ' A' ' 73' ' ' ILE . 93.8 mt -93.17 39.86 1.05 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.934 0.397 . . . . 0.0 110.93 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 29' ' ' GLU . 4.2 tttt -80.87 -37.57 29.62 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 3.2 p30 -120.71 63.68 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.837 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.405 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 13.0 mm-40 -117.18 -39.54 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 76.68 -2.12 2.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.698 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -162.64 139.45 7.76 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.533 0.206 . . . . 0.0 110.451 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.785 HG12 HD22 ' A' ' 101' ' ' LEU . 10.6 t -136.38 104.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -93.03 80.07 4.57 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.503 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.886 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.2 pt? -110.01 120.07 41.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.41 108.45 18.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.048 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.976 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -101.17 167.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.08 0.467 . . . . 0.0 111.787 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.602 -179.269 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -144.51 115.08 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 75.6 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.804 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.5 t -66.36 120.8 14.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.524 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.43 103.63 10.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.627 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 58' ' ' ALA . 14.3 mm -99.18 103.59 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.442 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 1.2 tt0 -95.49 111.53 23.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.6 pttt -130.84 -170.73 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.112 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.34 143.4 32.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.575 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 4.9 mttt -51.43 128.57 23.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.987 0.423 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 11.65 43.97 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.581 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -124.09 129.2 50.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -83.33 149.79 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -47.77 -46.06 29.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.53 7.81 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.05 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.69 HG13 ' CB ' ' A' ' 58' ' ' ALA . 4.7 m -95.9 126.09 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 111.438 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -102.41 98.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.092 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.817 HD13 HG12 ' A' ' 47' ' ' VAL . 2.6 pp -101.99 151.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 112.176 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.901 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.2 m -132.26 159.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.186 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.75 117.06 3.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.692 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 C--O 1.229 0.072 0 CA-C-O 120.805 0.252 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 79' ' ' VAL . 71.1 p -141.14 -72.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.171 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -160.12 148.06 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.029 0.442 . . . . 0.0 111.868 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.901 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -129.27 113.96 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 68' ' ' ASP . 36.5 mt -60.98 72.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.05 -28.64 58.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.399 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 26.0 m120 -145.57 169.52 18.24 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.681 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.684 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -166.77 117.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.676 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 ttm -45.42 124.03 4.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.605 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -68.21 105.83 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.623 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.39 -17.25 57.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -178.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' O ' HG23 ' A' ' 23' ' ' ILE . 77.1 Cg_exo -51.0 -47.41 25.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.902 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.43 -49.08 78.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.76 -26.56 62.5 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.738 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -48.96 75.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.9 p -52.87 -37.94 61.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.04 45.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.173 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -117.66 -61.64 1.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 101' ' ' LEU . 14.0 mt -66.06 131.09 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.841 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' ILE . 8.9 m-80 -134.18 123.7 24.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.124 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.1 mt -28.38 114.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.968 0.413 . . . . 0.0 111.789 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.98 -6.02 22.03 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.983 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.96 ' HB2' HD12 ' A' ' 49' ' ' ILE . 14.5 m-20 -68.5 135.6 51.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 110.515 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HB3' HG23 ' A' ' 104' ' ' VAL . 1.1 tm0? -92.63 81.52 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.862 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -54.9 141.32 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.0 ttm -111.26 -34.21 6.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.691 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 87.1 p -156.96 155.11 30.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -126.66 121.43 58.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.891 0.376 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 46.97 29.04 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.243 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.09 18.19 25.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.622 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 89' ' ' ILE . 9.0 m -119.42 95.63 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.756 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.774 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.4 m -63.56 131.23 47.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.337 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.966 HD13 HG21 ' A' ' 47' ' ' VAL . 3.2 mt -98.05 22.49 9.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.906 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.1 t -88.14 105.87 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.68 -30.17 8.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.931 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -80.53 143.4 55.12 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.94 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.81 169.94 13.69 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.744 2.296 . . . . 0.0 112.667 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.55 HD11 HE22 ' A' ' 87' ' ' GLN . 27.3 tp -58.38 -37.09 74.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -53.48 -48.61 68.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.733 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.628 ' O ' HG13 ' A' ' 89' ' ' ILE . 26.1 m -64.47 -43.58 93.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.497 ' HB3' HG11 ' A' ' 47' ' ' VAL . 13.6 m -56.6 -54.92 40.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.55 HE22 HD11 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -49.94 -53.58 25.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.172 0.511 . . . . 0.0 110.508 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -53.14 -32.21 46.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.422 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.638 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 20.6 mt -70.04 -36.98 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.201 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 33' ' ' VAL . 4.3 mt -77.64 -35.49 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.509 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -73.86 -42.7 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.981 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.35 39.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.488 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.687 HD11 HG21 ' A' ' 73' ' ' ILE . 21.8 mt -88.15 46.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.65 -30.99 41.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -135.18 69.16 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.567 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.417 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 8.2 mm-40 -119.1 -36.13 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.343 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.3 p 76.3 1.63 3.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.684 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -162.77 143.3 9.62 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.616 0.246 . . . . 0.0 110.883 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.777 HG11 ' CD1' ' A' ' 31' ' ' LEU . 4.1 t -137.58 103.54 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 111.671 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -93.04 74.53 4.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.646 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.19 119.5 39.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.277 0.56 . . . . 0.0 111.189 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.94 107.28 18.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.426 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.862 HG22 HG23 ' A' ' 70' ' ' ILE . 5.3 pt -103.06 173.6 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.417 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.316 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.579 0.228 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.81 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -152.9 142.63 21.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 111.99 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.49 72.4 7.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.784 HG11 ' HG ' ' A' ' 64' ' ' LEU . 72.2 t -57.85 125.72 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.25 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.09 103.83 10.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.249 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 61' ' ' SER . 10.1 mm -100.31 103.54 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -100.09 131.59 45.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.603 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -153.74 -172.85 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.968 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -94.88 145.3 25.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.442 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 5.6 mptt -49.2 122.95 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.056 0.455 . . . . 0.0 110.679 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.35 16.65 22.17 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -121.31 119.79 33.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 111.413 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -77.74 151.05 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.877 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.32 -52.24 16.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.316 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.98 -1.33 35.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.144 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.798 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -94.63 122.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.09 0.471 . . . . 0.0 111.324 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG21 ' ND2' ' A' ' 51' ' ' ASN . 46.1 t -97.17 98.65 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.079 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -95.62 149.8 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 112.051 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 2.9 m -133.78 157.72 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.365 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.85 111.99 0.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.853 0.358 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.725 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo . . . . . 0 CA--C 1.527 0.148 0 CA-C-O 120.935 0.306 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.928 HG22 ' HA ' ' A' ' 79' ' ' VAL . 41.2 p -135.98 -70.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.18 137.61 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -116.08 119.07 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.394 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.6 mt -64.75 70.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.34 -33.96 22.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.329 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.573 ' ND2' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -159.21 140.7 13.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.52 . . . . 0.0 110.506 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.444 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 2.8 ttp -123.34 163.03 21.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.47 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.5 ttm -76.92 137.01 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -80.87 92.78 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.33 -4.4 37.81 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.94 -179.38 50.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.58 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 23' ' ' ILE . 82.6 Cg_exo -47.36 -47.03 18.51 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.919 2.413 . . . . 0.0 112.902 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.798 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.64 -49.48 77.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.259 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.34 -24.78 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -64.45 -47.03 80.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.816 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.7 t -53.08 -41.73 65.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.802 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.02 85.94 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.349 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 1.3 mptt -100.16 -56.45 2.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.803 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.084 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -70.36 124.49 24.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.204 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' ILE . 23.1 m-80 -131.09 136.11 48.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.223 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 25.0 mt -34.76 124.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.49 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.52 -9.02 48.37 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.985 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -66.9 120.81 14.21 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.686 0.279 . . . . 0.0 110.693 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.4 82.54 7.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.04 0.448 . . . . 0.0 110.233 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.996 HG23 HG22 ' A' ' 103' ' ' ILE . 2.6 mt -55.68 139.3 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.981 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.42 ' HE3' HG21 ' A' ' 104' ' ' VAL . 2.9 mmt -106.04 -39.44 5.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.74 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 80.6 p -156.38 164.34 38.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 93' ' ' LEU . 8.3 mt -128.44 114.3 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.003 0.43 . . . . 0.0 111.471 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.927 ' ND2' HG22 ' A' ' 73' ' ' ILE . 12.3 p30 42.48 31.94 0.32 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.687 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.84 11.76 27.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.808 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.684 ' CG2' HD13 ' A' ' 89' ' ' ILE . 3.8 m -109.72 95.62 5.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.557 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.1 t -56.77 130.01 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.861 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.4 mt -107.36 22.19 16.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.67 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.928 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.2 t -98.26 112.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.328 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.04 -24.56 30.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.736 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -85.08 130.92 50.28 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 117.113 0.457 . . . . 0.0 110.975 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.04 -174.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.613 2.209 . . . . 0.0 112.644 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.627 HD11 HE22 ' A' ' 87' ' ' GLN . 35.0 tp -72.92 -37.32 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.023 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 m -53.76 -42.72 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 8.7 m -65.9 -48.02 72.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.575 ' SG ' HD22 ' A' ' 78' ' ' LEU . 19.9 m -57.0 -53.36 59.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.627 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.83 -53.96 22.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 t -53.35 -37.86 62.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.684 HD13 ' CG2' ' A' ' 76' ' ' THR . 27.5 mt -63.42 -46.44 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.506 HD11 HG13 ' A' ' 35' ' ' ILE . 3.1 mt -66.57 -37.45 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -33.98 71.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.241 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.33 -14.44 79.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.467 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 73' ' ' ILE . 94.4 mt -90.93 43.68 1.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.739 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 17.8 mttt -83.21 -47.78 11.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 1.4 p30 -112.47 57.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -112.27 -33.9 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.074 0.464 . . . . 0.0 110.09 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.577 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 9.0 t 73.3 5.07 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 2.5 mtm180 -167.37 147.91 5.43 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.356 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.877 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.8 t -142.65 102.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.0 0.428 . . . . 0.0 111.739 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -92.23 72.54 5.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.939 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -99.9 126.47 46.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.067 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.5 m120 -90.13 114.28 26.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.943 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.084 HG21 HD21 ' A' ' 64' ' ' LEU . 2.5 pt -117.01 173.32 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.452 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' GLN . 3.6 m . . . . . 0 C--O 1.235 0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.217 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CD1' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.621 0.248 . . . . 0.0 110.52 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HE2' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -145.8 150.37 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.26 0.552 . . . . 0.0 112.158 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.71 73.18 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HG ' ' A' ' 64' ' ' LEU . 93.1 t -59.25 125.77 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.312 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.7 103.74 10.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' HA ' ' A' ' 58' ' ' ALA . 7.6 mm -99.16 103.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.01 0.434 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 121.14 36.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.73 -171.95 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 111.062 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.56 138.4 38.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 7.5 mttt -48.32 127.22 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.23 37.81 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 28.6 mm-40 -128.43 130.31 47.43 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.851 0.358 . . . . 0.0 111.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.5 HD11 ' HE1' ' A' ' 53' ' ' MET . 1.1 pt -78.91 154.01 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.843 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.81 -52.17 19.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.59 29.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.122 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 58' ' ' ALA . 15.9 m -94.46 148.65 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.197 0.522 . . . . 0.0 111.186 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.499 HG21 HD21 ' A' ' 51' ' ' ASN . 91.0 t -126.99 98.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.626 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.2 pp -94.05 149.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.115 0.483 . . . . 0.0 111.523 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.5 m -122.54 162.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.568 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.14 93.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.629 ' HA ' HD11 ' A' ' 48' ' ' ILE . 3.3 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.604 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' SER . 52.6 Cg_exo . . . . . 0 C--O 1.232 0.18 0 N-CA-C 112.602 0.193 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -141.59 -66.67 0.41 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.366 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.788 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.34 165.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 111.455 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -143.83 116.88 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 76.2 mt -62.6 72.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.93 -26.09 5.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.945 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.499 HD21 HG21 ' A' ' 34' ' ' VAL . 4.6 p-10 -164.96 167.54 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.379 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.436 ' HG3' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -154.25 142.4 20.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.724 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -53.0 139.32 28.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.29 76.66 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.42 -18.51 7.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.669 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.49 -179.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 23' ' ' ILE . 82.1 Cg_exo -46.85 -45.18 21.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.795 2.33 . . . . 0.0 112.737 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.849 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.2 -47.63 82.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -70.7 -31.14 67.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.245 0.545 . . . . 0.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -62.46 -48.31 80.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.799 ' CB ' HD13 ' A' ' 23' ' ' ILE . 44.4 t -53.81 -31.15 48.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.98 20.24 72.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.461 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -113.65 -49.21 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.741 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 17.8 mt -82.83 119.65 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 111.804 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -119.9 138.34 53.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.866 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 19.9 mt -37.09 131.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.644 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 4.5 59.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.058 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.7 m-20 -77.34 121.27 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.776 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -79.11 81.11 5.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.894 HG23 HG22 ' A' ' 103' ' ' ILE . 3.9 mt -57.56 143.73 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.029 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.693 ' CG ' HG23 ' A' ' 104' ' ' VAL . 11.1 mmt -108.32 -41.96 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.589 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 64.3 p -156.41 155.2 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.008 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.008 HG21 HD11 ' A' ' 93' ' ' LEU . 6.3 mt -120.15 122.57 68.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 48.3 28.25 1.57 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.0 22.26 20.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.396 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -116.01 96.2 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.387 . . . . 0.0 110.796 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.482 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.29 135.39 32.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.214 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.788 HD13 HG21 ' A' ' 47' ' ' VAL . 58.8 mt -108.07 3.92 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.321 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 t -84.95 122.5 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.15 -23.42 36.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.833 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.688 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.43 127.85 42.58 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.023 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.34 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.692 2.261 . . . . 0.0 112.675 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.512 HD13 ' HA ' ' A' ' 36' ' ' VAL . 40.3 tp -69.93 -35.11 74.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -53.33 -45.6 69.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.3 m -65.09 -48.18 74.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.737 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.0 m -56.96 -50.55 72.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -53.05 -43.39 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 t -64.52 -31.25 72.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.15 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.778 HD12 ' CD2' ' A' ' 78' ' ' LEU . 27.9 mt -69.53 -36.7 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.937 0.398 . . . . 0.0 109.956 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.702 HD11 HG13 ' A' ' 35' ' ' ILE . 6.1 mt -77.23 -41.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.388 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -39.24 89.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.552 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.07 -10.76 65.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.755 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.008 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.92 37.49 1.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -80.49 -31.06 37.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 4.2 m-80 -127.88 67.19 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.774 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 14.1 mm-40 -121.25 -38.1 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.428 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.8 3.0 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -166.27 145.47 5.87 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.5 t -140.27 103.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -91.91 76.93 5.5 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.064 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -106.06 126.46 52.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.924 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 2.8 m120 -88.93 123.67 33.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 4.8 pt -122.29 165.91 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 111.868 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.693 HG23 ' CG ' ' A' ' 71' ' ' MET . 86.2 t . . . . . 0 C--O 1.234 0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CE1' HG22 ' A' ' 104' ' ' VAL . 1.7 m-85 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -146.81 117.5 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.6 73.21 2.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.789 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.0 t -62.46 126.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.011 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.88 103.57 10.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.872 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 58' ' ' ALA . 15.4 mm -101.0 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.162 0.506 . . . . 0.0 110.23 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.24 118.55 36.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE2' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -133.43 -170.01 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.023 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.26 135.89 41.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.0 mttt -47.62 120.83 3.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.191 0.52 . . . . 0.0 111.032 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.67 10.85 22.46 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.23 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -128.13 142.12 51.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.582 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.3 pt -93.3 161.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.8 tp -47.86 -51.99 20.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.159 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 105.26 -4.64 41.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.885 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.95 ' CG2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -94.83 127.28 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.052 0.453 . . . . 0.0 111.397 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 11.6 t -95.69 98.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.791 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.838 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -97.8 150.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 111.771 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.902 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.3 m -133.4 161.38 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.592 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.93 116.16 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.95 0.312 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 67.0 p -142.01 -72.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -158.67 144.68 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.169 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.902 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.43 114.62 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.233 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.951 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.6 mt -61.52 73.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -58.02 -29.28 65.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.507 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 27.5 m120 -147.5 -177.09 5.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.244 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.4 ptp -173.1 144.34 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tpp -65.82 124.27 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 49.7 p-80 -61.0 87.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.09 -14.24 31.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.73 175.87 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.641 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.564 ' O ' HG23 ' A' ' 23' ' ' ILE . 71.9 Cg_exo -50.01 -47.43 23.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.706 2.271 . . . . 0.0 112.885 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.838 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.1 -49.44 76.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.0 -27.6 61.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.95 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.589 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 23' ' ' ILE . 15.7 p -51.83 -46.88 64.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.33 -24.29 31.06 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.891 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -53.93 26.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.009 0.433 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 mt -72.79 129.97 39.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -134.6 137.71 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.158 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.3 mt -39.44 108.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.389 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -5.84 11.19 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.124 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.0 m-20 -69.8 119.42 14.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.7 80.04 3.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.04 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.058 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -55.01 145.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.915 ' CE ' HG21 ' A' ' 104' ' ' VAL . 2.5 tpp -115.64 -38.8 3.64 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 43.4 t -153.66 164.53 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.127 HG21 HD11 ' A' ' 93' ' ' LEU . 14.1 mt -130.04 112.83 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.655 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.898 ' ND2' HG22 ' A' ' 73' ' ' ILE . 10.1 p30 42.71 32.57 0.39 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.107 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 2.49 31.11 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.371 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 89' ' ' ILE . 2.8 m -102.32 95.67 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.675 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -61.08 113.77 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 47' ' ' VAL . 82.2 mt -82.53 -12.17 57.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.31 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 24.4 t -58.66 103.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.182 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.59 -30.27 9.37 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.7 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.598 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.5 mt -66.54 118.61 55.71 Favored Pre-proline 0 C--N 1.33 -0.241 0 O-C-N 122.832 -0.217 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.39 166.14 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.563 HD13 ' HA ' ' A' ' 36' ' ' VAL . 32.7 tp -54.39 -42.25 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 t -53.88 -43.77 69.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.808 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.51 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.8 m -68.57 -44.74 73.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.97 -56.97 14.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.509 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.73 -54.11 20.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 110.519 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.0 p -51.12 -41.37 60.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.257 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 HG21 ' A' ' 76' ' ' THR . 11.0 mt -59.75 -45.16 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -59.96 -38.56 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -47.5 79.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.27 -15.1 50.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.467 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.127 HD11 HG21 ' A' ' 73' ' ' ILE . 78.1 mt -91.23 31.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.041 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.4 tttt -81.01 -37.54 28.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 3.5 p30 -118.74 62.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.8 mm-40 -117.76 -41.25 2.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.4 t 78.9 -2.57 2.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.54 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.49 140.19 8.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.62 0.248 . . . . 0.0 110.451 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 31' ' ' LEU . 5.1 t -136.97 104.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 112.111 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -91.08 73.05 6.36 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -101.81 123.83 46.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.557 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.93 109.32 20.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.058 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -99.9 165.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.472 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.915 HG21 ' CE ' ' A' ' 71' ' ' MET . 22.2 t . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.792 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.61 121.5 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.21 77.29 5.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 27.7 t -68.2 121.18 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.011 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.27 103.64 11.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.509 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.7 mm -99.99 103.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.025 0.44 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.93 117.42 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -134.66 -172.11 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.32 136.66 39.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.656 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -47.51 123.55 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.148 0.499 . . . . 0.0 110.811 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.55 12.82 27.66 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.441 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.3 mm-40 -127.15 133.75 50.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.714 0.292 . . . . 0.0 111.265 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -84.43 154.37 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -48.16 -52.11 22.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.025 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.38 -0.39 37.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.454 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.855 HG13 ' CB ' ' A' ' 58' ' ' ALA . 2.3 m -94.72 128.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.06 0.43 . . . . 0.0 111.58 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.4 t -100.33 98.27 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.67 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.631 HD13 ' CG1' ' A' ' 47' ' ' VAL . 2.5 pp -96.95 158.78 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 0.0 111.958 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 48' ' ' ILE . 4.0 m -140.37 157.8 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.412 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.82 121.17 10.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.693 ' HA ' HD11 ' A' ' 48' ' ' ILE . 5.2 p . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.705 0.211 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.636 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -155.83 -67.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.255 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 78' ' ' LEU . 1.4 m -160.39 148.11 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.072 0.463 . . . . 0.0 112.023 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.997 HD12 HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -125.83 117.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.8 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 46.8 mt -61.86 74.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -57.71 -27.85 63.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.643 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.523 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 28.3 m120 -148.05 177.46 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.011 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 6.1 ttp -171.55 128.93 0.67 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.67 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.8 tpp -53.6 136.93 38.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.217 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -77.61 93.63 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.729 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.45 -17.12 28.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.566 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.74 179.02 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.633 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.521 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.6 Cg_exo -48.68 -50.26 12.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.777 2.318 . . . . 0.0 112.957 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.892 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.16 -49.21 77.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.766 0.317 . . . . 0.0 111.267 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.58 -22.41 61.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -66.0 -48.4 71.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB3' HD13 ' A' ' 23' ' ' ILE . 18.8 p -54.22 -43.08 70.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.69 -9.31 78.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.494 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -58.67 2.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.989 0.423 . . . . 0.0 111.107 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 13.6 mt -68.68 129.55 40.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.44 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.0 m-80 -134.25 135.06 42.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.033 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 13.0 mt -36.38 109.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 121.028 0.442 . . . . 0.0 111.494 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.48 -0.35 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.214 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.6 m-20 -75.3 118.9 18.71 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.784 0.326 . . . . 0.0 110.705 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -74.39 84.4 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.035 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -62.44 144.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.637 ' HG3' HG23 ' A' ' 104' ' ' VAL . 21.8 mmt -110.05 -41.82 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -158.09 157.75 33.43 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.399 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HD11 ' A' ' 93' ' ' LEU . 7.1 mt -119.13 118.31 57.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.023 0.44 . . . . 0.0 111.62 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.914 ' ND2' HG22 ' A' ' 73' ' ' ILE . 11.2 p30 42.37 31.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.87 14.69 24.32 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.945 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.694 HG21 HD13 ' A' ' 89' ' ' ILE . 5.2 m -111.62 95.61 5.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 99.2 p -58.41 126.84 29.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.261 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.837 ' CD1' HG21 ' A' ' 47' ' ' VAL . 30.1 mt -97.48 5.55 49.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.223 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 t -88.7 129.6 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.917 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.58 -22.67 37.73 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.817 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -95.15 144.11 27.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.717 0.294 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.23 175.46 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.673 2.248 . . . . 0.0 112.435 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 36' ' ' VAL . 22.7 tp -66.51 -33.24 75.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -53.99 -47.99 70.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.806 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.6 m -64.59 -47.54 78.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.6 m -56.88 -51.56 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.67 -37.66 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.0 110.467 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -68.41 -35.0 77.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.979 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.694 HD13 HG21 ' A' ' 76' ' ' THR . 18.8 mt -64.06 -46.37 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.475 HD11 HG13 ' A' ' 35' ' ' ILE . 3.5 mt -62.08 -37.63 78.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.614 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -34.34 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.878 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.24 -12.53 76.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.138 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.045 HD11 HG21 ' A' ' 73' ' ' ILE . 92.6 mt -93.69 33.67 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 110.525 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.7 ttpt -78.36 -30.46 48.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -124.51 65.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.886 0.374 . . . . 0.0 111.727 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.406 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 7.6 mm-40 -122.0 -39.31 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m 75.16 1.91 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.522 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.595 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -164.85 142.74 6.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.625 0.25 . . . . 0.0 110.326 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 31' ' ' LEU . 3.9 t -137.62 103.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.827 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.38 73.78 5.27 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.617 178.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.028 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -104.57 122.94 46.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 109.73 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -103.34 173.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.473 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 71' ' ' MET . 98.2 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.51 . . . . 0.0 111.665 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.596 0.236 . . . . 0.0 110.375 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -141.92 115.2 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.85 74.41 2.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.774 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.5 t -65.81 114.85 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.584 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -108.61 103.39 12.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.574 178.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.852 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -97.49 104.07 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -96.35 112.02 23.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.244 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -134.27 -169.21 2.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.954 0.407 . . . . 0.0 110.997 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -103.45 154.46 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.426 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 95' ' ' ASN . 2.5 mptt -59.54 132.29 53.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.03 14.75 50.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.747 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.4 mp0 -121.07 130.36 53.73 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -84.87 150.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.01 HD11 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -47.2 -52.04 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.315 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.62 -8.62 37.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.08 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.878 HG13 ' CB ' ' A' ' 58' ' ' ALA . 1.4 m -94.86 124.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.67 98.6 7.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.298 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -93.61 147.6 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.17 0.509 . . . . 0.0 111.699 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 17.1 m -129.19 159.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.197 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.8 114.22 2.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.819 0.342 . . . . 0.0 111.158 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.847 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.753 0.23 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -159.45 -58.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.26 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.532 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.51 155.17 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 111.282 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.29 115.6 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.604 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.032 HD11 HD22 ' A' ' 64' ' ' LEU . 20.9 mt -60.27 72.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.79 -24.18 21.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.904 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.15 166.53 31.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.146 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.59 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.1 ttp -154.44 137.04 15.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.6 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.04 117.64 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -62.77 83.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.49 1.45 19.98 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.568 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.89 -178.43 51.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 86.9 Cg_exo -47.87 -50.83 10.95 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 112.793 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.878 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.16 -42.15 85.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 0.0 110.799 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -66.32 -49.3 67.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.852 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 m -52.42 -40.76 62.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.93 10.97 82.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.31 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mptt -104.8 -48.71 3.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.881 0.372 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.107 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -77.76 119.12 20.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.271 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.9 136.68 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.362 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 28.2 mt -40.6 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.639 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.6 -11.46 8.43 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.151 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -72.36 134.14 45.31 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 117.024 0.412 . . . . 0.0 110.857 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.626 ' HB3' HG23 ' A' ' 104' ' ' VAL . 39.6 tt0 -87.6 83.75 7.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.028 0.442 . . . . 0.0 110.015 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.871 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -52.04 144.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.789 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.422 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 6.3 mmt -109.24 -41.51 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.8 p -160.99 158.41 27.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.332 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 93' ' ' LEU . 7.0 mt -122.27 118.2 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.263 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.533 HD22 HG22 ' A' ' 73' ' ' ILE . 70.0 m-80 52.22 25.81 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.92 32.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.55 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -107.89 95.76 5.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.726 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.486 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -55.68 131.64 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.234 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 89' ' ' ILE . 33.3 mt -101.48 1.18 37.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.322 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.36 132.81 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 111.052 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.19 -23.71 32.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.64 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.68 140.21 21.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.871 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 178.45 2.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.204 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.8 tp -63.98 -33.47 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 p -53.94 -45.7 71.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.821 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.7 m -67.1 -47.76 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.412 ' O ' HG13 ' A' ' 90' ' ' ILE . 13.3 m -57.23 -47.17 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -56.31 -45.97 80.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -60.26 -35.44 75.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 78' ' ' LEU . 39.8 mt -63.26 -46.0 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -62.91 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.791 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -42.22 98.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.175 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.13 -13.24 64.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.252 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.976 HD11 HG21 ' A' ' 73' ' ' ILE . 92.2 mt -94.06 37.36 1.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.932 0.396 . . . . 0.0 110.677 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -81.85 -41.2 21.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -120.85 64.18 0.86 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 9.2 mm-40 -113.95 -36.19 4.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 1.7 t 77.62 -2.34 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.697 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.4 mtm180 -161.99 148.46 13.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.569 0.223 . . . . 0.0 110.564 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.01 HG11 HD11 ' A' ' 31' ' ' LEU . 5.0 t -141.26 103.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 111.766 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -93.13 75.38 4.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.45 124.55 50.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -90.83 120.28 31.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.214 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.107 HG21 HD21 ' A' ' 64' ' ' LEU . 4.7 pt -117.39 150.89 19.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.546 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.5 m . . . . . 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.276 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.556 0.217 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -143.67 118.88 10.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.25 76.63 3.8 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.801 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.4 t -67.23 128.8 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.797 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.22 103.61 10.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.891 178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.774 HD12 ' HA ' ' A' ' 58' ' ' ALA . 9.3 mm -99.93 102.94 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' SER . 18.8 mt-10 -100.96 114.66 28.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 97' ' ' SER . 6.4 pttt -131.47 -168.69 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.18 137.14 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.6 mttt -50.21 125.46 12.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.126 0.489 . . . . 0.0 110.803 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.67 12.71 31.9 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 5.2 mm-40 -126.33 135.2 51.2 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.401 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.07 150.07 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.238 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.99 -52.19 20.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.307 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.15 18.75 10.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.856 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -112.27 129.57 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 51' ' ' ASN . 83.1 t -108.64 98.59 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.108 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -97.78 156.42 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.993 HG23 HD12 ' A' ' 48' ' ' ILE . 27.0 m -141.54 155.18 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.407 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.22 119.47 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 111.185 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.752 ' HA ' HD11 ' A' ' 48' ' ' ILE . 1.7 p . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.808 0.254 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.883 HG22 ' HA ' ' A' ' 79' ' ' VAL . 72.3 p -142.85 -75.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.09 137.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.448 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.993 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.39 119.49 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.27 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 68' ' ' ASP . 50.1 mt -64.18 73.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -51.41 -25.87 6.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.296 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.544 HD21 HG21 ' A' ' 34' ' ' VAL . 1.9 p-10 -173.57 150.29 1.76 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -129.55 167.63 17.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.678 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.1 ttm -82.99 128.45 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.44 104.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.94 -21.17 47.48 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.14 174.89 1.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.8 Cg_exo -48.28 -45.49 26.01 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.7 2.266 . . . . 0.0 112.735 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.47 -47.14 85.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -30.18 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.16 82.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.774 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB3' HD13 ' A' ' 23' ' ' ILE . 95.4 p -53.03 -39.48 63.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.58 72.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.272 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.5 mmpt? -117.22 -40.53 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.121 HD21 HG21 ' A' ' 103' ' ' ILE . 10.6 mt -88.96 111.24 21.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.308 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -114.16 144.63 42.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.0 mt -44.84 125.03 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.21 38.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.169 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.947 ' HB2' HD12 ' A' ' 49' ' ' ILE . 24.4 m-20 -73.11 125.84 28.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.621 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -85.59 79.8 9.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.11 0.481 . . . . 0.0 110.43 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.038 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -53.24 141.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.876 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -33.84 5.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 35.2 t -159.87 156.49 27.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.664 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.039 HG21 HD11 ' A' ' 93' ' ' LEU . 9.3 mt -129.23 115.98 38.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.494 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.612 HD21 HG13 ' A' ' 99' ' ' VAL . 69.2 m-80 53.04 23.91 3.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.2 35.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' SER . 11.8 m -106.68 95.05 5.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.937 0.368 . . . . 0.0 110.509 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' HD21 ' A' ' 81' ' ' LEU . 54.6 p -69.06 128.71 37.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.376 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.607 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -94.4 13.3 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.025 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 46' ' ' THR . 5.1 t -74.89 106.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.52 -31.81 7.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.896 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.721 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -82.62 138.82 43.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.983 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 179.35 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.77 2.314 . . . . 0.0 112.507 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.0 tp -65.24 -31.81 73.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -48.18 70.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.006 0.431 . . . . 0.0 110.585 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 89' ' ' ILE . 25.8 m -68.11 -45.76 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.807 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -56.77 -44.26 81.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.726 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 9.8 mm-40 -58.6 -52.33 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 3.4 t -56.76 -32.16 65.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.548 HG21 HD12 ' A' ' 73' ' ' ILE . 8.5 mt -62.74 -46.35 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 33' ' ' VAL . 3.6 mt -61.52 -35.33 66.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.898 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 23.4 mmtt -61.71 -48.69 79.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.125 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.55 -11.55 57.06 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.346 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.039 HD11 HG21 ' A' ' 73' ' ' ILE . 83.4 mt -89.28 27.78 1.36 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.914 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -84.71 -40.09 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.435 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -119.79 62.7 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.7 mm-40 -119.25 -41.01 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.5 t 79.55 -3.24 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.513 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -160.01 142.82 13.64 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.612 HG13 HD21 ' A' ' 74' ' ' ASN . 3.3 t -140.25 103.27 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -90.53 74.04 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 120.93 41.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.622 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.95 114.44 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.121 HG21 HD21 ' A' ' 64' ' ' LEU . 1.3 pt -111.79 171.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.014 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 69' ' ' GLN . 2.7 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.616 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.537 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.171 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -129.9 116.78 19.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.44 71.73 2.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.708 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.7 t -58.92 124.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.403 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.04 103.52 11.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.858 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 58' ' ' ALA . 5.8 mm -99.34 102.97 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -100.48 114.01 27.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.383 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -129.89 -169.63 2.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.1 132.7 49.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -45.64 118.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.176 0.512 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.75 12.62 16.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.256 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 94' ' ' LYS . 6.7 mm-40 -130.48 128.01 40.35 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 111.334 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -72.17 153.34 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.84 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -49.47 -52.1 31.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.66 20.83 9.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.869 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -114.72 127.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.433 . . . . 0.0 111.11 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.567 HG21 HD21 ' A' ' 51' ' ' ASN . 38.9 t -103.1 97.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.839 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -100.94 145.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.926 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.909 HG23 ' CD1' ' A' ' 48' ' ' ILE . 6.1 m -125.98 160.16 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.189 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.34 117.25 5.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.734 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.711 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.769 0.237 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.705 HG21 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -156.41 -66.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.201 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.42 151.65 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.887 0.375 . . . . 0.0 111.739 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.909 ' CD1' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.63 115.44 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.889 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 68' ' ' ASP . 37.9 mt -60.54 71.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.34 -26.3 11.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.567 HD21 HG21 ' A' ' 34' ' ' VAL . 1.3 p-10 -177.46 145.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.331 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.7 ptp -116.48 -170.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.0 tpp -94.46 125.22 38.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.0 81.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.796 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.37 20.44 7.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.41 175.56 28.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.454 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 23' ' ' ILE . 88.7 Cg_exo -47.48 -46.14 21.14 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.693 2.262 . . . . 0.0 112.807 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.871 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.43 -48.22 81.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.44 -34.36 72.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 110.554 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -58.5 -48.74 79.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.814 ' HB3' HD13 ' A' ' 23' ' ' ILE . 83.4 p -50.5 -39.86 49.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.01 2.39 82.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.599 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.7 mmpt? -96.94 -37.1 10.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.071 HD21 HG21 ' A' ' 103' ' ' ILE . 13.0 mt -91.67 111.64 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -110.19 141.0 43.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.9 mt -42.68 121.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.25 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.64 1.87 43.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.086 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.929 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.4 m-20 -71.49 130.73 42.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 110.782 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.59 78.25 9.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.987 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -55.62 144.7 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.104 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.762 ' HG2' HG23 ' A' ' 104' ' ' VAL . 15.3 mmt -111.11 -41.65 4.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.1 p -160.57 160.43 31.79 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.302 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HD11 ' A' ' 93' ' ' LEU . 8.7 mt -120.41 115.56 47.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.544 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.955 ' ND2' HG22 ' A' ' 73' ' ' ILE . 9.8 p30 43.46 33.08 0.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.853 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.94 33.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.133 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 89' ' ' ILE . 3.5 m -108.59 95.64 5.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.353 . . . . 0.0 110.695 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.707 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -58.54 130.71 48.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.131 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.767 ' HA ' HD11 ' A' ' 81' ' ' LEU . 26.2 mt -99.78 6.41 45.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.249 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -91.79 128.91 43.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.14 -23.98 33.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.45 143.87 27.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.885 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.31 178.67 2.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.635 2.223 . . . . 0.0 112.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 36' ' ' VAL . 15.6 tp -66.87 -35.06 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.967 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 m -53.81 -40.59 66.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.3 m -71.83 -48.77 43.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.918 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 10.1 m -56.95 -48.91 77.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.782 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -58.7 -46.74 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.331 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -59.01 -35.49 73.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.936 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.644 HD13 HG21 ' A' ' 76' ' ' THR . 11.4 mt -62.67 -45.27 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 93' ' ' LEU . 3.1 mt -60.92 -35.44 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.984 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -49.29 75.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.028 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.24 -11.01 60.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.103 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 73' ' ' ILE . 44.8 mt -86.61 18.16 3.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.608 0.242 . . . . 0.0 110.928 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.58 -33.66 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.539 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.83 62.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -124.32 -40.22 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.07 0.462 . . . . 0.0 110.346 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 79.46 -2.06 2.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.59 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.8 mtm180 -161.13 142.03 11.42 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.4 t -140.96 103.61 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.863 0.364 . . . . 0.0 111.846 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' NZ ' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.45 73.86 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 123.65 46.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.28 122.85 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.071 HG21 HD21 ' A' ' 64' ' ' LEU . 2.4 pt -117.4 162.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.706 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 71' ' ' MET . 41.3 t . . . . . 0 C--O 1.235 0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.398 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 115.38 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.33 79.07 3.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HG ' ' A' ' 64' ' ' LEU . 40.4 t -69.11 122.41 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.921 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.45 103.07 10.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.423 178.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.777 HD13 ' HB3' ' A' ' 61' ' ' SER . 9.4 mm -97.75 103.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -103.49 113.43 26.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.896 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -135.96 -174.39 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.807 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -89.53 141.24 28.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.503 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -49.45 119.69 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 110.651 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . 109.0 13.84 16.83 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.054 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.0 mp0 -119.13 127.63 53.52 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.514 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.42 146.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.753 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.49 -39.83 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.824 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . 90.95 11.49 61.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.373 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 58' ' ' ALA . 6.2 m -104.18 126.85 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.226 0.513 . . . . 0.0 111.443 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.5 t -100.85 98.29 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.83 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -100.74 148.11 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.228 0.537 . . . . 0.0 111.774 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG2' HD12 ' A' ' 48' ' ' ILE . 15.7 m -129.7 160.28 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.427 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.41 108.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.836 ' HA ' HD11 ' A' ' 48' ' ' ILE . 30.5 t . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--O 1.23 0.113 0 CA-C-O 120.825 0.261 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.519 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -158.02 -59.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.722 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.8 140.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 0.0 111.655 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.928 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.28 116.32 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.764 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 ' HB2' ' A' ' 68' ' ' ASP . 64.9 mt -62.7 71.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -28.68 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 25.3 m120 -146.75 168.57 21.03 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.94 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.557 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.09 134.73 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.24 127.19 26.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -73.78 68.93 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.45 -21.4 3.63 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.35 -176.07 0.61 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.64 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 23' ' ' ILE . 84.1 Cg_exo -48.0 -44.07 28.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.749 2.299 . . . . 0.0 112.766 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.68 -49.53 77.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.86 -29.68 64.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.514 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -62.99 -48.31 79.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.968 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.777 ' HB3' HD13 ' A' ' 23' ' ' ILE . 96.4 p -53.06 -38.25 62.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.15 19.0 70.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.263 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB2' HG13 ' A' ' 21' ' ' VAL . 6.4 mmpt? -116.35 -52.81 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.949 0.404 . . . . 0.0 110.747 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 101' ' ' LEU . 9.7 mt -77.97 120.65 23.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.51 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.436 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 13.7 m-80 -129.55 134.7 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.364 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 9.0 mt -33.34 122.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.37 2.31 55.63 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.994 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.1 m-20 -77.25 120.91 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.803 0.335 . . . . 0.0 110.618 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 86.46 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -62.75 143.21 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.46 ' HE2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -110.36 -40.11 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.813 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.8 p -159.73 156.91 28.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.182 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.819 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.9 mt -120.88 125.28 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.13 29.56 0.82 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.44 23.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.369 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.618 ' CG2' HD13 ' A' ' 89' ' ' ILE . 63.3 m -119.7 95.98 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.5 t -56.0 138.57 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.819 HD11 ' CD1' ' A' ' 73' ' ' ILE . 19.5 mt -109.1 4.32 22.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.04 126.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.92 -25.31 28.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.872 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.18 147.36 34.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.796 0.331 . . . . 0.0 111.016 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.48 173.97 8.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.354 . . . . 0.0 112.639 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.564 HD11 HE22 ' A' ' 87' ' ' GLN . 34.1 tp -62.36 -37.2 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.161 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -53.67 -46.42 70.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 89' ' ' ILE . 4.0 m -65.27 -44.28 88.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 90' ' ' ILE . 11.8 m -57.0 -56.2 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.785 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.564 HE22 HD11 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -49.44 -53.94 20.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.167 0.508 . . . . 0.0 110.854 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -53.72 -39.71 65.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.482 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 10.0 mt -61.64 -36.9 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.9 mt -77.99 -44.41 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.019 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.98 91.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.08 -17.36 44.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 69.9 mt -93.27 26.82 2.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.267 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -78.13 -12.23 59.98 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.983 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -134.52 48.46 2.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.877 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.476 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 15.4 mm-40 -111.76 -33.21 6.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 110.336 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 77.95 -0.55 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.737 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.589 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.3 mtm180 -160.31 142.87 13.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.598 0.237 . . . . 0.0 110.515 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 31' ' ' LEU . 4.0 t -139.35 103.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.898 0.38 . . . . 0.0 111.993 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -91.09 75.4 6.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.804 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -106.21 120.47 41.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 107.96 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.025 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -103.33 174.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.13 0.491 . . . . 0.0 111.5 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.23 0.071 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.6 120.25 9.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 79.92 6.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.713 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.7 t -69.31 122.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.882 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.97 103.25 10.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.252 178.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.1 mm -97.26 102.38 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.5 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 19.2 mt-10 -95.08 109.84 21.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.492 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -130.03 -169.9 2.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.829 0.347 . . . . 0.0 110.96 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.74 137.11 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 6.3 mttp -47.49 124.56 7.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 110.779 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.01 14.35 24.91 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 78.8 mm-40 -130.45 130.72 44.61 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.635 0.255 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.638 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -81.24 151.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.128 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.891 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.95 -42.41 27.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.089 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.04 6.62 59.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.034 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 HD13 ' A' ' 90' ' ' ILE . 4.2 m -95.76 143.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.42 . . . . 0.0 111.392 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -119.72 98.65 6.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 90' ' ' ILE . 2.0 pp -95.18 153.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 112.067 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.919 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.8 m -130.21 156.91 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.408 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.79 93.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.746 0.308 . . . . 0.0 111.352 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.72 ' HA ' HD11 ' A' ' 48' ' ' ILE . 6.8 p . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.479 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 17.8 Cg_endo . . . . . 0 C--O 1.233 0.225 0 N-CA-C 112.799 0.269 . . . . 0.0 112.799 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 47.3 p -141.64 -73.81 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.021 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.961 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.07 141.05 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.745 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.919 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -118.37 118.28 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.897 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 58.0 mt -62.83 72.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.38 -28.25 58.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.0 m120 -145.98 173.59 12.02 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.961 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.76 131.78 0.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.903 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 tpp -56.24 123.49 14.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.51 89.47 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.675 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.83 7.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.1 -163.8 25.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.292 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 23' ' ' ILE . 52.9 Cg_exo -55.93 -51.3 9.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.662 2.242 . . . . 0.0 112.711 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.891 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.36 -49.31 77.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.88 -28.14 65.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -64.47 -48.27 75.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.739 ' HB3' HD13 ' A' ' 23' ' ' ILE . 70.4 p -51.17 -39.8 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.74 23.79 59.37 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -121.12 -52.7 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.723 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.076 HD21 HG21 ' A' ' 103' ' ' ILE . 12.7 mt -77.82 119.79 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.553 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ILE . 2.4 p30 -127.52 133.28 49.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.248 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.5 mt -32.4 117.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.973 0.416 . . . . 0.0 111.769 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.16 4.81 29.03 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.134 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -80.32 127.77 32.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 110.771 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.91 83.34 7.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.091 HG23 HG22 ' A' ' 103' ' ' ILE . 1.9 mt -62.19 144.08 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.012 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.66 ' HG2' HG23 ' A' ' 104' ' ' VAL . 24.6 mmt -112.85 -36.39 5.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.862 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 52.4 p -160.3 160.11 32.12 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.238 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.005 HG21 HD11 ' A' ' 93' ' ' LEU . 9.5 mt -127.5 123.83 62.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.769 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 46.29 29.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.55 17.3 31.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.664 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.546 HG21 HD13 ' A' ' 89' ' ' ILE . 4.6 m -111.36 95.83 5.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.372 . . . . 0.0 110.578 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.8 m -57.29 124.2 18.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.961 HD13 HG21 ' A' ' 47' ' ' VAL . 45.7 mt -97.38 21.16 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 2.7 t -93.02 113.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.281 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.16 28.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.292 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.886 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -83.73 142.05 42.04 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 117.034 0.417 . . . . 0.0 110.934 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 -179.58 2.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.661 2.241 . . . . 0.0 112.45 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HA ' ' A' ' 36' ' ' VAL . 16.1 tp -66.15 -31.56 72.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.009 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -56.42 -45.92 80.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -67.9 -48.0 67.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.4 m -57.32 -53.07 62.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -55.59 -40.16 71.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.95 0.405 . . . . 0.0 110.484 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 p -66.64 -29.27 69.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.963 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 78' ' ' LEU . 3.8 mt -69.73 -46.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.779 HD13 HG23 ' A' ' 33' ' ' VAL . 5.4 mt -62.25 -38.99 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.473 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -37.65 79.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.54 -9.5 73.96 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.005 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.36 27.33 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.727 0.298 . . . . 0.0 110.786 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -80.96 -33.79 33.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.456 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m-80 -120.53 63.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.934 0.397 . . . . 0.0 111.792 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -124.65 -41.76 2.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.9 m 77.97 2.03 2.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.293 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.594 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -164.06 138.73 5.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.448 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.544 HG12 HD22 ' A' ' 101' ' ' LEU . 3.5 t -135.91 103.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.991 0.424 . . . . 0.0 112.023 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -90.04 72.91 7.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.044 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -103.14 120.44 40.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 111.404 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -88.66 112.83 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.091 HG22 HG23 ' A' ' 70' ' ' ILE . 2.2 pt -106.31 174.17 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.249 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.66 HG23 ' HG2' ' A' ' 71' ' ' MET . 46.1 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.158 0.504 . . . . 0.0 111.788 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -148.3 115.58 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.2 77.54 3.01 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.5 t -67.19 117.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.06 103.33 11.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.419 178.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 61' ' ' SER . 6.1 mm -98.94 103.24 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.845 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 109.97 22.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.178 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -128.36 -170.55 2.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.84 139.7 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.552 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 14.1 mttt -50.18 125.69 12.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.165 0.507 . . . . 0.0 110.826 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.55 15.19 30.27 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 94' ' ' LYS . 13.1 mm-40 -120.53 136.86 54.65 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 111.596 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.894 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -87.14 147.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.231 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.943 HD23 ' CG2' ' A' ' 33' ' ' VAL . 7.4 tp -49.94 -45.67 51.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -0.1 62.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.017 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.943 ' CG2' HD23 ' A' ' 31' ' ' LEU . 1.1 m -94.55 125.26 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.318 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.26 98.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.233 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -94.95 150.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.176 0.513 . . . . 0.0 111.787 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.992 HG23 HD12 ' A' ' 48' ' ' ILE . 2.4 m -132.67 158.94 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.31 117.57 5.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 70.9 Cg_exo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.771 0.238 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.774 HG21 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -163.73 -60.48 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.14 152.17 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.002 0.43 . . . . 0.0 111.881 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.992 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.61 118.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.859 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 68' ' ' ASP . 47.4 mt -63.25 74.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.3 -34.36 66.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.382 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -140.9 177.55 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.003 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.4 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -170.85 122.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.598 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -46.52 132.03 10.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.505 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.55 81.46 4.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.3 5.37 8.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.829 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.36 -176.95 51.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.405 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' HG23 ' A' ' 23' ' ' ILE . 70.7 Cg_exo -51.47 -47.74 24.66 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.53 2.153 . . . . 0.0 112.398 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.88 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.4 -43.38 88.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.69 -29.77 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.591 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.06 -48.92 74.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.8 ' HB3' HD13 ' A' ' 23' ' ' ILE . 79.1 p -53.16 -39.73 63.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.79 72.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.0 mmtt -109.48 -52.8 2.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.099 HD21 HG21 ' A' ' 103' ' ' ILE . 12.3 mt -76.05 120.61 21.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.408 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.75 136.54 53.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.156 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -37.17 110.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.66 3.33 22.22 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.127 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.6 m-20 -78.16 119.56 21.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.908 0.385 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -75.06 86.61 2.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.079 HG23 HG22 ' A' ' 103' ' ' ILE . 2.0 mt -64.7 144.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.774 ' HE2' HG21 ' A' ' 46' ' ' THR . 4.4 mmt -110.8 -39.84 4.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.709 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.7 p -160.35 157.28 27.64 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.376 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 93' ' ' LEU . 6.8 mt -122.12 124.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.482 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 46.46 28.74 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.035 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.99 21.63 22.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.579 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.623 HG21 HD13 ' A' ' 89' ' ' ILE . 8.4 m -115.86 95.84 5.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.369 . . . . 0.0 110.907 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' HD21 ' A' ' 81' ' ' LEU . 51.0 m -60.07 122.05 13.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.753 HD11 ' CD1' ' A' ' 73' ' ' ILE . 51.7 mt -91.37 12.17 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.264 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 46' ' ' THR . 4.2 t -87.24 126.31 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.61 -24.1 33.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.634 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -93.56 142.97 25.87 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.52 171.68 12.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.539 2.159 . . . . 0.0 112.429 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 35' ' ' ILE . 28.7 tp -60.12 -30.09 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 p -54.61 -49.6 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.794 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -68.07 -42.07 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.5 m -57.41 -52.22 66.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.33 -40.69 82.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.324 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 m -64.98 -30.03 70.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 76' ' ' THR . 2.3 mt -69.13 -46.15 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.503 HD13 HG23 ' A' ' 33' ' ' VAL . 4.8 mt -65.84 -38.67 82.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.67 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.14 71.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.067 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.69 -14.09 81.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.185 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.923 HD11 HG21 ' A' ' 73' ' ' ILE . 90.5 mt -91.93 38.28 0.99 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.94 0.4 . . . . 0.0 110.598 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.894 ' HG3' HG22 ' A' ' 30' ' ' ILE . 5.8 mtpt -81.36 -35.04 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 15.6 m-80 -121.92 63.63 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.756 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.58 -39.62 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.58 -4.14 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.599 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.4 mtm180 -160.92 138.46 9.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.896 HG12 HD22 ' A' ' 101' ' ' LEU . 17.7 t -133.74 103.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 112.168 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.09 79.75 5.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.608 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.062 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -110.46 120.49 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.113 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.03 108.7 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.099 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -104.48 174.15 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.605 HG23 ' CG ' ' A' ' 71' ' ' MET . 57.3 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.088 0.47 . . . . 0.0 111.683 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.661 0.267 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.08 7.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.48 75.74 2.53 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG11 ' HG ' ' A' ' 64' ' ' LEU . 41.5 t -67.9 123.49 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.27 103.24 10.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.452 178.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 58' ' ' ALA . 11.0 mm -98.03 103.5 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.846 0.355 . . . . 0.0 111.143 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 128.87 41.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.076 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -149.12 -173.75 4.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 111.169 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.82 136.51 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -47.21 120.39 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.141 0.496 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 12.2 22.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.337 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -122.98 133.19 54.38 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.84 0.352 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 32' ' ' GLY . 1.2 pt -83.11 150.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.813 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.46 -40.19 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 90.04 31.1 11.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.868 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG13 ' CB ' ' A' ' 58' ' ' ALA . 3.5 m -125.1 124.35 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.411 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.15 98.26 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.009 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 47' ' ' VAL . 2.7 pp -99.75 144.9 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.029 0.443 . . . . 0.0 111.854 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.908 HG23 HD12 ' A' ' 48' ' ' ILE . 3.7 m -124.32 155.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.29 111.12 0.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 111.162 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.732 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.708 0.212 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.3 t -161.8 -62.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.743 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 35' ' ' ILE . 3.2 m -160.88 150.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 112.035 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.908 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.85 113.88 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.986 HD12 ' HB2' ' A' ' 68' ' ' ASP . 35.8 mt -60.17 72.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -34.61 62.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.403 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.508 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.1 m-80 -141.68 179.54 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.982 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.66 125.41 0.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.442 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -48.23 124.01 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.35 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -72.24 88.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.37 26.1 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.41 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.45 -176.43 20.74 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 23' ' ' ILE . 89.3 Cg_exo -48.65 -46.12 25.27 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.596 2.197 . . . . 0.0 112.731 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.67 -49.25 78.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.51 -33.94 73.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.243 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -48.63 79.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.738 ' HB2' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -53.96 -37.9 64.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.77 17.06 79.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.808 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.62 -53.46 2.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 101' ' ' LEU . 15.4 mt -76.08 120.93 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.357 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' ILE . 15.8 m-80 -127.05 133.07 50.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.125 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.5 mt -33.69 113.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.963 0.411 . . . . 0.0 111.935 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.89 -6.87 15.42 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.17 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.986 ' HB2' HD12 ' A' ' 49' ' ' ILE . 33.6 m-20 -70.47 127.88 34.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.56 0.219 . . . . 0.0 110.519 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.761 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -87.66 81.27 7.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.121 0.486 . . . . 0.0 110.669 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.93 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -54.3 137.2 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.057 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.0 mmt -105.56 -37.61 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 92.4 p -157.4 153.47 27.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 111.172 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 78' ' ' LEU . 4.2 mt -124.07 123.95 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.446 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 48.01 28.34 1.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.86 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.402 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.702 HG21 HD13 ' A' ' 89' ' ' ILE . 91.3 m -124.72 95.79 4.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.608 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -68.3 130.13 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.897 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.2 mt -95.77 14.29 23.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 t -74.64 112.7 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.499 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.39 -39.45 2.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.068 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -73.32 146.43 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.995 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.44 167.88 12.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 35' ' ' ILE . 21.9 tp -62.98 -35.05 78.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.86 -42.93 69.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.559 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.572 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.1 m -69.85 -44.45 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 78' ' ' LEU . 9.8 m -56.62 -53.46 57.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 3.5 mm-40 -52.9 -50.4 63.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 14.1 p -56.05 -36.46 68.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.272 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' CD2' ' A' ' 78' ' ' LEU . 19.9 mt -63.72 -33.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 33' ' ' VAL . 6.1 mt -70.23 -36.03 65.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.456 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.5 mppt? -75.38 -47.15 28.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.45 -25.4 27.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.393 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.729 ' CD2' HG21 ' A' ' 73' ' ' ILE . 3.5 pp -99.57 31.7 3.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.009 0.433 . . . . 0.0 110.577 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.67 -22.31 50.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.824 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -121.65 52.38 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 37.8 mm-40 -113.49 -31.26 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.2 m 70.58 10.65 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.3 mtm180 -168.92 139.68 2.4 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.231 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.813 HG21 HD12 ' A' ' 31' ' ' LEU . 4.7 t -136.88 103.69 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -90.63 76.68 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.44 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.93 120.78 43.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.316 0.579 . . . . 0.0 111.613 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.92 112.97 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.122 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.995 HG21 HD21 ' A' ' 64' ' ' LEU . 1.1 pt -112.88 160.42 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.613 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 69' ' ' GLN . 7.2 m . . . . . 0 C--O 1.235 0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.107 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -148.46 117.27 6.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.38 82.1 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.681 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -71.87 123.12 25.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.857 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.62 103.73 11.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 61' ' ' SER . 11.8 mm -99.62 103.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.963 0.411 . . . . 0.0 110.947 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.74 123.76 38.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.12 -169.75 3.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 111.133 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -101.24 147.83 25.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.31 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 5.5 mttp -55.12 130.84 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.081 0.467 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.76 13.17 54.3 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.639 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.73 139.18 52.68 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.807 0.337 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -87.22 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.86 HD22 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.69 -52.26 18.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 114.43 -14.1 20.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.344 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.943 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.0 m -94.09 128.3 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.614 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.04 98.46 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.886 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.5 pp -94.51 140.93 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 111.587 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 48' ' ' ILE . 28.9 m -124.38 161.36 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.183 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -54.55 118.87 4.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.738 0.304 . . . . 0.0 111.14 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 C--O 1.232 0.176 0 N-CA-C 112.912 0.312 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.8 t -168.27 -61.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.34 153.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.576 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.13 115.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.965 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.5 mt -61.38 71.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -49.07 -27.55 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.4 p-10 -163.79 179.48 7.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.283 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.6 ttp -160.92 155.4 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.8 139.55 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.821 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -76.36 99.87 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.15 -19.3 52.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.2 175.44 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.593 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 23' ' ' ILE . 80.0 Cg_exo -46.81 -45.74 19.77 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.79 2.327 . . . . 0.0 112.876 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.943 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.63 -49.32 77.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.378 . . . . 0.0 111.133 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -72.48 -26.02 61.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -60.39 -48.02 83.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.811 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.1 t -54.69 -38.09 66.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.749 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.17 12.16 83.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.941 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -104.42 -45.18 4.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.965 0.412 . . . . 0.0 110.999 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.119 HD21 HG21 ' A' ' 103' ' ' ILE . 17.4 mt -81.6 117.11 21.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.532 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.2 137.45 51.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.896 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 20.0 mt -40.25 117.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.85 -3.1 25.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.174 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.965 ' HB2' HD12 ' A' ' 49' ' ' ILE . 1.7 m-20 -68.55 133.48 48.62 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.563 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -89.5 81.17 6.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.949 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.806 HG23 HG22 ' A' ' 103' ' ' ILE . 2.9 mt -55.62 145.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.589 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.52 -38.65 3.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.6 t -156.63 154.09 29.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.712 HG21 ' CD2' ' A' ' 93' ' ' LEU . 6.1 mt -123.2 122.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 48.59 27.89 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 20.49 25.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.655 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.601 ' CG2' HD13 ' A' ' 89' ' ' ILE . 6.4 m -115.75 97.74 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.5 m -53.32 142.44 21.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.765 HD12 HG21 ' A' ' 47' ' ' VAL . 22.2 mt -112.03 -5.76 14.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.377 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.3 t -78.44 129.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.405 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.59 -21.4 44.79 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.056 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.15 144.92 28.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.938 0.369 . . . . 0.0 110.975 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -174.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.579 HD11 HE22 ' A' ' 87' ' ' GLN . 31.0 tp -75.9 -38.77 57.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.1 p -53.77 -39.28 65.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.573 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.6 m -68.3 -47.22 68.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.5 m -56.53 -53.82 53.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.579 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.76 -53.91 22.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.348 0.594 . . . . 0.0 110.211 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -51.26 -35.7 38.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.128 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 78' ' ' LEU . 31.8 mt -68.31 -33.6 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.297 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 35' ' ' ILE . 6.7 mt -76.4 -37.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -38.43 57.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.645 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.3 -17.3 56.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' CD2' HG21 ' A' ' 73' ' ' ILE . 2.8 pp -109.2 39.2 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.701 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -78.95 -26.09 43.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 17.6 m-80 -121.58 54.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.519 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.416 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 31.9 mm-40 -114.43 -29.89 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 m 71.44 7.96 6.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.158 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.559 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -166.4 143.09 4.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 110.58 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.829 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.6 t -138.68 103.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.959 0.409 . . . . 0.0 111.928 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -89.25 73.66 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.807 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.5 pt? -104.87 118.04 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.3 0.571 . . . . 0.0 111.491 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 3.3 t-20 -87.3 111.79 21.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.234 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.119 HG21 HD21 ' A' ' 64' ' ' LEU . 6.4 pt -99.48 174.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.574 HG22 ' CE1' ' A' ' 18' ' ' PHE . 22.0 t . . . . . 0 C--O 1.236 0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 111.921 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -134.43 117.51 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.15 73.64 2.29 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 64' ' ' LEU . 44.1 t -64.21 120.41 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.554 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.522 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.74 102.85 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.445 178.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 8.7 mm -99.03 103.4 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.132 0.491 . . . . 0.0 110.58 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.08 109.93 22.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.317 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -127.04 -174.2 3.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.974 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -97.06 134.68 40.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.493 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -46.64 119.32 2.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 94' ' ' LYS . . . 110.51 12.55 16.71 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.365 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' LYS . 4.3 mm-40 -130.19 130.11 44.27 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.396 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.511 HG23 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -80.5 154.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.142 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -49.26 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.65 7.87 41.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.898 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 58' ' ' ALA . 13.9 m -100.22 127.2 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.22 101.22 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.216 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -96.48 165.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.204 0.526 . . . . 0.0 112.141 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 48' ' ' ILE . 35.9 m -152.34 148.69 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.6 121.09 6.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.695 0.283 . . . . 0.0 111.338 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.877 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.333 -0.124 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.856 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.758 0.232 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 79' ' ' VAL . 40.0 p -130.62 -72.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -158.78 137.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 111.684 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.032 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.59 118.76 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.108 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.95 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.2 mt -63.56 74.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.85 -24.45 23.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.127 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -157.07 164.99 37.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.086 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -159.88 128.47 4.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.754 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.3 tpp -46.51 131.36 11.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.452 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -76.99 90.21 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.64 -12.58 25.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.43 -175.48 5.36 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.68 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HB3' HG22 ' A' ' 23' ' ' ILE . 73.6 Cg_exo -50.0 -46.06 29.82 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.88 2.386 . . . . 0.0 112.606 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.19 -48.2 81.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.57 -31.32 66.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.252 0.549 . . . . 0.0 110.589 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -60.97 -48.67 80.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.04 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.8 t -55.28 -30.01 59.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.92 71.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -45.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.758 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 101' ' ' LEU . 13.5 mt -85.17 114.22 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.46 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -120.98 135.13 55.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.8 mt -34.82 119.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.972 0.415 . . . . 0.0 111.683 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.41 1.48 35.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.054 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.95 ' HB2' HD12 ' A' ' 49' ' ' ILE . 20.2 m-20 -76.44 119.04 19.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.782 0.325 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 12.4 tt0 -75.99 85.71 2.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.02 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -61.95 144.78 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.174 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 104' ' ' VAL . 5.0 mmt -110.3 -42.39 4.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.0 p -157.71 165.13 36.22 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.032 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.95 HG22 ' ND2' ' A' ' 74' ' ' ASN . 10.9 mt -126.99 114.57 37.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.032 0.444 . . . . 0.0 111.652 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.95 ' ND2' HG22 ' A' ' 73' ' ' ILE . 12.7 p30 43.19 33.36 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.78 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.42 6.06 36.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.938 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.625 HG21 HD13 ' A' ' 89' ' ' ILE . 3.3 m -104.85 95.42 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.701 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.9 t -59.22 133.24 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.212 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.861 HD13 HG21 ' A' ' 47' ' ' VAL . 88.4 mt -107.34 16.45 23.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.804 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 46' ' ' THR . 3.3 t -92.04 113.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.317 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.18 -27.34 20.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.256 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -82.54 141.22 45.01 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.081 0.44 . . . . 0.0 111.053 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.17 -179.84 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.605 2.203 . . . . 0.0 112.381 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 36' ' ' VAL . 21.7 tp -70.06 -33.32 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.012 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -54.02 -45.29 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 7.0 m -67.34 -50.36 60.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.95 -43.59 81.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -59.4 -46.16 89.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.452 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -61.23 -31.09 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.296 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.625 HD13 HG21 ' A' ' 76' ' ' THR . 23.6 mt -68.09 -46.2 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.711 HD13 HG23 ' A' ' 33' ' ' VAL . 3.5 mt -63.86 -36.8 77.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -36.03 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.795 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.28 -10.22 73.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.037 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 73' ' ' ILE . 35.7 mt -92.59 30.91 1.43 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.559 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -86.3 -12.8 48.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.664 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -143.91 58.08 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.715 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 mm-40 -117.75 -37.76 3.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.437 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 79.51 -4.73 1.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mtm180 -161.0 141.67 11.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.512 0.196 . . . . 0.0 110.549 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 31' ' ' LEU . 6.3 t -137.83 105.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 111.89 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -93.34 74.24 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.663 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.84 123.55 47.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.319 0.581 . . . . 0.0 111.644 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.22 115.61 25.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.059 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -112.8 174.05 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.563 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 71' ' ' MET . 11.2 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.725 0.298 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.3 148.23 52.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 7.9 tttt -143.12 114.79 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.3 78.16 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.716 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.2 t -68.23 123.2 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.018 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.04 102.86 10.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.127 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 22.3 mm -101.03 103.15 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 98' ' ' ARG . 2.4 mt-10 -92.82 132.76 36.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -179.54 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 139.53 30.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.732 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.9 mttt -49.85 126.08 13.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.731 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.72 33.25 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 94' ' ' LYS . 47.6 mm-40 -127.49 131.2 50.18 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 111.195 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.07 151.67 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.334 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.076 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.83 -52.09 20.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.89 16.27 17.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.83 HG13 ' HB2' ' A' ' 58' ' ' ALA . 3.6 m -109.01 139.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.962 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.05 98.68 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.568 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 90' ' ' ILE . 1.4 pp -95.5 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.971 HG23 HD12 ' A' ' 48' ' ' ILE . 1.8 m -123.53 158.42 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.507 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 95.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.356 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.842 ' HA ' HD11 ' A' ' 48' ' ' ILE . 24.5 p -59.85 122.59 14.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.574 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.19 11.65 5.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.0 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.428 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -66.49 -179.74 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.971 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.94 71.57 0.76 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.155 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.685 ' C ' HD12 ' A' ' 43' ' ' ILE . 9.7 t -174.52 151.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.706 0.289 . . . . 0.0 110.812 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.876 HG21 HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER 45.55 -169.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -92.71 117.43 67.58 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.599 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 72.8 Cg_exo -50.0 132.04 31.68 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.548 2.165 . . . . 0.0 112.62 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.2 t -162.5 -61.78 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.56 156.62 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.88 0.372 . . . . 0.0 111.791 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.971 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.8 116.63 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.823 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.93 HD12 ' HB2' ' A' ' 68' ' ' ASP . 62.5 mt -61.42 71.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -55.32 -38.79 69.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.75 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -134.58 165.46 25.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.002 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.44 126.33 1.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.695 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -66.93 75.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.39 -12.17 7.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.716 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.2 -172.2 4.4 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.699 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.556 ' O ' HG23 ' A' ' 23' ' ' ILE . 85.1 Cg_exo -47.03 -47.67 16.21 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.934 2.422 . . . . 0.0 112.905 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.83 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.48 -49.73 76.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.087 0.47 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -48.51 81.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 4.5 t -57.78 -30.09 65.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 110.57 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.75 69.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.371 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.3 -54.54 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.865 ' CD2' HD13 ' A' ' 103' ' ' ILE . 24.3 mt -75.65 125.14 28.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.514 0.674 . . . . 0.0 111.529 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.523 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.1 p30 -132.57 112.42 12.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.396 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' C ' ' O ' ' A' ' 65' ' ' ASN . 7.2 mt -13.61 114.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.7 -3.21 19.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.33 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.93 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -74.91 133.58 41.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.583 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.607 ' OE1' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -89.08 81.23 6.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.95 0.405 . . . . 0.0 110.766 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 103' ' ' ILE . 3.7 mt -53.58 145.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.532 ' HE2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -110.21 -41.59 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.86 158.78 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.837 0.351 . . . . 0.0 111.257 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.08 HG21 HD11 ' A' ' 93' ' ' LEU . 9.4 mt -125.48 121.82 61.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.367 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 49.36 26.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.01 19.38 24.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.731 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.527 HG21 ' CD1' ' A' ' 89' ' ' ILE . 5.4 m -113.12 95.79 5.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.7 p -56.55 125.36 21.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.729 ' HA ' HD11 ' A' ' 81' ' ' LEU . 40.5 mt -90.99 -3.47 57.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.256 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 t -80.55 128.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.103 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.48 -20.85 48.67 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.821 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.757 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -99.87 141.65 23.16 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.826 0.313 . . . . 0.0 110.878 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.86 -176.37 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.566 2.177 . . . . 0.0 112.358 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.8 -32.9 70.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.045 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.8 p -55.43 -41.78 73.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -68.17 -50.58 53.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.476 ' SG ' HD22 ' A' ' 78' ' ' LEU . 17.8 m -57.13 -48.82 77.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -54.29 -47.56 72.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.969 0.414 . . . . 0.0 110.668 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -59.2 -32.47 69.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.926 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 9.4 mt -67.99 -45.97 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.78 HD11 HG13 ' A' ' 35' ' ' ILE . 5.1 mt -64.07 -40.81 90.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.499 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -36.86 79.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.338 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.83 -4.43 76.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.339 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.08 HD11 HG21 ' A' ' 73' ' ' ILE . 64.1 mt -93.16 36.29 1.05 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.813 0.339 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 30' ' ' ILE . 2.5 tttt -85.65 -44.51 12.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.553 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.438 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.2 p30 -116.82 61.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG3' HD23 ' A' ' 93' ' ' LEU . 2.5 mm-40 -113.82 -35.4 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.334 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 6.3 m 90.16 -19.07 0.17 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.179 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -167.31 151.51 6.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.174 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.076 HG21 HD12 ' A' ' 31' ' ' LEU . 3.4 t -128.58 110.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -90.86 75.56 6.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.477 178.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.841 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.4 pt? -107.68 119.12 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.325 0.583 . . . . 0.0 111.736 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -86.51 111.55 20.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.246 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.865 HD13 ' CD2' ' A' ' 64' ' ' LEU . 6.8 pt -99.88 174.23 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.445 . . . . 0.0 111.882 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.876 HG11 HG21 ' A' ' 43' ' ' ILE . 71.9 t -118.15 128.44 75.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.272 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.04 149.09 38.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.807 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.6 117.97 10.81 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.83 80.12 2.75 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.711 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.7 t -71.91 127.35 33.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.598 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.03 102.9 9.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.913 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -99.78 103.75 15.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.942 0.401 . . . . 0.0 110.296 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.09 112.94 25.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.589 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HD3' ' CG ' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -130.47 -170.51 2.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.782 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -95.63 151.74 19.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.4 mttt -60.92 136.98 58.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.929 0.395 . . . . 0.0 110.491 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.21 11.46 62.89 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.555 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.93 135.92 54.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -86.26 148.31 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.857 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.65 -43.64 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.171 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 97.65 4.75 57.97 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.262 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 58' ' ' ALA . 5.2 m -96.44 140.83 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 117.079 0.44 . . . . 0.0 111.301 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.3 t -118.55 98.83 6.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -97.83 150.98 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.093 0.473 . . . . 0.0 111.937 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.941 HG23 HD12 ' A' ' 48' ' ' ILE . 3.5 m -129.73 164.52 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.494 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.77 103.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.392 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.845 ' HA ' HD11 ' A' ' 48' ' ' ILE . 43.0 p -55.75 142.86 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.701 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.1 49.09 0.55 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.91 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -170.26 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.14 54.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.543 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.659 ' C ' HD12 ' A' ' 43' ' ' ILE . 23.8 t -155.9 144.02 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.821 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.659 HD12 ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 49.33 -177.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.252 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 HG23 ' A' ' 46' ' ' THR . 1.1 pp -88.37 121.16 70.46 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.366 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 52.5 Cg_exo -52.81 127.16 23.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.49 2.127 . . . . 0.0 112.836 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 79' ' ' VAL . 73.3 p -148.91 -71.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.654 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -159.32 142.92 5.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.309 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.941 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -119.99 118.91 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.353 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 43.3 mt -63.49 71.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.44 -29.11 48.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.9 m120 -145.06 173.1 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.081 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -171.86 129.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.813 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.468 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -53.16 128.74 28.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.45 99.01 7.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.04 21.22 11.2 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.522 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 -160.57 22.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' CG ' ' HD3' ' A' ' 25' ' ' LYS . 44.5 Cg_exo -57.09 -54.44 3.63 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.733 2.289 . . . . 0.0 112.559 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.895 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.13 -49.31 77.42 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.33 -28.79 68.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.19 0.519 . . . . 0.0 110.196 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -48.76 78.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.978 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.913 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.5 m -48.46 -40.44 26.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.15 27.66 43.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.39 -47.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.056 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 101' ' ' LEU . 8.2 mt -74.69 107.44 6.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.032 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.28 138.79 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.761 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 16.9 mt -36.74 114.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.28 -6.15 11.92 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.0 m-20 -72.43 130.33 40.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.682 0.277 . . . . 0.0 110.643 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.515 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -88.25 79.98 7.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.116 0.484 . . . . 0.0 110.563 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -55.66 141.78 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.521 ' SD ' HD21 ' A' ' 44' ' ' LEU . 5.5 ttm -116.01 -33.88 4.92 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 94.2 p -153.85 151.96 30.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.77 0.319 . . . . 0.0 111.363 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 93' ' ' LEU . 6.9 mt -125.52 123.83 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.411 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 45.98 29.14 0.7 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.85 20.87 20.2 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.432 ' CG2' HD13 ' A' ' 89' ' ' ILE . 90.8 m -122.96 95.49 4.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.451 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.2 p -68.58 130.88 44.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.649 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -97.35 15.79 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.9 t -72.81 108.82 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.184 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.43 -26.82 17.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.207 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -84.52 144.17 42.55 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.185 0.493 . . . . 0.0 111.019 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.66 177.83 3.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.785 2.323 . . . . 0.0 112.643 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.707 HD13 ' HA ' ' A' ' 36' ' ' VAL . 33.5 tp -64.22 -34.24 77.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -48.64 69.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.999 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 17.5 m -65.87 -45.03 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.409 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 20.6 m -56.76 -54.5 45.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.743 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.641 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.92 -53.49 25.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.259 0.552 . . . . 0.0 110.634 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.548 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 1.5 m -54.47 -34.55 61.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.555 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 7.4 mt -63.96 -46.52 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.663 HD11 HG13 ' A' ' 35' ' ' ILE . 4.3 mt -61.45 -34.81 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.305 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 2.0 mmmt -68.31 -43.56 77.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.556 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.82 -16.37 51.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.984 HD11 HG21 ' A' ' 73' ' ' ILE . 26.9 mt -91.24 38.47 0.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 111.027 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -80.92 -40.47 24.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.802 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.4 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.3 p30 -126.07 59.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.745 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -109.61 -35.5 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 0.8 OUTLIER 81.49 -10.79 1.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.17 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -155.34 150.11 26.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.698 0.285 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.715 HG12 HD22 ' A' ' 101' ' ' LEU . 5.0 t -139.99 103.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.939 0.4 . . . . 0.0 112.002 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -93.89 77.53 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -104.78 121.44 43.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.344 0.592 . . . . 0.0 111.676 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.81 106.79 17.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.982 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -106.48 174.03 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.208 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -128.98 139.5 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.281 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -73.29 148.3 43.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.067 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -146.01 114.9 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.19 74.03 2.32 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.779 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.4 t -64.9 128.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.226 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.78 102.91 9.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.269 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.861 HD13 ' OG ' ' A' ' 61' ' ' SER . 12.6 mm -99.04 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.85 0.357 . . . . 0.0 110.906 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.98 128.87 37.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.802 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 31' ' ' LEU . 2.0 pttp -149.57 177.75 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.975 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -87.44 142.05 28.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -51.28 126.65 17.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 14.84 34.34 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.443 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.2 mm-40 -123.04 134.0 54.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -86.1 152.06 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.242 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 99' ' ' VAL . 1.7 tp -50.59 -51.96 43.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.91 36.16 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.649 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG13 ' CB ' ' A' ' 58' ' ' ALA . 8.8 m -95.29 138.98 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.063 0.458 . . . . 0.0 111.057 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.75 98.4 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 HG13 HD11 ' A' ' 90' ' ' ILE . 1.3 pp -95.94 143.72 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.182 0.515 . . . . 0.0 111.729 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.007 HG23 HD12 ' A' ' 48' ' ' ILE . 2.5 m -124.63 161.42 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.39 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.48 111.87 1.39 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.825 0.345 . . . . 0.0 111.134 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.809 ' HA ' HD11 ' A' ' 48' ' ' ILE . 22.7 t -70.26 128.56 36.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.887 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -135.12 5.98 4.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.147 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.405 ' NE1' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -68.69 176.26 3.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.967 0.383 . . . . 0.0 110.868 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.23 66.84 2.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.607 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.67 ' C ' HD12 ' A' ' 43' ' ' ILE . 20.9 p -167.61 148.68 5.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.019 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 44.72 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.419 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD12 HG13 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -96.02 131.95 27.93 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.669 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.86 140.99 88.34 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.531 2.154 . . . . 0.0 112.579 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.5 t -170.69 -62.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.772 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.88 146.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.814 0.34 . . . . 0.0 111.367 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.007 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.25 116.61 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.725 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 68' ' ' ASP . 90.3 mt -61.42 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.39 -38.49 63.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.52 169.16 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.955 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.568 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -164.83 132.39 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.833 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.6 113.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.095 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 75.53 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.75 -4.73 5.1 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.53 -173.16 47.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.649 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' ILE . 76.2 Cg_exo -48.5 -47.12 21.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.757 2.305 . . . . 0.0 112.67 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.38 -49.08 78.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.84 -27.28 64.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -62.73 -48.73 77.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.861 ' OG ' HD13 ' A' ' 23' ' ' ILE . 33.1 m -56.0 -32.24 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.217 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.31 4.74 80.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.518 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -98.28 -56.39 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 101' ' ' LEU . 12.5 mt -72.19 122.66 21.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 2.2 m-80 -131.54 135.74 47.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' ILE . 12.3 mt -35.14 116.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.965 0.412 . . . . 0.0 111.618 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.36 0.8 29.59 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.119 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 1.011 ' HB2' HD12 ' A' ' 49' ' ' ILE . 8.9 m-20 -78.25 113.66 16.43 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.914 0.387 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' NE2' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.7 79.7 0.6 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.132 -179.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.136 HG23 HG22 ' A' ' 103' ' ' ILE . 2.2 mt -54.5 145.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.479 ' SD ' HG21 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -112.45 -39.45 4.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.5 p -159.23 156.86 29.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.781 0.324 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 93' ' ' LEU . 7.8 mt -124.26 120.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' ND2' HG13 ' A' ' 99' ' ' VAL . 60.0 m-20 51.93 25.87 3.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.216 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.97 27.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.587 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.554 HG21 ' CD1' ' A' ' 89' ' ' ILE . 21.7 m -110.71 95.35 5.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.291 . . . . 0.0 110.66 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.633 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -59.02 128.6 38.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.179 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.772 HD12 HG21 ' A' ' 47' ' ' VAL . 29.8 mt -98.48 -8.91 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.285 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.638 HG13 HD12 ' A' ' 44' ' ' LEU . 15.5 t -59.54 109.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.78 -27.09 21.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.952 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -71.9 139.93 83.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.827 0.313 . . . . 0.0 110.723 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.28 179.71 2.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.322 2.015 . . . . 0.0 111.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.53 -41.06 89.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.95 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.5 m -53.9 -36.28 62.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.5 m -70.55 -54.34 12.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.008 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.9 m -57.29 -55.27 36.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.828 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -54.29 19.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.259 0.552 . . . . 0.0 110.823 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 t -53.31 -37.29 62.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.554 ' CD1' HG21 ' A' ' 76' ' ' THR . 6.8 mt -63.96 -46.12 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' ILE . 4.2 mt -60.16 -37.59 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.262 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -35.72 70.38 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.318 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.53 -7.85 83.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.53 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.088 HD11 HG21 ' A' ' 73' ' ' ILE . 87.0 mt -92.51 41.51 1.08 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.988 0.423 . . . . 0.0 110.688 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -84.77 -48.38 9.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.43 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.467 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 7.4 m-80 -116.74 61.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 97' ' ' SER . 5.5 mm-40 -108.04 -36.88 6.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.18 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 96' ' ' GLN . 7.6 t 91.29 -18.51 0.15 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.236 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 151.71 3.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.75 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 31' ' ' LEU . 8.0 t -131.31 107.54 13.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.556 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -88.17 77.87 8.21 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.114 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -107.29 119.11 38.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.359 0.6 . . . . 0.0 111.514 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -86.34 107.09 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.128 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.136 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -99.78 164.17 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 111.758 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HG21 ' A' ' 43' ' ' ILE . 45.1 t -116.62 139.48 43.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.742 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.404 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 2.1 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.522 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 1.5 tt0 . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.885 0.374 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.34 148.0 51.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.674 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -160.95 141.79 11.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.359 0.6 . . . . 0.0 112.469 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.4 72.79 8.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.722 HG11 ' HG ' ' A' ' 64' ' ' LEU . 76.8 t -58.58 124.52 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.626 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.96 103.28 11.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.915 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 61' ' ' SER . 13.3 mm -98.29 102.93 14.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.985 0.421 . . . . 0.0 110.258 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.94 117.38 33.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.426 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' SER . 22.4 pttt -136.64 -168.33 2.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.136 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.78 152.18 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 0.6 OUTLIER -59.49 132.96 55.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.34 13.98 54.74 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.63 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -122.85 136.26 54.81 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.799 0.333 . . . . 0.0 111.425 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' CG2' ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -89.37 161.29 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.806 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.972 HD11 HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -51.97 -52.11 52.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.102 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.5 -10.93 35.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.26 127.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.082 0.467 . . . . 0.0 111.367 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.01 100.04 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.808 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.688 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.4 pp -90.25 137.46 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.094 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.053 HG23 HD12 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -119.95 161.48 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.646 ' H ' HD12 ' A' ' 83' ' ' LEU . 2.1 tt0 -63.2 117.99 7.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.806 0.336 . . . . 0.0 110.796 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.657 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -57.73 143.17 42.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.031 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.7 -18.13 5.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.89 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -177.06 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.65 23.68 4.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.766 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -71.06 -32.64 69.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.74 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.29 -170.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.485 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.5 OUTLIER -71.98 118.93 71.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.86 143.58 95.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.351 2.034 . . . . 0.0 112.269 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -170.3 -64.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.85 143.48 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.053 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.25 117.53 48.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.421 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.96 HD11 HD22 ' A' ' 64' ' ' LEU . 58.4 mt -62.59 70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.05 -41.47 62.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.589 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -138.69 -169.97 2.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.599 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.63 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 5.3 ptp -168.32 162.51 12.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 8.0 tpp -88.56 117.11 27.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -55.41 103.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.74 77.27 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.729 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.72 171.91 37.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 23' ' ' ILE . 88.8 Cg_exo -49.01 -45.16 30.16 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.886 2.391 . . . . 0.0 112.975 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.768 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -57.83 -49.91 75.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.336 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -75.68 -30.72 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.139 0.495 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -53.35 -48.66 68.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.737 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 23' ' ' ILE . 1.4 t -55.7 -43.78 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.19 -6.51 83.46 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -87.77 -35.01 18.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.676 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 101' ' ' LEU . 11.0 mt -90.72 111.39 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.7 OUTLIER -120.4 140.89 50.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.1 mt -38.01 126.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 120.812 0.339 . . . . 0.0 111.412 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.09 -7.66 52.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.989 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.895 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.5 m-20 -69.32 109.24 4.04 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.682 ' OE1' HG23 ' A' ' 48' ' ' ILE . 14.3 tp60 -71.37 85.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.012 HG23 HG22 ' A' ' 103' ' ' ILE . 2.7 mt -58.86 138.9 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.704 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -105.57 -38.28 6.49 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 53.9 p -159.45 157.67 30.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.332 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.701 HG21 ' CD2' ' A' ' 93' ' ' LEU . 7.7 mt -122.14 126.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.699 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.673 ' ND2' HG22 ' A' ' 73' ' ' ILE . 5.9 p30 36.42 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.172 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.75 26.22 9.99 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.809 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.783 HG21 HD13 ' A' ' 89' ' ' ILE . 25.3 m -123.86 95.33 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 110.724 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.527 ' O ' HD11 ' A' ' 81' ' ' LEU . 5.0 m -60.62 120.8 10.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.048 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.775 HD21 HD12 ' A' ' 89' ' ' ILE . 38.1 mt -91.09 -11.15 39.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.362 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.528 HG22 HD12 ' A' ' 44' ' ' LEU . 21.9 t -55.94 107.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.264 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.26 -26.35 24.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.793 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 77' ' ' SER . 4.6 mt -68.24 127.49 93.26 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.556 0.217 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.59 164.54 2.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.337 2.025 . . . . 0.0 112.012 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.646 HD12 ' H ' ' A' ' 37' ' ' GLU . 8.7 tt -60.23 -44.64 95.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 m -53.49 -33.44 54.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.525 ' O ' HG13 ' A' ' 89' ' ' ILE . 2.9 m -72.88 -47.19 48.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.752 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.473 ' O ' HG13 ' A' ' 90' ' ' ILE . 74.9 m -56.8 -50.01 73.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' CG ' HD23 ' A' ' 83' ' ' LEU . 1.8 mm-40 -57.15 -53.17 61.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.184 0.516 . . . . 0.0 109.966 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 9.0 p -51.57 -39.76 58.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.255 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.783 HD13 HG21 ' A' ' 76' ' ' THR . 12.5 mt -61.36 -41.73 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.8 mt -60.4 -35.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.348 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.2 mppt? -76.28 -34.71 59.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.521 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.74 -30.05 76.54 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.619 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.701 ' CD2' HG21 ' A' ' 73' ' ' ILE . 1.7 pp -99.56 38.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.396 . . . . 0.0 110.805 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.53 -25.47 50.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.912 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 2.1 m120 -126.08 55.96 1.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.487 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.431 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 34.5 mm-40 -112.31 -30.39 7.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.555 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 74.97 1.42 3.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.599 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.01 146.9 12.83 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.718 0.294 . . . . 0.0 110.87 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.972 HG11 HD11 ' A' ' 31' ' ' LEU . 3.6 t -140.14 105.64 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 111.745 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -94.45 79.65 3.88 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.051 HD11 HD11 ' A' ' 64' ' ' LEU . 2.0 pt? -107.27 125.24 50.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.381 0.61 . . . . 0.0 111.763 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -87.5 109.15 19.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.851 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.012 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -114.88 174.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 69' ' ' GLN . 3.5 m -134.22 137.01 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.983 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.654 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 105' ' ' ARG . 2.3 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 2.6 m-85 -70.45 148.5 48.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.37 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -146.66 116.82 7.35 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.88 78.14 2.79 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.738 HG11 ' HG ' ' A' ' 64' ' ' LEU . 35.8 t -69.22 125.58 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.507 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.26 103.12 10.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.515 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.897 HD13 ' OG ' ' A' ' 61' ' ' SER . 8.9 mm -98.56 103.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.631 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -99.33 128.49 45.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.559 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -151.94 -174.96 5.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.942 0.401 . . . . 0.0 110.958 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -85.18 160.82 19.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.139 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.5 OUTLIER -67.12 123.25 19.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.303 0.573 . . . . 0.0 110.466 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' H ' ' HA ' ' A' ' 95' ' ' ASN . . . 100.68 18.74 19.84 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.299 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.1 mm-40 -117.46 131.49 56.72 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.826 0.346 . . . . 0.0 111.676 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -87.74 151.2 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.1 tp -48.21 -43.32 31.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.13 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 98.23 -5.06 60.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.783 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.935 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -95.31 125.12 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 111.39 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.28 98.57 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.954 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.853 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.4 pp -95.6 147.31 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 0.0 111.841 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.995 HG23 HD12 ' A' ' 48' ' ' ILE . 27.2 m -132.1 155.29 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -51.73 118.85 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.787 0.327 . . . . 0.0 111.29 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -68.34 103.39 1.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.68 10.33 41.54 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.984 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.47 178.42 4.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.72 55.89 1.64 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.563 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.661 ' C ' HD12 ' A' ' 43' ' ' ILE . 31.4 t -156.82 148.03 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.374 . . . . 0.0 110.817 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.661 HD12 ' C ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 44.98 -166.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.179 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.684 HD12 HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -93.79 142.89 25.67 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.699 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.33 120.93 8.01 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.581 2.187 . . . . 0.0 112.595 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.916 HG22 ' HA ' ' A' ' 79' ' ' VAL . 82.1 p -144.82 -74.27 0.24 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.908 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -159.99 141.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.658 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.995 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.07 119.07 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.13 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.924 HD12 ' HB2' ' A' ' 68' ' ' ASP . 31.3 mt -62.21 72.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -53.72 -25.95 20.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.904 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.479 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -165.41 166.67 18.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.705 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.551 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.3 ptp -143.48 171.09 14.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.818 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.401 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.9 ttm -87.65 112.98 22.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -56.88 90.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.08 21.91 8.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.438 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.22 179.26 27.07 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.408 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB3' HG22 ' A' ' 23' ' ' ILE . 78.5 Cg_exo -51.21 -45.38 37.32 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.68 2.253 . . . . 0.0 112.455 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.935 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.47 -49.46 77.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -71.34 -32.28 68.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -58.78 -48.65 80.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.897 ' OG ' HD13 ' A' ' 23' ' ' ILE . 7.8 m -50.04 -43.86 51.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.28 85.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.419 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 61' ' ' SER . 1.2 mptt -97.85 -53.1 3.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.44 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.074 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -74.62 125.17 28.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.172 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.551 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.7 p30 -128.24 136.51 51.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.027 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 15.7 mt -37.86 107.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.991 0.424 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.92 -6.93 10.22 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.917 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.924 ' HB2' HD12 ' A' ' 49' ' ' ILE . 10.0 m-20 -71.27 124.38 24.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.564 0.221 . . . . 0.0 110.428 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -86.97 97.16 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.14 0.495 . . . . 0.0 110.543 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.151 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -68.23 142.25 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.145 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.65 ' HE2' HG21 ' A' ' 104' ' ' VAL . 7.6 mmt -111.7 -32.97 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.008 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 45.3 t -159.62 154.6 24.81 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.139 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.834 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.1 mt -126.8 123.69 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 45.88 29.82 0.78 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.102 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.39 21.87 25.94 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.371 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -115.54 97.36 6.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.69 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -52.97 134.99 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 81' ' ' LEU . 63.7 mt -109.53 9.71 25.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.026 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.916 ' HA ' HG22 ' A' ' 46' ' ' THR . 11.8 t -86.19 114.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.398 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.74 -33.99 6.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.146 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.919 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -76.72 127.63 83.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.942 0.371 . . . . 0.0 111.072 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.81 170.43 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.541 2.161 . . . . 0.0 112.469 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 tp -59.52 -34.01 72.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -53.49 -51.02 64.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.546 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.541 ' O ' HG13 ' A' ' 89' ' ' ILE . 58.5 m -63.51 -43.38 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.425 ' HB3' HG11 ' A' ' 47' ' ' VAL . 18.6 m -57.03 -50.57 72.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -56.87 -38.52 72.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -33.77 74.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.115 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 22.7 mt -64.89 -38.97 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 120.969 0.414 . . . . 0.0 109.916 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -77.19 -42.87 31.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -44.17 97.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.364 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.09 -14.53 61.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.375 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 95.9 mt -93.83 37.82 1.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.794 ' HG3' HG22 ' A' ' 30' ' ' ILE . 7.2 mtpt -79.11 -34.49 43.38 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 28' ' ' GLY . 1.9 p30 -120.3 64.22 0.83 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.7 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HG3' HD22 ' A' ' 93' ' ' LEU . 16.3 mm-40 -119.21 -34.71 3.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.543 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.603 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 5.5 t 74.11 1.53 3.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.734 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.563 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -165.86 145.11 6.19 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.826 HG21 ' CD1' ' A' ' 31' ' ' LEU . 11.1 t -139.89 103.83 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.529 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -91.39 78.38 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.441 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.896 HD11 HD11 ' A' ' 64' ' ' LEU . 2.2 pt? -107.69 118.98 38.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.218 0.532 . . . . 0.0 111.403 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.99 111.48 20.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.439 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.151 HG22 HG23 ' A' ' 70' ' ' ILE . 1.1 pt -107.58 174.15 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.336 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.678 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -127.25 145.96 33.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.504 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 1.3 mtt-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.462 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.38 148.28 41.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.79 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -147.51 113.77 5.9 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.12 73.8 2.97 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.794 HG11 ' HG ' ' A' ' 64' ' ' LEU . 47.3 t -61.9 126.1 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.799 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.0 103.83 10.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.697 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.689 HD13 ' HB3' ' A' ' 61' ' ' SER . 16.6 mm -100.05 103.44 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.982 0.42 . . . . 0.0 110.99 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 109.94 22.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.241 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' NZ ' HG21 ' A' ' 99' ' ' VAL . 3.0 pttt -127.79 -170.27 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.133 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.6 138.3 40.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -47.66 124.41 7.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.027 0.442 . . . . 0.0 110.764 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.74 12.95 28.98 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.514 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' LYS . 10.5 mm-40 -129.22 126.63 39.57 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.788 0.328 . . . . 0.0 111.278 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.08 153.69 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.078 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -47.66 -52.24 18.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.072 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.91 1.21 42.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 58' ' ' ALA . 11.7 m -94.53 123.81 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.184 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.3 t -99.85 100.0 9.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.457 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.689 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.7 pp -95.6 142.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.111 0.481 . . . . 0.0 111.683 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -118.22 167.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.7 105.28 2.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.745 ' HA ' HD11 ' A' ' 48' ' ' ILE . 11.5 p -64.98 123.41 19.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.453 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.32 4.31 13.64 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.317 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -175.26 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.076 0.438 . . . . 0.0 110.75 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.46 53.96 0.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.986 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -113.03 -33.22 6.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.2 0.524 . . . . 0.0 110.918 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.2 179.77 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.516 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.008 HD11 ' HE2' ' A' ' 71' ' ' MET . 4.0 pp -61.32 135.35 93.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.268 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 57.7 Cg_endo -71.52 145.67 47.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.499 2.133 . . . . 0.0 113.047 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -175.14 -64.85 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.338 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.702 HG21 ' CD1' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.86 161.15 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.999 0.428 . . . . 0.0 111.765 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.985 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -142.42 114.85 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.933 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.9 mt -61.1 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 36' ' ' VAL . . . -53.79 -30.73 46.06 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.816 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.518 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -153.55 167.68 28.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.899 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 5.0 ttp -154.92 129.21 8.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tpp -54.0 98.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.068 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -52.06 123.17 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.66 21.66 59.48 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.95 -170.31 20.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 23' ' ' ILE . 53.8 Cg_exo -53.15 -47.62 26.52 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.646 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.796 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.71 -49.36 77.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.432 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.02 -30.37 63.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -48.57 75.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.689 ' HB3' HD13 ' A' ' 23' ' ' ILE . 98.8 p -56.25 -39.38 72.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.41 63.31 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.354 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -110.21 -54.21 2.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 101' ' ' LEU . 16.1 mt -72.38 127.83 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.721 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ILE . 4.7 m-80 -130.62 126.72 37.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 14.4 mt -30.61 113.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 121.06 0.457 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.74 5.31 22.36 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.094 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.964 ' HB2' HD12 ' A' ' 49' ' ' ILE . 15.7 m-20 -79.27 120.82 24.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.7 80.92 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.948 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.976 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -55.76 143.51 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 1.008 ' HE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.64 -41.38 4.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.928 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 77.2 p -158.29 156.87 31.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 111.404 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.945 HG21 HD11 ' A' ' 93' ' ' LEU . 6.7 mt -122.82 122.03 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.3 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.888 ' ND2' HG22 ' A' ' 73' ' ' ILE . 4.0 p30 40.32 33.86 0.19 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.865 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.51 22.18 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.811 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 89' ' ' ILE . 33.5 m -123.09 95.56 4.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.756 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -63.49 130.21 43.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.797 ' CD2' HD12 ' A' ' 89' ' ' ILE . 59.1 mt -96.23 12.59 30.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.428 ' CG1' HD13 ' A' ' 44' ' ' LEU . 6.8 t -89.3 123.74 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.087 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.63 -25.39 28.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.822 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.756 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -91.44 134.2 29.96 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.761 0.281 . . . . 0.0 110.869 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -52.03 -176.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.497 2.131 . . . . 0.0 112.302 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 36' ' ' VAL . 7.8 tt -75.55 -37.66 59.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -53.43 -36.89 62.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.556 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.2 m -68.76 -50.81 47.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.495 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.403 ' O ' HG13 ' A' ' 90' ' ' ILE . 21.5 m -56.77 -48.68 77.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.819 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.462 ' NE2' HD12 ' A' ' 35' ' ' ILE . 98.4 mm-40 -54.14 -48.1 71.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.633 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.3 t -61.42 -33.81 74.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.533 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.797 HD12 ' CD2' ' A' ' 78' ' ' LEU . 38.8 mt -64.6 -46.43 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 35' ' ' ILE . 3.6 mt -65.24 -39.08 84.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.443 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -69.35 -32.37 71.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.821 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.27 -11.54 84.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.468 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.945 HD11 HG21 ' A' ' 73' ' ' ILE . 93.8 mt -93.17 39.86 1.05 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.934 0.397 . . . . 0.0 110.93 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 29' ' ' GLU . 4.2 tttt -80.87 -37.57 29.62 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 3.2 p30 -120.71 63.68 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.837 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.405 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 13.0 mm-40 -117.18 -39.54 3.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 6.0 t 76.68 -2.12 2.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.698 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -162.64 139.45 7.76 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.533 0.206 . . . . 0.0 110.451 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.785 HG12 HD22 ' A' ' 101' ' ' LEU . 10.6 t -136.38 104.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -93.03 80.07 4.57 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.503 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.886 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.2 pt? -110.01 120.07 41.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.41 108.45 18.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.048 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.976 HG22 HG23 ' A' ' 70' ' ' ILE . 1.4 pt -101.17 167.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.08 0.467 . . . . 0.0 111.787 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 43' ' ' ILE . 38.3 t -116.16 137.31 50.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.602 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.496 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 105' ' ' ARG . 4.0 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.14 148.61 35.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -144.51 115.08 7.66 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 75.6 2.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.804 HG11 ' HG ' ' A' ' 64' ' ' LEU . 45.5 t -66.36 120.8 14.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.524 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.43 103.63 10.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.627 179.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.763 HD12 ' HA ' ' A' ' 58' ' ' ALA . 14.3 mm -99.18 103.59 14.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.442 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 1.2 tt0 -95.49 111.53 23.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.215 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 97' ' ' SER . 3.6 pttt -130.84 -170.73 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.112 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.34 143.4 32.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.575 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 4.9 mttt -51.43 128.57 23.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.987 0.423 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 11.65 43.97 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.581 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -124.09 129.2 50.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.574 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -83.33 149.79 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.902 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -47.77 -46.06 29.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.53 7.81 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.05 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.69 HG13 ' CB ' ' A' ' 58' ' ' ALA . 4.7 m -95.9 126.09 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 111.438 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -102.41 98.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.092 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.817 HD13 HG12 ' A' ' 47' ' ' VAL . 2.6 pp -101.99 151.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 112.176 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.901 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.2 m -132.26 159.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.186 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.75 117.06 3.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.692 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -64.83 106.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.02 -1.24 63.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.11 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -174.04 2.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.834 0.317 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.0 32.89 3.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.853 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -37.9 15.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.161 0.505 . . . . 0.0 110.665 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.609 HG22 HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -144.44 -171.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.624 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.628 HD11 ' HE2' ' A' ' 71' ' ' MET . 0.2 OUTLIER -68.66 130.62 91.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.657 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.65 113.15 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.507 2.138 . . . . 0.0 112.484 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 79' ' ' VAL . 71.1 p -141.14 -72.36 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.171 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -160.12 148.06 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.029 0.442 . . . . 0.0 111.868 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.901 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -129.27 113.96 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 68' ' ' ASP . 36.5 mt -60.98 72.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.05 -28.64 58.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.399 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 26.0 m120 -145.57 169.52 18.24 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.681 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.684 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -166.77 117.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.676 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.7 ttm -45.42 124.03 4.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.605 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -68.21 105.83 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.623 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.39 -17.25 57.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.14 -178.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' O ' HG23 ' A' ' 23' ' ' ILE . 77.1 Cg_exo -51.0 -47.41 25.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.902 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.43 -49.08 78.58 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.76 -26.56 62.5 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.738 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -48.96 75.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.635 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.9 p -52.87 -37.94 61.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.19 26.04 45.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.173 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -117.66 -61.64 1.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 101' ' ' LEU . 14.0 mt -66.06 131.09 45.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.841 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' ILE . 8.9 m-80 -134.18 123.7 24.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.124 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.1 mt -28.38 114.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.968 0.413 . . . . 0.0 111.789 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.98 -6.02 22.03 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.983 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.96 ' HB2' HD12 ' A' ' 49' ' ' ILE . 14.5 m-20 -68.5 135.6 51.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.636 0.255 . . . . 0.0 110.515 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HB3' HG23 ' A' ' 104' ' ' VAL . 1.1 tm0? -92.63 81.52 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.025 0.441 . . . . 0.0 110.741 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.862 HG23 HG22 ' A' ' 103' ' ' ILE . 2.5 mt -54.9 141.32 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.628 ' HE2' HD11 ' A' ' 44' ' ' LEU . 4.0 ttm -111.26 -34.21 6.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.691 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 87.1 p -156.96 155.11 30.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.825 HD11 HD11 ' A' ' 78' ' ' LEU . 4.9 mt -126.66 121.43 58.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.891 0.376 . . . . 0.0 111.37 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 46.97 29.04 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.243 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.09 18.19 25.2 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.622 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 89' ' ' ILE . 9.0 m -119.42 95.63 4.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.756 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.774 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.4 m -63.56 131.23 47.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.337 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.966 HD13 HG21 ' A' ' 47' ' ' VAL . 3.2 mt -98.05 22.49 9.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.906 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.1 t -88.14 105.87 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.68 -30.17 8.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.931 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -80.53 143.4 55.12 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.94 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.81 169.94 13.69 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.744 2.296 . . . . 0.0 112.667 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.55 HD11 HE22 ' A' ' 87' ' ' GLN . 27.3 tp -58.38 -37.09 74.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -53.48 -48.61 68.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.733 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.628 ' O ' HG13 ' A' ' 89' ' ' ILE . 26.1 m -64.47 -43.58 93.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.782 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.497 ' HB3' HG11 ' A' ' 47' ' ' VAL . 13.6 m -56.6 -54.92 40.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.55 HE22 HD11 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -49.94 -53.58 25.33 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.172 0.511 . . . . 0.0 110.508 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -53.14 -32.21 46.43 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.422 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.638 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 20.6 mt -70.04 -36.98 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.201 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 33' ' ' VAL . 4.3 mt -77.64 -35.49 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.509 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -73.86 -42.7 60.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.981 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.35 39.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.488 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.687 HD11 HG21 ' A' ' 73' ' ' ILE . 21.8 mt -88.15 46.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.955 0.407 . . . . 0.0 110.767 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.65 -30.99 41.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -135.18 69.16 1.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.567 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.417 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 8.2 mm-40 -119.1 -36.13 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.343 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.3 p 76.3 1.63 3.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.684 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -162.77 143.3 9.62 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.616 0.246 . . . . 0.0 110.883 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.777 HG11 ' CD1' ' A' ' 31' ' ' LEU . 4.1 t -137.58 103.54 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 111.671 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -93.04 74.53 4.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.646 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.19 119.5 39.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.277 0.56 . . . . 0.0 111.189 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.94 107.28 18.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.426 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.862 HG22 HG23 ' A' ' 70' ' ' ILE . 5.3 pt -103.06 173.6 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.417 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.6 139.72 51.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.223 0.535 . . . . 0.0 111.316 179.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.967 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.32 145.99 49.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.793 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' CE ' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -152.9 142.63 21.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 111.99 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.49 72.4 7.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.784 HG11 ' HG ' ' A' ' 64' ' ' LEU . 72.2 t -57.85 125.72 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.25 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -116.09 103.83 10.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.249 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 61' ' ' SER . 10.1 mm -100.31 103.54 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -100.09 131.59 45.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.603 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -153.74 -172.85 4.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.968 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -94.88 145.3 25.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.442 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' A' ' 95' ' ' ASN . 5.6 mptt -49.2 122.95 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.056 0.455 . . . . 0.0 110.679 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.35 16.65 22.17 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -121.31 119.79 33.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 111.413 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 1.1 pt -77.74 151.05 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.877 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.32 -52.24 16.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.316 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.98 -1.33 35.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.144 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.798 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -94.63 122.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.09 0.471 . . . . 0.0 111.324 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG21 ' ND2' ' A' ' 51' ' ' ASN . 46.1 t -97.17 98.65 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.079 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -95.62 149.8 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 112.051 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 2.9 m -133.78 157.72 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.365 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.85 111.99 0.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.853 0.358 . . . . 0.0 111.288 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.725 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -63.91 139.12 58.73 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.637 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.71 -9.25 4.44 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.373 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.67 176.16 5.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.009 0.404 . . . . 0.0 110.952 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.01 53.89 0.6 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.832 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.24 -35.34 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.189 0.519 . . . . 0.0 110.632 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -153.0 171.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.53 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -55.72 109.21 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.383 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.69 119.54 3.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.563 2.175 . . . . 0.0 112.598 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.928 HG22 ' HA ' ' A' ' 79' ' ' VAL . 41.2 p -135.98 -70.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.18 137.61 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.058 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -116.08 119.07 60.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.394 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.6 mt -64.75 70.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.34 -33.96 22.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.329 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.573 ' ND2' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -159.21 140.7 13.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.52 . . . . 0.0 110.506 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.444 ' HG3' ' HB3' ' A' ' 58' ' ' ALA . 2.8 ttp -123.34 163.03 21.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.705 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.47 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.5 ttm -76.92 137.01 38.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -80.87 92.78 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.33 -4.4 37.81 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.94 -179.38 50.06 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.58 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 23' ' ' ILE . 82.6 Cg_exo -47.36 -47.03 18.51 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.919 2.413 . . . . 0.0 112.902 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.798 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.64 -49.48 77.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 111.259 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.34 -24.78 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -64.45 -47.03 80.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.816 ' HB2' HD13 ' A' ' 23' ' ' ILE . 3.7 t -53.08 -41.73 65.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.802 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.02 85.94 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.349 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 21' ' ' VAL . 1.3 mptt -100.16 -56.45 2.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.854 0.359 . . . . 0.0 110.803 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.084 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -70.36 124.49 24.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.204 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' ILE . 23.1 m-80 -131.09 136.11 48.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.223 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 25.0 mt -34.76 124.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.49 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.52 -9.02 48.37 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.985 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -66.9 120.81 14.21 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.686 0.279 . . . . 0.0 110.693 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -81.4 82.54 7.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.04 0.448 . . . . 0.0 110.233 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.996 HG23 HG22 ' A' ' 103' ' ' ILE . 2.6 mt -55.68 139.3 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.981 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.9 mmt -106.04 -39.44 5.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.74 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 80.6 p -156.38 164.34 38.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.619 0.247 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 93' ' ' LEU . 8.3 mt -128.44 114.3 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 121.003 0.43 . . . . 0.0 111.471 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.927 ' ND2' HG22 ' A' ' 73' ' ' ILE . 12.3 p30 42.48 31.94 0.32 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.687 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.84 11.76 27.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.808 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.684 ' CG2' HD13 ' A' ' 89' ' ' ILE . 3.8 m -109.72 95.62 5.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.381 . . . . 0.0 110.557 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.1 t -56.77 130.01 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.303 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.861 HD11 ' CD1' ' A' ' 73' ' ' ILE . 17.4 mt -107.36 22.19 16.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.67 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.928 ' HA ' HG22 ' A' ' 46' ' ' THR . 4.2 t -98.26 112.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.328 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.04 -24.56 30.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.736 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -85.08 130.92 50.28 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 117.113 0.457 . . . . 0.0 110.975 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.04 -174.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.613 2.209 . . . . 0.0 112.644 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.627 HD11 HE22 ' A' ' 87' ' ' GLN . 35.0 tp -72.92 -37.32 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.023 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 m -53.76 -42.72 68.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 8.7 m -65.9 -48.02 72.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.575 ' SG ' HD22 ' A' ' 78' ' ' LEU . 19.9 m -57.0 -53.36 59.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.834 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.627 HE22 HD11 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -49.83 -53.96 22.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 t -53.35 -37.86 62.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.247 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.684 HD13 ' CG2' ' A' ' 76' ' ' THR . 27.5 mt -63.42 -46.44 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.506 HD11 HG13 ' A' ' 35' ' ' ILE . 3.1 mt -66.57 -37.45 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -33.98 71.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.241 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.33 -14.44 79.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.467 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.031 HD11 HG21 ' A' ' 73' ' ' ILE . 94.4 mt -90.93 43.68 1.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.849 0.357 . . . . 0.0 110.739 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' CG2' ' A' ' 30' ' ' ILE . 17.8 mttt -83.21 -47.78 11.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 1.4 p30 -112.47 57.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -112.27 -33.9 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.074 0.464 . . . . 0.0 110.09 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.577 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 9.0 t 73.3 5.07 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 2.5 mtm180 -167.37 147.91 5.43 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.356 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.877 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.8 t -142.65 102.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.0 0.428 . . . . 0.0 111.739 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' HE3' ' CE2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -92.23 72.54 5.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.939 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -99.9 126.47 46.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.067 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.5 m120 -90.13 114.28 26.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.943 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.084 HG21 HD21 ' A' ' 64' ' ' LEU . 2.5 pt -117.01 173.32 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.452 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' GLN . 3.6 m -128.7 138.29 54.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.217 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 3.2 mmm-85 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.729 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.986 0.422 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CD1' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -92.87 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.52 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HE2' HD11 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -145.8 150.37 36.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.26 0.552 . . . . 0.0 112.158 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.71 73.18 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HG ' ' A' ' 64' ' ' LEU . 93.1 t -59.25 125.77 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.312 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.7 103.74 10.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' HA ' ' A' ' 58' ' ' ALA . 7.6 mm -99.16 103.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.01 0.434 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 121.14 36.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -138.73 -171.95 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.863 0.363 . . . . 0.0 111.062 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -101.56 138.4 38.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 7.5 mttt -48.32 127.22 12.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.23 37.81 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 28.6 mm-40 -128.43 130.31 47.43 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.851 0.358 . . . . 0.0 111.172 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.5 HD11 ' HE1' ' A' ' 53' ' ' MET . 1.1 pt -78.91 154.01 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.134 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.843 ' CD1' HG11 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.81 -52.17 19.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.47 -2.59 29.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.122 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 58' ' ' ALA . 15.9 m -94.46 148.65 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.197 0.522 . . . . 0.0 111.186 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.499 HG21 HD21 ' A' ' 51' ' ' ASN . 91.0 t -126.99 98.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.626 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.2 pp -94.05 149.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.115 0.483 . . . . 0.0 111.523 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.5 m -122.54 162.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.568 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.14 93.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.251 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.629 ' HA ' HD11 ' A' ' 48' ' ' ILE . 3.3 t -61.58 83.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.604 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.33 62.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.088 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CH2' ' CG2' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -114.35 -170.22 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 111.029 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.96 65.9 0.59 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.72 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.664 ' C ' HD12 ' A' ' 43' ' ' ILE . 14.8 t -176.81 142.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.989 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.89 HD13 ' OE1' ' A' ' 69' ' ' GLN . 0.2 OUTLIER 51.44 178.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.22 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.736 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -77.53 116.73 60.39 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' SER . 52.6 Cg_exo -55.62 117.3 3.9 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.578 2.186 . . . . 0.0 112.602 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -141.59 -66.67 0.41 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.366 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.788 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -160.34 165.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.876 0.369 . . . . 0.0 111.455 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -143.83 116.88 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 76.2 mt -62.6 72.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -50.93 -26.09 5.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.945 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.499 HD21 HG21 ' A' ' 34' ' ' VAL . 4.6 p-10 -164.96 167.54 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.379 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.436 ' HG3' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -154.25 142.4 20.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.724 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -53.0 139.32 28.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -81.29 76.66 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.42 -18.51 7.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.669 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.49 -179.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' O ' HG23 ' A' ' 23' ' ' ILE . 82.1 Cg_exo -46.85 -45.18 21.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.795 2.33 . . . . 0.0 112.737 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.849 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.2 -47.63 82.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -70.7 -31.14 67.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.245 0.545 . . . . 0.0 110.488 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -62.46 -48.31 80.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.051 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.799 ' CB ' HD13 ' A' ' 23' ' ' ILE . 44.4 t -53.81 -31.15 48.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.98 20.24 72.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.461 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -113.65 -49.21 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.741 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 17.8 mt -82.83 119.65 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 111.804 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -119.9 138.34 53.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.866 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 19.9 mt -37.09 131.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.644 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.34 4.5 59.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.058 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.7 m-20 -77.34 121.27 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.776 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.89 ' OE1' HD13 ' A' ' 43' ' ' ILE . 31.8 tt0 -79.11 81.11 5.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.894 HG23 HG22 ' A' ' 103' ' ' ILE . 3.9 mt -57.56 143.73 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.029 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.736 ' SD ' HD11 ' A' ' 44' ' ' LEU . 11.1 mmt -108.32 -41.96 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.589 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 64.3 p -156.41 155.2 31.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.008 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.008 HG21 HD11 ' A' ' 93' ' ' LEU . 6.3 mt -120.15 122.57 68.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 48.3 28.25 1.57 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.0 22.26 20.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.396 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -116.01 96.2 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.387 . . . . 0.0 110.796 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.482 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.29 135.39 32.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.214 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.788 HD13 HG21 ' A' ' 47' ' ' VAL . 58.8 mt -108.07 3.92 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.321 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 44' ' ' LEU . 5.5 t -84.95 122.5 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.15 -23.42 36.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.833 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.688 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.43 127.85 42.58 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.023 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.34 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.692 2.261 . . . . 0.0 112.675 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.512 HD13 ' HA ' ' A' ' 36' ' ' VAL . 40.3 tp -69.93 -35.11 74.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -53.33 -45.6 69.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.539 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.3 m -65.09 -48.18 74.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.737 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.0 m -56.96 -50.55 72.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.655 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -53.05 -43.39 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 t -64.52 -31.25 72.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.15 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.778 HD12 ' CD2' ' A' ' 78' ' ' LEU . 27.9 mt -69.53 -36.7 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.937 0.398 . . . . 0.0 109.956 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.702 HD11 HG13 ' A' ' 35' ' ' ILE . 6.1 mt -77.23 -41.15 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.388 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -39.24 89.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.552 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.07 -10.76 65.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.755 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.008 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.92 37.49 1.08 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -80.49 -31.06 37.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.966 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 4.2 m-80 -127.88 67.19 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.774 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 14.1 mm-40 -121.25 -38.1 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.428 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.8 3.0 4.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.391 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.544 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -166.27 145.47 5.87 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.5 t -140.27 103.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -91.91 76.93 5.5 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.064 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -106.06 126.46 52.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.924 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 2.8 m120 -88.93 123.67 33.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 4.8 pt -122.29 165.91 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.0 111.868 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.693 HG23 ' CG ' ' A' ' 71' ' ' MET . 86.2 t -122.66 147.48 26.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.435 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.907 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 5.4 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.764 0.316 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CE1' HG22 ' A' ' 104' ' ' VAL . 1.7 m-85 -74.46 148.13 41.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.979 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -146.81 117.5 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.6 73.21 2.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.789 HG11 ' HG ' ' A' ' 64' ' ' LEU . 23.0 t -62.46 126.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.011 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.88 103.57 10.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.872 178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.838 HD12 ' HA ' ' A' ' 58' ' ' ALA . 15.4 mm -101.0 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.162 0.506 . . . . 0.0 110.23 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.24 118.55 36.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE2' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -133.43 -170.01 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.023 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -100.26 135.89 41.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 10.0 mttt -47.62 120.83 3.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.191 0.52 . . . . 0.0 111.032 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.67 10.85 22.46 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.23 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -128.13 142.12 51.29 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.582 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.3 pt -93.3 161.39 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 ' CG2' ' A' ' 33' ' ' VAL . 1.8 tp -47.86 -51.99 20.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.159 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 105.26 -4.64 41.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.885 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.95 ' CG2' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -94.83 127.28 46.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.052 0.453 . . . . 0.0 111.397 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 11.6 t -95.69 98.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.791 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.838 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -97.8 150.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.934 0.397 . . . . 0.0 111.771 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.902 ' CG2' HD12 ' A' ' 48' ' ' ILE . 16.3 m -133.4 161.38 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.592 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.93 116.16 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.758 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -58.95 141.32 54.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.61 -7.21 8.26 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.965 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.35 -174.18 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.858 0.329 . . . . 0.0 110.846 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.63 48.86 0.94 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.826 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 t -106.46 -31.08 8.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 0.0 110.805 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.18 170.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.517 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD11 ' HE3' ' A' ' 71' ' ' MET . 0.2 OUTLIER -57.62 110.05 2.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.521 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.04 128.54 22.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.511 2.141 . . . . 0.0 112.564 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 67.0 p -142.01 -72.19 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -158.67 144.68 7.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.169 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.902 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.43 114.62 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.233 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.951 HD12 ' HB2' ' A' ' 68' ' ' ASP . 48.6 mt -61.52 73.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -58.02 -29.28 65.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.507 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 27.5 m120 -147.5 -177.09 5.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.244 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 4.4 ptp -173.1 144.34 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.1 tpp -65.82 124.27 22.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 49.7 p-80 -61.0 87.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.09 -14.24 31.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.73 175.87 1.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.641 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.564 ' O ' HG23 ' A' ' 23' ' ' ILE . 71.9 Cg_exo -50.01 -47.43 23.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.706 2.271 . . . . 0.0 112.885 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.838 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.1 -49.44 76.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -74.0 -27.6 61.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.95 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.589 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 23' ' ' ILE . 15.7 p -51.83 -46.88 64.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.33 -24.29 31.06 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.891 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -53.93 26.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.009 0.433 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 103' ' ' ILE . 12.9 mt -72.79 129.97 39.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.42 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -134.6 137.71 43.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.158 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 10.3 mt -39.44 108.25 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.931 0.396 . . . . 0.0 111.389 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -5.84 11.19 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.124 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.0 m-20 -69.8 119.42 14.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 110.898 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.7 80.04 3.34 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.04 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.058 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -55.01 145.9 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.915 ' CE ' HG21 ' A' ' 104' ' ' VAL . 2.5 tpp -115.64 -38.8 3.64 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 43.4 t -153.66 164.53 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.097 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.127 HG21 HD11 ' A' ' 93' ' ' LEU . 14.1 mt -130.04 112.83 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.655 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.898 ' ND2' HG22 ' A' ' 73' ' ' ILE . 10.1 p30 42.71 32.57 0.39 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.107 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 2.49 31.11 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.371 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 89' ' ' ILE . 2.8 m -102.32 95.67 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.675 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.555 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -61.08 113.77 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 47' ' ' VAL . 82.2 mt -82.53 -12.17 57.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.31 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 24.4 t -58.66 103.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.182 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.59 -30.27 9.37 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.7 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.598 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.5 mt -66.54 118.61 55.71 Favored Pre-proline 0 C--N 1.33 -0.241 0 O-C-N 122.832 -0.217 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.39 166.14 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.387 2.058 . . . . 0.0 112.084 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.563 HD13 ' HA ' ' A' ' 36' ' ' VAL . 32.7 tp -54.39 -42.25 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 t -53.88 -43.77 69.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.808 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.51 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.8 m -68.57 -44.74 73.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.97 -56.97 14.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.56 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.509 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.73 -54.11 20.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 110.519 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.0 p -51.12 -41.37 60.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.257 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 HG21 ' A' ' 76' ' ' THR . 11.0 mt -59.75 -45.16 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -59.96 -38.56 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.643 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -47.5 79.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.27 -15.1 50.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.467 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.127 HD11 HG21 ' A' ' 73' ' ' ILE . 78.1 mt -91.23 31.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 111.041 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 30' ' ' ILE . 6.4 tttt -81.01 -37.54 28.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 3.5 p30 -118.74 62.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.459 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.8 mm-40 -117.76 -41.25 2.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.4 t 78.9 -2.57 2.28 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.54 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.49 140.19 8.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.62 0.248 . . . . 0.0 110.451 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.86 HG21 ' CD1' ' A' ' 31' ' ' LEU . 5.1 t -136.97 104.01 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 112.111 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.9 mtpt -91.08 73.05 6.36 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.847 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -101.81 123.83 46.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.557 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.93 109.32 20.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.412 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.058 HG22 HG23 ' A' ' 70' ' ' ILE . 1.2 pt -99.9 165.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.472 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.915 HG21 ' CE ' ' A' ' 71' ' ' MET . 22.2 t -119.42 136.97 54.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.792 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 3.8 mtp85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.061 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 105' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.862 0.363 . . . . 0.0 111.605 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -78.34 148.58 33.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.877 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.61 121.5 9.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.21 77.29 5.73 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG11 ' HG ' ' A' ' 64' ' ' LEU . 27.7 t -68.2 121.18 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.011 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.27 103.64 11.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.509 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.7 mm -99.99 103.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.025 0.44 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.93 117.42 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.402 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -134.66 -172.11 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.831 0.348 . . . . 0.0 110.996 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.32 136.66 39.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.656 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -47.51 123.55 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.148 0.499 . . . . 0.0 110.811 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.55 12.82 27.66 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.441 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.3 mm-40 -127.15 133.75 50.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.714 0.292 . . . . 0.0 111.265 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -84.43 154.37 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -48.16 -52.11 22.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.025 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.38 -0.39 37.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.454 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.855 HG13 ' CB ' ' A' ' 58' ' ' ALA . 2.3 m -94.72 128.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.06 0.43 . . . . 0.0 111.58 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.4 t -100.33 98.27 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.67 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.631 HD13 ' CG1' ' A' ' 47' ' ' VAL . 2.5 pp -96.95 158.78 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 0.0 111.958 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 48' ' ' ILE . 4.0 m -140.37 157.8 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.412 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.82 121.17 10.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.693 ' HA ' HD11 ' A' ' 48' ' ' ILE . 5.2 p -58.01 149.21 23.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.13 -23.1 3.97 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.929 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.33 -177.27 1.4 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.13 25.61 3.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.689 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -27.83 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 0.0 110.898 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.585 HD13 ' CD ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -148.8 178.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.648 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.3 OUTLIER -60.88 117.87 29.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.581 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.01 138.38 56.74 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.346 2.03 . . . . 0.0 112.429 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.636 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -155.83 -67.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.255 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 78' ' ' LEU . 1.4 m -160.39 148.11 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.072 0.463 . . . . 0.0 112.023 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.997 HD12 HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -125.83 117.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.8 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 46.8 mt -61.86 74.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -57.71 -27.85 63.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.643 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.523 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 28.3 m120 -148.05 177.46 9.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.011 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 65' ' ' ASN . 6.1 ttp -171.55 128.93 0.67 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.67 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.8 tpp -53.6 136.93 38.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.217 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -77.61 93.63 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.729 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.45 -17.12 28.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.566 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.74 179.02 2.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.633 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.521 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.6 Cg_exo -48.68 -50.26 12.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.777 2.318 . . . . 0.0 112.957 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.892 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.16 -49.21 77.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.766 0.317 . . . . 0.0 111.267 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.58 -22.41 61.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -66.0 -48.4 71.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB3' HD13 ' A' ' 23' ' ' ILE . 18.8 p -54.22 -43.08 70.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.69 -9.31 78.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.494 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -58.67 2.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.989 0.423 . . . . 0.0 111.107 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.106 HD21 HG21 ' A' ' 103' ' ' ILE . 13.6 mt -68.68 129.55 40.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.44 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 2.0 m-80 -134.25 135.06 42.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.033 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 13.0 mt -36.38 109.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 121.028 0.442 . . . . 0.0 111.494 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.48 -0.35 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.214 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.6 m-20 -75.3 118.9 18.71 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.784 0.326 . . . . 0.0 110.705 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.585 ' CD ' HD13 ' A' ' 43' ' ' ILE . 8.2 tt0 -74.39 84.4 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.035 HG23 HG22 ' A' ' 103' ' ' ILE . 1.7 mt -62.44 144.1 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.969 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.637 ' HG3' HG23 ' A' ' 104' ' ' VAL . 21.8 mmt -110.05 -41.82 4.36 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -158.09 157.75 33.43 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.399 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HD11 ' A' ' 93' ' ' LEU . 7.1 mt -119.13 118.31 57.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.023 0.44 . . . . 0.0 111.62 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.914 ' ND2' HG22 ' A' ' 73' ' ' ILE . 11.2 p30 42.37 31.4 0.26 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.837 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.87 14.69 24.32 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.945 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.694 HG21 HD13 ' A' ' 89' ' ' ILE . 5.2 m -111.62 95.61 5.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.348 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.695 ' O ' HD21 ' A' ' 81' ' ' LEU . 99.2 p -58.41 126.84 29.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.261 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.837 ' CD1' HG21 ' A' ' 47' ' ' VAL . 30.1 mt -97.48 5.55 49.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.223 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 44' ' ' LEU . 8.0 t -88.7 129.6 39.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.58 -22.67 37.73 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.817 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -95.15 144.11 27.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.717 0.294 . . . . 0.0 110.856 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.23 175.46 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.673 2.248 . . . . 0.0 112.435 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 36' ' ' VAL . 22.7 tp -66.51 -33.24 75.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -53.99 -47.99 70.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.921 0.391 . . . . 0.0 110.806 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 6.6 m -64.59 -47.54 78.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.6 m -56.88 -51.56 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.67 -37.66 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.422 . . . . 0.0 110.467 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 m -68.41 -35.0 77.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.979 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.694 HD13 HG21 ' A' ' 76' ' ' THR . 18.8 mt -64.06 -46.37 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.475 HD11 HG13 ' A' ' 35' ' ' ILE . 3.5 mt -62.08 -37.63 78.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.614 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -34.34 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.878 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.24 -12.53 76.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.138 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.045 HD11 HG21 ' A' ' 73' ' ' ILE . 92.6 mt -93.69 33.67 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 110.525 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' GLU . 2.7 ttpt -78.36 -30.46 48.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -124.51 65.46 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.886 0.374 . . . . 0.0 111.727 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.406 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 7.6 mm-40 -122.0 -39.31 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.553 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m 75.16 1.91 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.522 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.595 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -164.85 142.74 6.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.625 0.25 . . . . 0.0 110.326 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 31' ' ' LEU . 3.9 t -137.62 103.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.827 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.38 73.78 5.27 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.617 178.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.028 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -104.57 122.94 46.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 109.73 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.106 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -103.34 173.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.473 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 71' ' ' MET . 98.2 t -133.99 148.53 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.51 . . . . 0.0 111.665 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.418 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.373 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.819 0.343 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 71' ' ' MET . 0.6 OUTLIER -61.84 148.42 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.375 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -141.92 115.2 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.85 74.41 2.12 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.774 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.5 t -65.81 114.85 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.584 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -108.61 103.39 12.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.574 178.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.852 HD13 ' OG ' ' A' ' 61' ' ' SER . 6.1 mm -97.49 104.07 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.19 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -96.35 112.02 23.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.244 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -134.27 -169.21 2.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.954 0.407 . . . . 0.0 110.997 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -103.45 154.46 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.426 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 95' ' ' ASN . 2.5 mptt -59.54 132.29 53.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.03 14.75 50.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.747 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.4 mp0 -121.07 130.36 53.73 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -84.87 150.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.01 HD11 HG11 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -47.2 -52.04 16.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.315 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.62 -8.62 37.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.08 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.878 HG13 ' CB ' ' A' ' 58' ' ' ALA . 1.4 m -94.86 124.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.67 98.6 7.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.298 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.775 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.8 pp -93.61 147.6 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.17 0.509 . . . . 0.0 111.699 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG23 HD12 ' A' ' 48' ' ' ILE . 17.1 m -129.19 159.34 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.197 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -58.8 114.22 2.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.819 0.342 . . . . 0.0 111.158 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.847 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -62.29 129.15 39.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.43 45.63 1.11 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.663 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -169.84 1.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 59.77 0.35 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.69 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.667 ' C ' HD12 ' A' ' 43' ' ' ILE . 69.1 m -162.59 151.59 15.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 45.68 -168.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.186 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -96.04 114.55 64.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.852 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.89 131.63 34.91 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.574 2.182 . . . . 0.0 112.4 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -159.45 -58.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.26 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.532 ' H ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -160.51 155.17 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 111.282 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.959 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.29 115.6 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.604 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.032 HD11 HD22 ' A' ' 64' ' ' LEU . 20.9 mt -60.27 72.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.79 -24.18 21.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.904 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -159.15 166.53 31.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.146 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.59 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.1 ttp -154.44 137.04 15.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.6 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.04 117.64 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.084 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -62.77 83.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.49 1.45 19.98 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.568 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.89 -178.43 51.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 86.9 Cg_exo -47.87 -50.83 10.95 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 112.793 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.878 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.16 -42.15 85.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 0.0 110.799 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -66.32 -49.3 67.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.852 ' OG ' HD13 ' A' ' 23' ' ' ILE . 4.7 m -52.42 -40.76 62.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.93 10.97 82.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.31 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 21' ' ' VAL . 1.4 mptt -104.8 -48.71 3.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.881 0.372 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.107 HD21 HG21 ' A' ' 103' ' ' ILE . 13.8 mt -77.76 119.12 20.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.271 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -123.9 136.68 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.362 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 28.2 mt -40.6 110.29 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.639 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.6 -11.46 8.43 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.151 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 49' ' ' ILE . 4.9 m-20 -72.36 134.14 45.31 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 117.024 0.412 . . . . 0.0 110.857 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.626 ' HB3' HG23 ' A' ' 104' ' ' VAL . 39.6 tt0 -87.6 83.75 7.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.028 0.442 . . . . 0.0 110.015 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.871 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -52.04 144.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.789 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.422 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 6.3 mmt -109.24 -41.51 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.8 p -160.99 158.41 27.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.332 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 93' ' ' LEU . 7.0 mt -122.27 118.2 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.263 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.533 HD22 HG22 ' A' ' 73' ' ' ILE . 70.0 m-80 52.22 25.81 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.92 32.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.55 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.7 m -107.89 95.76 5.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.726 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.486 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -55.68 131.64 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.234 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.848 HD21 HD12 ' A' ' 89' ' ' ILE . 33.3 mt -101.48 1.18 37.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.322 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 44' ' ' LEU . 9.0 t -83.36 132.81 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 111.052 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.19 -23.71 32.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.64 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.68 140.21 21.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.871 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 178.45 2.59 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.204 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.8 tp -63.98 -33.47 75.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 p -53.94 -45.7 71.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.821 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.7 m -67.1 -47.76 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.412 ' O ' HG13 ' A' ' 90' ' ' ILE . 13.3 m -57.23 -47.17 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.664 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -56.31 -45.97 80.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -60.26 -35.44 75.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.848 HD12 HD21 ' A' ' 78' ' ' LEU . 39.8 mt -63.26 -46.0 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 35' ' ' ILE . 3.9 mt -62.91 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.791 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -42.22 98.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.175 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.13 -13.24 64.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.252 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.976 HD11 HG21 ' A' ' 73' ' ' ILE . 92.2 mt -94.06 37.36 1.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.932 0.396 . . . . 0.0 110.677 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -81.85 -41.2 21.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -120.85 64.18 0.86 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 9.2 mm-40 -113.95 -36.19 4.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 1.7 t 77.62 -2.34 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.697 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 1.4 mtm180 -161.99 148.46 13.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.569 0.223 . . . . 0.0 110.564 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.01 HG11 HD11 ' A' ' 31' ' ' LEU . 5.0 t -141.26 103.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 111.766 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -93.13 75.38 4.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.45 124.55 50.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.0 OUTLIER -90.83 120.28 31.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.214 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.107 HG21 HD21 ' A' ' 64' ' ' LEU . 4.7 pt -117.39 150.89 19.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.546 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.626 HG23 ' HB3' ' A' ' 69' ' ' GLN . 2.5 m -104.12 135.07 43.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.276 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.95 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.825 0.345 . . . . 0.0 111.125 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.26 148.54 47.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.448 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -143.67 118.88 10.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.25 76.63 3.8 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.801 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.4 t -67.23 128.8 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.797 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -118.22 103.61 10.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.891 178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.774 HD12 ' HA ' ' A' ' 58' ' ' ALA . 9.3 mm -99.93 102.94 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' SER . 18.8 mt-10 -100.96 114.66 28.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.145 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 97' ' ' SER . 6.4 pttt -131.47 -168.69 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.18 137.14 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.327 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 95' ' ' ASN . 13.6 mttt -50.21 125.46 12.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.126 0.489 . . . . 0.0 110.803 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.67 12.71 31.9 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 94' ' ' LYS . 5.2 mm-40 -126.33 135.2 51.2 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.401 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.07 150.07 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.238 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -47.99 -52.19 20.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.307 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 106.15 18.75 10.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.856 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -112.27 129.57 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 51' ' ' ASN . 83.1 t -108.64 98.59 7.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.108 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 1.7 pp -97.78 156.42 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.993 HG23 HD12 ' A' ' 48' ' ' ILE . 27.0 m -141.54 155.18 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.407 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.22 119.47 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 111.185 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.752 ' HA ' HD11 ' A' ' 48' ' ' ILE . 1.7 p -57.44 135.32 56.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.719 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.89 -5.2 47.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.158 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -91.17 -177.64 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.99 0.395 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.13 26.2 3.26 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.78 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -30.91 58.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.199 0.523 . . . . 0.0 110.752 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.489 HD13 ' OE1' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -145.65 174.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.487 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.627 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -57.45 109.16 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.794 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.23 129.68 35.76 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.383 2.056 . . . . 0.0 112.252 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.883 HG22 ' HA ' ' A' ' 79' ' ' VAL . 72.3 p -142.85 -75.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.09 137.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.952 0.406 . . . . 0.0 111.448 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.993 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.39 119.49 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.27 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 68' ' ' ASP . 50.1 mt -64.18 73.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -51.41 -25.87 6.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.296 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.544 HD21 HG21 ' A' ' 34' ' ' VAL . 1.9 p-10 -173.57 150.29 1.76 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.737 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -129.55 167.63 17.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.678 -179.109 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 2.1 ttm -82.99 128.45 34.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.44 104.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.94 -21.17 47.48 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.14 174.89 1.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' O ' HG23 ' A' ' 23' ' ' ILE . 81.8 Cg_exo -48.28 -45.49 26.01 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.7 2.266 . . . . 0.0 112.735 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.47 -47.14 85.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -30.18 60.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.16 82.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.774 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.75 ' HB3' HD13 ' A' ' 23' ' ' ILE . 95.4 p -53.03 -39.48 63.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.58 72.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.272 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.5 mmpt? -117.22 -40.53 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.121 HD21 HG21 ' A' ' 103' ' ' ILE . 10.6 mt -88.96 111.24 21.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.308 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -114.16 144.63 42.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.184 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.0 mt -44.84 125.03 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 111.392 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.21 38.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.169 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.947 ' HB2' HD12 ' A' ' 49' ' ' ILE . 24.4 m-20 -73.11 125.84 28.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.621 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -85.59 79.8 9.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.11 0.481 . . . . 0.0 110.43 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.038 HG23 HG22 ' A' ' 103' ' ' ILE . 2.1 mt -53.24 141.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.876 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.627 ' SD ' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -114.63 -33.84 5.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 35.2 t -159.87 156.49 27.44 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.664 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.039 HG21 HD11 ' A' ' 93' ' ' LEU . 9.3 mt -129.23 115.98 38.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.494 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.612 HD21 HG13 ' A' ' 99' ' ' VAL . 69.2 m-80 53.04 23.91 3.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.2 35.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' SER . 11.8 m -106.68 95.05 5.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.937 0.368 . . . . 0.0 110.509 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' HD21 ' A' ' 81' ' ' LEU . 54.6 p -69.06 128.71 37.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.376 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.607 ' HA ' HD11 ' A' ' 81' ' ' LEU . 1.1 mp -94.4 13.3 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.025 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.883 ' HA ' HG22 ' A' ' 46' ' ' THR . 5.1 t -74.89 106.43 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.52 -31.81 7.08 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.896 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.721 HD21 ' O ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -82.62 138.82 43.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.983 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 179.35 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.77 2.314 . . . . 0.0 112.507 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 36' ' ' VAL . 20.0 tp -65.24 -31.81 73.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -48.18 70.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.006 0.431 . . . . 0.0 110.585 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 89' ' ' ILE . 25.8 m -68.11 -45.76 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.807 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 32.7 m -56.77 -44.26 81.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.726 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 9.8 mm-40 -58.6 -52.33 66.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.211 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 3.4 t -56.76 -32.16 65.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.548 HG21 HD12 ' A' ' 73' ' ' ILE . 8.5 mt -62.74 -46.35 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 33' ' ' VAL . 3.6 mt -61.52 -35.33 66.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.898 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 88' ' ' SER . 23.4 mmtt -61.71 -48.69 79.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.125 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.55 -11.55 57.06 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.346 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.039 HD11 HG21 ' A' ' 73' ' ' ILE . 83.4 mt -89.28 27.78 1.36 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.739 0.304 . . . . 0.0 110.914 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -84.71 -40.09 17.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.435 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -119.79 62.7 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 6.7 mm-40 -119.25 -41.01 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.5 t 79.55 -3.24 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.513 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.593 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -160.01 142.82 13.64 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.612 HG13 HD21 ' A' ' 74' ' ' ASN . 3.3 t -140.25 103.27 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -90.53 74.04 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.031 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 120.93 41.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.622 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.95 114.44 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.121 HG21 HD21 ' A' ' 64' ' ' LEU . 1.3 pt -111.79 171.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.014 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 69' ' ' GLN . 2.7 m -125.84 145.84 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.108 0.48 . . . . 0.0 111.616 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 3.5 mtm180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.486 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.537 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -72.35 137.93 46.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.082 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -129.9 116.78 19.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.44 71.73 2.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.708 HG11 ' HG ' ' A' ' 64' ' ' LEU . 46.7 t -58.92 124.79 13.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.403 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.04 103.52 11.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.858 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 58' ' ' ALA . 5.8 mm -99.34 102.97 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 2.3 mt-10 -100.48 114.01 27.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.383 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -129.89 -169.63 2.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.849 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.1 132.7 49.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -45.64 118.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.176 0.512 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.75 12.62 16.01 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.256 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 94' ' ' LYS . 6.7 mm-40 -130.48 128.01 40.35 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 111.334 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -72.17 153.34 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.84 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -49.47 -52.1 31.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.66 20.83 9.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.869 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -114.72 127.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.433 . . . . 0.0 111.11 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.567 HG21 HD21 ' A' ' 51' ' ' ASN . 38.9 t -103.1 97.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.839 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -100.94 145.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.926 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.909 HG23 ' CD1' ' A' ' 48' ' ' ILE . 6.1 m -125.98 160.16 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.189 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.34 117.25 5.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.734 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -61.61 97.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.711 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.22 4.45 81.01 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.212 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -175.78 5.89 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.887 0.344 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.03 32.75 3.71 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.76 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.58 -39.83 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 110.71 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.801 HD13 ' HG3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -143.64 175.65 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.687 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -58.49 110.59 2.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.914 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.79 129.75 21.43 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.532 2.155 . . . . 0.0 112.57 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.561 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -156.41 -66.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.201 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -160.42 151.65 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.887 0.375 . . . . 0.0 111.739 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.909 ' CD1' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.63 115.44 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.889 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' A' ' 68' ' ' ASP . 37.9 mt -60.54 71.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -52.34 -26.3 11.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.567 HD21 HG21 ' A' ' 34' ' ' VAL . 1.3 p-10 -177.46 145.0 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.331 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.7 ptp -116.48 -170.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.932 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 9.0 tpp -94.46 125.22 38.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.0 81.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.796 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.37 20.44 7.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.41 175.56 28.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.454 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 23' ' ' ILE . 88.7 Cg_exo -47.48 -46.14 21.14 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.693 2.262 . . . . 0.0 112.807 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.871 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.43 -48.22 81.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.843 0.354 . . . . 0.0 110.739 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -70.44 -34.36 72.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.299 0.571 . . . . 0.0 110.554 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -58.5 -48.74 79.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.814 ' HB3' HD13 ' A' ' 23' ' ' ILE . 83.4 p -50.5 -39.86 49.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.01 2.39 82.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.599 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.7 mmpt? -96.94 -37.1 10.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.071 HD21 HG21 ' A' ' 103' ' ' ILE . 13.0 mt -91.67 111.64 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -110.19 141.0 43.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.9 mt -42.68 121.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.25 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.64 1.87 43.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.086 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.929 ' HB2' HD12 ' A' ' 49' ' ' ILE . 6.4 m-20 -71.49 130.73 42.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 110.782 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.801 ' HG3' HD13 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -86.59 78.25 9.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.951 0.405 . . . . 0.0 110.595 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.987 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -55.62 144.7 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.104 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.762 ' HG2' HG23 ' A' ' 104' ' ' VAL . 15.3 mmt -111.11 -41.65 4.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.1 p -160.57 160.43 31.79 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.302 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HD11 ' A' ' 93' ' ' LEU . 8.7 mt -120.41 115.56 47.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.544 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.955 ' ND2' HG22 ' A' ' 73' ' ' ILE . 9.8 p30 43.46 33.08 0.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.853 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.85 9.94 33.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.133 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 89' ' ' ILE . 3.5 m -108.59 95.64 5.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.353 . . . . 0.0 110.695 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.707 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -58.54 130.71 48.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.131 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.767 ' HA ' HD11 ' A' ' 81' ' ' LEU . 26.2 mt -99.78 6.41 45.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.249 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 44' ' ' LEU . 6.4 t -91.79 128.91 43.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.891 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.14 -23.98 33.37 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.45 143.87 27.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.885 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.31 178.67 2.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.635 2.223 . . . . 0.0 112.42 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 36' ' ' VAL . 15.6 tp -66.87 -35.06 79.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.967 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.2 m -53.81 -40.59 66.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.3 m -71.83 -48.77 43.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.918 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 10.1 m -56.95 -48.91 77.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.782 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -58.7 -46.74 86.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.331 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -59.01 -35.49 73.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.936 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.644 HD13 HG21 ' A' ' 76' ' ' THR . 11.4 mt -62.67 -45.27 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 93' ' ' LEU . 3.1 mt -60.92 -35.44 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.984 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -49.29 75.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.028 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.24 -11.01 60.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.103 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.013 HD11 HG21 ' A' ' 73' ' ' ILE . 44.8 mt -86.61 18.16 3.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.608 0.242 . . . . 0.0 110.928 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -82.58 -33.66 27.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.539 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -119.83 62.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -124.32 -40.22 2.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.07 0.462 . . . . 0.0 110.346 179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 79.46 -2.06 2.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.59 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.8 mtm180 -161.13 142.03 11.42 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 31' ' ' LEU . 3.4 t -140.96 103.61 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.863 0.364 . . . . 0.0 111.846 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' NZ ' ' CE2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -92.45 73.86 5.21 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.972 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -102.74 123.65 46.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.28 122.85 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.162 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.071 HG21 HD21 ' A' ' 64' ' ' LEU . 2.4 pt -117.4 162.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.706 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.762 HG23 ' HG2' ' A' ' 71' ' ' MET . 41.3 t -107.35 132.06 55.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.398 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.136 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.151 0.5 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 149.31 25.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.995 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.02 115.38 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.33 79.07 3.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HG ' ' A' ' 64' ' ' LEU . 40.4 t -69.11 122.41 20.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.921 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -115.45 103.07 10.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.423 178.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.777 HD13 ' HB3' ' A' ' 61' ' ' SER . 9.4 mm -97.75 103.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.407 . . . . 0.0 110.509 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 97' ' ' SER . 0.7 OUTLIER -103.49 113.43 26.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.896 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -135.96 -174.39 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.807 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -89.53 141.24 28.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.503 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -49.45 119.69 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.201 0.524 . . . . 0.0 110.651 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' LYS . . . 109.0 13.84 16.83 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.054 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.0 mp0 -119.13 127.63 53.52 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 111.514 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.1 pt -81.42 146.69 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.753 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -47.49 -39.83 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.824 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . 90.95 11.49 61.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.373 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 58' ' ' ALA . 6.2 m -104.18 126.85 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 117.226 0.513 . . . . 0.0 111.443 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.5 t -100.85 98.29 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.83 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.3 pp -100.74 148.11 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.228 0.537 . . . . 0.0 111.774 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG2' HD12 ' A' ' 48' ' ' ILE . 15.7 m -129.7 160.28 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.427 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.41 108.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.836 ' HA ' HD11 ' A' ' 48' ' ' ILE . 30.5 t -59.17 138.93 57.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.749 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.37 1.79 5.73 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.26 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.424 ' CD1' ' OG ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -81.2 -178.87 7.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.988 0.394 . . . . 0.0 110.888 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.43 55.56 0.58 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.646 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.33 -37.64 4.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.214 0.53 . . . . 0.0 111.007 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -149.97 174.8 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' SD ' ' A' ' 71' ' ' MET . 0.2 OUTLIER -57.14 109.12 1.51 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.75 129.59 34.78 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.113 . . . . 0.0 112.513 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.519 ' OG1' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -158.02 -59.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.722 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -160.8 140.11 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.981 0.419 . . . . 0.0 111.655 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.928 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -124.28 116.32 47.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.764 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 ' HB2' ' A' ' 68' ' ' ASP . 64.9 mt -62.7 71.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -28.68 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 25.3 m120 -146.75 168.57 21.03 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.94 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.557 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.09 134.73 3.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.24 127.19 26.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -73.78 68.93 1.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.45 -21.4 3.63 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.35 -176.07 0.61 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.64 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 23' ' ' ILE . 84.1 Cg_exo -48.0 -44.07 28.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.749 2.299 . . . . 0.0 112.766 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB2' HG13 ' A' ' 33' ' ' VAL . . . -58.68 -49.53 77.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.86 -29.68 64.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.514 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -62.99 -48.31 79.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.968 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.777 ' HB3' HD13 ' A' ' 23' ' ' ILE . 96.4 p -53.06 -38.25 62.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.15 19.0 70.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.263 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HB2' HG13 ' A' ' 21' ' ' VAL . 6.4 mmpt? -116.35 -52.81 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.949 0.404 . . . . 0.0 110.747 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 101' ' ' LEU . 9.7 mt -77.97 120.65 23.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.51 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.436 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 13.7 m-80 -129.55 134.7 47.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.364 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 9.0 mt -33.34 122.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.37 2.31 55.63 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.169 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.994 ' HB2' HD12 ' A' ' 49' ' ' ILE . 12.1 m-20 -77.25 120.91 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.803 0.335 . . . . 0.0 110.618 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.409 ' CD ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -76.68 86.46 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 103' ' ' ILE . 1.5 mt -62.75 143.21 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.778 ' SD ' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.36 -40.11 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.813 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 59.8 p -159.73 156.91 28.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.182 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.819 ' CD1' HD11 ' A' ' 78' ' ' LEU . 6.9 mt -120.88 125.28 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.13 29.56 0.82 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.44 23.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.369 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.618 ' CG2' HD13 ' A' ' 89' ' ' ILE . 63.3 m -119.7 95.98 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.5 t -56.0 138.57 48.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.819 HD11 ' CD1' ' A' ' 73' ' ' ILE . 19.5 mt -109.1 4.32 22.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.04 126.17 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.92 -25.31 28.77 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.872 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.18 147.36 34.5 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.796 0.331 . . . . 0.0 111.016 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.48 173.97 8.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.354 . . . . 0.0 112.639 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.564 HD11 HE22 ' A' ' 87' ' ' GLN . 34.1 tp -62.36 -37.2 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.161 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -53.67 -46.42 70.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.524 ' O ' HG13 ' A' ' 89' ' ' ILE . 4.0 m -65.27 -44.28 88.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 90' ' ' ILE . 11.8 m -57.0 -56.2 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.785 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.564 HE22 HD11 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -49.44 -53.94 20.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.167 0.508 . . . . 0.0 110.854 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -53.72 -39.71 65.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.482 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 10.0 mt -61.64 -36.9 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 120.672 0.273 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' CYS . 3.9 mt -77.99 -44.41 28.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.019 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.98 91.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.08 -17.36 44.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 89' ' ' ILE . 69.9 mt -93.27 26.82 2.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.267 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -78.13 -12.23 59.98 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.983 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -134.52 48.46 2.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.877 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.476 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 15.4 mm-40 -111.76 -33.21 6.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 110.336 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 77.95 -0.55 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.737 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.589 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.3 mtm180 -160.31 142.87 13.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.598 0.237 . . . . 0.0 110.515 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 31' ' ' LEU . 4.0 t -139.35 103.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.898 0.38 . . . . 0.0 111.993 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -91.09 75.4 6.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.804 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.092 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -106.21 120.47 41.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.51 107.96 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.025 HG22 HG23 ' A' ' 70' ' ' ILE . 1.3 pt -103.33 174.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.01 129.12 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.13 0.491 . . . . 0.0 111.5 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.363 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.897 0.379 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -77.15 148.27 36.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.9 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.6 120.25 9.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 79.92 6.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.713 HG11 ' HG ' ' A' ' 64' ' ' LEU . 42.7 t -69.31 122.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.882 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.97 103.25 10.74 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.252 178.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 58' ' ' ALA . 12.1 mm -97.26 102.38 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.5 ' CG ' ' HG3' ' A' ' 98' ' ' ARG . 19.2 mt-10 -95.08 109.84 21.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.492 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -130.03 -169.9 2.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.829 0.347 . . . . 0.0 110.96 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.74 137.11 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 6.3 mttp -47.49 124.56 7.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.0 110.779 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.01 14.35 24.91 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 94' ' ' LYS . 78.8 mm-40 -130.45 130.72 44.61 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.635 0.255 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.638 HG23 ' HG3' ' A' ' 94' ' ' LYS . 1.2 pt -81.24 151.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.128 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.891 HD23 ' HB2' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -47.95 -42.41 27.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.089 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.04 6.62 59.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.034 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.779 HG23 HD13 ' A' ' 90' ' ' ILE . 4.2 m -95.76 143.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.42 . . . . 0.0 111.392 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 51' ' ' ASN . 2.1 t -119.72 98.65 6.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.033 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 90' ' ' ILE . 2.0 pp -95.18 153.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 112.067 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.919 ' CG2' HD12 ' A' ' 48' ' ' ILE . 2.8 m -130.21 156.91 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.408 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.79 93.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.746 0.308 . . . . 0.0 111.352 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.72 ' HA ' HD11 ' A' ' 48' ' ' ILE . 6.8 p -63.43 104.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.479 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.59 17.28 8.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.014 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.449 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -69.44 176.68 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 110.923 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.44 57.56 4.19 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.518 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.683 ' C ' HD12 ' A' ' 43' ' ' ILE . 8.3 t -159.63 145.59 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.683 HD12 ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 45.72 -171.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.289 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -88.55 128.64 52.07 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 17.8 Cg_endo -59.04 118.14 4.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.53 2.153 . . . . 0.0 112.799 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 79' ' ' VAL . 47.3 p -141.64 -73.81 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.021 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.961 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.07 141.05 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.745 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.919 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -118.37 118.28 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.897 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.953 HD12 ' HB2' ' A' ' 68' ' ' ASP . 58.0 mt -62.83 72.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.38 -28.25 58.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.521 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 26.0 m120 -145.98 173.59 12.02 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.961 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.76 131.78 0.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.903 -179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.7 tpp -56.24 123.49 14.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.51 89.47 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.675 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.7 13.83 7.12 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.1 -163.8 25.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.292 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HB3' HG22 ' A' ' 23' ' ' ILE . 52.9 Cg_exo -55.93 -51.3 9.94 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.662 2.242 . . . . 0.0 112.711 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.891 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.36 -49.31 77.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.88 -28.14 65.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.0 mtpt -64.47 -48.27 75.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.909 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.739 ' HB3' HD13 ' A' ' 23' ' ' ILE . 70.4 p -51.17 -39.8 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.74 23.79 59.37 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.984 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -121.12 -52.7 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.723 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.076 HD21 HG21 ' A' ' 103' ' ' ILE . 12.7 mt -77.82 119.79 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.553 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ILE . 2.4 p30 -127.52 133.28 49.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.248 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 11.5 mt -32.4 117.07 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.973 0.416 . . . . 0.0 111.769 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.16 4.81 29.03 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.134 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.953 ' HB2' HD12 ' A' ' 49' ' ' ILE . 2.7 m-20 -80.32 127.77 32.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.782 0.325 . . . . 0.0 110.771 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.642 ' HG3' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -82.91 83.34 7.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.091 HG23 HG22 ' A' ' 103' ' ' ILE . 1.9 mt -62.19 144.08 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.012 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.66 ' HG2' HG23 ' A' ' 104' ' ' VAL . 24.6 mmt -112.85 -36.39 5.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.862 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 52.4 p -160.3 160.11 32.12 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.238 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.005 HG21 HD11 ' A' ' 93' ' ' LEU . 9.5 mt -127.5 123.83 62.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.769 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 46.29 29.23 0.8 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.55 17.3 31.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.664 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.546 HG21 HD13 ' A' ' 89' ' ' ILE . 4.6 m -111.36 95.83 5.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.882 0.372 . . . . 0.0 110.578 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.757 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.8 m -57.29 124.2 18.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.3 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.961 HD13 HG21 ' A' ' 47' ' ' VAL . 45.7 mt -97.38 21.16 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.944 ' HA ' HG22 ' A' ' 46' ' ' THR . 2.7 t -93.02 113.76 28.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.281 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.16 28.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.292 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.886 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -83.73 142.05 42.04 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 117.034 0.417 . . . . 0.0 110.934 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 -179.58 2.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.661 2.241 . . . . 0.0 112.45 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HA ' ' A' ' 36' ' ' VAL . 16.1 tp -66.15 -31.56 72.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.009 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -56.42 -45.92 80.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -67.9 -48.0 67.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.4 m -57.32 -53.07 62.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -55.59 -40.16 71.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.95 0.405 . . . . 0.0 110.484 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 p -66.64 -29.27 69.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.963 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 78' ' ' LEU . 3.8 mt -69.73 -46.05 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.779 HD13 HG23 ' A' ' 33' ' ' VAL . 5.4 mt -62.25 -38.99 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.473 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -37.65 79.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.54 -9.5 73.96 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.005 HD11 HG21 ' A' ' 73' ' ' ILE . 68.8 mt -93.36 27.33 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.727 0.298 . . . . 0.0 110.786 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HG3' HG23 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -80.96 -33.79 33.65 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.456 -179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 10.4 m-80 -120.53 63.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.934 0.397 . . . . 0.0 111.792 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -124.65 -41.76 2.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.475 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 2.9 m 77.97 2.03 2.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.293 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.594 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -164.06 138.73 5.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.448 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.544 HG12 HD22 ' A' ' 101' ' ' LEU . 3.5 t -135.91 103.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.991 0.424 . . . . 0.0 112.023 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -90.04 72.91 7.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.044 HD11 HD11 ' A' ' 64' ' ' LEU . 2.5 pt? -103.14 120.44 40.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 111.404 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -88.66 112.83 23.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.091 HG22 HG23 ' A' ' 70' ' ' ILE . 2.2 pt -106.31 174.17 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.249 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.66 HG23 ' HG2' ' A' ' 71' ' ' MET . 46.1 t -130.6 148.56 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.158 0.504 . . . . 0.0 111.788 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.365 179.592 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 105' ' ' ARG . 3.9 tt0 . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.835 0.35 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -70.29 148.61 48.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -148.3 115.58 6.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.2 77.54 3.01 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 64' ' ' LEU . 38.5 t -67.19 117.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -113.06 103.33 11.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.419 178.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 61' ' ' SER . 6.1 mm -98.94 103.24 14.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 0.0 110.845 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.33 109.97 22.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.178 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -128.36 -170.55 2.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.84 139.7 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.552 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 14.1 mttt -50.18 125.69 12.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.165 0.507 . . . . 0.0 110.826 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.55 15.19 30.27 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 94' ' ' LYS . 13.1 mm-40 -120.53 136.86 54.65 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 111.596 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.894 HG22 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -87.14 147.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.231 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.943 HD23 ' CG2' ' A' ' 33' ' ' VAL . 7.4 tp -49.94 -45.67 51.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.79 -0.1 62.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.017 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.943 ' CG2' HD23 ' A' ' 31' ' ' LEU . 1.1 m -94.55 125.26 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.998 0.428 . . . . 0.0 111.318 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.26 98.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.233 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.0 pp -94.95 150.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.176 0.513 . . . . 0.0 111.787 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.992 HG23 HD12 ' A' ' 48' ' ' ILE . 2.4 m -132.67 158.94 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.281 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.31 117.57 5.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.762 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -60.65 139.69 57.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.796 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -138.51 33.86 2.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.724 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.88 -170.73 1.71 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.44 65.67 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.711 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.681 ' C ' HD12 ' A' ' 43' ' ' ILE . 48.5 m -164.62 151.06 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.681 HD12 ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 47.96 -174.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.238 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 46' ' ' THR . 0.3 OUTLIER -90.8 113.53 58.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.642 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 70.9 Cg_exo -49.12 131.6 26.44 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.599 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.778 HG21 ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -163.73 -60.48 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG21 HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -160.14 152.17 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.002 0.43 . . . . 0.0 111.881 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.992 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -134.61 118.76 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.859 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 68' ' ' ASP . 47.4 mt -63.25 74.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -56.3 -34.36 66.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.382 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -140.9 177.55 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.003 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.4 ' HE3' ' HB3' ' A' ' 52' ' ' MET . 0.0 OUTLIER -170.85 122.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.598 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -46.52 132.03 10.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.505 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.55 81.46 4.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.3 5.37 8.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.829 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.36 -176.95 51.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.405 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' HG23 ' A' ' 23' ' ' ILE . 70.7 Cg_exo -51.47 -47.74 24.66 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.53 2.153 . . . . 0.0 112.398 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.88 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.4 -43.38 88.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.69 -29.77 62.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.591 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -64.06 -48.92 74.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.8 ' HB3' HD13 ' A' ' 23' ' ' ILE . 79.1 p -53.16 -39.73 63.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.79 72.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.487 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.0 mmtt -109.48 -52.8 2.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.622 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.099 HD21 HG21 ' A' ' 103' ' ' ILE . 12.3 mt -76.05 120.61 21.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.408 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.75 136.54 53.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.156 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.3 mt -37.17 110.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.987 0.422 . . . . 0.0 111.659 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.66 3.33 22.22 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.127 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.6 m-20 -78.16 119.56 21.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.908 0.385 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.469 ' HG3' HD13 ' A' ' 43' ' ' ILE . 3.3 tm0? -75.06 86.61 2.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.856 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.079 HG23 HG22 ' A' ' 103' ' ' ILE . 2.0 mt -64.7 144.89 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.778 ' HE2' HG21 ' A' ' 46' ' ' THR . 4.4 mmt -110.8 -39.84 4.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.709 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.7 p -160.35 157.28 27.64 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.376 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 93' ' ' LEU . 6.8 mt -122.12 124.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.482 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 46.46 28.74 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.035 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.99 21.63 22.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.579 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.623 HG21 HD13 ' A' ' 89' ' ' ILE . 8.4 m -115.86 95.84 5.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.876 0.369 . . . . 0.0 110.907 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.649 ' O ' HD21 ' A' ' 81' ' ' LEU . 51.0 m -60.07 122.05 13.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.997 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.753 HD11 ' CD1' ' A' ' 73' ' ' ILE . 51.7 mt -91.37 12.17 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.264 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.584 HG21 ' CD1' ' A' ' 44' ' ' LEU . 4.2 t -87.24 126.31 41.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.61 -24.1 33.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.634 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -93.56 142.97 25.87 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.52 171.68 12.65 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.539 2.159 . . . . 0.0 112.429 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 35' ' ' ILE . 28.7 tp -60.12 -30.09 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.818 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 p -54.61 -49.6 70.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.794 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.8 m -68.07 -42.07 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.5 m -57.41 -52.22 66.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -58.33 -40.69 82.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.324 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.3 m -64.98 -30.03 70.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 76' ' ' THR . 2.3 mt -69.13 -46.15 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.503 HD13 HG23 ' A' ' 33' ' ' VAL . 4.8 mt -65.84 -38.67 82.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.67 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -33.14 71.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.067 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.69 -14.09 81.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.185 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.923 HD11 HG21 ' A' ' 73' ' ' ILE . 90.5 mt -91.93 38.28 0.99 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.94 0.4 . . . . 0.0 110.598 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.894 ' HG3' HG22 ' A' ' 30' ' ' ILE . 5.8 mtpt -81.36 -35.04 31.34 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 15.6 m-80 -121.92 63.63 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.756 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.58 -39.62 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.415 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 77.58 -4.14 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.599 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.4 mtm180 -160.92 138.46 9.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.896 HG12 HD22 ' A' ' 101' ' ' LEU . 17.7 t -133.74 103.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 112.168 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -92.09 79.75 5.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.608 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.062 HD11 HD11 ' A' ' 64' ' ' LEU . 2.3 pt? -110.46 120.49 42.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.347 0.594 . . . . 0.0 111.113 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.03 108.7 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.099 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -104.48 174.15 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.096 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.605 HG23 ' CG ' ' A' ' 71' ' ' MET . 57.3 t -132.77 144.44 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.088 0.47 . . . . 0.0 111.683 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 2.8 ttp85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.36 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.59 148.4 24.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.415 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 117.08 7.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.48 75.74 2.53 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG11 ' HG ' ' A' ' 64' ' ' LEU . 41.5 t -67.9 123.49 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.556 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.27 103.24 10.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.452 178.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 58' ' ' ALA . 11.0 mm -98.03 103.5 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.846 0.355 . . . . 0.0 111.143 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 128.87 41.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.076 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -149.12 -173.75 4.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 111.169 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -97.82 136.51 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -47.21 120.39 3.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.141 0.496 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 12.2 22.32 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.337 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -122.98 133.19 54.38 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.84 0.352 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 32' ' ' GLY . 1.2 pt -83.11 150.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.813 HD12 HG21 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -47.46 -40.19 17.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 53' ' ' MET . . . 90.04 31.1 11.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.868 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG13 ' CB ' ' A' ' 58' ' ' ALA . 3.5 m -125.1 124.35 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.871 0.367 . . . . 0.0 111.411 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.15 98.26 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.009 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 47' ' ' VAL . 2.7 pp -99.75 144.9 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.029 0.443 . . . . 0.0 111.854 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.908 HG23 HD12 ' A' ' 48' ' ' ILE . 3.7 m -124.32 155.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.347 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.29 111.12 0.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 111.162 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.732 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -61.34 84.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.803 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.19 22.78 36.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.844 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.56 -179.44 6.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.8 0.333 . . . . 0.0 111.02 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.98 72.79 0.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.527 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.676 ' C ' HD12 ' A' ' 43' ' ' ILE . 22.7 t -174.68 147.26 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.313 . . . . 0.0 110.957 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.8 HD13 ' OE1' ' A' ' 69' ' ' GLN . 0.1 OUTLIER 44.83 -167.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.541 HD12 HG13 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -90.96 128.5 47.63 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.615 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.55 130.43 31.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.542 2.161 . . . . 0.0 112.464 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 47' ' ' VAL . 4.3 t -161.8 -62.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.743 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 35' ' ' ILE . 3.2 m -160.88 150.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 112.035 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.908 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -138.85 113.88 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.986 HD12 ' HB2' ' A' ' 68' ' ' ASP . 35.8 mt -60.17 72.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.72 -34.61 62.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.403 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.508 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.1 m-80 -141.68 179.54 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.982 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.66 125.41 0.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.442 ' HE3' ' HA2' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -48.23 124.01 7.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.35 -179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -72.24 88.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.37 26.1 3.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.41 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.45 -176.43 20.74 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 23' ' ' ILE . 89.3 Cg_exo -48.65 -46.12 25.27 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.596 2.197 . . . . 0.0 112.731 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -58.67 -49.25 78.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.51 -33.94 73.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.243 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -48.63 79.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.738 ' HB2' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -53.96 -37.9 64.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.77 17.06 79.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.808 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.62 -53.46 2.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 101' ' ' LEU . 15.4 mt -76.08 120.93 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.357 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 66' ' ' ILE . 15.8 m-80 -127.05 133.07 50.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.125 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 27.5 mt -33.69 113.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.963 0.411 . . . . 0.0 111.935 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.89 -6.87 15.42 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.17 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.986 ' HB2' HD12 ' A' ' 49' ' ' ILE . 33.6 m-20 -70.47 127.88 34.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.56 0.219 . . . . 0.0 110.519 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.8 ' OE1' HD13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -87.66 81.27 7.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.121 0.486 . . . . 0.0 110.669 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.93 HG23 HG22 ' A' ' 103' ' ' ILE . 2.8 mt -54.3 137.2 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.057 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.0 mmt -105.56 -37.61 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.63 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 92.4 p -157.4 153.47 27.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.736 0.303 . . . . 0.0 111.172 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.813 HD11 HD11 ' A' ' 78' ' ' LEU . 4.2 mt -124.07 123.95 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.446 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 48.01 28.34 1.43 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.48 23.86 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.402 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.702 HG21 HD13 ' A' ' 89' ' ' ILE . 91.3 m -124.72 95.79 4.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.608 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -68.3 130.13 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.216 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.897 ' CD2' HD12 ' A' ' 89' ' ' ILE . 21.2 mt -95.77 14.29 23.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.541 HG13 HD12 ' A' ' 44' ' ' LEU . 8.6 t -74.64 112.7 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.499 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.39 -39.45 2.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.068 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -73.32 146.43 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.995 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.44 167.88 12.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.421 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 35' ' ' ILE . 21.9 tp -62.98 -35.05 78.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.86 -42.93 69.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 110.559 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.572 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.1 m -69.85 -44.45 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.585 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 78' ' ' LEU . 9.8 m -56.62 -53.46 57.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 3.5 mm-40 -52.9 -50.4 63.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 0.0 110.219 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 14.1 p -56.05 -36.46 68.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.272 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.897 HD12 ' CD2' ' A' ' 78' ' ' LEU . 19.9 mt -63.72 -33.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 33' ' ' VAL . 6.1 mt -70.23 -36.03 65.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.456 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 87' ' ' GLN . 1.5 mppt? -75.38 -47.15 28.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.825 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -53.45 -25.4 27.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.393 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.729 ' CD2' HG21 ' A' ' 73' ' ' ILE . 3.5 pp -99.57 31.7 3.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.009 0.433 . . . . 0.0 110.577 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG3' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.67 -22.31 50.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.824 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -121.65 52.38 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 37.8 mm-40 -113.49 -31.26 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 5.2 m 70.58 10.65 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.542 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 2.3 mtm180 -168.92 139.68 2.4 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.231 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.813 HG21 HD12 ' A' ' 31' ' ' LEU . 4.7 t -136.88 103.69 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -90.63 76.68 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.44 178.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.162 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -107.93 120.78 43.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.316 0.579 . . . . 0.0 111.613 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.92 112.97 22.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.122 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.995 HG21 HD21 ' A' ' 64' ' ' LEU . 1.1 pt -112.88 160.42 12.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.613 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 69' ' ' GLN . 7.2 m -109.39 140.99 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.825 -179.639 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 105' ' ' ARG . 12.4 mm-40 . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CE1' HG22 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -75.58 148.56 38.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.124 179.33 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -148.46 117.27 6.68 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.38 82.1 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.681 HG11 ' HG ' ' A' ' 64' ' ' LEU . 21.8 t -71.87 123.12 25.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.857 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.62 103.73 11.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 178.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 61' ' ' SER . 11.8 mm -99.62 103.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.963 0.411 . . . . 0.0 110.947 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.74 123.76 38.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.12 -169.75 3.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 111.133 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -101.24 147.83 25.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.31 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 5.5 mttp -55.12 130.84 43.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.081 0.467 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.76 13.17 54.3 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.639 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.73 139.18 52.68 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.807 0.337 . . . . 0.0 111.393 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -87.22 150.8 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.86 HD22 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -47.69 -52.26 18.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.201 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 52' ' ' MET . . . 114.43 -14.1 20.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.344 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.943 HG13 ' CB ' ' A' ' 58' ' ' ALA . 15.0 m -94.09 128.3 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.614 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.04 98.46 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.886 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 35' ' ' ILE . 1.5 pp -94.51 140.93 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.047 0.451 . . . . 0.0 111.587 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 48' ' ' ILE . 28.9 m -124.38 161.36 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.183 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' O ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -54.55 118.87 4.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.738 0.304 . . . . 0.0 111.14 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -71.29 136.95 48.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.48 -0.95 3.98 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.116 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.65 -177.47 1.55 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.086 0.443 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.46 54.73 0.59 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.787 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.2 m -116.31 -39.96 3.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.267 0.556 . . . . 0.0 110.766 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.594 HD13 ' CD ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -149.21 179.84 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.445 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.754 HD12 ' CG1' ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.13 131.13 95.04 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.304 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.43 141.42 95.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.572 2.181 . . . . 0.0 112.912 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 47' ' ' VAL . 1.8 t -168.27 -61.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.765 HG21 HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -161.34 153.22 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.863 0.364 . . . . 0.0 111.576 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.13 115.77 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.965 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.5 mt -61.38 71.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -49.07 -27.55 3.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 1.4 p-10 -163.79 179.48 7.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.283 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 2.6 ttp -160.92 155.4 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.892 0.377 . . . . 0.0 110.836 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.8 139.55 45.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.821 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -76.36 99.87 4.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.15 -19.3 52.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.2 175.44 1.09 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.593 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 23' ' ' ILE . 80.0 Cg_exo -46.81 -45.74 19.77 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.79 2.327 . . . . 0.0 112.876 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.943 ' CB ' HG13 ' A' ' 33' ' ' VAL . . . -58.63 -49.32 77.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.378 . . . . 0.0 111.133 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -72.48 -26.02 61.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -60.39 -48.02 83.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.811 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.1 t -54.69 -38.09 66.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.749 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.17 12.16 83.64 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.941 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -104.42 -45.18 4.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.965 0.412 . . . . 0.0 110.999 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.119 HD21 HG21 ' A' ' 103' ' ' ILE . 17.4 mt -81.6 117.11 21.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.532 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.2 137.45 51.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.896 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 20.0 mt -40.25 117.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.894 0.378 . . . . 0.0 111.28 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.85 -3.1 25.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.174 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.965 ' HB2' HD12 ' A' ' 49' ' ' ILE . 1.7 m-20 -68.55 133.48 48.62 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.638 0.256 . . . . 0.0 110.563 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.594 ' CD ' HD13 ' A' ' 43' ' ' ILE . 3.0 tt0 -89.5 81.17 6.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.949 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.806 HG23 HG22 ' A' ' 103' ' ' ILE . 2.9 mt -55.62 145.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.589 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.698 ' HE1' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -115.52 -38.65 3.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.6 t -156.63 154.09 29.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.712 HG21 ' CD2' ' A' ' 93' ' ' LEU . 6.1 mt -123.2 122.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.285 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 48.59 27.89 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.24 20.49 25.26 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.655 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.601 ' CG2' HD13 ' A' ' 89' ' ' ILE . 6.4 m -115.75 97.74 6.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.881 0.372 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.5 m -53.32 142.44 21.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.765 HD12 HG21 ' A' ' 47' ' ' VAL . 22.2 mt -112.03 -5.76 14.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.377 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.754 ' CG1' HD12 ' A' ' 44' ' ' LEU . 15.3 t -78.44 129.24 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.59 -21.4 44.79 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.056 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -97.15 144.92 28.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.938 0.369 . . . . 0.0 110.975 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.19 -174.41 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.369 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.579 HD11 HE22 ' A' ' 87' ' ' GLN . 31.0 tp -75.9 -38.77 57.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.1 p -53.77 -39.28 65.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.573 ' O ' HG13 ' A' ' 89' ' ' ILE . 3.6 m -68.3 -47.22 68.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 23.5 m -56.53 -53.82 53.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.579 HE22 HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -49.76 -53.91 22.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.348 0.594 . . . . 0.0 110.211 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -51.26 -35.7 38.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.128 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 78' ' ' LEU . 31.8 mt -68.31 -33.6 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.297 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.425 HD11 HG13 ' A' ' 35' ' ' ILE . 6.7 mt -76.4 -37.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -38.43 57.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.645 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.3 -17.3 56.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' CD2' HG21 ' A' ' 73' ' ' ILE . 2.8 pp -109.2 39.2 2.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.701 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -78.95 -26.09 43.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 17.6 m-80 -121.58 54.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.519 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.416 ' HG3' ' HB2' ' A' ' 93' ' ' LEU . 31.9 mm-40 -114.43 -29.89 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.5 m 71.44 7.96 6.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.158 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.559 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -166.4 143.09 4.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 110.58 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.829 HG11 ' CD1' ' A' ' 31' ' ' LEU . 2.6 t -138.68 103.53 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.959 0.409 . . . . 0.0 111.928 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.1 mtpt -89.25 73.66 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.807 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.5 pt? -104.87 118.04 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.3 0.571 . . . . 0.0 111.491 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.407 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 3.3 t-20 -87.3 111.79 21.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.234 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.119 HG21 HD21 ' A' ' 64' ' ' LEU . 6.4 pt -99.48 174.17 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.574 HG22 ' CE1' ' A' ' 18' ' ' PHE . 22.0 t -130.58 144.78 36.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 111.921 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.077 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.904 0.383 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.7 148.48 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -134.43 117.51 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.15 73.64 2.29 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.734 HG11 ' HG ' ' A' ' 64' ' ' LEU . 44.1 t -64.21 120.41 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.554 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.522 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -114.74 102.85 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.445 178.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.766 HD13 ' HB2' ' A' ' 61' ' ' SER . 8.7 mm -99.03 103.4 14.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.132 0.491 . . . . 0.0 110.58 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.08 109.93 22.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.317 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.3 OUTLIER -127.04 -174.2 3.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.974 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -97.06 134.68 40.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.493 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -46.64 119.32 2.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 94' ' ' LYS . . . 110.51 12.55 16.71 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.365 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' LYS . 4.3 mm-40 -130.19 130.11 44.27 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.396 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.511 HG23 ' HG2' ' A' ' 94' ' ' LYS . 1.1 pt -80.5 154.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.142 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 HG21 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -49.26 -50.25 39.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.65 7.87 41.31 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.898 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 58' ' ' ALA . 13.9 m -100.22 127.2 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.22 101.22 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.216 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 48' ' ' ILE . 2.4 pp -96.48 165.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.204 0.526 . . . . 0.0 112.141 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 48' ' ' ILE . 35.9 m -152.34 148.69 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.6 121.09 6.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.695 0.283 . . . . 0.0 111.338 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.877 ' HA ' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -61.92 152.84 30.88 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.856 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.13 7.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.825 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -175.49 1.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.781 0.324 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.52 26.34 2.8 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.737 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.19 -26.06 29.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.902 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -147.0 169.15 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.661 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.85 108.64 1.29 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.829 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.78 118.65 5.57 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.42 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 79' ' ' VAL . 40.0 p -130.62 -72.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.861 HG21 HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -158.78 137.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 111.684 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.032 HD12 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -114.59 118.76 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.108 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.95 HD12 ' HB2' ' A' ' 68' ' ' ASP . 53.2 mt -63.56 74.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' ILE . . . -54.85 -24.45 23.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.127 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.503 ' HA ' ' CD1' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -157.07 164.99 37.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.086 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -159.88 128.47 4.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.754 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 4.3 tpp -46.51 131.36 11.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.452 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -76.99 90.21 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.64 -12.58 25.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.43 -175.48 5.36 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.68 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HB3' HG22 ' A' ' 23' ' ' ILE . 73.6 Cg_exo -50.0 -46.06 29.82 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.88 2.386 . . . . 0.0 112.606 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 23' ' ' ILE . . . -58.19 -48.2 81.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.87 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -71.57 -31.32 66.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.252 0.549 . . . . 0.0 110.589 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -60.97 -48.67 80.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.04 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.766 ' HB2' HD13 ' A' ' 23' ' ' ILE . 5.8 t -55.28 -30.01 59.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.944 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.92 71.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.29 -45.71 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.758 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 101' ' ' LEU . 13.5 mt -85.17 114.22 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.46 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -120.98 135.13 55.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 51' ' ' ASN . 12.8 mt -34.82 119.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.972 0.415 . . . . 0.0 111.683 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.41 1.48 35.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.054 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.95 ' HB2' HD12 ' A' ' 49' ' ' ILE . 20.2 m-20 -76.44 119.04 19.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.782 0.325 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . 12.4 tt0 -75.99 85.71 2.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.76 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.02 HG23 HG22 ' A' ' 103' ' ' ILE . 1.8 mt -61.95 144.78 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.174 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 104' ' ' VAL . 5.0 mmt -110.3 -42.39 4.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 58.0 p -157.71 165.13 36.22 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.032 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.95 HG22 ' ND2' ' A' ' 74' ' ' ASN . 10.9 mt -126.99 114.57 37.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.032 0.444 . . . . 0.0 111.652 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.95 ' ND2' HG22 ' A' ' 73' ' ' ILE . 12.7 p30 43.19 33.36 0.55 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.78 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.42 6.06 36.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.938 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.625 HG21 HD13 ' A' ' 89' ' ' ILE . 3.3 m -104.85 95.42 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.525 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.701 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.9 t -59.22 133.24 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.212 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.861 HD13 HG21 ' A' ' 47' ' ' VAL . 88.4 mt -107.34 16.45 23.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.804 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 46' ' ' THR . 3.3 t -92.04 113.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.317 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.18 -27.34 20.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.256 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.707 HD11 HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -82.54 141.22 45.01 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.081 0.44 . . . . 0.0 111.053 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.17 -179.84 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.605 2.203 . . . . 0.0 112.381 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 36' ' ' VAL . 21.7 tp -70.06 -33.32 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.012 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -54.02 -45.29 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 89' ' ' ILE . 7.0 m -67.34 -50.36 60.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.95 -43.59 81.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -59.4 -46.16 89.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.002 0.429 . . . . 0.0 110.452 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.3 m -61.23 -31.09 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.296 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.625 HD13 HG21 ' A' ' 76' ' ' THR . 23.6 mt -68.09 -46.2 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.711 HD13 HG23 ' A' ' 33' ' ' VAL . 3.5 mt -63.86 -36.8 77.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -36.03 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.795 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.28 -10.22 73.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.037 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 73' ' ' ILE . 35.7 mt -92.59 30.91 1.43 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.835 0.35 . . . . 0.0 110.559 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' HG2' HG23 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -86.3 -12.8 48.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.664 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -143.91 58.08 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.715 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 mm-40 -117.75 -37.76 3.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.437 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 79.51 -4.73 1.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.652 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.522 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mtm180 -161.0 141.67 11.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.512 0.196 . . . . 0.0 110.549 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.818 HG21 HD12 ' A' ' 31' ' ' LEU . 6.3 t -137.83 105.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 0.0 111.89 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -93.34 74.24 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.663 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.073 HD11 HD11 ' A' ' 64' ' ' LEU . 2.4 pt? -104.84 123.55 47.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.319 0.581 . . . . 0.0 111.644 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.22 115.61 25.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.059 HG21 HD21 ' A' ' 64' ' ' LEU . 1.2 pt -112.8 174.05 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.563 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 71' ' ' MET . 11.2 t -118.16 121.5 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.103 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.089 -179.887 . . . . . . . . 0 0 . 1 stop_ save_